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ABSTRACT 
 
Perfectionism has been proposed to be a process which occurs across 
psychological disorders, namely a transdiagnostic process (Egan, Wade, & Shafran, 
2011). This was based on findings of perfectionism being associated with depressive 
disorders, eating disorders, bipolar disorder and anxiety disorders (Egan et al., 2011; 
Shafran & Mansell, 2001). An implication of this transdiagnostic conceptualisation was 
that interventions that target perfectionism could potentially decrease the symptoms of 
multiple psychological disorders (Egan et al., 2011). One limitation of this literature 
was that studies had not examined the associations between perfectionism and the 
symptoms of generalised anxiety disorder in a clinical sample. This was important to 
examine as it would provide information about whether perfectionism treatments could 
potentially decrease generalised anxiety disorder in addition to other psychological 
disorders.  
An additional limitation of the literature was that the only randomised controlled 
trials (RCTs) examining cognitive behaviour therapy (CBT) for perfectionism in 
clinical samples had been administered in an individual format (Riley, Lee, Cooper, 
Fairburn, & Shafran, 2007; Steele & Wade, 2008).  No RCT had examined CBT for 
perfectionism delivered in a group format using a clinical sample. This was important to 
consider as group treatments can offer cost savings for clients, increased time efficiency 
for psychologists (Himle, Van Etten, & Fischer, 2003) and the potential for additional 
therapeutic advantages relative to individual treatments (Bieling, McCabe, & Antony, 
2006; Yalom, 1995; Yalom & Leszcz, 2005). 
This thesis contained two linked studies that sought to overcome these 
limitations. In Study I, the relationships between dimensions of perfectionism and 
pathological worry were examined in individuals with elevated perfectionism and 
xviii 
 
generalised anxiety disorder who presented for perfectionism treatment. The utility of 
perfectionism in predicting a principal diagnosis of generalised anxiety disorder was 
also explored in a larger sample with elevated perfectionism and a range of diagnoses 
who presented for perfectionism treatment. Perfectionism as measured by Concern over 
Mistakes, Personal Standards and Clinical Perfectionism Questionnaire scores each 
significantly predicted pathological worry after accounting for gender, anxiety and 
depression. Perfectionism as measured by Doubts about Actions significantly predicted 
a principal diagnosis of generalised anxiety disorder. These findings supported 
perfectionism being a transdiagnostic process (Egan et al., 2011). Importantly, these 
findings provided a rationale for Study II to investigate whether perfectionism 
interventions could reduce generalised anxiety disorder symptoms as well as the 
symptoms of other disorders. 
Study II examined the efficacy of group cognitive behavioural therapy targeting 
clinical perfectionism (group CBT-CP) using a randomised controlled design and a 
clinical sample. Participants randomised to 8 sessions of group CBT-CP exhibited 
significantly greater decreases in multiple dimensions of perfectionism, eating disorder 
symptoms, depression, social anxiety and anxiety sensitivity, as well as significantly 
greater increases in self-esteem and quality of life relative to a waitlist control condition. 
Treatment gains were maintained at 6-month follow-up. While group CBT-CP tended to 
produce greater reductions in pathological worry compared to a waitlist control group, 
this was not significant, which was likely due to a Type II error (Tabachnick & Fidell, 
2007). There was reliable change in dimensions of perfectionism, eating disorder 
symptoms, self-esteem and quality of life as well as some clinically significant change 
in perfectionism (Concern over Mistakes) and recovery from psychological disorders. 
Collectively, the findings contributed toward establishing the efficacy of group CBT-CP 
xix 
 
(Chambless & Hollon, 1998) and highlighted the multidimensional effect of this 
treatment in reducing multiple psychological symptoms and improving quality of life. 
1 
 
CHAPTER 1  
 
Introduction and Literature Review 
1.1. Overview  
This thesis consists of two linked studies that aim to increase knowledge of 
perfectionism and how it can be treated. Reviews have highlighted that perfectionism 
is associated with eating disorders, depressive disorders, bipolar I and II disorder, 
obsessive-compulsive disorder and anxiety disorders (Egan, Wade, & Shafran, 2011; 
Shafran & Mansell, 2001). Perfectionism has therefore been argued to be a process 
which occurs across psychological disorders, namely a transdiagnostic process (Egan 
et al., 2011). This implies that treatments that target perfectionism may concurrently 
decrease the symptoms of multiple disorders (Egan et al., 2011). One limitation of 
this literature is that research has not yet examined the association between 
perfectionism and generalised anxiety disorder (GAD) symptoms in a clinical 
sample. This is important to consider as it provides information about whether 
perfectionism treatments could potentially reduce GAD symptoms in addition to the 
symptoms of other disorders. In Study I of this thesis, the relationships between 
dimensions of perfectionism and pathological worry are examined in individuals 
with elevated perfectionism and GAD who presented for perfectionism treatment. 
Additionally, the utility of perfectionism in predicting a principal diagnosis of GAD 
is explored in a larger clinical sample with elevated perfectionism and a range of 
diagnoses who presented for perfectionism treatment.  
The findings of Study I are an important precursor to the principal study of 
this thesis (Study II) which examines the efficacy of group cognitive behavioural 
therapy (CBT) for clinical perfectionism using a randomised controlled design and a 
clinical sample. To date, no randomised controlled trial has investigated the efficacy 
2 
 
of group CBT for clinical perfectionism in a clinical sample. This is important to 
investigate as group treatments offer greater time efficiency for psychologists, cost 
savings for clients (Himle, Van Etten, & Fischer, 2003), as well as the potential for 
therapeutic advantages compared to individual treatments (Bieling, McCabe, & 
Antony, 2006; Yalom, 1995; Yalom & Leszcz, 2005). Collectively, the studies of 
this thesis further the knowledge and treatment of perfectionism. 
1.2. Definitions and Measures of Perfectionism  
1.2.1. Unidimensional definitions and measures of perfectionism.  
Perfectionism has been described in the literature for over 100 years (Frost & 
Steketee, 1997), with the earliest writings on the construct dating back to Janet 
(1898). Since then numerous definitions of perfectionism have been proposed 
(Shafran, Cooper, & Fairburn, 2002).  Theorists have defined perfectionism in a 
unidimensional manner based on the establishment of disproportionately high 
personal standards upon which self-esteem is centred (Burns, 1980a; Hollender, 
1965; Sorotzkin, 1985). In his seminal article, Hollender (1965) quoted English and 
English’s (1958, p.379) dictionary definition of perfectionism, which was “the 
practice of demanding of oneself or others a higher quality of performance than that 
required by the situation”. Hollender (1965) further asserted that an individual with 
perfectionism “sees himself as being judged for what he does, not for what he is” 
(p.99) and “is continually dependent upon his performance for feelings of 
acceptability, adequacy and goodness” (p.99). Burns (1980a) identified 
perfectionism as involving setting impractically high standards, ceaselessly striving 
for these standards and evaluating oneself predominantly on the attainment of these 
standards. Burns (1980a, p.34) stated that individuals with perfectionism “are likely 
to respond to the perception of failure or inadequacy with a precipitous loss of self-
3 
 
esteem that can trigger episodes of severe depression and anxiety”.  Sorotzkin (1985, 
p.564) emphasised that “perfectionists measure their self-worth in terms of 
unachievable goals of accomplishment and productivity and thus any deviation from 
the perfectionistic goal is likely to be accompanied by moralistic self-criticism and 
lowered self-esteem”. Across these definitions, perfectionism is depicted as a 
maladaptive trait that involves seeking to attain excessively high personal standards 
and centring self-evaluation upon whether such standards are attained (Burns, 1980a; 
English & English, 1958; Hollender, 1965; Sorotzkin, 1985). 
There are several measures of unidimensional perfectionism. The 
perfectionism subscale of the Dysfunctional Attitudes Scale (DAS-SC; Imber et al., 
1990; Weissman & Beck, 1978) examines the perception individuals have of 
themselves and others when their standards are not reached. This subscale has high 
internal consistency (Steele et al., 2013) and validity (Dunkley, Sanislow, Grilo, & 
McGlashan, 2004; Dunkley, Zuroff, & Blankstein, 2006) and is still frequently 
utilised to assess the relationship between perfectionism and psychopathology (e.g., 
Dunkley et al., 2004).  Burns’ (1980a) Perfectionism Scale was adapted from the 
Dysfunctional Attitudes Scale (Weissman & Beck, 1978) and assesses the degree to 
which one endorses perfectionist beliefs linking performance to self-evaluation. 
While studies have indicated that this measure has adequate internal consistency 
(Hewitt & Dyck, 1986) and validity (Hewitt, Mittelstaedt, & Wollert, 1989), these 
studies used non-clinical samples thus do not generalise to clinical populations. Few 
studies have investigated the psychometric properties of the Burns Perfectionism 
Scale (Burns, 1980a) in clinical samples, which may explain why this measure is no 
longer frequently used (Enns & Cox, 2002).  
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The perfectionism subscale of the Eating Disorders Inventory (EDI-P; 
Garner, Olmsted, & Polivy, 1983) assesses the setting of disproportionate personal 
standards. It is one of eight subscales developed to measure the psychological 
constructs pertinent to eating disorders (Enns & Cox, 2002; Garner et al., 1983). The 
reliability and validity of the EDI-P in eating disorder samples is well established 
and it is frequently used to assess perfectionism in individuals with eating disorders. 
However, the EDI-P is rarely used in other clinical samples therefore it is 
questionable whether its psychometric properties extend to these samples (Bardone-
Cone et al., 2007; Enns & Cox, 2002). The perfectionism subscale of the Setting 
Conditions for Anorexia Nervosa Scale (Slade & Dewey, 1986) is one of five 
subscales measuring risk factors for an eating disorder. It has acceptable validity but 
only modest internal consistency (Enns & Cox, 2002), so is now rarely used. The 
Neurotic Perfectionism Questionnaire (Mitzman, Slade, & Dewey, 1994) assesses 
the experiences and attitudes related to neurotic perfectionism (e.g., excessively high 
standards, dissatisfaction with performance and self) in individuals with eating 
disorders. It has acceptable internal consistency and validity; however, it is not often 
used (Enns & Cox, 2002; Mitzman et al., 1994).  
The perfectionism subscale of the Obsessive Beliefs Questionnaire (OBQ-P; 
Obsessive Compulsive Cognitions Working Group [OCCWG], 1997; 2001) assesses 
beliefs about there being perfect solutions, the necessity of flawless performance and 
concern over mistakes that are involved in the onset and maintenance of obsessive-
compulsive disorder. While the OBQ-P demonstrated adequate reliability and 
validity, it exhibited high correlations with the Intolerance of Uncertainty subscale. 
Other subscales in the OBQ were also intercorrelated (OCCWG; 2003). A 
subsequent factor analysis of the OBQ items produced three subscales, one of which 
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included Perfectionism/Certainty (OBQ-PC), which has high internal consistency 
and convergent validity (OCCWG, 2005). The OBQ-PC is frequently utilised to 
assess perfectionism in obsessive-compulsive disorder research (OCCWG; 2005).  
1.2.2. Critique of the unidimensional conceptualisation of perfectionism. 
The unidimensional definition of perfectionism has been critiqued for multiple 
reasons (Frost, Marten, Lahart, & Rosenblate, 1990). The first critique was that the 
unidimensional definition depicted perfectionism as always being dysfunctional and 
related to psychopathology (Stoeber & Otto, 2006). It did not adequately 
differentiate between individuals who seek to attain high standards in a healthy, 
functional manner and those who seek to attain high standards in an unhealthy 
manner associated with distress (Frost et al., 1990).  Hamachek (1978) had 
previously highlighted the differences between healthy and unhealthy striving using 
the concepts of normal perfectionists and neurotic perfectionists. Normal 
perfectionists set high standards for themselves but can accept that these standards 
may not always be attained and derive pleasure from striving. Neurotic perfectionists 
set high standards for themselves but have difficulties accepting when they have not 
attained these standards and rarely feel satisfied with their performance. The 
motivation behind their striving is a fear of failure (Hamachek, 1978). Therefore, the 
main difference between normal and neurotic perfectionists is not the setting of high 
standards, but the added tendency of neurotic perfectionists to be excessively critical 
about their performance. Definitions of perfectionism therefore needed to better 
differentiate between individuals who strive for standards in a healthy manner and 
those who strive for standards in an unhealthy manner where they excessively 
criticise their performance (Frost et al., 1990; Hamacheck, 1978). 
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A second critique of the unidimensional definition of perfectionism was that 
it is too narrow in focus (Frost et al., 1990). Frost et al. (1990) argued that definitions 
of perfectionism needed to encapsulate additional clinical features of perfectionism, 
such as excessive concern with errors of performance, doubts about performance, 
excessive need for orderliness and the importance assigned to parents’ expectations 
and appraisals. Hewitt and Flett (1991a) further stated that the unidimensional 
definition of perfectionism did not acknowledge the interpersonal elements of 
perfectionism that play a role in the adjustment difficulties perfectionist individuals 
experience. Such interpersonal elements include when perfectionist standards are 
imposed on others or when one believes that others have perfectionist standards for 
oneself.  
1.2.3. Multidimensional conceptualisation and measures of 
perfectionism. As a result of the critique of the unidimensional definition of 
perfectionism, several researchers in the 1990s posited that perfectionism is better 
conceptualised as a multidimensional construct (Frost et al., 1990; Hewitt & Flett, 
1991a). Frost et al. (1990) and Hewitt and Flett (1991a) each constructed scales that 
measured components deemed to depict multidimensional perfectionism. Frost et 
al.’s (1990) Multidimensional Perfectionism Scale (FMPS) assesses six dimensions: 
Concern over Mistakes (CM): a heightened concern over making performance 
errors; Personal Standards (PS): setting oneself very high standards of performance; 
Parental Criticism (PC): believing one’s parents will be critical of errors in 
performance; Parental Expectations (PE): believing one’s parents expect a high level 
of performance; Doubts about Actions (DA): doubts surrounding one’s performance; 
and Organisation (O): an excessive concern with being neat and organised. The sum 
of all of these subscales except O form the total FMPS score. Frost et al. (1990) did 
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not include O in the total FMPS score as it demonstrated weaker correlations with 
the other subscales as well as with the sum of the five FMPS subscales.   
Hewitt and Flett’s (1991a) Multidimensional Perfectionism Scale (HMPS) 
measures three elements of perfectionism: Self-Oriented Perfectionism (SOP): 
setting oneself high standards and being self-critical if one thinks these standards 
have not been met; Socially-Prescribed Perfectionism (SPP): believing others expect 
one to be perfect; and Other-Oriented Perfectionism (OOP): holding expectations of 
others being perfect. A vast amount of evidence has supported the reliability and 
validity of both multidimensional perfectionism scales (Enns & Cox, 2002; Egan et 
al., 2011). Numerous studies have utilised these multidimensional measures to assess 
the relationship between perfectionism and psychopathology (Egan et al., 2011). 
Other measures of multidimensional perfectionism have been developed; 
however, these have been used to a lesser extent than the FMPS and HMPS scales. 
The Almost Perfect Scale-Revised (APS-R; Slaney, Rice, Mobley, Trippi, & Ashby, 
2001) is a revision of the Almost Perfect Scale (Slaney & Johnson, 1992, as cited in 
Slaney et al., 2001) and assesses three dimensions of perfectionism: APS-R- High 
Standards: having high personal standards; APS-R-Order: being orderly; and APSR-
Discrepancy: the perceived discrepancy in one’s standards and performance. These 
subscales have acceptable internal consistency and validity (Slaney et al., 2001). The 
Positive and Negative Perfectionism Scale (PANPS; Terry-Short, Owens, Slade, & 
Dewey, 1995) has a positive perfectionism subscale that assesses perfectionism 
aimed at achieving positive outcomes and a negative perfectionism subscale that 
assesses perfectionism aimed at avoiding negative outcomes (Terry-Short et al., 
1995). These subscales have demonstrated high internal consistency in a clinical and 
an athlete sample (Egan, Piek, Dyck, & Kane, 2011). The validity of the negative 
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perfectionism subscale was supported in a clinical sample; however, the validity of 
the positive perfectionism scale was weaker in a clinical sample than in an athlete 
sample and a control sample as it was associated with measures of pathology such as 
the Beck Depression Inventory-II (BDI-II; Beck, Steer, & Brown, 1996; Egan, Piek, 
et al., 2011).  
Flett, Hewitt, Blankstein, and Gray (1998) asserted that all of the 
multidimensional perfectionism measures have focused on trait perfectionism. 
However, there are additional aspects that require measurement such as the 
frequency of automatic, perfectionist cognitions that arise when individuals with 
elevated perfectionism experience a discrepancy between their ideal and actual self, 
or between their ideal and actual performance outcome. Flett et al. (1998) developed 
the Perfectionism Cognitions Inventory (PCI; Flett et al., 1998) to assess the 
frequency of perfectionist cognitions in the past week. This measure has been found 
to have high internal consistency and validity in clinical samples (Flett et al., 1998). 
 The Perfectionism Inventory (Hill et al., 2004) was designed to assess the 
constructs from the FMPS and HMPS scales as well as additional constructs such as 
rumination over imperfect performance. It assesses eight dimensions: Striving for 
Excellence: the propensity to strive for high standards; High Standards for Others: 
having perfectionist standards for others; Need for Approval: obtaining validation 
from others and sensitivity to criticism; Concern over Mistakes: the propensity to be 
anxious or distressed in relation to making an error; Perceived Parental Pressure: the 
need for perfect performance to seek approval from parents; Planfulness: the 
propensity to plan in advance and ponder over decisions; Organisation: orderliness 
and neatness; and Rumination: the propensity to ruminate over past errors, imperfect 
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performance and future errors. Each subscale has high internal consistency and 
validity (Hill et al., 2004). 
Factor analyses of many of the multidimensional perfectionism scales have 
predominantly supported there being two higher order dimensions of perfectionism: 
a maladaptive dimension and an adaptive dimension. This factor structure appears to 
be stable, although different researchers refer to the dimensions by different names 
(Bieling, Israeli, & Antony, 2004; Frost, Heimberg, Holt, Mattia, & Neubauer, 
1993). Frost, Heimberg, et al. (1993) and Bieling, Israeli, et al. (2004) found that 
items from the FMPS and HMPS loaded on factors of maladaptive evaluative 
concerns (DA, CM, PE, PC, and SPP) and positive achievement striving (PS, O, 
OOP, and SOP).  Frost et al. (1993) reported that maladaptive evaluative concerns 
(MEC) was positively correlated with depressive symptoms and negative affect, 
whereas positive achievement striving (PAS) was positively correlated with positive 
affect. Bieling, Israeli, et al. (2004) found that MEC had stronger relationships with 
stress, anxiety, depression and test-taking anxiety than did PAS. These findings 
supported MEC being a maladaptive form of perfectionism associated with 
psychological symptoms and PAS being adaptive (Bieling, Israeli, et al., 2004; Frost 
et al., 1993).   
Attempts to replicate the two factor structure with items from the FMPS, 
HMPS and APS-R have primarily supported a two factor solution (Blankstein & 
Dunkley, 2002; Blankstein, Dunkley, & Wilson, 2008). Blankstein and Dunkley 
(2002) and Blankstein et al. (2008) found that items loaded on two factors of 
evaluative concerns perfectionism (CM, DA, SPP, APS-R-Discrepancy) and 
personal standards perfectionism (Standards, PS, SOP). Suddarth and Slaney (2001) 
found support for maladaptive perfectionism (CM, DA, PC, PE, SPP, and APS-R-
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Discrepancy) and adaptive perfectionism (PS, SOP, OOP, and APS-High Standards); 
however, also found support for a third factor of Order/Organisation (O and APS-
Order).  Suddarth and Slaney (2001) argued that the first two factors are consistent 
with there being a maladaptive and an adaptive form of perfectionism and that while 
researchers such as Frost at al. (1990) did not deem organisation to be central to 
perfectionism, it may be worthy of further consideration.  
These studies predominantly support there being two higher order 
perfectionism dimensions: MEC and PAS (Bieling, Israeli, et al., 2004; Blankstein & 
Dunkley, 2002; Blankstein et al., 2008; Frost et al., 1993); however, the non-clinical 
samples used prevent generalisation to clinical populations. Cox, Enns, and Clara 
(2002) conducted a factor analysis of the FMPS and HMPS items in a clinical 
sample and provided support for a two factor solution of maladaptive perfectionism 
(CM, DA, PC, SPP) and adaptive perfectionism (PS, O, SOP). While this solution 
can be generalised to clinical samples, a reduced number of subscale items were 
included in this confirmatory factor analysis, thus replication of this factor analysis 
in clinical samples is required.   
Cross-sectional and prospective studies have frequently supported MEC 
perfectionism and its component subscales (e.g., CM, DA, SPP) being associated 
with a wide variety of psychopathology (Egan et al., 2011) as discussed later in this 
chapter. However, the clinical literature in regard to PAS being benign is mixed 
(Egan et al., 2011; Egan, Wade, & Shafran, 2012; Stoeber & Otto, 2006). Stoeber 
and Otto (2006) reviewed the perfectionism literature and concluded that 
perfectionistic strivings (PS, SOP), particularly when controlling for perfectionistic 
concerns (DA, CM, SPP) is not only benign but is a positive dispositional 
characteristic associated with positive outcomes. The positive outcomes associated 
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with perfectionistic strivings included endurance, achievement, positive affect, life 
satisfaction, greater extraversion, conscientiousness and reduced suicidal ideation. 
Once perfectionistic concerns were accounted for, the positive outcomes associated 
with perfectionistic strivings extended to greater perceived social support and 
reduced depression (Stoeber & Otto, 2006). As Stoeber and Otto’s (2006) conclusion 
was based on a review of a large number of studies, this adds strength to their claim 
that PAS is associated with positive outcomes. 
Nonetheless, other researchers have presented evidence that challenges 
Stoeber and Otto’s (2006) claims of there being an adaptive form of perfectionism. 
There is evidence that PS is a risk factor for eating disorder pathology (Wade et al., 
2008) and that PS and SOP influence the severity of eating disorder pathology 
(Bardone-Cone et al., 2008; Lethbridge, Watson, Egan, Street, & Nathan, 2012). 
There is also support for SOP being related to depressive symptoms (Hewitt & Flett, 
1993) and PS being associated with panic disorder symptoms (Iketani et al., 2002a). 
Reviews by Egan et al. (2011) and Egan et al. (2012) have drawn upon such 
evidence to posit that PAS perfectionism may not be universally adaptive. In view of 
all of the evidence presented, it appears that MEC is a maladaptive form of 
perfectionism, whereas PAS, despite being associated with some positive 
characteristics, may not be adaptive in all circumstances.  
1.2.4. Critique of the multidimensional conceptualisation of 
perfectionism. The frequent use of the multidimensional perfectionism scales (Frost 
et al., 1990; Hewitt & Flett, 1991a) in the perfectionism literature has resulted in 
many researchers accepting the notion of perfectionism being a multidimensional 
construct; however, this conceptualisation is not without critique (Shafran et al., 
2002). Shafran et al. (2002) criticised definitions of multidimensional perfectionism 
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as being overly equated with scores on the FMPS and HMPS (Frost et al., 1990; 
Hewitt & Flett, 1991a), rather than being defined solely on theoretical and clinical 
descriptions of perfectionism. This was argued to be problematic because the 
multidimensional perfectionism scales assess not only the key components of 
perfectionism but also related constructs that are not essential to perfectionism 
definitions. Shafran et al. (2002) specified that only items from the PS, CM and SOP 
subscales provide the closest approximations to theoretical descriptions of 
perfectionism (e.g., Burns, 1980a), whereas the remaining subscales of the FMPS 
and HMPS measure related constructs (Shafran et al., 2002). Shafran et al. (2002) 
contended that this reliance on the multidimensional conceptualisation of 
perfectionism was one of the reasons why there had been not been greater 
progression in the use of perfectionism to inform theoretical models or interventions 
for psychological disorders. They asserted that if researchers are to focus on 
perfectionism as a mechanism to better understand and treat psychological disorders, 
perfectionism needed to be defined in a more clinically-relevant manner.  
1.2.5. Definition and measurement of clinical perfectionism. Shafran et al. 
(2002, p.778) put forward the term ‘clinical perfectionism’, defined as “the 
overdependence of self-evaluation on the determined pursuit of personally 
demanding, self-imposed standards in at least one highly salient domain despite 
adverse consequences”.  This definition encompasses three key features. The first 
feature is the setting of personally demanding standards accompanied by self-
criticism. Individuals with clinical perfectionism set standards for themselves that 
they view to be extremely demanding. These standards do not necessarily have to be 
objectively challenging, what is crucial is that the standards are demanding for that 
person. The standards are set in areas of life deemed personally relevant to the 
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individual (e.g., work, body shape). Individuals with clinical perfectionism 
selectively attend to the instances where they think they have not reached their 
standards and respond with self-criticism (Shafran et al., 2002).  
The second feature of clinical perfectionism is striving for standards despite 
negative consequences. Individuals with clinical perfectionism unremittingly strive 
to attain their standards even when it results in negative outcomes.  These negative 
outcomes may occur in physical, cognitive, emotional, social and behavioural 
domains (Shafran et al., 2002). Physically, individuals may experience muscle 
tension, an upset stomach, insomnia, exhaustion or tiredness. In the cognitive 
domain, individuals may experience heightened self-criticism, lowered 
concentration, increased rumination over mistakes and low self-esteem. Emotional 
effects may include anxiety, stress and low mood. In the behavioural domain, 
individuals may engage in procrastination, avoidance, repetitive checking or may 
spend extraordinary amounts of time on tasks. Individuals may experience social 
isolation due to devoting excess time to achievement-related areas. Regardless of 
these negative consequences, individuals with clinical perfectionism will continue to 
strive for their standards (Shafran et al., 2002; Shafran, Egan, & Wade, 2010). 
 The third feature of clinical perfectionism is that a person’s self-evaluation is 
almost singularly dependent on whether they believe they have reached their 
standards in their important domain(s). As alternate domains of self-evaluation are 
disregarded, if individuals believe they have not attained their standards in their area, 
they are likely to adopt a global negative perception of themselves, such as being a 
failure as a person, which further creates negative outcomes (Shafran et al., 2002, 
Shafran et al., 2010). Shafran et al. (2002) highlighted that striving for standards by 
itself can be adaptive; it is when self-worth is excessively based on striving and 
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meeting standards, when one continues to strive in the presence of negative 
consequences and when one is self-critical when they perceive their standards have 
not been attained, that they are experiencing clinical perfectionism rather than the 
healthy pursuit of excellence.   
As Shafran et al.’s (2002) definition of clinical perfectionism incorporates 
setting and striving for personally demanding standards and responding in a negative 
manner to perceived errors in performance, some researchers have measured this 
construct using the CM and PS subscales (Egan et al., 2012). A measure directly 
based on the clinical perfectionism definition has also been constructed.  The 
Clinical Perfectionism Questionnaire (CPQ; Fairburn, Cooper, & Shafran, 2003b) 
assesses the setting of and striving to attain standards and the impact on self-esteem 
if an individual perceives that his/her standards have not been attained (Fairburn et 
al., 2003b; Riley et al., 2007). As the CPQ assesses clinical perfectionism over the 
past four weeks it is sensitive to clinical change (Riley et al., 2007). There is also 
evidence of the CPQ having high internal consistency and validity in community 
samples and eating disorder samples (Chang & Sanna, 2012; Dickie, Surgenor, 
Wilson, & McDowall, 2012; Egan, Shafran, et al., 2014; Steele, O’Shea, Murdock, 
& Wade, 2011). 
1.2.6. The maintenance model of clinical perfectionism. Shafran et al. 
(2002) created a model of how clinical perfectionism is maintained.  This was 
updated by Shafran et al. (2010) to emphasise the role of performance-related 
behaviours and is presented in Figure 1.  
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Figure 1. The revised cognitive behavioural model of the maintenance of clinical 
perfectionism (reproduced from Shafran et al., 2010). 
 
The top of this model depicts the self-esteem of individuals with clinical 
perfectionism being excessively reliant on striving toward and attaining personally 
demanding standards in personally relevant areas. These standards are expressed in 
the form of dichotomous, inflexible rules. For example, in the domain of study, a 
personally demanding standard expressed as a rule might be: I must always receive a 
high distinction mark. In the domain of eating, shape and weight, the rule might be: I 
must always weigh 48 kilograms (Shafran et al., 2002; Shafran et al., 2010).  
The model further proposes that individuals with clinical perfectionism 
possess cognitive biases of hypervigilant monitoring, negative filter, discounting the 
positive and dichotomous thinking, which impact upon how they evaluate their 
striving toward and achievement of standards (Shafran et al., 2002; Shafran et al., 
2010). Individuals continually monitor their performance, selectively attend to 
perceived flaws in striving or performance and disregard successes (Antony & 
Swinson, 1998; Egan et al., 2011; Shafran et al., 2002; Shafran et al., 2010). 
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Additionally, these individuals partake in a variety of performance-related 
behaviours. These may include performance checking behaviours such as testing 
performance, reassurance seeking or making comparisons to others. Other 
performance-related behaviours may include procrastination, avoidance and other 
counter-productive behaviours such as spending excessive time organising, making 
lists, being over-thorough or working at the expense of sleep (Egan et al., 2011; 
Shafran et al., 2002; Shafran et al., 2010). 
It is posited that this combination of dichotomous rigid standards, the biased 
appraisal of striving and performance and the presence of performance-related 
behaviours creates a high likelihood that individuals will conclude that they have 
failed to attain their standards (Shafran et al., 2002; Shafran et al., 2010). Individuals 
respond to this perceived failure by criticising themselves. This self-criticism is often 
accompanied by lowered mood and participation in additional behaviours such as 
procrastination and avoidance. As self-esteem is excessively reliant on striving and 
attaining standards in personally relevant domains, these individuals over-generalise 
to adopt a global negative perception of themselves. The reliance of their self-esteem 
on striving and attaining their standards is fortified (Egan et al., 2011; Shafran et al., 
2002; Shafran et al., 2010). 
An alternative pathway in this model is that perfectionist individuals set 
standards that are so personally demanding and have such a great fear about not 
attaining these standards that they avoid trying to reach their standards (Shafran et 
al., 2002; Shafran et al., 2010). An example of this is when an individual has a 
standard of needing to receive a high distinction mark and fears not attaining this 
standard to the extent that he/she does not submit an assignment. A consequence of 
individuals avoiding to attain a standard is that they fail to reach the standard. This 
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failure again engenders self-criticism and participation in counter-productive 
behaviours. These individuals adopt a global negative view of themselves and their 
self-esteem being overly contingent on striving and achievement is strengthened 
(Egan et al., 2011; Shafran et al., 2002; Shafran et al., 2010). 
According to this model, there are some occasions when perfectionist 
individuals achieve their standards (Shafran et al., 2002; Shafran et al., 2010). For 
example, they may receive a high distinction mark. This results in two outcomes. 
First, meeting standards may momentarily enhance self-esteem or avert negative 
self-perceptions, which may increase the likelihood of individuals striving for these 
standards in the future (Burns, 1980a; Shafran et al., 2002; Shafran et al., 2010). 
Second, individuals may disregard their accomplishments and reframe their 
standards as not being hard enough. They will re-set their standards to be more 
personally demanding. Striving for higher standards will further increase the 
likelihood of individuals judging that they have failed to attain their standards, which 
will result in self-criticism, global negative perceptions of themselves and will fortify 
the reliance of their self-worth on striving and achievement (Egan et al., 2011; 
Shafran et al., 2002; Shafran et al., 2010). 
Shafran et al. (2002) specified that when one’s area of clinical perfectionism 
overlaps with the area impacted by a psychological disorder, the clinical 
perfectionism will interact with the maintenance factors of the disorder to maintain 
the disorder and impede treatment outcome. For example, clinical perfectionism has 
been argued to interact with the over-valuation of eating, weight and shape and how 
they are controlled to maintain eating disorder symptoms (Fairburn, Cooper, & 
Shafran, 2003a). It has been proposed that under these circumstances, interventions 
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that focus on perfectionism will assist to reduce psychopathology (Egan et al., 2011; 
Fairburn et al. 2003a, Shafran et al., 2002; Shafran et al., 2010). 
1.2.7. Studies examining components of the maintenance model.  
Evidence from qualitative studies has supported the maintenance model of clinical 
perfectionism (Egan, Piek, Dyck, Rees, & Hagger, 2012; Riley & Shafran, 2005; 
Shafran et al., 2002; Shafran et al., 2010). Riley and Shafran (2005) found that 
individuals with clinical perfectionism, as determined by a semi-structured 
interview, frequently stated that they set themselves dysfunctional standards, strived 
in the presence of negative effects and reacted in a self-critical manner to failure, 
whereas individuals without clinical perfectionism did not. Individuals with clinical 
perfectionism also exhibited cognitive biases such as dichotomous thinking, negative 
filter, discounting the positive, double-standards and catastrophising. There was also 
support for individuals with clinical perfectionism setting dichotomous rules, as well 
as engaging in performance-checking behaviours, procrastination, avoidance and 
counter-productive behaviours such as list making.  
Egan, Piek et al.’s (2012) qualitative study compared a clinical sample of 
participants with high negative perfectionism scores on the PANPS to an athlete 
sample with low negative perfectionism scores. Consistent with perfectionist 
individuals exhibiting cognitive biases when appraising their striving and 
performance (Shafran et al., 2002; Shafran et al., 2010), Egan, Piek, et al. (2012) 
found that the sample with high negative perfectionism reported dichotomous 
thinking in relation to attaining a standard, whereas the sample with low negative 
perfectionism did not. In line with perfectionist individuals experiencing negative 
self-evaluation in relation to not attaining a standard (Shafran et al., 2002; Shafran et 
al., 2010), Egan, Piek, et al. (2012) found that the sample with high negative 
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perfectionism reported negative internal attributions regarding not attaining a 
standard where they viewed themselves as a failure. The sample with low negative 
perfectionism stated that they had not failed and made external attributions for not 
attaining a standard. These qualitative studies provide support for the validity of the 
maintenance model of clinical perfectionism (Shafran et al., 2002; Shafran et al., 
2010); however, each study had moderately small sample sizes, which prevented the 
researchers from examining whether there were statistically significant differences in 
the characteristics of clinical perfectionism endorsed by individuals with and without 
elevated perfectionism. As the primary researchers conducted the interviews and 
interpreted the qualitative data, it is also possible that the data was influenced by 
researcher bias (Egan, Piek, et al., 2012; Riley & Shafran, 2005). 
Quantitative studies have also supported aspects of the maintenance model of 
clinical perfectionism (Bieling, Israeli, Smith, & Antony, 2003; Egan, Dick, & 
Allen, 2012; Shafran et al., 2002; Shafran et al., 2010). Consistent with perfectionist 
individuals setting themselves demanding, unrealistic standards, Bieling et al. (2003) 
found that significant associations existed between total FMPS, adaptive 
perfectionism (PS, SOP, O, OOP) and maladaptive perfectionism (CM, DA, PE, PC, 
SPP) with students setting higher standards for an assessment and students not 
attaining these standards. Egan, Dick, et al. (2012) found that higher scores on the 
CPQ were significantly associated with setting greater standards in a non-verbal 
reasoning task as well as a higher likelihood of not attaining these standards. These 
studies support elements of clinical perfectionism (PS, SOP, CM, CPQ) and related 
perfectionism dimensions being associated with the setting of demanding, unrealistic 
standards (Shafran et al., 2002; Shafran et al., 2010).  
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Studies have also offered support for perfectionist individuals exhibiting 
cognitive biases (Egan, Piek, Dyck, & Rees, 2007; Yiend, Savulich, Coughtrey, & 
Shafran, 2011). Egan et al. (2007) found that dichotomous thinking as measured by 
the Dichotomous Thinking Scale (Byrne, Cooper, & Fairburn, 2004) was a 
significant positive predictor of negative perfectionism scores on the PANPS in a 
clinical sample, a student sample and a triathlete sample.  This supported significant 
associations existing between dichotomous thinking and negative perfectionism 
(Egan et al., 2007). Consistent with perfectionist individuals demonstrating 
interpretative biases, Yiend et al. (2011) found that when individuals were asked to 
interpret ambiguous text passages, those with higher DAS-SC and CPQ scores were 
significantly more likely to rate perfectionist interpretations as bearing greater 
similarity to the text passage than those with low DAS-SC and CPQ scores, whereas 
the opposite pattern occurred in regard to non-perfectionist interpretations. This 
interpretative bias occurred for the passages that were ambiguous in perfectionist 
meaning but not those that were ambiguous in emotional meaning. Yiend et al. 
(2011) contended that this pattern was consistent with perfectionist individuals 
having interpretation biases specific to perfection-relevant material that are not a by-
product of a general negative interpretation bias (Yiend et al., 2011).  
There is also evidence consistent with perfectionist individuals engaging in 
performance-related behaviours (Lee, Roberts-Collin, Coughtrey, Phillips, & 
Shafran, 2013; Yiend et al., 2011). Yiend et al. (2011) found that significantly more 
individuals with higher DAS-SC and CPQ scores opted to check for mistakes in their 
performance on a bead-sorting task and spent a significantly greater time checking 
for these mistakes than those with lower DAS-SC and CPQ scores.  Lee et al. (2013) 
similarly found that individuals with high perfectionism, based on a median split of 
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FMPS total perfectionism score, spent significantly longer on tasks, participated in a 
greater number of safety and checking behaviours, experienced greater difficulties 
stopping tasks and had greater concerns about finishing tasks relative to individuals 
classified as having low perfectionism. 
The above findings are consistent with perfectionist individuals having 
certain cognitive biases and exhibiting performance-related behaviours (Shafran et 
al., 2002; Shafran et al., 2010); however, based on the cross-sectional designs of 
these studies, inferences cannot be made about the aetiological role of cognitive 
biases and performance-related behaviours in perfectionism. Few studies in this area 
enable such inferences to be made. One exception is a second study by Yiend et al. 
(2011). Yiend et al. (2011) induced perfectionist or non-perfectionist biases in 
individuals without elevated perfectionism and examined whether this manipulation 
led to changes in perfectionist behaviours on a bead sorting task. Individuals 
randomised to the perfectionist-induced condition more readily endorsed 
perfectionist interpretations of ambiguous text passages and increased their time 
checking for mistakes, whereas those in the non-perfectionist induced condition 
more readily endorsed non-perfectionist interpretations and decreased their time 
checking for mistakes. This study is commendable due to its experimental design, 
which provides greater support for the maintaining role of interpretative biases in 
clinical perfectionism (Shafran et al., 2002; Shafran et al., 2010; Yiend et al., 2011).  
  Studies have found that elevated perfectionism is associated with negative 
reactions to perceived failure to meet standards; however, there are inconsistencies in 
which dimensions of perfectionism are associated with such reactions (Besser, Flett, 
& Hewitt, 2004; Besser, Flett, Hewitt, & Guez, 2008; Stoeber & Yang, 2010). 
Besser et al. (2004) discovered that individuals with higher SOP demonstrated 
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increased rumination and reduced levels of positive affect following feedback of 
failure. Besser et al. (2008) however, found that elevated SPP not SOP was 
associated with significantly greater anxiety and dysphoria as well as significantly 
lower self-esteem following feedback of poor performance. Stoeber and Yang (2010) 
reported that higher SOP and SPP were significantly associated with greater 
embarrassment and dissatisfaction after achievement of a flawed outcome. Future 
research is needed to clarify the associations between SOP, SPP and negative 
reactions to perceived failure. 
 There is mixed support for perfectionist individuals reframing their standards 
after attaining success (Egan, Dick, et al., 2012; Kobori, Hayakawa, & Tanno, 2009; 
Stoeber, Hutchfield, & Wood, 2008). Kobori et al. (2009) found that SOP was a 
significant predictor of whether students chose to increase their standards following 
success. Stoeber et al. (2008) found that perfectionistic striving, as measured by the 
Striving for Perfection Scale (Stoeber & Rambow, 2007) was a significant predictor 
of whether students selected a more difficult standard to pursue following success; 
however, self-critical perfectionism, as measured by the self-criticism subscale of the 
revised Attitude Towards Self Scale (Carver, La Voie, Kuhl, & Ganellen, 1988) was 
a significant positive predictor of decreasing standards after both success and failure 
feedback (Stoeber et al., 2008). Egan, Dick, et al. (2012) did not find support for 
CPQ scores significantly predicting the reframing of standards after failure or 
success in a non-clinical sample; it was only participants’ actual level of failure or 
success on a task that predicted their reframing of standards. Additional research is 
needed to clarify the influence of perfectionism on the reframing of standards after 
failure or success, with a view to investigating variables that may differentially 
mediate this relationship.  
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In sum, there is support for perfectionist individuals setting demanding 
standards (Bieling et al., 2003; Egan, Dick, et al., 2012), engaging in cognitive 
biases and performance-related behaviours (Egan et al., 2007; Lee et al., 2013; Yiend 
et al., 2011), and some evidence that these cognitive biases have an aetiological role 
in the maintenance of perfectionism (Yiend et al., 2011). There is support for 
perfectionist individuals exhibiting negative reactions to failure, although the precise 
relationships between SOP, SPP and these negative reactions require clarification 
(Besser et al., 2004; Besser et al., 2008; Stoeber & Yang, 2010). There is mixed 
evidence for perfectionist individuals reframing their standards after success (Egan, 
Dick, et al., 2012; Kobori et al., 2009; Stoeber et al., 2008). These studies provide 
some support for the maintenance model of clinical perfectionism (Shafran et al., 
2002; Shafran et al., 2010); however, the majority of these studies are correlational 
studies in non-clinical samples, which have only examined one or two components 
of the maintenance model (Shafran et al., 2002; Shafran et al., 2010). To provide 
greater support for the model, confirmatory factor analytic studies need to be 
conducted to examine the fit of the whole model to data. Furthermore, studies 
utilising clinical samples are needed to ensure that the model is applicable for 
clinical populations. 
1.2.8. Critique of the conceptualisation of clinical perfectionism. Shafran 
et al.’s (2002) definition of clinical perfectionism is not without critique. Hewitt, 
Flett, Besser, Sherry, and McGee (2003) posited that perfectionism is still better 
conceptualised as a multidimensional construct rather than a unidimensional 
construct. These researchers contended that Shafran et al.’s (2002) clinical 
perfectionism construct does not sufficiently depict the essential psychopathology of 
clinical perfectionism and listed various reasons for this, one being that the clinical 
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perfectionism definition did not make reference to interpersonal processes. Shafran, 
Cooper, and Fairburn (2003) responded to this critique by stating that their (2002) 
clinical perfectionism definition concentrated on the self-oriented factors necessary 
for the persistence of clinical perfectionism. Shafran et al. (2003) maintained that 
concentrating on these factors is more likely to enable the successful treatment of 
psychopathology as opposed to concentrating on broader definitions of perfectionism 
that encompassed self-focussed and interpersonal processes. Currently, there is still 
no consensus among researchers as to the best conceptualisation of perfectionism. 
1.2.9. The conceptualisation of perfectionism adopted by the current  
research. As many different conceptualisations of perfectionism have been  
discussed, it is fitting to conclude this section by expressing the conceptualisation of 
perfectionism with which the current research aligns. The current study aligns with 
Shafran et al.’s (2002) conceptualisation of clinical perfectionism. The primary 
reason for adopting this conceptualisation is that it is a clearer definition that has 
greater clinical relevance than the multidimensional conceptualisation (Shafran et al., 
2002). The primary researcher agrees with Shafran et al. (2002) that the reliance on 
the multidimensional conceptualisation of perfectionism did not lead to clinical 
interventions for perfectionism. As Shafran et al.’s (2002) conceptualisation 
concentrates on the maintenance factors of clinical perfectionism, it parallels the 
approach to conceptualisation adopted by other psychological disorders that now 
have efficacious treatments (Shafran et al., 2002). Furthermore, conceptualising 
clinical perfectionism in this manner has already led to studies trialling cognitive 
behavioural therapies for clinical perfectionism (e.g., Riley et al., 2007; Steele et al., 
2013). As Study II of the current research examines the efficacy of group cognitive 
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behavioural therapy for clinical perfectionism, it is logical for this study to align with 
Shafran et al.’s (2002) conceptualisation of clinical perfectionism.  
Nevertheless, one cannot circumvent the fact that the majority of the previous 
perfectionism literature has utilised the multidimensional measures of perfectionism, 
as well as unidimensional measures such as EDI-P and DAS-SC. When providing a 
comprehensive summary of the perfectionism literature, these studies need to be 
considered (Shafran et al., 2002). As Shafran et al. (2002, p.777) stated, “despite the 
problems with the broadening of the construct of perfectionism, it is worthwhile 
looking at how the existing literature can further our understanding of the core 
concept”. Consequently, the following sections on the aetiology of perfectionism as 
well as perfectionism being a transdiagnostic process will include studies that have 
assessed perfectionism using a variety of different measures.   
1.3. The Aetiology of Perfectionism 
 In regard to the aetiology of perfectionism, the factor that has received the 
most theoretical and research attention has been parenting (Kawamura, Frost, & 
Harmatz, 2002). Many theorists have posited that perfectionism develops as a result 
of the communications that children have with their parents (Kawamura et al. 2002). 
Hamachek (1978) theorised that maladaptive perfectionism may develop when 
children are raised by parents who have high performance expectations but are never 
content with what the child has achieved. Pacht (1984) proposed that environments 
where children receive criticism for less than perfect performance may cultivate 
perfectionism as these children may not acquire less critical methods in which to 
appraise their performance. Barrow and Moore (1983) summarised four early 
parental interactions that may contribute to the emergence of perfectionism, 
including experiences with parents who are demanding and blatantly critical; 
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experiences with parents who have disproportionately high standards and 
expectations for performance; experiences with perfectionist parents who model 
perfectionist behaviours and attitudes; and experiences with parents who provide 
contingent, irregular or no parental approval.  Frost et al. (1990) acknowledged the 
importance of parenting in the development of perfectionism by including items in 
the FMPS to measure parental expectations (PE) and parental criticism (PC).  
There is empirical support for these theorised associations between parenting 
and perfectionism. Frost, Lahart, and Rosenblate (1991) discovered that a significant 
relationship existed between mothers’ and daughters’ total FMPS scores but not 
fathers’ and daughters’ total FMPS scores. Frost et al. (1991) argued that this finding 
was consistent with mothers modelling perfectionist attitudes and behaviours to their 
daughters. The authors further contended that the significant relationship occurring 
only between mothers and daughters may be due to same-sex modelling or because 
mothers may spend greater time with their daughters than fathers, which may enable 
greater opportunity for modelling of perfectionism to occur. Frost et al. (1991) also 
found daughters’ reports of maternal and paternal harshness as well as mothers’ self-
reported harshness on the Father/Mother Trait Scale (Steketee, Grayson, & Foa, 
1985) were each significantly associated with daughters’ total FMPS scores. These 
findings support perceived parental harshness being associated with perfectionism; 
however, due to the cross-sectional design of the study, inferences cannot be made 
about causality. 
Vieth and Trull (1999) provided further support for perfectionism being 
transmitted through same-sex modelling by demonstrating that the correlations 
between the SOP levels of mothers and daughters were significantly greater than the 
correlations between fathers’ and daughters’ SOP levels. Furthermore, the 
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correlations between the SOP levels of fathers and sons were significantly greater 
than the correlations between mothers’ and sons’ SOP levels. Flett, Hewitt, and 
Singer (1995) found that significant associations existed between men’s ratings of 
their mothers’ and fathers’ authoritarian parenting styles on the Parental Authority 
Questionnaire (PAQ; Buri, 1991) and men’s SPP levels; however, this relationship 
did not occur in women. Kawamura et al. (2002) reported that the perception of 
having experienced harsh parenting as measured by the Parental Harshness Scale 
(Frost et al., 1990), as well as the perception of having experienced authoritarian 
parenting as assessed by the PAQ (Buri, 1991), were each significantly related to 
greater DA and CM. This relationship occurred in females and males. Kawamura et 
al. (2002) posited that Flett et al.’s (1995) findings may have only occurred in males 
due to their use of SPP as their measure of maladaptive perfectionism, which has a 
greater interpersonal component than CM and DA which were used in Kawamura et 
al.’s (2002) study.  
 These studies have highlighted the associations between parental modelling, 
harshness, authoritarian parenting and total FMPS, SOP, SPP, CM and DA (Flett et 
al., 1995; Frost et al., 1991; Kawamura et al., 2002; Vieth & Trull, 1999). 
Nonetheless, the correlational designs of these studies prevent causal inferences. 
Furthermore, as some of these studies relied on individuals retrospectively reporting 
the perceived harshness and authoritarianism of their parents, this may have 
introduced bias into the data. 
Based on the research on parenting, Flett, Hewitt, Oliver, and Macdonald 
(2002) put forward a model of the aetiology of perfectionism, expressed in terms of 
SPP, SOP and OOP. It is interesting that this model not only considers parenting 
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factors but also makes propositions about the role of the environment and the child 
in the development of perfectionism. This model is depicted in Figure 2.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Preliminary model of the development of perfectionism (reproduced from 
Flett et al., 2002) 
 
Flett et al.’s (2002) model posits that three types of risk factors can place 
perfectionistic pressures upon an individual: parent factors, environmental pressures, 
and child factors. In regard to parent factors, a child may acquire perfectionism upon 
exposure to authoritarian parents who behave in ways that promote perfectionism, 
such as putting their child in environments that accentuate meeting standards. 
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Perfectionism may also develop upon exposure to a parent who articulates high 
personal standards, performance-related goals and models perfectionist behaviours. 
In reference to environmental pressures, a child may acquire perfectionism from 
being raised in societal contexts that promote attaining certain standards, as well as 
being in competitive school and work contexts that foster social comparison. In 
regard to child factors, a child is more likely to develop perfectionism if they have a 
greater openness to socialisation and therefore internalise parental and societal 
values to a greater extent. Additionally, a child with a temperament characterised by 
elevated emotionality and high persistence may be more likely to acquire 
perfectionism (Flett et al., 2002). 
Flett et al.’s (2002) model posits that in the presence of such pressure to be 
perfect, whether an individual actually develops perfectionism and the type of 
perfectionism they develop is contingent on additional factors. In a child with greater 
openness to socialisation and ability to achieve, the pressure to be perfect may lead 
to SOP. In a child who is capable, but has undergone trauma in a chaotic 
environment, the pressure to be perfect may lead to OOP. It is possible however, for 
a child to reject the pressure to be perfect that is placed upon them and consequently 
not develop perfectionism. 
While Flett et al.’s (2002) model considered a number of factors that may be 
involved in the aetiology of perfectionism, most of the factors with the exception of 
parenting and modelling have a very limited evidence base to support them. 
Moreover, there have not been any studies that have provided an empirical test of the 
whole model, thus there is a need for additional research to support the validity of 
this model.  Another critique of Flett et al.’s (2002) model is that it does not specify 
factors that would contribute to the maintenance of SOP or OOP once it is acquired. 
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Studies have continued to test smaller models of the relationships between 
parenting and specific dimensions of perfectionism (Cook & Kearney, 2009; 
Soenens et al., 2005; Soenens et al., 2008). Cook and Kearney (2009) found that 
mothers’ SOP was significantly associated with sons’ SOP and that this relationship 
was completely mediated by maternal obsessive-compulsive symptoms. The authors 
contended that this relationship may have emerged because mothers who have 
perfectionism and anxiety symptoms may model perfectionism. These mothers may 
also impart information about the necessity of being cautious and responsible and the 
consequences of being uncertain and making errors (Cook & Kearney, 2009). 
Soenens et al. (2005) reported significant relationships between mothers’ and 
daughters’ PS scores as well as fathers’ and daughters’ PS scores. Significant direct 
associations also occurred between mothers’ and daughters’ CM and DA scores, but 
not fathers’ and daughters’ CM and DA scores. Soenens et al. (2005) then tested a 
mediational model in which psychological control mediated the intergenerational 
transmission of CM and DA. Psychological control is a parenting style in which 
parents use methods such as the withdrawal of affection or the induction of guilt to 
coerce a child into meeting their personal standards (Barber, 1996; Soenens et al., 
2005). Support was obtained for a model in which psychological control fully 
mediated the associations between parents’ CM and DA and daughters’ CM and DA. 
The authors argued that these findings suggest that the direct association between the 
CM and DA of mothers and daughters is completely mediated by the mother 
employing psychological control (Soenens et al., 2005). The studies by Soenens et 
al. (2005) and Cook and Kearney (2009) are commended for examining mediators of 
the intergenerational transmission of perfectionism; however, the cross-sectional 
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nature of the studies still prevents inferences of causality. Longitudinal studies are 
required to enable inferences about the direction of effects. 
One of the only longitudinal studies to examine the relationship between 
parenting and perfectionism was conducted by Soenens et al. (2008). Soenens et al. 
found in a sample of mixed gender that both adolescents’ and parents’ ratings of 
psychological control on the Psychological Control Scale (Barber, 1996) 
significantly predicted adolescents’ CM and DA one year later. This emerged after 
having accounted for baseline levels of CM and DA. This finding provided evidence 
that psychological control is a risk factor for the development of elevated CM and 
DA (Soenens et al., 2008). Additional longitudinal studies, ideally those that follow 
children from birth, are needed to make inferences about the variables that are risk 
factors for the development of perfectionism. 
Studies have indicated that genetic factors may at least partially influence the 
aetiology of perfectionism (Lilenfeld et al., 2000; Rector, Cassin, Richter, & 
Burroughs, 2009; Woodside et al., 2002). Lilenfeld et al. (2000) found that the first 
degree relatives of individuals with bulimia nervosa had significantly higher EDI-P, 
CM, PC and total FMPS compared to the first-degree relatives of women without 
eating disorders. Woodside et al. (2002) reported that mothers of women with 
anorexia nervosa had significantly higher CM, PC and total FMPS compared to the 
mothers of women without an eating disorder. Rector et al. (2009) found that the first 
degree relatives of individuals with early-onset obsessive-compulsive disorder had 
significantly higher scores on OBQ-PC compared to the relatives of individuals 
without obsessive-compulsive disorder. As dimensions of perfectionism such as 
EDI-P, CM and OBQ-PC are associated with eating disorders and/or obsessive-
compulsive disorder symptoms (e.g., Bardone-Cone et al., 2007; Manos et al., 2010), 
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the findings of first-degree relatives also having elevated levels of these dimensions 
support notions of perfectionism being at least partially genetically transmitted 
(Lilenfeld et al., 2000; Rector et al., 2009; Woodside et al., 2002). Nevertheless, 
these studies cannot disentangle the relative contribution of genes and shared 
environment to these dimensions of perfectionism. 
Twin studies have provided support for both genetic and environmental 
components being involved in the aetiology of perfectionism as measured by EDI-P, 
CM, PS and DA. These studies have also enabled estimates of how much genetic 
and environmental components contribute toward these perfectionism dimensions 
(Kamakura, Ando, Ono, & Maekawa, 2003; Tozzi et al., 2004; Wade & Bulik, 
2007). In these twin studies, the correlations between monozygotic twins on EDI-P, 
CM, PS and DA were compared to those of dizygotic twins. Following this, models 
of components of variance (additive genetic components, specific environment and 
shared environment) were specified. Statistical programs were then utilised to fit 
these models to the data and estimate the proportion of variance in the perfectionism 
measure accounted for by genetic and environmental factors (Kamakura et al., 2003; 
Tozzi et al., 2004; Wade & Bulik, 2007).  
In Kamakura et al.’s (2003) study of 162 Japanese adult female twins, the 
correlations between monozygotic twins on EDI-P were significantly higher than 
that of dizygotic twins. Thirty-seven per cent of the variance in EDI-P was accounted 
for by additive genetic components and 66 per cent was accounted for by 
environmental factors (Kamakura et al., 2003). In Tozzi et al.’s (2004) study of 1022 
American adult female twins, the correlations between monozygotic twins on CM, 
PS and DA were higher than the correlations between dizygotic twins, leading the 
authors to argue that perfectionism has moderate heritability. Additive genetic 
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factors accounted for 29 per cent of the variance in CM, 42 per cent of the variance 
in PS and 32 per cent of the variance in DA; whereas environmental factors 
accounted for 60 per cent of the variance in CM, 58 per cent of the variance in PS 
and 68 per cent of the variance in DA. Wade and Bulik (2007) utilised a sample of 
4268 Australian adult twins and found greater correlations between monozygotic 
twins on CM, PS and DA relative to dizygotic twins. Additive genetic factors 
accounted for 39 per cent of the variance in CM, 36 per cent of the variance in PS 
and 27 per cent of the variance in DA. Environmental factors accounted for 61 per 
cent of the variance in CM, 64 per cent of the variance in PS and 73 per cent of the 
variance in DA.  
These studies support the perfectionism dimensions of EDI-P, CM, PS and 
DA having genetic and environmental components, with the environmental 
component being larger than the genetic component. The latter two studies are 
particularly robust due to the large sample sizes. Furthermore, all three studies used 
reputable statistical procedures to estimate the contribution of genetic and 
environmental components, which indicates that these findings are reliable 
(Kamakura et al., 2003; Tozzi et al., 2004; Wade & Bulik, 2007). 
In sum, while Flett et al.’s (2002) model of the aetiology of perfectionism 
considered many risk factors for the development of perfectionism, a review of the 
evidence suggests that the main factor with empirical support is parenting (e.g., 
Soenens et al., 2008). Although not specified in Flett et al.’s (2002) model, there is 
evidence from family and twin studies to support genetic factors also being involved 
in the aetiology of perfectionism dimensions such as EDI-P, OBQ-PC, CM, PS and 
DA (Kamakura et al., 2003; Lilenfeld et al., 2000; Rector et al., 2009; Tozzi et al., 
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2004; Wade & Bulik, 2007; Woodside et al., 2002). There is a need for additional 
research on the aetiology of perfectionism.  
1.4. The Transdiagnostic Approach 
For decades researchers adopted a disorder-focus approach where the 
emphasis was on examining the cognitive and behavioural mechanisms that 
underpinned a specific disorder (Harvey, Watkins, Mansell, & Shafran, 2004). This 
was based on the premise that the processes responsible for the onset and 
maintenance of psychological disorders are significantly different in each disorder 
(Mansell, Harvey, Watkins, & Shafran, 2009). While this approach resulted in 
increased knowledge of specific disorders and the promulgation of evidence-based 
treatments for specific disorders, it became apparent that many of the behavioural 
and cognitive mechanisms that played a role across psychological disorders were 
similar (Craske, 2012; Harvey et al., 2004). This resulted in groups of researchers 
beginning to explore the value of changing from a disorder-focus orientation to an 
across-disorder or ‘transdiagnostic’ orientation (Harvey et al., 2004, p.1). Fairburn et 
al. (2003) applied this transdiagnostic orientation to the conceptualisation of eating 
disorders by arguing that common cognitive and behavioural constructs, one being 
clinical perfectionism, were directly implicated in the maintenance of anorexia 
nervosa, bulimia nervosa and atypical eating disorders. Harvey et al. (2004) asserted 
that certain behavioural and cognitive constructs responsible for the onset or 
maintenance of symptoms of a psychological disorder are shared across disorders. 
Such constructs were labelled transdiagnostic processes (Harvey et al., 2004).   
Harvey et al. (2004) and Mansell, Harvey, Watkins, and Shafran (2008) 
outlined three benefits of the transdiagnostic approach. First, the proposition of 
transdiagnostic processes being shared across disorders may offer a plausible 
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explanation for the high degree of co-morbidity of psychological disorders (Kessler, 
Chiu, Demler, & Walters, 2005). Second, the transdiagnostic approach may assist 
researchers to generalise information about the maintenance processes of well-
researched disorders to other disorders that are not yet well understood (Harvey et 
al., 2004; Mansell et al., 2008). The third and perhaps greatest advantage of the 
transdiagnostic approach is that treatments that focus specifically on a 
transdiagnostic process have the potential to concurrently ameliorate the symptoms 
of multiple psychological disorders (Fairburn et al., 2003; Harvey et al., 2004; 
Mansell et al., 2008). In support of the transdiagnostic approach, comprehensive 
reviews have provided evidence for many aspects of cognition and behaviour being 
transdiagnostic processes, some of which include thought suppression, selective 
attention and repetitive negative thinking (Harvey et al., 2004; Mansell et al., 2009). 
Notwithstanding the proposed benefits of the transdiagnostic approach, this 
approach is also subject to critique. The most salient challenge to the validity of the 
transdiagnostic approach is that it does not answer the question of why psychological 
disorders differ in their presentation. If psychological disorders share transdiagnostic 
processes, one would expect their presentations to be more similar than they are 
(Mansell et al., 2008). Mansell et al. (2008) provided three possible explanations for 
the differing presentation of psychological disorders. First, a person’s present area of 
concern will be the determinant of how a transdiagnostic process expresses itself as 
psychological symptoms. For example, the transdiagnostic process of hypervigilance 
may express itself as hypervigilance for panic symptoms in panic disorder and 
hypervigilance for threat in generalised anxiety disorder (Harvey et al., 2004; 
Mansell et al., 2008). Second, transdiagnostic processes may exist to different 
extents in different disorders, which may explain the different presentations of 
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disorders. Third, in addition to shared transdiagnostic processes, disorders may have 
processes that are specific to that disorder, which may explain why different 
disorders present differently (Mansell et al., 2008). While Mansell et al. (2008) 
reviewed evidence to support each of these propositions, it is to be acknowledged the 
evidence is preliminary and sufficiently more evidence is needed to support these 
propositions.  
Overall, while the transdiagnostic approach is very promising, it is still a 
recent approach with many questions to be answered. Additional research needs to 
be done to garner further support for the validity of the transdiagnostic approach 
(Harvey et al., 2004; Mansell et al., 2008). It is important to note that the 
transdiagnostic approach does not necessarily need to be seen as mutually exclusive 
to a disorder-specific approach, it may be a complementary approach (Mansell et al., 
2009). Mansell et al. (2009) purported that both the transdiagnostic and disorder-
specific approaches may be valuable based on the notion that transdiagnostic and 
disorder-specific processes may underpin different psychological disorders and the 
way in which these disorders present in certain individuals.  Future research is 
needed to explore this (Mansell et al., 2009). 
1.5. Perfectionism Posited to be a Transdiagnostic Process 
Egan et al. (2011) declared that perfectionism can be regarded as a 
transdiagnostic process. This was based on three arguments. First, there is an 
increasing body of literature highlighting that dimensions of perfectionism are 
associated with the onset, severity and maintenance of multiple psychological 
disorders. These disorders include depressive disorders, bi-polar I and II disorder, 
anxiety disorders, obsessive-compulsive and related disorders, feeding and eating 
disorders, as well as certain personality disorders (Egan et al., 2011). Second, there is 
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evidence consistent with the notion of perfectionism explaining the high co-
morbidity of psychological disorders (Bieling, Summerfeldt, Israeli, & Antony, 
2004; Brown, Campbell, Lehman, Grisham, & Mancill, 2001; Egan et al., 2011; 
Kessler, Chiu, et al., 2005). Third, dimensions of perfectionism have been shown to 
impede the outcome of interventions for certain psychological disorders (Egan et al., 
2011).  The evidence upon which these arguments are based is described in detail in 
the proceeding sections. The greatest implication of perfectionism being a 
transdiagnostic process is that interventions that focus on perfectionism may 
concurrently decrease the symptoms of multiple psychological disorders (Bieling et 
al., 2004; Egan et al., 2011; Fairburn et al., 2003; Harvey et al., 2004). 
1.5.1. The role of perfectionism in psychological disorders. 
1.5.1.1. Depressive disorders. The association between perfectionism and 
depression has been frequently reported in non-clinical and clinical studies (Egan et 
al., 2011). Studies of student samples have reported associations between CPQ 
scores, CM, DA, PE, PC and SPP with depression symptoms (Bieling, Israeli, et al., 
2004; Chang & Sanna, 2012; Flett, Hewitt, Blankstein, & O’Brien, 1991; Minarik & 
Ahrens, 1996; Steele, O’Shea, Murdock, Karney, & Wade, 2009; Wyatt & Gilbert, 
1998). There is mixed support for SOP being associated with depression symptoms, 
as some studies have found that SOP was related to depression symptoms (Flett, 
Hewitt, Blankstein, & Mosher, 1995), whereas other studies have not (Flett et al., 
1991; Wyatt & Gilbert, 1998). As these findings emerged from studies using cross-
sectional designs, causal inferences cannot be made. However, Flett, Hewitt, 
Blankstein et al. (1995) followed their cross-sectional research with prospective 
research and found that SOP was a prospective predictor of depression three months 
later. This provides evidence for SOP being a risk factor for the onset of depressive 
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symptoms. Nevertheless, the non-clinical sample prevents generalisation to clinical 
populations with depression.  
Studies in clinical samples have reported that individuals with depression 
score significantly higher on SOP, SPP (Hewitt & Flett, 1991b; Enns, Cox, & 
Borger, 2001; Wheeler, Blankstein, Antony, McCabe, & Bieling, 2011), CM, PS, 
DA, PC, total FMPS (Enns et al., 2001; Gelabert et al., 2012; Sassaroli et al., 2008; 
Wheeler et al., 2011) and DAS-SC (Batmaz, Kaymak, Soygur, Ozalp, & Turkcapar, 
2013) compared to non-depressed controls.  While these studies highlight significant 
associations between these perfectionism variables and depression that can be 
generalised to clinical samples, the cross-sectional designs of the studies prevent the 
direction of effect being ascertained. 
Additional cross-sectional studies in clinical samples have provided evidence 
of SOP, SPP, CM and total FMPS predicting current depressive symptoms (Enns & 
Cox, 1999; Enns et al., 2001; Gelabert et al., 2012; Hewitt & Flett, 1993; Wheeler et 
al., 2011). Hewitt and Flett (1993) found in a sample with mixed diagnoses that SOP 
and SPP predicted depression scores on the Beck Depression Inventory (BDI; Beck 
& Steer, 1987) in the context of achievement-related stress. In a depressed sample, 
however, SOP predicted depression symptoms in situations of achievement-related 
stress, whereas SPP predicted depression symptoms in situations of interpersonal 
stress. Enns and Cox (1999) found that SPP and CM were significantly related to 
BDI scores in a depressed sample after controlling for extroversion and neuroticism; 
whereas Enns et al. (2001) demonstrated that SPP significantly predicted BDI scores 
in a depressed sample after controlling for extraversion and rumination. Wheeler et 
al. (2011) found that CM and MEC each significantly predicted depression scores on 
the Depression, Anxiety and Stress Scale-21 (DASS-21; Lovibond & Lovibond, 
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1995) in a clinical sample with mixed diagnoses. Gelabert et al. (2012) demonstrated 
that high CM was a significant positive predictor of a post-partum depression 
diagnosis, with this variable being related to a four-fold increase in the likelihood of 
post-partum depression after accounting for neuroticism, psychiatric history and a 
specific genotype combination.  
Collectively, these cross-sectional studies provide support for SOP, SPP, CM 
and MEC predicting current depressive symptoms across multiple clinical samples, 
which promotes generalisation to depressed populations (Enns & Cox, 1999; Enns et 
al., 2001; Gelabert et al., 2012; Hewitt & Flett, 1993; Wheeler et al., 2011). In many 
of these studies the relationships emerged after controlling for confounds, which 
provides greater support for the uniqueness of these relationships. Nevertheless, the 
cross-sectional designs of these studies prevent inferences of causality. To determine 
the direction of effect between these perfectionism dimensions and depression, 
studies utilising longitudinal designs are needed. 
Prospective studies conducted in mixed and clinical samples have provided 
support for SOP, SPP and DAS-SC prospectively predicting depression onset 
(Dunkley, Sanislow, Grilo, & McGlashan, 2006; 2009; Hewitt, Flett, & Ediger, 
1996). Hewitt et al. (1996) found that under circumstances of achievement-related 
stress, SOP was a significant positive predictor of depressive symptoms on the BDI 
(Beck & Steer, 1987) four months later in a sample with chronic unipolar or bipolar 
depression after controlling for initial depression. SPP also predicted BDI scores 
four months later in this sample. Dunkley et al. (2006) found that DAS-SC was a 
significant positive predictor of BDI-II scores three years later in a clinical sample 
with mixed diagnoses after controlling for baseline depression and neuroticism. The 
mediators of this relationship were an avoidant coping style, negative social 
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encounters and negative perceptions of support from others. Dunkley et al. (2009) 
reported that DAS-SC scores significantly predicted self-report and interviewer-
assigned depression, as well as functional impairment in broad psycho-social 
domains four years later, after controlling for baseline depression and neuroticism.  
A mediator of this relationship was negative perceptions of support from others. The 
findings of these prospective studies are important as they provide support for SOP, 
SPP and DAS-SC being risk factors for the onset of depression, which can be 
generalised to depressed populations (Dunkley et al., 2006; 2009; Hewitt et al., 
1996). Additionally, these studies controlled for confounds such as initial level of 
depression. Moreover, Dunkley et al.’s (2006; 2009) studies assessed depressive 
symptoms up to four years later and examined mediators of this relationship. Thus, 
there is reliable evidence for SOP, SPP and DAS-SC being prospective factors in 
depressive symptom onset (Dunkley et al., 2006; 2009; Hewitt et al., 1996). 
Studies have also supported SOP being associated with the maintenance of 
depression (Enns & Cox, 2005; Hewitt, Flett, Ediger, Norton, & Flynn, 1998). 
Hewitt, Flett, et al. (1998) found that SOP significantly predicted the chronicity of 
unipolar depression in a clinical sample after controlling for current state depression 
levels and the chronicity of bipolar symptoms. While this study highlights an 
association between SOP and the persistence of depression, with findings that can be 
generalised to clinical samples; the cross-sectional design prevents causal inferences. 
Enns and Cox (2005) conducted a prospective study and found that SOP interacted 
with achievement-related life events to significantly predict the non-remission of 
depressive symptoms in depressed outpatients at 1-year follow-up. The findings of 
this study support SOP prospectively predicting the maintenance of depression under 
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circumstances of achievement-related stress, with the clinical sample enabling 
findings to be generalised to depressed adult populations. 
In sum, there is evidence from cross-sectional studies conducted in clinical 
samples of SOP, CM, PS, SPP, DA, PC, total FMPS and DAS-SC being associated 
with depressive symptoms (Batmaz et al., 2013; Enns & Cox, 1999; Enns et al., 
2001, Gelabert et al., 2012; Hewitt & Flett, 1993; Sassaroli et al., 2008; Wheeler et 
al., 2011) with findings that can be generalised to clinically depressed populations, 
but not enabling inferences of causality. The findings from prospective studies in 
clinical samples provide stronger support for SOP, SPP and DAS-SC being risk 
factors for the onset of depression (Dunkley et al., 2006; 2009; Hewitt et al., 1996), 
with SOP also being involved in the maintenance of depression (Enns & Cox, 2005; 
Hewitt, Flett, et al. 1998). 
1.5.1.2. Bipolar and related disorders. There is only a small body of research 
on the associations between specific dimensions of perfectionism and bipolar 
symptoms. Significantly higher DAS-SC scores have been obtained by individuals 
with current or previous bipolar I disorder relative to healthy controls (Goldberg, 
Gerstein, Wenze, Welker, & Beck, 2008; Scott, Stanton, Garland, & Ferrier, 2000), 
as well as by adults with bipolar I or II disorder relative to controls (Batmaz et al., 
2013). Goldberg et al. (2008) also found evidence of DAS-SC scores being 
significantly related to manic symptom severity as measured by the Cognitive 
Checklist-Revised (Beck, Colis, Steer, Madrak, & Goldberg, 2006). While these 
studies support a relationship between DAS-SC scores and bipolar symptoms that 
can be generalised to clinical samples with bipolar disorder, the cross-sectional 
design of these studies prevent inferences being made about the direction of cause 
and effect. 
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Prospective studies have provided mixed support for a perfectionist cognitive 
style being related to the onset of bipolar symptoms (Alloy et al., 2009; Francis-
Raniere, Alloy, & Abramson, 2006). Francis-Raniere et al.’s (2006) study suggested 
that a perfectionist cognitive style was associated with the onset of bipolar symptoms 
in the context of cognitive-style congruent life events (Francis-Raniere et al., 2006). 
Francis-Raniere et al. (2006) assessed the cognitive styles of individuals with bipolar 
II disorder and cyclothymia through administering the subscales of the Dysfunctional 
Attitudes Scale (Weissman & Beck, 1978), the Depressive Experiences 
Questionnaire (DEQ; Beck, 1976) and the Sociotropy Autonomy Scale (SAS; Beck, 
Epstein, Harrison & Emery, unpublished, in Francis-Raniere et al., 2006). Factor 
analyses of these measures identified four factors, one of which included a self-
criticism/performance evaluation factor. This factor depicted a cognitive style 
typified by a focus on performance, elevated autonomy and heightened self-
criticism. Self-criticism/performance evaluation significantly predicted increased 
hyper-manic symptoms four months later in the context of cognitive-style congruent 
positive events. This cognitive style also significantly predicted increased depressive 
symptoms four months later in the context of cognitive-style congruent negative 
events. These relationships emerged after controlling for baseline symptoms and 
number of life events. The findings of this prospective study are consistent with a 
perfectionist cognitive style being involved in the onset of bipolar symptoms in the 
context of cognitive-style congruent life events (Francis-Raniere et al., 2006). 
Alloy et al.’s (2009) prospective study reported different findings to those of 
Francis-Raniere et al. (2006). Alloy et al. (2009) examined whether each measure 
that comprised the self-criticism/performance evaluation factor individually 
predicted bipolar symptoms over 3.2 years. Only DEQ-self-criticism and SAS-
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autonomy were significant positive predictors of manic/hypomanic episodes, 
whereas SAS-autonomy was a significant negative predictor of depressive episodes 
after accounting for past mood episodes and baseline symptoms. DAS-SC scores did 
not significantly predict increased manic/hypomanic or depressive episodes. The 
findings of Alloy et al.’s (2009) and Francis-Raniere et al.’s (2006) prospective 
studies are difficult to reconcile; however, one possibility may be that a cognitive 
style including perfectionism may only predict bipolar symptoms under 
circumstances of cognitive-style congruent events; without these events, a cognitive 
style including perfectionism may not have predictive utility in bipolar symptoms. 
Additional prospective studies are needed to clarify this issue. 
There is evidence from one cross-sectional study of SPP and OOP being 
associated with the maintenance of bipolar symptoms (Hewitt, Flett, et al., 1998). 
Hewitt, Flett, et al. (1998) reported in a clinical sample that SPP and OOP were 
significant positive predictors of the chronicity of bipolar symptoms and that this 
relationship remained after accounting for state depression and chronic unipolar 
depression symptoms. This provides support for SPP and OOP being related to the 
non-remission of bipolar symptoms; however, the cross-sectional design of this 
study prevents causal inferences. 
In sum, there is evidence from cross-sectional studies of DAS-SC being 
associated with bipolar symptoms (Batmaz et al., 2013; Goldberg et al., 2008; Scott 
et al., 2000). Prospective studies have provided mixed support for a perfectionist 
cognitive style being involved in the onset of bipolar symptoms, with one possibility 
being that this style is only involved in the onset of bipolar symptoms under 
circumstances of cognitive-style congruent events (Alloy et al., 2009; Francis-
Raniere et al., 2006). One cross-sectional study has also reported SPP and OOP 
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being associated with the maintenance of bipolar symptoms (Hewitt, Flett, et al., 
1998). Additional research using prospective studies is needed to further inform this 
area. 
1.5.1.3. Suicidal ideation, self-harm and suicidal behaviour. Studies in 
student samples have consistently reported associations between SPP, CM, DA and 
total FMPS with suicidal ideation; however, there is mixed support for the 
association between SOP and suicidal ideation (Adkins & Parker, 2006; Blankstein, 
Lumley, & Crawford, 2007; Dean, Range, & Goggin, 1996; Hamilton & Schweizer, 
2001; Hewitt, Flett, & Weber, 1994). Individuals who endorsed experiencing 
suicidal ideation obtained higher total FMPS, CM and DA than those without 
suicidal ideation (Hamilton & Schweizer, 2001). CM and DA were also significantly 
correlated with suicidal ideation and CM was correlated with having made a suicide 
plan in the past year (Adkins & Parker, 2006). Hewitt, Flett, & Weber (1994) 
reported that individuals with moderate or high suicidal ideation had significantly 
higher SOP and SPP than those with low suicidal ideation. SOP and SPP also 
significantly predicted suicidal ideation in situations of life stress. Dean et al. (1996) 
found that SPP significantly predicted suicidal ideation after accounting for 
hopelessness and depression, but did not measure SOP. Blankstein et al. (2007) 
reported that SPP significantly predicted suicidal ideation, but SOP did not.  
The evidence from these studies in student samples suggests that CM, DA, 
total FMPS and SPP are significantly associated with suicidal ideation, with mixed 
support for SOP being associated with suicidal ideation (Adkins & Parker, 2006; 
Blankstein et al., 2007; Dean et al., 1996; Hamilton & Schweizer, 2001; Hewitt, 
Flett, & Weber, 1994). Each of these studies used large sample sizes, which enables 
generalisation to student populations; however, the cross-sectional designs of these 
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studies prevent causal inferences and results cannot be generalised to clinical 
populations. O’Connor et al. (2010) conducted a prospective study in a student 
sample and found that SPP significantly predicted self-harm in adolescents under 
circumstances of life stress. Due to the stronger design, these findings support SPP 
being a risk factor for self-harm among adolescent students; nonetheless, these 
findings do not generalise to clinical samples. 
Cross-sectional studies in clinical samples have consistently reported 
associations between SPP and suicidal ideation, self-harm and suicide attempts; 
however, there is mixed evidence for the associations between SOP and OOP with 
suicidal ideation and self-harm (Hewitt, Flett, & Weber, 1994; Hewitt, Norton, Flett, 
Callander, & Cowan, 1998; Hunter & O’Connor, 2003; Rasmussen, O’Connor, & 
Brodie, 2008). Hewitt, Flett, and Weber (1994) found in a psychiatric sample that 
individuals with moderate or high suicidal ideation scored significantly higher on 
SPP and SOP than individuals with low or no suicidal ideation. SPP and SOP each 
significantly contributed to discriminating between groups after accounting for 
hopelessness and depression. Hunter and O’Connor (2003) reported significantly 
greater SPP in patients hospitalised for self-harm relative to controls, with SPP 
significantly contributing to discriminating between groups after accounting for 
hopelessness, anxiety and depression; however there were no significant results for 
SOP.  
Rasmussen et al. (2008) found that SPP but not SOP significantly predicted 
suicidal ideation in a sample hospitalised for self-harm, with a moderator of this 
relationship being high levels of over-general positive memory recall. Hewitt, 
Norton, et al. (1998) found in a sample with alcohol dependence that adults who had 
attempted suicide had significantly higher SPP compared to adults who had not 
46 
 
attempted suicide. SPP and OOP significantly contributed to discriminating between 
groups after accounting for depression and social hopelessness. Thus, there is 
consistent support for SPP and mixed support for SOP being related to suicidal 
ideation, self-harm and suicide attempts in clinical samples (Hewitt, Flett, & Weber, 
1994; Hewitt, Norton, et al., 1998; Hunter & O’Connor, 2003; Rasmussen et al., 
2008). While these findings can be generalised to clinical populations, the cross-
sectional nature of these studies does not enable inferences about the direction of 
effect. 
Prospective studies in clinical samples have supported DAS-SC and SPP 
being risk factors for suicidal ideation (Beevers & Miller, 2004; O’Connor et al., 
2007). Beevers and Miller (2004) reported that depressed inpatients’ DAS-SC scores 
significantly predicted their suicidal ideation level six months after discharge, after 
accounting for baseline depression and baseline suicidal severity. This association 
was not mediated by hopelessness (Beevers & Miller, 2004).  O’Connor et al. (2007) 
found that in individuals with a repetitive self-harm history who had recently self-
harmed with suicidal intent, high SPP attenuated the relationship between positive 
future thinking and lowered suicidal ideation two months later. In individuals with 
low SPP, high positive future thinking on a future thinking task (MacLeod, 
Pankhania, Lee, & Mitchell, 1997) was significantly related to lowered suicidal 
ideation two months later. For participants with high SPP there was no significant 
relationship between high positive future thinking and lowered suicidal ideation two 
months later (O’Connor et al., 2007). The findings of these prospective studies 
support DAS-SC and SPP being risk factors for suicidal ideation and such findings 
can be generalised to clinical samples (Beevers & Miller, 2004; O’Connor et al., 
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2007). Additional prospective studies in clinical samples are needed to investigate 
the role of other perfectionism constructs (e.g., CPQ, CM, DA) in suicidal ideation. 
1.5.1.4. Feeding and eating disorders. Comprehensive reviews have reported 
that certain dimensions of perfectionism are not only associated with eating disorder 
symptoms in non-clinical and clinical samples, but dimensions such as SOP, PS, 
CM, DA and EDI-P are risk factors and/or maintenance factors for eating disorders 
(Bardone-Cone et al., 2007; Egan et al., 2011; Lilenfeld et al., 2006; Stice, 2002).  It 
is interesting that SOP, PS and CM are implicated in the onset and maintenance of 
eating disorders as these dimensions most closely align with Shafran et al.’s (2002) 
definition of clinical perfectionism.  
Studies in non-clinical samples have consistently reported associations 
between SOP and eating-disordered attitudes and behaviours; however, there is 
mixed support for SPP being associated with eating disorder symptoms (Bardone-
Cone, 2007; Fitzsimmons-Craft, Bardone-Cone, Brown-Stone, & Harney, 2012). 
Bardone-Cone (2007) found that female students reporting high levels of bulimic 
symptoms had significantly greater SOP and SPP than those with low levels of 
bulimic symptoms. SOP was a significant predictor of bulimic symptoms after 
controlling for negative affect, whereas SPP was not. Bardone-Cone (2007) also 
reported that females engaging in high levels of dieting had significantly higher SOP 
than those engaging in low levels of dieting and found that SOP significantly 
predicted dieting. Fitzsimmons-Craft et al. (2012) discovered that both SOP and SPP 
significantly predicted binge-eating in female students. Joyce, Watson, Egan, and 
Kane (2012) reported in a community sample that a SOP dimension derived from a 
factor analysis of the EDI (Sherry, Hewitt, Besser, McGee, & Flett, 2004) was 
significantly associated with eating disorder symptoms on the Eating Disorders 
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Examination Questionnaire (Fairburn & Beglin, 1994), with this association being 
mediated by conditional goal setting and over-valuation of shape and weight (Joyce 
et al., 2012).  
There is also support for CM, DA and O being significantly associated with 
body dissatisfaction (Wade & Tiggemann, 2013). Wade and Tiggemann (2013) 
examined data from a twin study involving 1083 women and found that heightened 
CM and O significantly predicted a lower desired Body Mass Index (BMI) after 
having controlled for current BMI. Wade and Tiggemann (2013) also found that 
heightened CM, O and DA significantly predicted a smaller ideal silhouette. This 
study utilised a large sample size, which promotes generalisation to female twins; 
however, studies should also examine this in a non-twin sample.  
Overall, these studies provide support for SOP, CM, DA and O being 
associated with eating disordered attitudes and behaviours in non-clinical samples, 
with some support for SPP being related to eating pathology (Bardone-Cone, 2007; 
Fitzsimmons-Craft et al., 2012; Joyce et al., 2012; Wade & Tiggemann, 2013). 
Nevertheless, these studies all used cross-sectional designs, which prevent inferences 
of causality. The use of non-clinical samples also prevents generalisation to eating 
disorder populations. 
 Studies utilising experimental designs have provided stronger support for 
PS, CM and DA being aetiologically involved in eating disorder symptoms in non-
clinical samples (Boone, Soenens, Vansteenkiste, & Braet, 2012; Shafran, Lee, 
Payne, & Fairburn, 2006). Shafran et al. (2006) examined the effect of manipulating 
personal standards upon eating attitudes and behaviour. Forty-one women were 
randomised to a high personal standards or low personal standards condition, in 
which they signed a contract to complete all tasks over the following 24 hours to the 
49 
 
highest or the minimal standard respectively. Females randomised to the high 
personal standards condition had significantly greater ratings on a visual analogue 
scale of clinical perfectionism (Shafran et al., 2004), engaged in a significantly 
greater number of attempts to restrict their food intake, consumed significantly less 
high calorie foods and exhibited significantly greater regret following eating relative 
to those in the low standards condition (Shafran et al., 2006).  
Boone, Soenens, et al. (2012) conducted an extension of this research in 
which males and females were randomised to a high personal standards condition, a 
low personal standards condition or a personal standards plus evaluative concerns 
condition. The first two conditions were as in Shafran et al. (2006), whereas the third 
condition involved participants signing a contract to complete all tasks over the 
following 24 hours to the highest standard and ensuring that they did not fail to meet 
their standards. After the manipulation, individuals in the high personal standards 
condition, as well as the personal standards plus evaluative concerns condition 
exhibited significantly greater levels of PS, evaluative perfectionism (CM +DA), and 
significantly greater restraint and binge-eating relative to individuals in the low 
personal standards condition. As these studies utilised experimental designs, this 
enables one to infer that PS, CM and DA are aetiological factors in eating disorder 
symptoms (Boone, Soenens, et al., 2012; Shafran et al., 2006). Nevertheless, the use 
of non-clinical samples prevents generalisation to eating disorder populations.  
Prospective studies in student samples have provided support for EDI-P and 
PS interacting with factors such as self-esteem, perceived weight status and body 
dissatisfaction to prospectively predict bulimic symptoms up to nine months later 
(Steele, Corsini, & Wade, 2007; Vohs, Bardone, Joiner, Abramson, & Heatherton, 
1999; Vohs et al., 2001). Vohs et al. (1999) found that high EDI-P under 
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circumstances of low self-esteem and high perceived weight status significantly 
predicted scores on the EDI-Bulimia subscale (Garner et al., 1983) nine months later. 
This was after accounting for baseline BMI and bulimic symptoms. Vohs et al. 
(2001) reported that high EDI-P, low self-esteem and high body dissatisfaction 
significantly predicted EDI-bulimia scores five weeks later. This was after 
controlling for baseline bulimia, anxiety and depression. Steele et al. (2007) 
however, found that high PS under circumstances of high self-esteem and high 
perceived weight status significantly predicted EDI-bulimia scores three months later 
after accounting for baseline BMI and bulimia scores. As these studies have utilised 
prospective designs, they provide support for EDI-P and PS being risk factors for 
bulimic symptoms in situations of high perceived weight status, high body 
dissatisfaction as well as low and high self-esteem. Additional research is needed to 
ascertain the levels of self-esteem that place individuals at greater risk of bulimic 
symptom onset in the context of elevated EDI-P, PS, high perceived weight and high 
body dissatisfaction (Steele et al., 2007; Vohs et al., 1999; Vohs et al., 2001). Future 
research should also use clinical samples to promote generalisation of these findings 
to eating disorder populations. 
Studies using clinical samples have found that adults with anorexia nervosa 
have significantly higher EDI-P, PS, CM, DA, PE, PC, O (Bastiani, Rao, Weltzin, & 
Kaye, 1995; Halmi et al., 2000; Moor, Vartanian, Touyz, & Beumont, 2004), SOP 
and SPP (Bastiani et al., 1995; Cockell et al., 2002) relative to controls or population 
norms. Adults with bulimia nervosa have significantly higher EDI-P, PS, CM, DA, 
PC, PE, total FMPS (Lilenfeld et al., 2000; Moor et al., 2004), as well as SOP 
relative to controls (Pratt, Telch, Labouvie, Wilson, & Agras, 2001). A mixed 
sample of individuals with anorexia nervosa or bulimia nervosa also scored 
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significantly higher on PS, CM, DA, PC and PE relative to non-clinical controls 
(Sassoroli et al., 2008).  
A limited number of studies have examined perfectionism in individuals with 
binge-eating disorder or an other-specified feeding or eating disorder (Egan, Shafran, 
et al., 2014; Lethbridge et al., 2012; Moor et al., 2004). It is important to note that 
these two eating disorder diagnoses are terms from the DSM-5 (APA, 2013). The 
DSM-IV-TR (APA, 2000) categorised the symptoms of each of these disorders as 
eating disorder not otherwise specified (EDNOS), thus research in this area refers to 
the EDNOS diagnostic category. Moor et al. (2004) found that individuals with 
EDNOS did not significantly differ on EDI-P compared to controls. However, 
Lethbridge et al. (2012) reported that a sample who had anorexia nervosa, bulimia 
nervosa or EDNOS scored significantly higher on SOP compared to non-eating 
disordered controls. Egan, Shafran, et al. (2014) found that a sample who had 
bulimia nervosa or EDNOS had significantly higher CPQ scores than controls. In the 
latter two studies, the mixed nature of the sample may have enabled the individuals 
with anorexia nervosa and/or bulimia nervosa to inflate the mean SOP or CPQ score, 
even if individuals with EDNOS did not have elevated SOP or CPQ scores (Egan, 
Shafran, et al., 2014; Lethbridge et al., 2012). Further research investigating whether 
EDI-P, SOP and CPQ are elevated in individuals with binge-eating disorder or an 
other-specified feeding or eating disorder is needed.  
In sum, the findings of these studies offer support for EDI-P, PS, CM, DA, 
PE, PC and SOP being associated with anorexic and bulimic symptoms (Bastiani et 
al., 1995; Halmi et al., 2000; Lilenfeld et al., 2000; Moor et al., 2004; Pratt et al., 
2001) and SPP being associated with anorexic symptoms (Bastiani et al., 1995; 
Cockell et al., 2002). There is also some evidence of elevated SOP and CPQ scores 
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in samples with binge-eating disorder or an other-specified feeding or eating disorder 
(Egan, Shafran, et al., 2014; Lethbridge et al., 2012). Nevertheless, the designs of 
these studies do not enable causal inferences. 
Cross-sectional studies have shown that SOP, PS, CM and DA are associated 
with the severity of eating disorder symptoms in clinical samples (Bardone-Cone et 
al., 2008; Boone, Braet, Vandereycken, & Claes, 2012; Egan, Watson, et al., 2013; 
Lethbridge et al., 2012; Watson, Raykos, Street, Fursland, & Nathan, 2011). SOP 
has been found to significantly predict eating disorder severity in individuals with 
anorexia nervosa, bulimia nervosa or EDNOS (Lethbridge et al., 2012), with 
mediators of this relationship being conditional goal setting, shape and weight over-
valuation (Watson et al., 2011) and anxiety (Egan, Watson, et al., 2013). Moreover, 
evaluative concerns perfectionism (CM and DA) significantly predicted body image 
concerns among female inpatients with anorexia nervosa, bulimia nervosa or 
EDNOS (Boone, Braet, et al., 2012). Bardone-Cone et al. (2008) found that in 
women with current or sub-clinical bulimia nervosa who were vomiting, CM and PS 
each moderated the relationship between weight/ shape concern and vomiting 
frequency. Weight/shape concern only had a significant relationship with vomiting 
frequency in individuals with elevated PS or CM and low self-efficacy. Additionally, 
in women who were binge-eating, CM moderated the relationship between 
weight/shape concern and binge eating frequency. Weight/shape concern was only 
significantly related to binge-eating frequency under circumstances of high CM and 
low self-efficacy. The findings from these cross-sectional studies support SOP, PS, 
CM and DA being related to eating disorder severity in clinical samples; however,  
again, the cross-sectional designs do not enable inferences about the direction of 
effect (Bardone-Cone et al., 2008; Boone, Braet, et al., 2012; Egan, Watson, et al., 
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2013; Lethbridge et al., 2012; Watson et al., 2011). Studies with longitudinal designs 
are needed to ascertain the temporal order of effects.  
Retrospective studies have demonstrated that females with current anorexia 
nervosa (Fairburn, Cooper, Doll, & Welch, 1999) and current bulimia nervosa 
(Fairburn, Welch, Doll, Davies, & O’Connor, 1997) reported experiencing greater 
levels of perfectionism in their childhood relative to females without disorders. The 
retrospective designs used in these studies enable one to infer that perfectionism is 
likely to be a risk factor for eating disorder symptoms; however, the data may have 
been affected by recall biases. The clinical samples enable findings to be generalised 
to females with anorexia nervosa and bulimia nervosa.  
Family and twin studies have suggested that EDI-P, PS, CM and PC are risk 
factors for eating disorder onset (Lilenfeld et al., 2000; Wade et al., 2008; Woodside 
et al., 2002). Studies have reported elevated EDI-P, CM, PC and total FMPS in the 
first degree relatives of individuals with eating disorders compared to the relatives of 
controls (Lilenfeld et al., 2000; Woodside et al., 2002). In Wade et al.’s (2008) twin 
study, the co-twins of women with anorexia nervosa had significantly higher PS 
compared to the co-twins of women without eating disorders. This relationship 
remained significant after accounting for the temperaments of the women with 
anorexia nervosa and the control women. These studies suggest that EDI-P, PS, CM 
and PC may increase an individual’s vulnerability to an eating disorder. 
Clinical perfectionism has also been posited to be a significant maintaining 
factor in eating disorders (Fairburn et al., 2003a). Fairburn et al.’s (2003a) 
transdiagnostic model of eating disorders theorises that clinical perfectionism is one 
of the four mechanisms that can interact with the primary eating disorder 
maintenance factors to contribute to the maintenance of an eating disorder in specific 
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individuals. Fairburn et al. (2003a) claimed that if clinical perfectionism was reduced 
then “a potent additional network of maintaining mechanisms would be removed 
thereby facilitating change” (p. 516). Based on this theory, Fairburn et al. (2003a) 
developed a transdiagnostic treatment called Enhanced Cognitive Behaviour Therapy 
(CBT-E) to be used with outpatients with an eating disorder. CBT-E not only targets 
the primary eating disorder maintenance factors, but also includes treatment modules 
that address clinical perfectionism and three other maintenance factors, which are 
used when these factors contribute to the persistence of an individual’s eating 
disorder (Fairburn et al., 2003a). Studies have supported the efficacy of CBT-E 
(Fairburn et al., 2009), as well as the effectiveness of CBT-E in outpatients with 
eating disorders (Byrne, Fursland, Allen, & Watson, 2011; Dalle Grave, Callugi, 
Doll, & Fairburn, 2013; Fairburn et al., 2013) and inpatients with eating disorders 
(Dalle Grave, Calugi, Conti, Doll, & Fairburn, 2013). This evidence of the efficacy 
and effectiveness of CBT-E in reducing eating disorder symptoms provides support 
for clinical perfectionism maintaining eating disorder pathology. 
 Cross-sectional studies have offered support for EDI-P, SOP, SPP and PCI 
scores being associated with eating disorder maintenance. This is through showing 
that individuals recovering from eating disorders have similar levels of these 
perfectionism dimensions to individuals with current eating disorders (Bardone-
Cone, Sturm, Lawson, Robinson, & Smith, 2010; Holland, Bodell, & Keel, 2013; 
Niv, Kaplan, Mitrani, & Shang, 1998; Santonastaso, Friederici, & Favaro, 1999). 
Niv et al. (1998) found that individuals with current anorexia nervosa and those 
recovering from anorexia nervosa did not significantly differ on EDI-P; however, 
both groups had significantly higher EDI-P than controls. Bardone-Cone et al. 
(2010) reported that females with a current eating disorder diagnosis and females 
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who were partially recovered did not significantly differ in SOP, SPP and PCI 
scores; however, their scores on these measures were significantly greater than those 
of females who had fully recovered and controls. While these findings highlight the 
associations between EDI-P, SOP, SPP and PCI scores with the maintenance of 
eating disorder pathology, the cross-sectional designs prevent the direction of effect 
from being established. 
Prospective studies have provided stronger support for EDI-P predicting the 
maintenance of an eating disorder up to ten years later (Holland et al., 2013; 
Santonastaso et al., 1999). Santonastaso et al. (1999) found that in 16-year olds who 
had anorexia nervosa, bulimia nervosa, EDNOS or a partial eating disorder (i.e., 
abnormal eating behaviours and cognitions), EDI-P significantly predicted eating 
disorder maintenance at 1-year follow-up. Holland et al. (2013) reported that among 
150 participants with an eating disorder at baseline, EDI-P was a significant positive 
predictor of maintenance of the eating disorder ten years later. Thus, there is support 
for EDI-P being a factor in the maintenance of eating disorder pathology. 
In sum, cross-sectional studies in clinical samples have demonstrated that 
many dimensions of perfectionism have been associated with eating disorder 
pathology (Bardone-Cone et al., 2008; Boone, Braet, et al., 2012; Egan, Watson, et 
al., 2013; Lethbridge et al., 2012; Watson et al., 2011). Importantly, evidence from 
retrospective, family, twin, intervention and prospective studies have offered support 
for dimensions of perfectionism such as SOP, PS, CM, PC, DA being onset and/or 
maintenance factors in eating disorders (Fairburn et al., 1997; Fairburn et al., 1999; 
Fairburn et al., 2009; Holland et al., 2013; Lilenfeld et al., 2000; Santonastaso et al., 
1999; Woodside et al., 2002). 
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1.5.1.5 Anxiety disorders. 
1.5.1.5.1. Social anxiety disorder. Models of social anxiety implicate 
perfectionism as a factor in the onset and maintenance of social anxiety 
symptomatology (e.g., Clark & Wells, 1995). Clark and Wells’ (1995) model of 
social anxiety disorder purports that socially anxious individuals possess excessively 
high standards in relation to social performance (e.g., believing that one must never 
exhibit weakness), conditional beliefs relating to social evaluation (e.g., if I make a 
mistake I will be rejected) and unconditional beliefs relating to the self (e.g., I am not 
acceptable). According to this model, such dysfunctional beliefs lead socially 
anxious individuals to perceive social situations in a threatening manner (Clark & 
Wells, 1995). 
 Perfectionism has also been theorised to maintain the symptoms of social 
anxiety (Clark & Wells, 1995; Egan et al., 2011; Mansell et al., 2008; Shafran et al., 
2002). For example, perfectionist standards for social performance may maintain 
social anxiety symptoms by interacting with disorder-specific maintenance factors 
such as self-focussed attention in a social interaction (Clark & Wells, 1995; Egan et 
al., 2011; Mansell et al., 2008; Shafran et al., 2002). Alternatively, perfectionist 
cognitive biases of focussing on the negative and discounting the positive aspects of 
performance may occur in post-event processing of social interactions. This may 
lead the individual to believe that they have not met their standards for a social 
interaction, maintaining social anxiety (Clark & Wells, 1995; Shafran et al., 2002).  
Studies in student samples have found CM, DA (Saboonchi & Lundh, 1997; 
Shumaker & Rodebaugh, 2009), SPP (Flett, Hewitt, & DeRosa, 1996) and MEC 
(DiBartolo, Li, & Frost, 2008) to be related to social anxiety symptoms. There is 
mixed support for PS being associated with social anxiety symptoms. Some studies 
57 
 
have found that PS is not correlated with social anxiety (Saboonchi & Lundh, 1997), 
some studies have shown that PS is significantly related to lower social anxiety 
(Shumaker & Rodebaugh, 2009), and other studies have reported that PS is related to 
elevated social anxiety, with this relationship disappearing once the overlap between 
PS and MEC is accounted for (DiBartolo et al., 2008). Nevertheless, causal 
inferences cannot be made and the use of non-clinical samples prevents the 
generalisation of findings to clinical populations.  
Studies in clinical samples have supported CM, DA, PC and SPP being 
associated with social anxiety symptoms, with mixed support for SOP being related 
to these symptoms (Antony, Purdon, Huta, & Swinson, 1998; Juster et al., 1996; 
Lundh & Ost, 1996; Saboonchi, Lundh, & Ost, 1999; Wheeler et al., 2011). 
Individuals with social anxiety disorder have reported significantly greater CM, DA, 
PC (Antony, Purdon, et al., 1998; Juster et al., 1996; Lundh & Ost, 1996; Saboonchi 
et al., 1999; Wheeler et al., 2011), SOP (Wheeler et al., 2011) and SPP (Antony, 
Purdon, et al., 1998; Bieling & Alden, 1997; Wheeler et al., 2011) compared to 
controls.  Juster et al. (1996) found that CM and DA were significantly related to 
social anxiety after controlling for depression. Saboonchi et al. (1999) found that CM 
and DA were significantly correlated with social anxiety and that the association 
between DA and social anxiety remained significant after controlling for public self-
consciousness. While these studies support associations occurring between CM, DA, 
PC, SPP and social anxiety, with some support for SOP being related to these 
symptoms, causal inferences cannot be made from the findings of these studies. 
Prospective studies are needed to determine the direction of these effects. 
Lundh and Ost (2001) posited that if perfectionism played a role in 
maintaining social anxiety, treatments for social anxiety disorder should result in 
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decreased perfectionism. In support of this, Lundh and Ost (2001) discovered that 
CBT for social anxiety simultaneously reduced PS, CM, PC and DA in addition to 
social anxiety scores. Pre-post treatment change in DA significantly predicted pre-
post treatment change in social anxiety after accounting for general psychopathology 
and pre-treatment social anxiety. Participants who did not respond to the social 
anxiety intervention commenced the intervention with significantly higher PS, CM 
and DA scores than those who responded.  
Nonetheless, studies attempting to replicate Lundh and Ost’s (2001) finding 
have produced inconsistent results (Ashbaugh et al., 2007; Rosser, Issakidis, & 
Peters, 2003). Rosser et al. (2003) found that CBT for social anxiety decreased CM 
and social anxiety, but found that pre-treatment CM was not a significant predictor 
of treatment outcome beyond pre-treatment social anxiety level. In contrast, 
Ashbaugh et al. (2007) discovered that CBT for social anxiety resulted in significant 
decreases in total FMPS, DA and CM and that pre-post treatment change in CM and 
DA scores were each significant predictors of post-treatment social anxiety scores 
after accounting for pre-treatment social anxiety. Further research is required to 
clarify the roles of CM and DA in maintaining social anxiety. 
In sum, studies in student samples have offered support for CM, DA, SPP 
and MEC being associated with social anxiety symptoms, with mixed support for PS 
being related to these symptoms (DiBartolo et al., 2008; Flett et al., 1996; Saboonchi 
& Lundh, 1997; Shumaker & Rodebaugh, 2009). In clinical samples, the findings 
suggest that CM, DA, PC and SPP are associated with social anxiety symptoms, with 
mixed support for SOP being associated with these symptoms (Antony, Purdon, et 
al., 1998; Juster et al., 1996; Lundh & Ost, 1996; Saboonchi et al., 1999; Wheeler et 
al., 2011). There is inconsistent evidence for the role of CM and DA in maintaining 
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social anxiety (Ashbaugh et al., 2007; Lundh & Ost, 2001; Rosser et al., 2003), thus 
future research is needed to clarify this. 
1.5.1.5.2. Panic disorder with or without agoraphobia. Elevated 
perfectionism has been theorised to be a risk factor for panic disorder, as well as a 
risk and maintenance factor for agoraphobia (Ehlers, 1995; Ellis, 2002; Iketani et al., 
2002a). It has long been theorised that heightened anxiety sensitivity, or fear about 
fear, predisposes an individual to experience panic symptoms (Ellis, 1962), with 
empirical evidence to support this (Ehlers, 1995). Ellis (2002) theorised that 
perfectionist individuals are likely to have elevated anxiety sensitivity. This is 
because they possess dichotomous beliefs of needing to be completely free from 
panic symptoms, which are activated as panic symptoms occur. Iketani et al. (2002a) 
theorised a role for perfectionism in the development and maintenance of 
agoraphobia in individuals with panic disorder. This hypothesis arose based on 
descriptions of individuals who have panic disorder with agoraphobia only being 
willing to leave their safety zone or engage in certain activities if they were 
completely certain that panic attacks would not occur. 
Despite these theories, few studies have explored the relationships between 
perfectionism dimensions, anxiety sensitivity, panic and agoraphobia across student 
and clinical samples. In a student sample, Flett, Greene, and Hewitt (2004) found 
that SPP and PCI scores were associated with total anxiety sensitivity score on the 
Anxiety Sensitivity Index-Revised (Taylor & Cox, 1998); however, the findings of 
this study cannot be generalised to clinical samples. Cox, Enns, Walker, Kjernisted, 
and Pidlubney (2001) found that SOP was significantly related to anxiety sensitivity 
in individuals with panic disorder and depression. Nonetheless, from these studies, 
inferences about the direction of effect cannot be made. There is a need for 
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additional research, particularly prospective studies utilising clinical samples, to 
investigate the relationships between perfectionism, anxiety sensitivity and panic 
disorder symptoms. 
The remaining studies in this area have examined whether perfectionism 
dimensions are elevated in clinical samples with panic disorder (PD) and panic 
disorder with agoraphobia (PDA) relative to controls (Antony, Purdon, et al., 1998; 
Frost & Steketee, 1997; Iketani et al., 2002a; 2002b; Saboonchi et al., 1999; Wheeler 
et al., 2011). These studies have yielded inconsistent findings. Saboonchi et al. 
(1999) found that participants with PDA had significantly elevated CM and PC 
compared to controls. Two other studies have reported that individuals with PDA or 
PD have significantly higher CM (Antony, Purdon, et al., 1998; Frost & Steketee, 
1997), PC, total FMPS (Frost & Steketee, 1997) DA and SPP (Antony, Purdon, et 
al., 1998) compared to non-anxious controls. While Iketani et al. (2002a; 2002b) 
found that individuals with PDA have significantly higher PS, CM (Iketani et al., 
2002a; 2002b) and DA (Iketani et al., 2002a) compared to those with PD and non-
anxious controls, and significantly higher PE and PC compared to controls (Iketani 
et al., 2002a; 2002b); there were no significant differences in perfectionism between 
individuals with PD and controls.  Wheeler et al. (2011) found that a combined 
sample of individuals with PD and PDA did not significantly differ on any of the 
FMPS dimensions compared to controls. 
 Iketani et al. (2002a) stated that the discrepancies between their findings and 
those of previous research (Antony, Purdon, et al., 1998; Frost & Steketee, 1997) 
may be because of the different sample compositions across studies. Previous studies 
have used combined samples of individuals with PDA and PD, which may have 
enabled the individuals with PDA to impact the outcome. Iketani et al. (2002a; 
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2002b) however, had separate samples of individuals with PDA and PD. Iketani et 
al. (2002) asserted that elevated perfectionism may therefore be specific to those 
with PDA rather than all panic disorder individuals. Consistent with this, Wheeler et 
al. (2011) stated that their findings of no differences in the FMPS dimensions in their 
combined sample compared to controls may have been due to the low numbers of 
individuals with PDA in their sample. Wheeler et al. (2011) contended that a 
stronger presence of agoraphobia may have been needed for significant findings to 
emerge.  
In further support of an association between perfectionism and agoraphobia, 
Iketani et al. (2002a) found that total FMPS was a significant positive predictor of 
agoraphobia after controlling for panic symptoms and age of onset. Every 1-point 
FMPS increase was associated with a three per cent increase in the odds of 
experiencing agoraphobia. Iketani et al. (2002a) argued that their findings were 
consistent with perfectionism dimensions being associated with agoraphobia 
development and maintenance. Nevertheless, the cross-sectional designs of these 
studies prevent causal inferences. Research using prospective designs is needed to 
clarify the role of perfectionism dimensions in panic and agoraphobic 
symptomatology. 
In summary, there is some evidence of SPP and PCI scores being associated 
with anxiety sensitivity in a student sample (Flett et al., 2004) and evidence of SOP 
being associated with anxiety sensitivity in a clinical sample (Cox et al., 2001). The 
clinical research examining whether dimensions of perfectionism are elevated in 
individuals with PDA and PD compared to controls has yielded inconsistent findings 
(Antony, Purdon, et al., 1998; Frost & Steketee, 1997; Iketani et al., 2002a, 2002b); 
however, one explanation may be that elevated PS, CM, DA, PC and PE may be 
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specific to individuals with PDA, rather than all panic disorder individuals. This, in 
combination with findings of total FMPS score being related to agoraphobia may 
suggest a role for perfectionism in agoraphobia development and maintenance 
(Iketani et al., 2002a, 2002b). Additional research is needed to investigate this 
possibility. 
1.5.1.5.3. Specific phobia. Antony, Purdon, et al. (1998) reported that 
individuals with specific phobia did not differ on any of the FMPS or HMPS 
dimensions compared to non-anxious controls. To date, this is the only study that has 
investigated the association between perfectionism and specific phobia symptoms. 
This is an under-researched area so there is currently insufficient evidence to make 
inferences about whether perfectionism has any role in this disorder.     
1.5.1.5.4. Generalised anxiety disorder. Few studies have investigated the 
relationship between dimensions of perfectionism and the symptoms of generalised 
anxiety disorder (GAD). The only studies that have investigated the associations 
between the FMPS and HMPS subscales and pathological worry have used student 
samples (Buhr & Dugas, 2006; Flett, Hewitt, Endler, & Tassone, 1994; Kawamura, 
Hunt, Frost, & DiBartolo, 2001; Santanello & Gardner, 2007; Stoeber & Joormann, 
2001). Flett et al. (1994) reported that SPP and SOP were significantly correlated 
with the autonomic arousal and cognitive worry facets of state anxiety as assessed by 
the Endler Multidimensional Anxiety Scales (Endler, Edwards, & Vitelli, 1991). 
Nevertheless, when males and females were considered separately, SPP remained 
related to cognitive worry in both genders; however, SOP was only associated with 
cognitive worry in females. Buhr and Dugas (2006) discovered that SPP and SOP 
were each significantly correlated with pathological worry as measured by the Penn 
State Worry Questionnaire (PSWQ; Meyer, Miller, Metzger, & Borkovec, 1990) 
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after accounting for gender. SOP still significantly predicted PSWQ after accounting 
for demographics and intolerance of uncertainty, but SPP did not. This was 
important as it suggested that SOP explains additional variance in pathological worry 
to that explained by intolerance of uncertainty, which is an important construct in an 
established model of GAD (Dugas, Gagnon, LaDouceur, & Freeston, 1998). 
Three studies have investigated the associations between the FMPS scales 
and pathological worry in student samples (Kawamura et al., 2001; Santanello & 
Gardner, 2007; Stoeber & Joormann, 2001). These studies each examined whether 
the FMPS dimensions are uniquely related to pathological worry after controlling for 
depression and anxiety. Kawamura et al. (2001) found that MEC was significantly 
correlated with three anxiety factors: social/worry/trait anxiety, post-traumatic stress 
and obsessive-compulsive symptoms; however, MEC only significantly predicted 
social/worry/trait anxiety after accounting for depression. PS was only related to 
post-traumatic stress disorder symptoms and this became non-significant after 
accounting for depression. Kawamura et al. (2001) asserted that such findings 
support the association between MEC and social/worry/trait anxiety being important 
of its own accord and not just emerging due to perfectionism being associated with 
depression (Enns et al., 2001; Kawamura et al., 2001). Nevertheless, as the 
composite construct of MEC was used as a measure of perfectionism, one cannot 
determine which dimensions of MEC are related to social/worry/trait anxiety. 
Moreover, as pathological worry was part of a composite construct with trait anxiety 
and social anxiety, one cannot dismiss that the findings may be accounted for by the 
relationships perfectionism has with social anxiety (e.g., Frost et al., 1990) and trait 
anxiety (Hewitt & Flett, 1991a) in non-clinical samples. 
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Stoeber and Joormann (2001) and Santanello and Gardner (2007) separated 
MEC into smaller composite constructs of CM+DA and PE+PC and assessed 
whether these constructs, as well as PS, were associated with PSWQ scores. Stoeber 
and Joormann (2001) reported that CM+DA was significantly related to PSWQ 
scores after accounting for depression, anxiety and the amount of everyday worries. 
PE+PC and PS were not significantly related to PSWQ scores (Stoeber & Joormann, 
2001). Santanello and Gardner (2007) found that CM+DA was significantly 
associated with PSWQ scores after partialling out depression, social anxiety and 
experiential avoidance. PE+PC and PS did not have significant associations with 
PSWQ scores. Thus, there is evidence to support there being a relationship between 
CM+DA and pathological worry in student samples (Santanello & Gardner, 2007; 
Stoeber & Joormann, 2001); however, these findings cannot be generalised to 
clinical samples with GAD. 
To date, there have been no studies examining the relationship between 
Shafran et al.’s (2002) clinical perfectionism construct and pathological worry across 
student or clinical samples. Studies have only examined the relationship between 
CPQ scores and measures of anxiety and stress (Chang & Sanna, 2012; Egan, 
Shafran, et al., 2014). Egan, Shafran, et al. (2014) reported that students with DASS-
anxiety scores in the upper quartile of the sample had significantly higher CPQ 
scores than students with DASS-anxiety scores in the lower quartile of the sample. 
Chang and Sanna (2012) found that CPQ scores significantly predicted anxiety 
scores on the Beck Anxiety Inventory (Beck, Epstein, Brown, & Steer, 1988), as 
well as stress scores on the Perceived Stress Scale (Cohen, Kamarck, & 
Mermelstein, 1983) after controlling for negative affect. While these studies 
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supported associations between CPQ scores, anxiety and stress, causal inferences 
cannot be made and findings cannot be generalised to clinical populations.  
 To date, research has not investigated the relationships between 
perfectionism dimensions and pathological worry in a sample of individuals with 
GAD. This is a limitation of the perfectionism literature, particularly when compared 
to the number of studies that have investigated the relationships between 
perfectionism dimensions and the symptoms of other psychological disorders (Egan 
et al., 2011). Furthermore, as gender has been shown to moderate the relationship 
between perfectionism dimensions and pathological worry (e.g., Flett et al., 1994) 
and perfectionism dimensions have demonstrated associations with anxiety and 
depression (Egan et al., 2011), there is a need to investigate the associations between 
perfectionism dimensions and pathological worry after controlling for gender, 
depression and anxiety. Evidence of significant associations between perfectionism 
dimensions and pathological worry after controlling for these confounds would 
further support perfectionism being a transdiagnostic process (Egan et al., 2011). In 
Study I of this PhD thesis, the associations between perfectionism dimensions and 
pathological worry are investigated in individuals with elevated perfectionism and 
GAD who presented for perfectionism treatment. 
 Furthermore, while research has examined whether perfectionism 
dimensions can predict whether individuals have other disorders such as OCD, social 
phobia and panic disorder with or without agoraphobia (Antony, Purdon, et al., 
1998), studies have not examined whether dimensions of perfectionism can predict a 
principal diagnosis of GAD from a clinical sample with a range of diagnoses. There 
is a need to investigate this association after controlling for gender and depression 
(Egan et al., 2011; Flett et al., 1994). In Study I of this PhD thesis, the utility of 
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perfectionism dimensions in predicting a principal diagnosis of GAD is examined in 
a clinical sample with elevated perfectionism and a range of diagnoses who 
presented for perfectionism treatment. Evidence of significant associations between 
perfectionism dimensions, pathological worry and a principal diagnosis of GAD will 
provide a rationale for Study II of this thesis and future studies to investigate whether 
a perfectionism intervention can reduce the symptoms of GAD along with the 
symptoms of other disorders. 
1.5.1.6. Trauma and stressor-related disorders. 
1.5.1.6.1. Post-traumatic stress disorder. To date, only one study in a non-
clinical sample (Kawamura et al., 2001) and one study in a clinical sample (Egan, 
Hattaway, & Kane, 2014) have examined the relationships between dimensions of 
perfectionism and post-traumatic stress disorder (PTSD) symptoms.  Kawamura et 
al. (2001) found that MEC and PS were both significantly associated with a post-
traumatic stress factor derived from the Post-Traumatic Stress Disorder Checklist 
(Weathers, Huska, & Keane, 1991). Only PS was a significant positive predictor of 
post-traumatic stress after controlling for depression. This highlights a unique 
association between PS and post-traumatic stress symptoms; however, causal 
inferences cannot be made and results do not generalise to clinical populations. 
Egan, Hattaway, et al. (2014) found in a clinical sample of individuals with PTSD 
following sexual assault that CPQ scores significantly predicted PTSD symptoms 
and that this was partially mediated by rumination. CM was also a significant 
positive predictor of PTSD symptoms and this was completely mediated by 
rumination (Egan, Hattaway, et al., 2014). While the cross-sectional design of this 
study limits causal inferences, a strength of this study is that findings can be 
generalised to clinical populations of individuals with PTSD following sexual 
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assault. There is a need for additional research in this area, particularly studies 
utilising prospective designs and clinical samples so that questions of whether any 
dimensions of perfectionism are risk or maintenance factors of PTSD can be 
examined. 
1.5.1.7. Obsessive-compulsive and related disorders. 
1.5.1.7.1. Obsessive-compulsive disorder. Perfectionism has been posited to 
be a key factor in the onset and maintenance of obsessive-compulsive disorder 
(OCCWG; 1997). A large body of researchers referred to as the Obsessive-
Compulsive Cognitions Working Group (OCCWG, 1997) postulated that 
perfectionism was one of six central beliefs in OCD. They defined perfectionism as 
“the tendency to believe there is a perfect solution to every problem, that doing 
something perfectly (i.e., mistake free) is not only possible, but also necessary and 
that even minor mistakes have serious consequences” (OCCWG, 1997, p.678). The 
importance of this construct in OCD was further highlighted by these researchers 
incorporating a perfectionism subscale when developing the OBQ (OCCWG, 2001).  
Studies in non-clinical samples support CM, DA, PE and PC being associated 
with OCD symptoms; with some support for PS and total FMPS also being related to 
these symptoms (Frost & Shows, 1993; Frost, Steketee, Cohn, & Greiss, 1994; 
Moretz & McKay, 2009; Rheaume, Freeston, Dugas, Letarte, & LaDouceur, 1995; 
Wu & Cortesi, 2009). Specifically, individuals with sub-clinical compulsive 
behaviour have obtained significantly higher scores on PS, CM and DA relative to 
non-obsessive controls (Frost et al., 1994). DA and CM were also found to have 
significant relationships with the OCD symptom compulsive indecisiveness (Frost & 
Shows, 1993). Furthermore, MEC was significantly associated with not just right 
obsessions and checking behaviours, with this association being completely 
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mediated by anxiety (Moretz & McKay, 2009). MEC was also found to predict total 
obsessive-compulsive symptoms as well as washing behaviours, checking 
behaviours and rituals after controlling for anhedonic depression (Wu & Cortesi, 
2009). Total FMPS score significantly predicted obsessive-compulsive symptom 
severity after accounting for responsibility appraisals (Rheaume et al., 1995). 
There is also support in non-clinical samples for OBQ-P, OBQ-PC, SOP and 
SPP being associated with obsessive-compulsive symptoms (Tolin, Woods, & 
Abramowitz, 2003; Wu & Cortesi, 2009; Yorulmaz, Karanci, & Tekok-Kilic, 2006). 
OBQ-P was a significant predictor of ordering symptoms after accounting for social 
anxiety and depression (Tolin et al. 2003). OBQ-PC significantly predicted total 
obsessive-compulsive score after controlling for responsibility/threat estimation and 
anhedonic depression. This subscale also significantly predicted washing, checking 
and ritualistic behaviours after accounting for anhedonic depression (Wu & Cortesi, 
2009). Yorulmaz et al. (2006) reported that SOP and SPP were significantly 
associated with checking and cleaning behaviours. These associations were all 
completely mediated by elevated responsibility, with the exception of the 
relationship between SOP and cleaning, which was only partially mediated by 
elevated responsibility.  
Overall, these studies provide support for associations existing between CM, 
DA, PE, PC, PS, total FMPS, SOP, SPP, OBQ-P and OCQ-PC with obsessive-
compulsive symptoms in non-clinical samples (Frost & Shows, 1993; Frost et al. 
1994; Moretz & McKay, 2009; Rheaume et al., 1995; Tolin et al., 2003; Wu & 
Cortesi, 2009; Yorulmaz et al., 2006). In many of these studies, these associations 
remained after controlling for various confounds. Nonetheless, the cross-sectional 
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designs of these studies prevent inferences of causality and findings cannot be 
generalised to populations who have OCD. 
Studies using clinical samples have indicated that adults with OCD have  
significantly higher scores on CM, DA (Antony, Purdon, et al., 1998, Boisseau, 
Thompson-Brenner, Pratt, Farchione, & Barlow, 2013; Frost & Steketee, 1997; 
Sassaroli et al., 2008; Wheeler et al., 2011), PC, PE (Boisseau et al., 2013; Sassaroli 
et al., 2008), MEC (Wheeler et al., 2011) and SPP (Antony, Purdon, et al., 1998) 
compared to controls. Furthermore, in a psychiatric sample, MEC and positive 
achievement striving (PS, O) were each significantly related to obsessive-compulsive 
symptoms (Norman, Davies, Nicholson, Cortese, & Malla, 1998). Additionally, in 
individuals with OCD, OBQ-PC was found to be a significant predictor of checking 
and grooming behaviours after accounting for depression and anxiety (OCCWG, 
2005).  
Studies in clinical samples have also demonstrated significantly greater rates 
of obsessive-compulsive personality disorder (OCPD) in samples with OCD relative 
to controls (Denys, Tenney, van Megen, de Gues, & Westenberg, 2004; Samuels et 
al., 2000). Samuels et al. (2000) further documented that the relatives of individuals 
with obsessive-compulsive disorder had a greater prevalence of OCPD than the 
relatives of controls, which suggested that OCPD may be a predisposing factor for 
OCD. These studies are relevant as perfectionism is one of the diagnostic criteria for 
OCPD (DSM-5, APA, 2013). Even so, these studies do not confirm that it is the 
perfectionism criterion of an OCPD diagnosis that is related to OCD. Nevertheless, 
additional studies have suggested that the perfectionism criterion is associated with 
the overlap that occurs between OCPD and OCD (Eisen et al., 2006). Eisen et al. 
(2006) found that individuals with both OCPD and OCD met the OCPD criterion of 
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perfectionism significantly more frequently than individuals with only OCPD.  
Wetterneck et al. (2011) investigated the associations between measures of each 
OCPD criterion and OCD severity. The only criteria of an OCPD diagnosis that were 
significantly related to OCD severity were perfectionism, hoarding and flexibility. 
Even so, additional studies utilising prospective designs are needed to determine 
whether the perfectionism criterion of OCPD prospectively predicts OCD severity 
(Eisen et al., 2006; Wetterneck et al., 2011).  
There is also support for perfectionism as measured by OBQ-P and OBQ-PC 
maintaining OCD (Kyrios et al., 2007, as cited in Egan et al., 2011; Manos et al., 
2010). Kyrios et al. (2007; as cited in Egan et al., 2011) discovered that change in 
OBQ-P was one of the few significant predictors of OCD therapy outcome after 
having controlled for pre-treatment OCD severity. Manos et al. (2010) found that 
change in OBQ-PC was a significant predictor of change in the severity of 
obsessive-compulsive symptoms from pre- to post treatment of OCD after 
accounting for general psychiatric distress. These studies support perfectionism as 
measured by OBQ-P and OBQ-PC maintaining OCD. 
In sum, studies in clinical samples have indicated that CM, DA, PE, PC, SPP 
and OBQ-PC are associated with obsessive-compulsive symptoms, with some 
support for PS and O also being related to obsessive-compulsive symptoms (Antony, 
Purdon, et al., 1998, Boisseau et al., 2013; Frost & Steketee, 1997; Norman et al., 
1998; OCCWG, 2005; Sassaroli et al., 2008; Wheeler et al., 2011). There is evidence 
that the perfectionism criterion of OCPD may be associated with the overlap 
occurring between OCPD and OCD (Eisen et al., 2006; Wetterneck et al., 2011), as 
well as support for OBQ-P and OBQ-PC maintaining OCD symptoms (Kyrios et al., 
2007, as cited in Egan et al., 2011; Manos et al., 2010). While many of these 
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findings occurred after controlling for factors such as depression and anxiety, there is 
need for additional research to investigate the unique predictive utility of 
perfectionism dimensions in obsessive-compulsive symptoms after accounting for 
meta-cognitive factors. This is because there is some evidence to suggest that meta-
cognitive factors such as the importance/control of thoughts may have greater 
predictive utility in obsessive-compulsive symptoms than perfectionism (e.g., Myers, 
Fisher, & Wells, 2008). 
 1.5.1.7.2. Body dysmorphic disorder. Cognitive behavioural models of body 
dysmorphic disorder by Veale (2004) and Wilhelm (2006) depict perfectionism as 
one of the personality traits that is a risk factor for body dysmorphic disorder. 
Individuals with elevated perfectionism may detect minor imperfections in their 
appearance and excessively focus upon these imperfections, leading to distress 
(Scheiber, Kollei, de Zwaan, Muller, & Martin, 2013; Wilhelm, 2006). Nonetheless, 
only four studies have examined the associations between dimensions of 
perfectionism and body dysmorphic disorder (Bartsch, 2007; Buhlmann, Etcoff, & 
Wilhelm, 2008; Hanstock & O’Mahony, 2002; Scheiber et al., 2013). Hanstock and 
O’Mahony (2002) found in a student sample that SPP significantly predicted levels 
of dysmorphic concern on the Dysmorphic Concerns Questionnaire (Oostuizen, 
Lambert, & Castle, 1998) after accounting for acne severity and general 
psychopathology. Bartsch (2007) however, reported that both SPP and SOP were 
significant positive predictors of Dysmorphic Concerns Questionnaire scores in a 
student sample. Thus, while SPP is consistently associated with dysmorphic 
concerns, there is mixed support for the association between SOP and dysmorphic 
concerns in student samples. The use of non-clinical samples also prevents 
generalisation to clinical samples with body dysmorphic disorder.  
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Two studies have examined the relationships between perfectionism 
dimensions and dysmorphic concerns in clinical samples (Buhlmann et al., 2008; 
Scheiber et al., 2013).  Buhlmann (2008) found that adults with body dysmorphic 
disorder scored significantly higher on CM and DA than controls; whereas Scheiber 
et al. (2013) reported that adults with body dysmorphic disorder had significantly 
higher EDI-P relative to controls. EDI-P also significantly predicted dysmorphic 
concerns in the entire sample. These studies provide preliminary evidence of the 
associations between CM, DA and EDI-P with body dysmorphic disorder; however, 
inferences of causality cannot be made. Longitudinal research is needed to 
investigate whether various dimensions of perfectionism impact on body dysmorphic 
disorder development to provide additional support for the cognitive behavioural 
theories of this disorder (Buhlmann et al., 2008; Scheiber et al., 2013; Veale, 2004; 
Wilhelm, 2006). 
1.5.1.8. Personality disorders. 
1.5.1.8.1. Obsessive-compulsive personality disorder. The significance of 
perfectionism in obsessive-compulsive personality disorder (OCPD) is reflected in 
the fact that “perfectionism that interferes with task completion” is one of the 
diagnostic criteria for OCPD (DSM-5, APA, 2013, p. 678). Shafran and Mansell 
(2001 p.896) stated “it could be argued that the essence of OCPD is perfectionism 
centred on performance plus rigidity, and that the other features are a consequence of 
this”. Empirical studies have also supported the stability of perfectionism as a feature 
in OCPD (Ansell, Pinto, Edelen, & Grilo, 2008; Ansell et al., 2010; Grilo, 2004; 
Hummelen, Wilberg, Pedersen, & Karterud, 2008; McGlashan et al., 2005). 
McGlashan et al. (2005) examined the stability of the criteria for OCPD over a 
period of two years in 221 individuals with OCPD. The three criteria deemed to have 
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the greatest prevalence and stability in these patients over the two year period were 
rigidity, difficulties delegating tasks and perfectionism. This study is credible 
because of its use of a large clinical sample as well as its two year period of 
assessment. Furthermore, participants were assessed by trained raters who used a 
reliable measure of personality disorder assessment and at 2-year follow-up the 
raters were blind to participants’ baseline data. Therefore, these findings are reliable.  
In further support of the stability of perfectionism as a feature of OCPD, 
factor analytic studies of OCPD in clinical samples have consistently found 
perfectionism to be a latent construct (Ansell et al., 2008; Ansell et al., 2010; Grilo, 
2004; Hummelen et al., 2008), with the majority of studies reporting rigidity as an 
additional latent construct (Ansell et al., 2008; Ansell et al., 2010; Grilo, 2004). As 
multiple studies have reported these findings, this increases confidence in the 
reliability of these findings. Such findings highlight the significance of perfectionism 
in OCPD and can generalise to clinical populations.  
Shafran and Mansell (2001) have stated that it is very likely that individuals 
with elevated perfectionism will have OCPD. However, as Shafran et al. (2002) and 
Egan et al. (2011) have highlighted, perfectionism and OCPD are not identical. This 
is because there are other criteria for an OCPD diagnosis, such as being miserly and 
hoarding that are not related to perfectionism. Thus, technically an individual can 
have elevated perfectionism but not meet enough criteria for OCPD; or an individual 
can have OCPD without being elevated in perfectionism due to meeting the other 
OCPD criteria (e.g., hoarding) (DSM-5, APA, 2013; Egan et al., 2011; Shafran et al., 
2002).  
Other studies have provided evidence of associations occurring between 
perfectionism and OCPD in clinical samples (Anderluh, Tchanturia, Rabe-Hesketh, 
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& Treasure, 2003; Halmi et al., 2005). Anderluh et al.’s (2003) retrospective study 
reported that women with eating disorders who recalled experiencing traits of 
rigidity and perfectionism in childhood demonstrated significantly greater rates of 
OCPD and co-morbid OCD in adulthood relative to women with eating disorders 
who did not recall experiencing such traits. While this supports perfectionism being 
involved in OCPD onset in females with eating disorders, one must be cautious in 
interpreting these findings as retrospective recall may introduce inaccuracies and 
biases into the data. Halmi et al. (2005) also investigated the association between 
perfectionism and OCPD in an eating disorder sample. Individuals who had OCPD 
and OCD had significantly higher CM and DA scores than individuals with just 
OCD and significantly higher CM, DA, PS, PE, and PC scores than individuals 
without OCD or OCPD. While DA and CM were the best subscales to discriminate 
between groups who had an obsessive-compulsive diagnosis and groups who did 
not, DA and CM were better predictors of OCPD than OCD. PS was also found to be 
significantly related to OCPD. The authors argued that OCPD and perfectionism 
may interact to be a key factor placing individuals at risk of developing an eating 
disorder (Halmi et al., 2005).  
Pinto, Liebowitz, Foa, and Simpson (2011) found that in adults with OCD, a 
co-morbid OCPD diagnosis and OCPD severity were each significant predictors of 
lower treatment response to exposure and response prevention. Upon examination of 
the utility of each OCPD criterion in predicting poorer treatment response, only 
perfectionism was a significant predictor of lowered treatment response after having 
controlled for confounds such as baseline OCD severity. This study provides 
evidence for perfectionism being one of the main symptoms in OCPD that is 
associated with poor response to this OCD treatment. 
75 
 
In sum, there is evidence that perfectionism is a stable feature of OCPD 
(Ansell et al., 2008; Ansell et al., 2010; DSM-5, APA, 2013; Grilo, 2004; Hummelen 
et al., 2008; McGlashan et al., 2005). Additionally, studies in eating disorder 
samples have supported perfectionism being associated with the onset of OCPD, as 
well as both perfectionism and OCPD being related to the onset of eating disorders 
and impeding response to OCD treatment (Anderluh et al., 2003; Halmi et al., 2005; 
Pinto et al., 2011). Nevertheless, more research is needed to directly assess the 
association between perfectionism as measured by different measures (e.g., CPQ; 
FMPS dimensions, HMPS dimensions) and an OCPD diagnosis. Future research 
should also utilise longitudinal designs to enable inferences about the direction of 
effects.  
1.5.1.8.2. Other personality disorders. There is limited research on the 
associations between perfectionism and other personality disorders (McCown & 
Carlson, 2004; Hewitt, Flett, & Turnbull, 1994). McCown and Carlson (2004) 
reported significantly higher SPP in individuals with narcissistic personality disorder 
in comparison to participants with a mood disorder and antisocial personality 
disorder. Hewitt, Flett, and Turnbull (1994) found significantly greater SPP in 
inpatients with borderline personality disorder relative to controls. These studies 
provide preliminary evidence for associations between SPP and narcissistic and 
borderline personality disorder; however, the design of these studies prevents 
causality from being inferred. Prospective studies are needed to examine the role of 
SPP and other perfectionism dimensions in these and other personality disorders. 
1.5.1.9. Physical health. 
1.5.1.9.1. Somatic symptoms. Studies in non-clinical samples have 
consistently reported associations between SPP and the experience of somatic 
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symptoms; however, there is mixed evidence for associations between SOP and 
somatic symptoms (Martin, Flett, Hewitt, Krames, & Szanto, 1996; Molnar et al., 
2006; Saboonchi & Lundh, 2003). Saboonchi and Lunch (2003) reported that SPP 
and SOP significantly predicted self-reported somatic symptoms; whereas Martin et 
al. (1996) found that SPP significantly predicted self-reported somatic symptoms in 
those who scored low in self-efficacy. Molnar et al. (2006) discovered that SPP was 
significantly related to poorer physical health ratings and that this was partially 
mediated by high negative affect and low positive affect. Interestingly, SOP was 
significantly related to ratings of better physical health with complete mediators 
being high positive affect and low negative affect. The large sample sizes of these 
studies promote generalisation to non-clinical populations; however, inferences of 
causality cannot be made and research is needed to clarify the relationship between 
SOP and somatic complaints. 
Studies have reported associations between CM, PS, DA, PC, SPP and the 
specific somatic symptom of insomnia (Lundh, Broman, Hetta, & Saboonchi, 1994; 
Vincent & Walker, 2000). Individuals diagnosed with insomnia have obtained 
significantly greater scores on CM (Lundh et al., 1994; Vincent & Walker, 2000), PS 
(Lundh et al., 1994), DA and PC (Vincent & Walker, 2000) relative to community 
controls. Furthermore, in individuals with insomnia, PC displayed significant 
correlations with participants’ reports of delayed sleep onset latency (Vincent & 
Walker, 2000). These studies provide preliminary evidence for associations between 
CM, PS, DA, PC and insomnia. The use of clinical samples of adequate size enables 
generalisation to clinical populations of individuals with insomnia; however, 
research utilising prospective designs is needed to make inferences about the 
direction of effects.  
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Prospective studies in community samples have provided support for CM and 
SPP being risk factors for insomnia symptoms (Azevedo et al., 2010; Jansson-
Frojmark, & Linton, 2007). Jansson-Frojmark and Linton (2007) reported that CM 
significantly predicted insomnia symptoms at 1-year follow-up; whereas Azevedo et 
al. (2010) reported that SPP significantly predicted problems falling asleep and 
maintaining sleep at 1-year and 2-year follow-up. The prospective designs utilised 
enable inferences of CM and SPP temporally preceding insomnia symptoms. 
Additional prospective studies need to be conducted in individuals diagnosed with 
insomnia disorder (DSM-5, APA, 2013), so that findings can be generalised to this 
population. 
 One study has provided preliminary evidence for an association between 
SOP, SPP and chronic headaches in a student sample (Bottos & Dewey, 2004).  
Bottos and Dewey (2004) reported that individuals classified as having chronic 
headaches (15+ headaches each month) obtained significantly greater SOP and SPP 
scores than individuals classified as having frequent headaches (one to 14 headaches 
each month) and infrequent headaches (less than one headache each month). Total 
HMPS score also significantly predicted the frequency of headaches per month as 
well as headache intensity. While this study provides support for a relationship 
between SOP, SPP and chronic headaches, the assessment of headache frequency, 
intensity and duration was based on retrospective self-report which may introduce 
bias. Causal inferences cannot be made and findings can only be generalised to 
student samples. Prospective studies using clinical samples are needed to add 
information to this area (Bottos & Dewey, 2004).  
1.5.1.9.2. Irritable bowel syndrome. Cognitive behavioural theories of 
irritable bowel syndrome (IBS) have suggested that perfectionism is one of the 
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personality traits that place an individual at risk of irritable bowel syndrome (Moss-
Morris & Wrapson, 2003; Sharpe, Peveler, & Mayal, 1992; Spence & Moss-Morris, 
2007). However, few studies have investigated the associations between dimensions 
of perfectionism and irritable bowel syndrome (Moss-Morris, McAlpine, Didsbury, 
& Spence, 2010; Spence & Moss-Morris, 2007). Spence and Moss-Morris’s (2007) 
prospective study examined whether the negative perfectionism subscale of the 
PANPS as well as other psychological risk factors would interact with gastroenteritis 
to predict IBS onset six months later. Negative perfectionism did not independently 
predict IBS onset; however, analyses of whether clusters of variables had predictive 
utility in IBS onset revealed that an ‘anxious achievement’ cluster comprised of 
negative perfectionism, stress and anxiety significantly predicted IBS onset six 
months later. The authors contended that negative perfectionism in combination with 
heightened anxiety and perceived stress may interact with gastroenteritis to predict 
IBS onset. Therefore, under such circumstances, elevated negative perfectionism is a 
risk factor for IBS. This study is credible due to its prospective design and large 
sample of individuals with gastroenteritis, which enables generalisation of results to 
this population (Spence & Moss-Morris, 2007).  
Moss-Morris et al. (2010) discovered that a cognitive behavioural treatment 
for IBS that assisted individuals to change their maladaptive perfectionist beliefs, 
decrease their anxiety and stress, and change how they respond to IBS symptoms 
produced greater relief from IBS symptoms than a treatment as usual condition that  
consisted of psycho-education. Treatment gains were maintained at 6-month follow-
up. This study provides support for the argument that targeting perfectionism and 
other risk factors for IBS reduces IBS symptoms (Moss-Morris et al., 2010). This 
research is commendable due to its RCT design and sample size; however, one 
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limitation is that participants’ level of perfectionism was not measured at baseline or 
throughout the trial. Future studies of IBS interventions should measure 
perfectionism, anxiety and stress throughout the trial to examine how changes in 
these factors are related to changes in IBS symptoms. 
1.5.1.9.3. Chronic fatigue syndrome. There is mixed support for the 
associations between total FMPS, CM, DA, PC and chronic fatigue syndrome 
(Deary & Chalder, 2010). Some studies have reported that individuals with chronic 
fatigue syndrome obtain significantly higher scores on CM, DA (Deary & Chalder, 
2010; White & Schweitzer, 2000), PC (Deary & Chalder, 2010) and total FMPS 
(White & Schweitzer, 2000) than controls; however, other studies have found no 
significant differences in these perfectionism dimensions between individuals with 
chronic fatigue syndrome and controls (Blenikorn, Edwards, & Lynch, 1999; Woods 
& Wessely, 1999). 
Kempke et al. (2011) used structural equation modelling to examine the 
relationships between dimensions of perfectionism, the severity of chronic fatigue 
and the severity of depression in patients with chronic fatigue syndrome. These 
researchers found support for a model where maladaptive perfectionism, as 
measured by CM and DA, exhibited significant positive relationships with fatigue 
severity and depression severity. Moreover, depression was a complete mediator of 
the association between maladaptive perfectionism and fatigue severity. This 
provided support for CM and DA being related to chronic fatigue symptom 
maintenance via level of depression. Nevertheless, the cross-sectional design of this 
study averts inferences of causality. Research using prospective designs is needed to 
draw stronger conclusions about the role of CM and DA in chronic fatigue 
symptoms. 
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1.5.2. Explaining the co-morbidity of psychological disorders. The second 
argument put forward by Egan et al. (2011) for perfectionism being a transdiagnostic 
process is that there is evidence consistent with perfectionism explaining the high co-
morbidity of psychological disorders (Bieling et al., 2004; Brown et al., 2001; Egan 
et al., 2011; Kessler, Chui, et al. 2005). Harvey et al. (2004) proposed that the co-
morbidity of psychological disorders is due to these disorders having shared 
maintenance factors. Bieling et al. (2004) argued that because perfectionism is an 
enduring personality trait (Blatt, 1995) that is associated with the symptoms of many 
disorders (Shafran & Mansell, 2001), perfectionism may provide an explanation for 
disorder co-morbidity (Bieling et al., 2004). 
Consistent with this, Bieling et al. (2004) found in a large clinical sample that 
significant positive correlations existed between SOP, SPP, CM, DA, PC and total 
FMPS with the number of co-morbid anxiety and mood disorders.  Furthermore, 
MEC was a significant positive predictor of co-morbidity after accounting for 
current symptom severity. Wheeler et al. (2011) found in a clinical sample of mixed 
diagnoses that CM, DA and SPP were significantly related to co-morbidity after 
controlling for symptom severity. Binary logistic regression analyses controlling for 
symptom severity and positive achievement striving indicated that MEC 
significantly predicted participants’ co-morbidity status, which was whether 
participants had two or more co-morbid diagnoses or no co-morbidity. These studies 
have shown that SOP and dimensions of MEC are associated with disorder co-
morbidity (Bieling et al., 2004; Wheeler et al., 2001). While prospective studies are 
needed to further inform this area, Bieling et al. (2004) did argue that the current 
findings raise the possibility of perfectionism treatments being able to 
simultaneously reduce the symptoms of multiple psychological disorders. 
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1.5.3. Perfectionism impedes treatment outcome. The third argument put 
forward by Egan et al. (2011) for perfectionism being a transdiagnostic process is 
that perfectionism has been found to negatively affect the treatment outcome of 
numerous psychological disorders. Blatt, Quinlan, Pilkonis, and Shea (1995) 
investigated how DAS-SC levels influenced participants’ response to depression 
interventions using data from Elkin et al.’s (1989) National Institute of Mental 
Health Treatment of Depression Collaborative Research Program Study. DAS-SC 
was a significant predictor of poorer post-treatment response to CBT, interpersonal 
psychotherapy and anti-depressant treatments. In an extension of this research, Blatt 
et al. (1998) reported that pre-treatment DAS-SC remained a significant predictor of 
poor treatment response to these interventions at 18-month follow-up (Elkin et al., 
1989). This relationship was mediated by DAS-SC having a negative effect on the 
therapeutic alliance (Zuroff et al., 2000). Specifically, higher DAS-SC scores were 
related to clients not increasing their contribution to the alliance over the course of 
therapy. The authors contended that clients with high DAS-SC scores may have a 
reduced ability to form open, collaborative relationships; or alternatively, may 
require longer time periods to form these relationships (Zuroff et al., 2000). The 
relationship between pre-treatment DAS-SC and poor treatment response at 18-
month follow-up (Blatt et al., 1998; Elkin et al., 1989) was also mediated by DAS-
SC being associated with poorer networks of social support (Shahar, Blatt, Zuroff, 
Krupnik, & Sotsky, 2004). Blatt and Zuroff (2005) found that pre-treatment DAS-SC 
was also a significant predictor of lower capacity to cope with life stress at 18-
months following treatment.  
DAS-SC has also been found to negatively affect treatment response in an 
adolescent sample (Jacobs et al., 2009). Jacobs et al. (2009) found that adolescents 
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who had higher pre-treatment DAS-SC scores continued to exhibit heightened 
symptoms of depression throughout twelve week treatment for depression, regardless 
of whether they received fluoxetine, CBT, a combination of fluoxetine/CBT or a pill 
placebo. Adolescents with higher pre-treatment DAS-SC scores also exhibited lower 
reduction in suicidality at post-treatment, which was independent of the type of 
treatment administered. Overall, these prospective studies provide support for 
elevated DAS-SC scores negatively affecting adults’ and adolescents’ response to 
multiple treatments for depression (Blatt et al., 1998; Blatt & Zuroff, 2005; Jacobs et 
al., 2009; Shahar et al., 2004; Zuroff et al., 2000).  
Studies have indicated that EDI-P is associated with a poorer treatment 
response in individuals with anorexia nervosa (Sutandar-Pinnock, Woodside, & 
Carter, 2003); however, there is mixed evidence for EDI-P and CM being related to a 
poorer treatment response in bulimia nervosa (Mussel et al., 2000; Steele, Bergin, & 
Wade, 2011). In individuals with anorexia nervosa, pre-treatment EDI-P was 
positively correlated with not completing treatment and was also a significant 
predictor of poor treatment outcome five to ten years later (Sutandar-Pinnock et al., 
2003). Mussell et al. (2000) reported that in individuals with bulimia nervosa, EDI-P 
was not a significant predictor of treatment completer status or remission of bulimic 
symptoms at post-treatment or follow-up after accounting for depression and bulimic 
symptom severity. However, Steele et al. (2011) found that in adults with bulimia 
nervosa, higher pre-treatment CM was a significant positive predictor of a smaller 
decrease in global score on the Eating Disorder Examination (Fairburn & Cooper, 
1993) at post-treatment. Further research is needed to examine the role of EDI-P, 
CM and other perfectionism dimensions in treatment response in bulimia nervosa 
samples. Nevertheless, Egan al. (2012) argued that based on the studies showing 
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EDI-P to remain high in individuals deemed recovered from an eating disorder (e.g., 
Bastiani et al., 1995; Lilenfeld et al., 2000), elevated EDI-P may still be a significant 
component contributing toward eating disorder relapse if it is not treated (Egan et al., 
2012).  
There is mixed evidence for PS, CM and DA negatively affecting response to 
social anxiety treatment (Lundh & Ost, 2001; Rosser et al., 2003). Lundh and Ost 
(2001) found that adults who did not respond to CBT for social anxiety had elevated 
PS, CM and DA relative to those who responded; whereas Rosser et al. (2003) found 
that elevated pre-treatment CM did not significantly predict poor treatment response. 
There is a need for additional research to clarify the impact of these dimensions on 
treatment outcome for individuals with social phobia.   
There is also some evidence that DA and the perfectionism criterion of 
OCPD predicts poorer response to OCD treatment (Chik, Whittal, & O’Neill, 2008; 
Pinto et al., 2011). In adults with OCD, DA was a significant predictor of higher 
total scores on the Yale-Brown Obsessive Compulsive Scale (Y-BOCS; Goodman et 
al., 1989) as well as higher compulsion scores on the Y-BOCs at post-treatment 
(Chik et al., 2008). The perfectionism criterion of an OCPD diagnosis also 
significantly predicted lower response to exposure and response prevention treatment 
in individuals with OCD (Pinto et al., 2011). There is currently no research on the 
impact of perfectionism on response to treatments for panic disorder with or without 
agoraphobia, specific phobia or generalised anxiety disorder, therefore additional 
research is needed in this area. 
1.6. Transdiagnostic Treatments 
Reviews by Craske (2012) and Egan et al. (2012) have summarised the 
advantages of trandiagnostic treatments. For clients with co-morbid disorders, a 
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transdiagnostic treatment may simultaneously ameliorate the symptoms of these 
disorders. This would prevent psychologists having to select between numerous 
treatment protocols designed for specific disorders. It would offer an alternative to 
psychologists concurrently implementing multiple protocols for specific disorders, 
which actually does not improve treatment outcome (Craske et al., 2007; Craske, 
2012; Egan et al., 2012). Transdiagnostic treatments would also prevent 
psychologists sequentially administering specific treatment protocols for each 
disorder (Egan et al., 2012). A related advantage of a transdiagnostic treatment is 
that it would have greater practicality and cost-effectiveness than disorder-specific 
treatments (Craske, 2012; Egan et al., 2012). Administering one treatment to 
decrease the symptoms of multiple disorders rather than multiple protocols would 
confer greater time efficiency for the psychologist and client and would substantially 
reduce the cost for the client (Egan et al., 2012). This is important given real-world 
constraints such as clients only receiving a government rebate on ten clinical 
psychology sessions per year and the long waitlists for psychology services at 
Government organisations. Furthermore, it may be easier and more efficient for 
psychologists to be trained in the principles and treatment strategies of one 
transdiagnostic intervention as opposed to numerous disorder-specific interventions 
(Egan et al., 2012). Egan et al. (2012) argued that transdiagnostic treatments may 
also be more ethical in comparison to sequentially administering numerous treatment 
protocols because transdiagnostic treatments may alleviate the symptoms of multiple 
disorders in a shorter time frame. 
Craske (2012) and Egan et al. (2012) have outlined some of the 
transdiagnostic treatments that have emerged in the past decade. As discussed, 
Fairburn et al. (2003a) developed CBT-E, which has evidence of efficacy and 
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effectiveness (Byrne et al., 2011; Dalle-Grave, Callugi, Doll, et al., 2013; Dalle-
Grave, Callugi, Conti, et al., 2013; Fairburn et al., 2009; Fairburn et al., 2013). A 
number of transdiagnostic cognitive-behavioural treatments for anxiety disorders 
have also been developed by different research groups (Norton & Phillip; 2008). For 
example, Nathan, Rees, and Smith’s (2001) transdiagnostic treatment used cognitive 
behavioural techniques to target common maintenance factors in anxiety and 
depression. McEvoy and Nathan (2007) evaluated the effectiveness of this program 
in a clinical sample with depression and anxiety diagnoses and then used bench-
marking strategies to compare the results to those of other effectiveness and efficacy 
studies. The effect sizes for the reductions in anxiety and depression observed in this 
transdiagnostic treatment were in the range reported in the bench-marking studies.   
Craske et al. (2011) developed the Coordinated Anxiety Learning and 
Management (CALM) Tools for Living Program to address the symptoms of GAD, 
social anxiety disorder, panic disorder and PTSD. There is evidence of the efficacy 
of this treatment relative to usual care in patients with GAD, social anxiety disorder, 
panic disorder and PTSD (Craske et al., 2011; Roy-Byrne et al., 2010). The Unified 
Protocol for the Transdiagnostic Treatment of Emotional Disorders (Bossieau, 
Farchione, Fairholme, Ellard, & Barlow, 2010; Ellard, Fairholme, Bossieau, 
Farchione, & Barlow, 2010; Wilamowska et al., 2010) utilises CBT strategies to 
target the maintenance factors of anxiety disorders and unipolar mood disorders with 
a particular focus on how individuals react to emotions (Craske, 2012; Wilamowska 
et al., 2010). To date, one RCT had supported the efficacy of this intervention 
(Farchione et al., 2012). 
While there is some evidence to support the efficacy and effectiveness of a 
transdiagnostic treatment for eating disorders (e.g., Fairburn et al., 2009) as well as 
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transdiagnostic treatments for anxiety and depression (e.g., Farchione et al., 2012), 
none of these transdiagnostic treatments target the symptoms of anxiety disorders, 
depression and eating disorders (Egan et al., 2012). Egan et al. (2011) argued that a 
significant implication of perfectionism being a transdiagnostic process is that 
interventions for perfectionism could concurrently reduce the symptoms of related 
psychological disorders, which include eating disorders, anxiety disorders and 
depression (Bieling et al., 2004; Egan et al., 2011; Fairburn et al., 2003a; Harvey et 
al., 2004).  
Nonetheless, it is to be noted that there is currently a substantially smaller 
evidence base supporting the efficacy and effectiveness of transdiagnostic treatments 
compared to the evidence base for disorder-specific treatments (Egan et al., 2012). 
This is because transdiagnostic treatments have only primarily emerged in the past 
decade. Given the importance of relying on the evidence-base to inform treatment 
decisions and the current imbalance in the evidence base for transdiagnostic versus 
disorder-specific treatments, psychologists would need to carefully contemplate their 
decision to administer a transdiagnostic treatment instead of a disorder-specific 
treatment. While transdiagnostic treatments are very promising, there is a need for 
additional research to examine the efficacy and effectiveness of transdiagnostic 
treatments to guide treatment selection (Egan et al., 2012). 
1.7. CBT for Clinical Perfectionism as a Transdiagnostic Treatment 
Shafran et al. (2002) argued that based on the maintenance model of clinical 
perfectionism, CBT for clinical perfectionism (CBT-CP) needs to contain four 
components. First, the therapist needs to assist clients to recognise that their clinical 
perfectionism is a problem and to help clients to personalise the cognitive-
behavioural formulation of what maintains their clinical perfectionism (Shafran et 
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al., 2002). In this step, it is important for clients to gain an understanding that it is 
maladaptive for their self-esteem to be overly reliant on striving for and attaining 
standards in a specific area. Second, CBT-CP needs to assist clients to identify and 
engage in different methods of thinking and behaving that will effectively broaden 
the domains upon which their self-esteem is based. Clients should be helped to adopt 
multiple domains upon which to base their self-esteem, including areas of their life 
that may have been previously neglected due to striving, such as friendships and 
hobbies (Shafran et al., 2002).  
Third, CBT-CP should include behavioural experiments to challenge 
perfectionist predictions. These behavioural experiments frequently consist of 
exposure to situations that clients have previously avoided (Shafran et al., 2002). 
Based on a revision of the model (Shafran et al., 2010) behavioural experiments 
should also target counter-productive behaviours such as performance checking. 
Fourth, CBT-CP needs to contain cognitive behavioural techniques that help the 
clients to identify and challenge the way in which they set standards in the form of 
rigid dichotomous rules. These cognitive behavioural techniques also assist clients to 
challenge the self-criticism that occurs when a standard is not attained. Additionally, 
treatment needs to target cognitive biases such as negative filter and hypervigilant 
monitoring of performance (Shafran et al. 2002). Based on the updated model of 
clinical perfectionism (Shafran et al., 2010), treatment also needs to include 
cognitive-behavioural strategies that target performance-related behaviours such as 
procrastination (Egan et al., 2011; Shafran et al., 2010). 
1.7.1. CBT for perfectionism in non-clinical samples. Only a handful of 
studies have evaluated CBT for perfectionism in non-clinical samples (Arpin-Cribbie 
et al., 2008; Arpin-Cribbie, Irvine, & Ritvo, 2012; DiBartolo, Frost, Dixon, & 
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Almodovar, 2001; Ferguson & Rodway, 1994; Pleva & Wade, 2006; Radhu et al., 
2012). In these studies, the CBT administered was not based on Shafran et al.’s 
(2002) model of clinical perfectionism as most of these non-clinical studies occurred 
before Shafran et al.’s (2002) article. The remaining non-clinical studies utilised 
other CBT strategies for perfectionism such as Antony and Swinson’s (1998) guided 
self-help book. Nevertheless, these studies are still worthy of discussion as they 
provide support for CBT targeting perfectionism being effective. Ferguson and 
Rodway (1994) employed an ABA design to investigate the effectiveness of CBT for 
perfectionism in nine adults with elevated scores on Burns’ Perfectionism Scale 
(Burns, 1980a). The CBT centred upon identifying, challenging and restructuring 
perfectionist thoughts as well as changing perfectionist behaviours (Burns, 1980b). 
Visual inspection of the data suggested decreases in perfectionism on the Burns’ 
Perfectionism Scale, decreases in perfectionist cognitions (Irrational Values Scale; 
McDonald & Games, 1987) and decreases in self-rated perfectionist behaviours 
(Self-Anchored Scales; Ferguson & Rodway, 1994) for all clients following the 
intervention. However, there was no control group and no official statistical 
analyses, which prevent these changes from being confidently attributed to the 
intervention (Ferguson & Rodway, 1994).  
DiBartolo et al. (2001) used a 2 x 2 factorial design to evaluate the 
effectiveness of an eight minute CBT treatment for perfectionism in 30 female 
students. These participants were selected as they had obtained CM scores in the 
upper quartile or lower quartile of a sample of 138 students. Participants were 
randomised to receive a CBT intervention or be in a distraction condition before 
giving an oral presentation. The CBT intervention focussed on challenging 
probability overestimation and catastrophising and then forming a coping statement 
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about the oral presentation (DiBartolo et al., 2001). The distraction condition 
involved crossing out letters in a textbook. After the CBT treatment, individuals high 
in CM and those low in CM exhibited significant decreases in their ratings of the 
probability and cost of their feared predictions about the oral presentation; however, 
this decrease was greater for individuals high in CM. One limitation was that the 
researchers did not assess whether the changes in probability and cost ratings 
demonstrated by the treatment condition were greater than those occurring in the 
distraction condition. Even so, participants who had received the CBT did report 
significantly lower anxiety prior to the speech than those from the distraction 
condition. This intervention was very short and a sufficient follow-up assessment 
was not provided (DiBartolo et al., 2001). 
Four RCTs have evaluated the efficacy of CBT for perfectionism in non-
clinical samples (Arpin-Cribbie et al., 2008; Arpin-Cribbie et al., 2012; Pleva & 
Wade, 2006; Radhu et al., 2012). These designs have greater internal validity than 
the previous studies reviewed in this section; however, the findings still do not 
generalise to clinical populations. Arpin-Cribbie et al. (2008) used a sample of 83 
students with elevated PCI scores to examine the efficacy of a 10-session online 
treatment for perfectionism. This treatment contained stress management techniques 
as well CBT techniques for perfectionism that focused on altering perfectionist 
beliefs and the impact of these beliefs on mood (Arpin-Cribbie et al., 2008). This 
treatment was compared to a pure stress management condition that did not 
incorporate cognitive components, as well as a control condition. Students in the 
combined stress management plus CBT for perfectionism condition displayed 
significantly greater reductions in SPP and depression compared to those in the pure 
stress management and control conditions. Those in the combined condition also 
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exhibited significantly greater reductions in CM, SOP and PCI scores compared to 
the control condition. Structural equation modelling indicated that greater level of 
treatment was a significant predictor of greater reduction in perfectionism (SOP, 
SPP, CM, PCI scores) and distress. Greater reduction in perfectionism (SOP, SPP, 
CM, PCI scores) was also significantly associated with greater decreases in distress. 
This study provides support for online CBT for perfectionism significantly reducing 
perfectionism and psychological distress in a non-clinical sample. 
 Arpin-Cribbie et al. (2012) evaluated the stress management plus CBT for 
perfectionism treatment relative to pure stress management and control conditions in 
77 participants with elevated PCI scores.  Participants in the combined stress 
management and CBT for perfectionism condition demonstrated significantly greater 
reductions in CM, SOP, SPP and PCI scores compared to those in the stress 
management and control conditions; and significantly greater decreases in anxiety 
and depression compared to the control condition. For participants in the CBT for 
perfectionism plus stress management condition, changes in SOP, SPP, CM and PCI 
scores were significantly associated with changes in anxiety, anxiety sensitivity and 
depression. Radhu et al. (2012) compared an online CBT intervention for 
perfectionism to a waitlist control condition in 24 adults with elevated PCI scores. 
The treatment focused on reframing beliefs associated with perfectionism and the 
influence of these beliefs on mood (Radhu et al., 2012). Participants in the 
intervention condition exhibited significantly greater reductions in automatic 
thoughts and anxiety sensitivity relative to those in the waitlist control condition. 
Collectively, these studies indicate that web-based CBT interventions can produce 
reductions in dimensions of perfectionism and psychopathology; however, the non-
91 
 
clinical samples prevent generalisations to clinical populations (Arpin-Cribbie et al., 
2008; Arpin-Cribbie et al., 2012; Radhu et al., 2012).  
Pleva and Wade’s (2007) RCT evaluated the efficacy of guided self-help 
CBT for perfectionism compared to pure self-help CBT for perfectionism in a non-
clinical sample. Forty nine adults with elevated total FMPS scores were randomised 
to a guided self-help or a pure self-help condition. In the guided self-help condition, 
participants read and completed exercises from Antony and Swinson’s (1998) 
cognitive behavioural self-help book for perfectionism with minimal therapist 
guidance. In the pure self-help condition, participants read and completed exercises 
from Antony and Swinson’s (1998) book in line with written guidelines. Adults 
receiving guided self-help exhibited significantly greater reductions in obsessive-
compulsive symptoms relative to adults receiving pure self-help. Both guided and 
pure self-help conditions displayed decreases in perfectionism and depression 
between pre- and post-treatment; however, there were no significant differences 
between conditions. Specifically, participants receiving guided self-help 
demonstrated significant pre-post decreases in CM, PS, DA, depression and 
obsessive-compulsive symptoms. These decreases were maintained at 3-month 
follow-up with the exception of depression; however, this still remained at a lower 
level than pre-treatment depression scores. Individuals receiving pure self-help 
exhibited significant pre-post decreases in CM and depression, which were 
maintained at 3-month follow-up. There was also a significant decrease in DA and 
obsessive-compulsive symptoms between post-treatment and 3-month follow-up. 
Thus, while there are improvements in dimensions of perfectionism and depression 
following both guided and pure self-help, it appears that guided self-help is more 
effective than pure self-help in the treatment of obsessive-compulsive symptoms. A 
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greater percentage of participants from the guided self-help condition tended to 
demonstrate reliable change in PS and obsessive-compulsive symptoms; however, 
tests of the significance of these differences were not conducted.  This study did not 
include a pure control group. It also did not control for differences in reading and 
homework compliance that may have occurred between groups and accounted for 
any interaction effects (Pleva & Wade, 2007). The non-clinical sample prevents 
generalisation to clinical populations. 
1.7.2. CBT for perfectionism in clinical samples. Two single-case studies 
have explored the effectiveness of CBT for perfectionism using clinical participants 
(Hirsch & Hayward, 1998; Shafran, Lee, & Fairburn, 2004). In Hirsch and 
Hayward’s (1998) study, CBT strategies were administered to a 40-year old male 
who had an elevated DAS-SC score as well as anxiety and depression. The CBT 
strategies focused on the identification and challenging of rigid perfectionist beliefs 
about performance (Hirsch & Hayward, 1998). Following CBT for perfectionism, 
the participant demonstrated reductions in perfectionism. Hirsch and Hayward 
(1998) contended that these reductions were evident by the participant’s engagement 
in activities he could not perform perfectly and his willingness to no longer be 
perfect in consistently completing his therapy homework. Furthermore, there were 
reductions in the extent to which the participant believed his rigid perfectionist 
beliefs and increases in the extent to which the participant believed his flexible 
beliefs. These reductions in perfectionism were followed by decreases in anxiety and 
depression. While this study provides preliminary evidence for the effectiveness of 
CBT for perfectionism in reducing perfectionism, anxiety and depression, post-
treatment DAS-SC scores were not recorded to support the reported reductions in 
perfectionism. This study did not have a control group so does not have high internal 
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validity. Furthermore, there was only one participant, which limits the generalisation 
of findings. 
In Shafran et al.’s (2004) study, CBT for clinical perfectionism (CBT-CP) 
based on the treatment principles of Shafran et al. (2002) was administered to a 26-
year old female with an elevated CPQ score and binge-eating disorder. Following 
CBT-CP, the participant reported reductions in CPQ score, eating disorder 
symptoms and depression that were maintained at 5-month follow-up (Shafran et al., 
2004). Given the absence of a control group, it is still possible that these effects 
arose from non-specific effects such as the passage of time (Gravetter & Wallnau, 
2004). Furthermore, it is possible that improvements in binge-eating resulted in 
reductions in CPQ scores. The use of only one participant limits the generalisation of 
findings (Shafran et al., 2004). 
Two studies used multiple baseline single-case series designs with clinical 
samples to explore the effectiveness of CBT-CP (Egan & Hine, 2008; Glover, 
Brown, Fairburn, & Shafran, 2007). In Glover et al.’s (2007) study, nine adults with 
elevated CPQ scores as well as a diagnosis of an anxiety disorder or depression 
received ten sessions of CBT-CP. This CBT included treatment components by 
Shafran et al. (2002) and Fairburn et al. (2003). Between baseline and post-
treatment, there were statistically significant decreases in CPQ, SOP and DAS-SC 
scores, which were maintained at 3-month follow-up. There were no statistically 
significant reductions in depression or anxiety. Between baseline and 3-month 
follow-up, three participants exhibited clinically significant change in CPQ scores 
and six participants made clinically significant change in DAS-SC and SOP scores. 
Between baseline and post-treatment, three participants exhibited clinically 
significant change in depression and one participant maintained this at 3-month 
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follow-up. Clinically significant change in anxiety did not occur. Nevertheless, this 
study did not have a stable baseline phase or separate waitlist control group, which 
prevents these findings from being confidently attributed to the CBT-CP intervention 
(Glover et al., 2007; Gravetter & Wallnau, 2004).   
In Egan and Hine’s (2008) study, eight sessions of CBT-CP were 
administered to four adults with elevated perfectionism and either depression or an 
anxiety disorder. These participants were deemed to have heightened perfectionism 
as they had obtained total FMPS scores within or above the mean FMPS range 
calculated from four studies of clinical samples with an anxiety disorder (Shafran & 
Mansell, 2001). The CBT strategies were based on Shafran et al.’s (2002) model. 
Between baseline and post-treatment three adults exhibited clinically significant 
change in total FMPS scores and two adults made clinically significant change in 
CM; however, there were no clinically significant changes in PS. Two adults 
maintained their changes on total FMPS and CM at 2-week follow-up. No clinically 
significant decreases in depression or anxiety occurred, although the authors argued 
that low pre-treatment depression and anxiety scores may have limited these 
findings. There was no waitlist control group and the sample size was small, which 
restricts the conclusions that can be drawn (Egan & Hine, 2008).  
Only two RCTs have investigated the efficacy of individual CBT for 
perfectionism in clinical samples (Riley et al., 2007; Steele & Wade, 2008). Steele 
and Wade (2008) conducted an RCT to explore the efficacy of guided self-help CBT 
for perfectionism. This intervention was based on Antony and Swinson’s (1998) 
self-help book. Forty-eight females who had EDNOS or bulimia nervosa were 
randomised to receive guided self-help CBT for perfectionism (Antony & Swinson, 
1998), conventional CBT for eating disorders (Cooper, 1993, in Steele & Wade, 
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2008) or a condition containing dismantled mindfulness components (Segal, 
Williams, & Teasdale, 2002). Every condition displayed significant reductions in 
CM, PS, eating disorder symptoms and depression as well as significant increases in 
self-esteem between pre-treatment and post-treatment. All treatment gains with the 
exception of PS were maintained at 6-month follow-up. These findings are consistent 
with guided self-help CBT for perfectionism producing similar therapeutic outcomes 
to a conventional eating disorder treatment as well as a dismantled mindfulness 
condition that was argued to contain active treatment components. Interestingly, the 
guided self-help CBT for perfectionism condition tended to produce greater effect 
sizes for the non-targeted psychopathology of co-morbid depression and anxiety 
compared to the other conditions (Steele & Wade, 2008). These trends are clinically 
relevant as they are in line with perfectionism having a transdiagnostic role (Egan et 
al., 2011). A limitation of this study is that there was no pure control condition 
(Steele & Wade, 2008).   
Riley et al. (2007) investigated the efficacy of individual CBT for clinical 
perfectionism (CBT-CP) by comparing it to a waitlist control condition. The CBT-
CP was based on Shafran et al.’s (2002) model of clinical perfectionism. Twenty 
adults deemed to have clinical levels of perfectionism as assessed by a semi-
structured interview participated in this trial. Seventy per cent of these adults had an 
anxiety disorder or depression. Participants were randomised to either immediately 
receive CBT-CP (immediate treatment condition) or be on an 8-week waitlist 
(waitlist condition). Participants in the immediate treatment condition demonstrated 
significantly greater reductions in clinical perfectionism as measured by the CPQ 
and the Clinical Perfectionism Examination (CPE; Riley, Cooper, Fairburn, & 
Shafran, unpublished, in Riley et al., 2007) compared to the waitlist condition. For 
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the immediate treatment condition the effect sizes were large. There were no 
significant interaction effects for the FMPS or HMPS scales. Participants in the 
immediate treatment condition also demonstrated significantly greater decreases in 
BDI-II scores and Brief Symptom Inventory scores (Derogatis & Melisaratos, 1983) 
relative to the waitlist condition; however, there was no significant interaction effect 
for anxiety. After the entire sample had received CBT-CP, post-treatment scores on 
CPQ, CPE, total FMPS and SOP were significantly lower than baseline scores and 
reductions were maintained at 4-month follow-up. Post-treatment BDI-II, Brief 
Symptom Inventory (Derogatis & Melisaratos, 1983) and Beck Anxiety Inventory 
scores (Beck et al. 1988) were also significantly lower than baseline scores and 
decreases on the latter two measures were maintained at 4-month follow-up. After 
receiving CBT-CP, 75 per cent of the sample exhibited clinically significant 
reductions in CPE scores and the number of adults who had depression and anxiety 
diagnoses had halved. This study has high internal validity due to the inclusion of a 
control group and randomisation to conditions; however, the sample size was small 
and it was not a pure clinical sample (Riley et al., 2007).  
1.8. Group CBT 
Numerous controlled studies have supported the efficacy of group CBT for 
psychological disorders including depression (e.g., Shaw, 1977; Oei & Dingle, 
2008), bipolar disorder (e.g., da Costa et al., 2011), obsessive-compulsive disorder 
(e.g., Anderson & Rees, 2007, Cordioli et al., 2003), social anxiety disorder (e.g., 
Heimberg, Dodge, Hope, Kennedy, & Zollo, 1990), panic disorder (e.g., Telch et al., 
1993), generalised anxiety disorder (Dugas et al., 2003), post-traumatic stress 
disorder (e.g.,  Beck, Coffey, Foy, Keane, & Blanchard, 2009) as well as eating 
disorders (e.g., Wilfley et al., 1993). 
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There are also advantages of administering CBT in a group format 
(Australian Psychological Society, 2013; Himle et al., 2003). The first advantage is 
the reduced cost of group therapy relative to individual therapy (Himle et al., 2003). 
Himle et al. (2003) estimated this cost-saving to be $600 per patient over 12 sessions 
of therapy. One decade later this cost-saving has increased. The Australian 
Psychological Society (APS; 2013) recommended that for a 45 to 60 minute 
individual therapy session a fee of $228 should be charged, whereas for a 45 to 60 
minute group therapy session a fee of $46 should be charged. Over twelve sessions 
this equates to a cost-savings of $2,184 per client. The second advantage of group 
therapy is increased time efficiency for the psychologist (Himle et al., 2013). Himle 
et al. (2003) argued that group therapy could equate to a 67 to 75 per cent decrease in 
the time psychologists spend with each client. If one psychologist delivered a 12-
week treatment protocol to six clients in the form of 1.5 hour to 2 hour group 
sessions, this would equate to 18 to 24 hours of therapy time. This is contrasted to 
the 72 hours it would take a psychologist to deliver a 12-week treatment protocol in 
the form of 1-hour individual treatment sessions to six clients. Himle et al. (2003) 
stated that while this time efficiency decreases when psychologists co-facilitate a 
group, group therapy is still more time efficient compared to individual therapy.  
In addition to practical advantages, delivery of CBT in a group format has 
been proposed to confer therapeutic advantages (Bieling et al., 2006; Yalom, 1995; 
Yalom & Leszcz, 2005). Bieling et al. (2006) drew upon the seminal work of Yalom 
(1995) to put forward several mechanisms of change that can occur within the 
context of a CBT group. The first mechanism of change was optimism, where the 
group context fosters optimistic expectations and hopefulness about recovery, which 
were posited to positively influence therapeutic outcome (Bieling et al., 2006). 
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Optimism was argued to arise in a group CBT setting because in addition to the 
client receiving information about the efficacy and effectiveness of CBT from the 
therapist, they are able to observe and acquire information about other group 
members who are progressing as a result of treatment. Bieling et al. (2006) 
contended that this setting was supportive of behaviour change, which would further 
increase clients’ motivation to recover.  
The second mechanism of change put forward was inclusion, where in a 
group context clients become aware that others share similar concerns to their own. 
This awareness was proposed to bring a sense of relief, decreased feelings of 
isolation and increased feelings of belonging as clients learn that they are not alone 
in experiencing their concerns (Bieling et al., 2006; Yalom, 1995; Yalom & Leszcz, 
2005). This mechanism of change is very similar to Yalom’s (1995) concept of 
universality, which was argued to be particularly powerful in a therapy context as 
some clients have previously had limited opportunities to discover the similar 
concerns of others due to their interpersonal difficulties or excessive social isolation 
(Yalom, 1995; Yalom & Leszcz, 2005).  
The third mechanism of change proposed was group learning, where the 
group environment presents multiple chances for clients to learn (Bieling et al., 
2006; Yalom, 1995; Yalom & Leszcz, 2005). Bieling et al. (2006) stated that in 
addition to the CBT material received from the therapist, clients in group therapy can 
learn through the information and feedback given to them from other members of the 
group. The therapist can assist in this process to ensure that information and 
feedback from other group members is delivered in a helpful manner. Bieling et al. 
(2006) argued that clients can also learn through observing the therapist and other 
members of the group. The therapist can promote adaptive behaviour to be modelled 
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by assisting - and having other group members assist - a group member to engage in 
various CBT techniques (e.g., exposure exercises, role playing and problem solving).  
The fourth mechanism of change proposed was shifting self-focus (Bieling et 
al., 2006). Bieling et al. (2006) posited that the group therapy context enables clients 
to experience the benefit of assisting other clients, be it through their communication 
of information or techniques or through the provision of reassurance or support. The 
act of helping other members is beneficial to the client as they learn that they can be 
effective to other members and assist these members to make progress (Bieling et al., 
2006; Holmes & Kivlighan, 2000; Yalom, 1995; Yalom & Leszcz, 2005). It was 
argued that in helping others, emphasis is shifted away from a self-focus and toward 
a focus on others in the group and the group itself (Bieling et al., 2006).  
The fifth mechanism of change put forward was the modification of 
maladaptive relational patterns (Bieling et al., 2006). Bieling et al. (2006) purported 
that in a group setting, a client’s unhelpful interpersonal patterns can be corrected. 
Specifically, in this setting the therapist can draw attention to the manner in which a 
group member interacts with the therapist and with others in the group and extract 
feedback from the group members as to the impact of this interaction upon them. 
This feedback can assist the group member to gain insight into their unhelpful styles 
of interpersonal communication and the impact of their style on others. The therapist 
can then assist the client to adopt more helpful styles of communication.  
The sixth mechanism of change was group cohesiveness (Bieling et al., 2006; 
Yalom, 1995; Yalom & Leszcz, 2005). Bieling et al. (2006) referred to group 
cohesiveness as the factors that make a group attractive to the individuals within the 
group and posited that these factors assist with behavioural and cognitive change. 
Examples of these factors included feeling like one belongs in the group, feelings of 
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comfort in the group and unreserved acceptance by individuals within the group 
(Bieling et al., 2006; Bloch & Crouch, 1985). The seventh mechanism of change was 
emotional processing in the group setting (Bieling et al., 2006). Bieling et al. (2006) 
contended that the group setting fosters an environment where group members can 
overtly express and process thoughts and emotions and that the therapist can utilise 
these times to extract underlying automatic thoughts and beliefs, which become a 
focus of treatment. Importantly, Bieling et al. (2006) argued that one group member 
expressing and processing their thoughts and emotions can benefit the other 
members of the group as it may raise an issue to be discussed and managed that may 
have otherwise remained undiscussed. This can further enhance group cohesion and 
provide group members with a chance to offer support to one another. 
These proposed mechanisms of change have been derived from clinicians 
with many years of experience delivering psychotherapy (Bieling et al., 2006). 
Bieling et al. (2006) contended that these mechanisms of change are likely to 
positively influence therapeutic outcome. While this provides support for the 
credibility of these mechanisms of change, it is to be noted that there are limited 
empirical studies that directly link these mechanisms of change to therapeutic 
outcomes (Bieling et al., 2006). One of the main reasons for this is that the majority 
of studies investigating group psychotherapy have investigated whether therapeutic 
change actually occurs, rather than exploring the specific factors that brought about 
this change. Future studies need to investigate whether these mechanisms of change 
are significantly associated with therapeutic outcomes (Bieling et al., 2006; Greene, 
2000). 
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1.9. Group CBT for Perfectionism 
As discussed, CBT for perfectionism has the potential to simultaneously 
ameliorate the symptoms of multiple psychological disorders (Bieling et al., 2004; 
Egan et al., 2011). This transdiagnostic treatment may confer increased time 
efficiency for psychologists and clients, as well as decreased cost for clients relative 
to disorder-specific treatments. This is because delivery of this intervention may 
prevent psychologists having to administer multiple disorder-specific treatment 
protocols (Craske, 2012; Egan et al., 2012). If this transdiagnostic treatment is then 
administered in a group format rather than in an individual format, this would result 
in additional time efficiency for the psychologist, as well as additional cost savings 
for the clients, which arise from treating multiple clients at the same time (APS, 
2013; Himle et al., 2003). The clients receiving this group transdiagnostic treatment 
may also benefit from the mechanisms of change that were proposed to occur in a 
group setting (Bieling et al., 2006; Yalom, 1995; Yalom & Leszcz, 2005). Therefore, 
group CBT for perfectionism would be advantageous given real-world financial and 
time constraints (Craske, 2012; Egan et al., 2012; Himle et al., 2003). Despite these 
advantages, there is a dearth of studies in the literature that have examined the 
efficacy or effectiveness of group CBT for perfectionism. While the limited studies 
that have investigated the effectiveness of group CBT for perfectionism have 
produced promising results, these studies have been limited by insufficiently 
rigorous designs (Kutlesa & Arthur, 2008), the use of non-clinical samples (Kutlesa 
& Arthur, 2008), small sample sizes (Egan & Stout, 2007), or the absence of a 
separate control condition (Egan & Stout, 2007; Steele et al., 2013), which 
undermine the internal validity of these studies and limit the generalisation of 
findings.  
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1.9.1. Group CBT for perfectionism in non-clinical samples. One of the 
earliest studies of group CBT for perfectionism was conducted by Barrow and 
Moore (1983). Barrow and Moore (1983) designed a group CBT program for 
perfectionism that had four aims i) to assist clients in being more selective with their 
goals and standards; ii) to help clients acquire greater acceptance of the instances 
when their standards have not been attained; iii) to assist clients to separate their self-
esteem from their performance; and iv) to help clients challenge their perfectionist 
cognitions. However, no studies have examined the effectiveness of this group CBT 
program.  
Only one study has examined the effectiveness of a group CBT intervention 
for perfectionism in a student sample (Kutlesa & Arthur, 2008). Kutlesa and Arthur 
(2008) employed a quasi-experimental design with 90 students to evaluate the 
effectiveness of group CBT for perfectionism compared to a career planning group 
and a psychology class. The 8-week CBT course was based on techniques by Beck 
(1993) and also included interpersonal process techniques by Yalom (1995). Thus, it 
was not based on Shafran et al.’s (2002) maintenance model of clinical 
perfectionism. Participants receiving group CBT for perfectionism exhibited 
significantly greater decreases in SOP, OOP, anxiety and depression than 
participants in the psychology class and career planning group. This study has many 
limitations, some of which include self-selection to groups, the treatment group 
having substantially greater SOP, SPP, OOP, anxiety and depression scores at pre-
treatment compared to the other groups and the absence of a follow-up period. Thus, 
it is difficult to attribute these changes in perfectionism and psychopathology to the 
group CBT intervention (Kutlesa & Arthur, 2008). 
103 
 
1.9.2. Group CBT for clinical perfectionism in clinical samples. There are 
only two studies that have investigated the effectiveness of group CBT for clinical 
perfectionism in clinical samples (Egan & Stout, 2007; Steele et al., 2013). In both 
of these studies, the CBT intervention was based on the maintenance model of 
clinical perfectionism (Shafran et al., 2002). Steele et al.’s (2013) group CBT-CP 
also targeted performance-related behaviours based on Shafran et al.’s (2010) 
updated model of clinical perfectionism. For simplicity, the group CBT for clinical 
perfectionism treatment can be referred to as group CBT-CP. Egan and Stout (2007) 
used single case experimental design series methodology to examine the impact of 
eight sessions of group CBT-CP on three participants. Participants had elevated 
scores on total FMPS, PS and CM as well as depression or an anxiety disorder. 
Between baseline and post-treatment, each participant exhibited downward trends in 
total FMPS and CM. One participant demonstrated a downward trend in PS. 
Downward trends in total FMPS continued during 3-week follow-up for all 
participants, whereas downward trends in CM and PS continued throughout 3-week 
follow-up for one participant; however, these decreases were not clinically 
significant. Between baseline and post-treatment, all participants exhibited 
downward trends in depression, which continued throughout 3-week follow-up for 
two participants. Between baseline and post-treatment, all participants exhibited 
downward trends in anxiety that continued during 3-week follow-up for one 
participant and were maintained at 3-week follow-up for two participants. One adult 
exhibited a clinically significant decrease in depression at post-treatment that was 
maintained at 3-week follow-up. Limitations of this study include the small sample 
and the study not incorporating a control group (Egan & Stout, 2007). 
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 Steele et al. (2013) investigated the effectiveness of psycho-education and 
group CBT-CP in 21 adults with elevated CM scores as well as an anxiety disorder 
or current or past depression. Steele et al. (2013) utilised a case series design where 
participants first had a 4-week no treatment period that functioned as a control 
period. Participants then received psycho-education material and after another four 
weeks received eight weeks of group CBT-CP. The psycho-education and group 
CBT-CP material were from Shafran et al.’s (2010) book ‘Overcoming 
perfectionism: a self-help manual using cognitive-behavioural techniques’. While 
there were no statistically significant improvements following the psycho-education, 
after receiving the group CBT-CP participants exhibited significant pre-post 
reductions in CPQ scores, PS, CM, DAS-SC scores, anxiety, depression and stress, 
which were all maintained at 3-month follow-up. Nevertheless, as the design did not 
incorporate a separate control group, one cannot exclude the possibility that these 
results emerged due to confounds such as the passage of time instead of the 
intervention. To overcome this limitation, a study needs to evaluate the efficacy of 
group CBT-CP in a clinical sample utilising a design that has a separate control 
group. Therefore, in Study II of this thesis, an RCT design is used to evaluate the 
efficacy of group CBT-CP in a clinical sample. Employing this RCT design and 
ensuring there are enough participants for sufficient power will enable any findings 
to be confidently attributed to the intervention (Chambless & Hollon, 1998).  
1.10. Investigating the Effect of Group CBT-CP on Quality of Life 
Adults with depressive disorders, anxiety disorders and eating disorders have 
been found to have a significantly lower quality of life compared to adults who do 
not have a psychological disorder (Mond, Hay, Owens, Rogers, & Beaumont, 2005; 
Rapaport, Clary, Fayyad, & Endicott, 2005). Rapaport et al. (2005) examined the 
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Quality of Life, Enjoyment and Satisfaction Questionnaire-18 (Q-LES-Q-18; 
Endicott, Nee, Harrison, & Blumenthal, 1993) scores provided by 11 samples of 
adults with mood or anxiety disorders before they participated in treatment trials.  
These scores were compared to those from a community sample. The Q-LES-Q 
scores from the clinical samples were significantly lower than those from the 
community sample. Mond et al. (2005) similarly found that a sample of 87 
individuals with eating disorders scored significantly lower on health-related quality 
of life and subjective quality of life relative to a sample of young females from the 
general population. While these studies do not enable causal inferences, they do 
highlight an association between the presence of depressive disorders, anxiety 
disorders and eating disorders and lower quality of life that generalise to clinical 
populations (Mond et al., 2005; Rapaport et al., 2005). 
A study has also suggested that having co-morbid psychological disorders is 
associated with a lower quality of life than having one or no psychological disorder 
(Pirkola et al., 2009). Pirkola et al. (2009) reported that adults who had co-morbid 
depressive and anxiety disorders scored the lowest on health-related quality of life 
and perceived health and the highest on psychological distress relative to adults with 
a single disorder or no psychological disorder. Disorder co-morbidity was a 
significant negative predictor of perceived health and health-related quality of life, 
and a significant positive predictor of psychological distress after accounting for age, 
gender, diagnostic subgroup and being a recipient of mental health treatment. This 
study supports the presence of disorder co-morbidity being associated with lower 
quality of life, perceived health and higher distress after accounting for important 
confounds (Pirkola et al., 2009). These findings can generalise to clinical 
populations. 
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As treatments targeting perfectionism have the potential to simultaneously 
reduce the symptoms of multiple psychological disorders (Egan et al., 2011), it 
would be of interest to determine whether group CBT-CP also increases quality of 
life. Examining whether psychological treatments can reduce psychological 
symptoms and improve quality of life is important given that the World Health 
Organisation (1948, p. 100) has defined health as “a state of complete physical, 
mental and social well-being and not merely the absence of disease”. Currently, no 
published perfectionism treatment trials have included a quality of life outcome 
measure. Therefore, an additional unique contribution of this thesis is to examine 
whether group CBT-CP significantly increases quality of life.  
1.11. Rationale, Significance and Aims of PhD Thesis 
1.11.1. Rationale, significance and aims of Study I. While research has 
supported perfectionism dimensions being associated with depressive disorders, 
eating disorders and anxiety disorders using clinical samples (Egan et al., 2011), 
studies have not examined the relationships between perfectionism and pathological 
worry in individuals with GAD. Moreover, while research has examined whether 
perfectionism dimensions can predict whether individuals have disorders such as 
OCD, social phobia and panic disorder with or without agoraphobia (Antony, 
Purdon, et al., 1998), no studies have examined whether perfectionism dimensions 
can predict a principal diagnosis of GAD from a clinical sample with a range of 
diagnoses. If dimensions of perfectionism are found to be significantly associated 
with pathological worry and a principal diagnosis of GAD, this would provide 
further support for perfectionism being a transdiagnostic process (Egan et al., 2011). 
Such evidence would also provide a rationale for Study II of this thesis and future 
studies to investigate whether perfectionism interventions can reduce the symptoms 
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of GAD in addition to the symptoms of other disorders. In Study I of this PhD thesis, 
the relationships between perfectionism dimensions and pathological worry are 
investigated in individuals with elevated perfectionism and GAD who presented for 
perfectionism treatment. Furthermore, the utility of perfectionism dimensions in 
predicting a principal diagnosis of GAD is examined in a larger clinical sample with 
elevated perfectionism and a range of diagnoses who presented for perfectionism 
treatment.  
1.11.2. Rationale, significance and aims of Study II. The argument of 
perfectionism being a transdiagnostic process implies that treatments that target 
perfectionism have the potential to simultaneously reduce the symptoms of multiple 
psychological disorders (Egan et al., 2011). While this transdiagnostic treatment may 
confer increased time efficiency for psychologists and reduced costs for clients 
(Craske, 2012; Egan et al., 2012), limited studies have examined the efficacy of CBT 
for perfectionism. Furthermore, the few RCTs in the area have all investigated CBT 
for perfectionism delivered in an individual format (Pleva & Wade, 2006; Riley et 
al., 2007; Steele & Wade, 2008). Only one of these RCTs utilised CBT strategies 
based on Shafran et al.’s (2002) maintenance model of clinical perfectionism (Riley 
et al., 2007). Although group therapy confers additional time and cost savings, as 
well as the potential for added therapeutic benefits relative to individual treatments 
(Bieling et al., 2006; Himle et al., 2003; Yalom, 1995; Yalom & Leszcz, 2005), no 
RCT has compared group CBT-CP to a separate control group in a clinical sample. It 
is important to conduct this study to determine whether group CBT-CP works 
(Chambless & Hollon, 1998). Therefore, in Study II of this PhD thesis, a randomised 
controlled design is used to examine the efficacy of group CBT-CP in a clinical 
sample. This is the most significant unique contribution of this thesis. Furthermore, 
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to date, perfectionism treatment trials have not included a quality of life measure. 
Thus, in Study II of this PhD thesis, the effect of group CBT-CP on quality of life is 
examined to provide an additional unique contribution to the literature.  
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CHAPTER 2 
 STUDY I  
Examining the Associations between Perfectionism Dimensions, 
Pathological Worry and Generalised Anxiety Disorder in 
Individuals Presenting for Perfectionism Treatment 
2.1. Overview of Study I 
Dimensions of perfectionism have demonstrated significant relationships 
with major depressive disorder, bipolar I and II disorder, obsessive-compulsive 
disorder, eating disorders, personality disorders and anxiety disorders (Egan et al. 
2011). In regard to anxiety disorders, studies in clinical samples have found that 
dimensions of perfectionism are significantly associated with social phobia and panic 
disorder with agoraphobia (Antony, Purdon, et al., 1998; Juster et al., 1996; Iketani 
et al., 2002a). Dimensions of perfectionism have also predicted whether individuals 
receive a diagnosis of social phobia or panic disorder with or without agoraphobia 
from a clinical sample with a range of diagnoses (Antony, Purdon, et al., 1998).  
To date however, studies have not investigated the associations between 
perfectionism dimensions and pathological worry in adults with generalised anxiety 
disorder (GAD). Furthermore, research has not investigated whether perfectionism 
dimensions can predict a principal diagnosis of GAD from a clinical sample with a 
range of diagnoses. Examining the associations between perfectionism, pathological 
worry and GAD is important as evidence of significant relationships between these 
constructs would further support perfectionism being a transdiagnostic process (Egan 
et al., 2011). Such evidence would also provide a rationale for Study II of this PhD 
thesis and future studies to examine whether treatments targeting perfectionism can 
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decrease the symptoms of GAD in addition to the symptoms of other psychological 
disorders (Bieling, Summerfeldt, et al., 2004; Egan et al. 2011). In Study I of this 
PhD thesis, the relationships between perfectionism dimensions and pathological 
worry are investigated in adults with elevated perfectionism and GAD who presented 
for perfectionism treatment. Additionally, the utility of perfectionism dimensions in 
predicting a principal diagnosis of GAD is explored in a larger clinical sample with 
elevated perfectionism and a range of diagnoses who presented for perfectionism 
treatment.  
2.2. Perfectionism, Pathological Worry and Generalised Anxiety Disorder 
Worry is deemed to be pathological when it is perceived to be unrelenting, 
excessive, difficult to control and of a distressing nature (Stoeber & Joormann, 
2001). Pathological worry is a defining feature of GAD, as is evident by the 
diagnostic criteria for GAD (DSM-5, APA, 2013, p.222) which include:  
A. “Excessive anxiety and worry (apprehensive expectation) occurring more 
days than not for at least 6 months, about a number of events or activities 
(such as work or school performance)”  
B. “The individual finds it difficult to control the worry”  
C. “The anxiety and worry are associated with three (or more) of the 
following six symptoms (with at least some symptoms having been present 
for more days than not for the past 6 months)…restlessness or feeling keyed 
up or on edge; being easily fatigued; difficulty concentrating or mind going 
blank; irritability; muscle tension; sleep disturbance”. 
D: “The anxiety, worry or physical symptoms cause clinically significant 
distress or impairment in social, occupational, or other important areas of 
functioning”. 
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Findings from large scale studies have highlighted the prevalence of GAD 
(Kessler, Berglund, Demler, Jin, & Walters, 2005; Kessler, Chiu, et al., 2005; 
Kessler & Merikangas, 2004). Using data from the National Co-morbidity Survey 
Replication (Kessler & Merikangas, 2004), the lifetime prevalence of GAD was 
estimated to be 5.7 per cent (Kessler, Berglund, et al., 2005) and the 12-month 
prevalence was estimated to be 3.1 per cent (Kessler, Chiu, et al., 2005). The 
statistics from these studies have also indicated that GAD can be associated with 
high levels of distress and functional impairment (Kessler, Chiu, et al., 2005). 
Among individuals who had GAD in the last 12 months, nearly one third (32.9 per 
cent) of individuals were classified as having a severe level of the disorder. This 
classification was reserved for individuals who in the past 12 months had either 
attempted suicide with intent to die or those who had experienced extreme functional 
impairment. Moreover, nearly one half (44.6 per cent) of individuals were deemed to 
have a moderate level of GAD, which was defined by the presence of suicidal 
ideation, a suicide plan, or moderate functional impairment. The remaining 23.1 per 
cent were deemed to have a mild level of the disorder (Kessler, Chiu, et al., 2005). 
As the statistics in these studies are based on large sample sizes, this provides 
support for the reliability of these estimates. Given that GAD can be associated with 
these levels of distress and functional impairment, it is important for attention to be 
directed toward understanding the constructs associated with pathological worry as it 
occurs in GAD, with a view to targeting these constructs in treatments for this 
disorder. 
Researchers have found various constructs to be associated with the presence 
and maintenance of pathological worry in GAD (Buhr & Dugas, 2006; Dugas et al., 
1998; Wells, 1995; 1999). Dugas et al. (1998) postulated a cognitive model that 
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emphasised the role of four constructs in GAD: intolerance of uncertainty, beliefs 
about worry, poor problem orientation and cognitive avoidance. Wells’ (1995; 1999) 
meta-cognitive model highlighted the role of positive and negative meta-beliefs 
about worry, as well as behaviours such as trying to control worry, checking, 
reassurance seeking and avoidance in the onset and maintenance of Type 1 and Type 
2 worries. The constructs from these models have received empirical support as they 
have shown significant associations with pathological worry (e.g., Dugas et al., 
2007; Dugas, LaDouceur, & Freeston, 1997; Wells & Carter, 1999) and found to 
differentiate between individuals with a diagnosis of GAD and those without this 
diagnosis (Cartwright-Hatton & Wells, 1997; Dugas et al., 1998; LaDouceur, Blais, 
Freeston, & Dugas, 1998). Treatments targeting these constructs have also resulted 
in reductions in the symptoms of GAD, which provides support for the maintaining 
role of these constructs in GAD (Dugas et al., 2010; LaDouceur et al., 2000; van der 
Heiden, Muris, van der Molen, 2012; Wells, Welford, King, Wisely, & Mendel, 
2010). 
Nevertheless, accumulating research suggests that the constructs specified in 
these cognitive models (Dugas et al. 1998; Wells, 1995; 1999) may not be the only 
constructs involved in pathological worry. Dimensions of perfectionism may also be 
associated with pathological worry. There are three arguments for why perfectionism 
dimensions may be associated with pathological worry in individuals with GAD. 
The first argument is that dimensions of perfectionism are associated with the 
symptoms of multiple psychological disorders (Egan et al., 2011); including anxiety 
disorders such as social phobia (Juster et al., 1996), and panic disorder with 
agoraphobia (Iketani et al., 2002a). Perfectionism has consequently been posited to 
be a transdiagnostic process (Egan et al., 2011; Harvey et al., 2004). It is therefore 
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reasonable for research to examine whether perfectionism is also related to the 
symptoms of GAD. 
The second argument is that researchers have proposed links between 
perfectionism and worry for years (Flett, Madorsky, et al., 2002; Norman et al., 
1998; Pratt, Tallis, & Eysenck, 1997; Shafran et al., 2002; Shafran et al., 2010). It 
has been argued that in some individuals, heightened worry and psychological 
distress may be caused by perfectionist striving for unrealistic goals and fear of 
mistakes (Flett, Madorsky, et al., 2002; Norman et al., 1998). Based on studies 
demonstrating that those with high worry took longer than those with low worry to 
make decisions when categorising ambiguous stimuli (Metzger, Miller, Cohen, 
Sofka, & Borkovec, 1990; Pratt et al., 1997; Tallis, Eysenck, & Matthews, 1991), 
researchers reported that worriers possessed elevated evidence requirements. 
Specifically, individuals who engaged in high levels of worry needed a greater 
amount of evidence before making a decision compared to individuals who worried 
to a lesser extent (Pratt et al., 1997; Tallis et al., 1991). Pratt et al. (1997) argued that 
this need for a greater amount of evidence may stem from perfectionism. When 
individuals are engaged in the worry process, they have unreasonably high standards 
where they seek to obtain a perfect solution. They require additional information to 
be completely certain that they are making the right decision before responding. As a 
perfect solution is often not obtainable, the individual continues to engage in the 
worry process without selecting an effective solution to the worry. Shafran et al. 
(2002) and Shafran et al. (2010) have also proposed links between clinical 
perfectionism and worry. These researchers contended that individuals with clinical 
perfectionism strive to attain personally demanding standards even when it leads to 
adverse consequences, some of which include worry, stress and anxiety. While this 
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literature has posited connections between perfectionism and worry, there needs to 
be greater empirical evidence to support the associations between dimensions of 
perfectionism and worry (Flett, Madorsky, et al., 2002; Norman et al., 1998; Pratt et 
al., 1997; Shafran et al., 2002; Shafran et al., 2010). 
The third argument is that there is support for Self-Oriented Perfectionism 
(SOP), Socially-Prescribed Perfectionism (SPP), Concern over Mistakes (CM) and 
Doubts about Actions (DA) being related to pathological worry in student samples 
(Buhr & Dugas, 2006; Flett et al., 1994; Kawamura et al., 2001; Santanello & 
Gardner, 2007; Stoeber & Joormann, 2001). While these findings cannot be 
generalised to clinical samples, they are worthy of consideration because they 
provide a rationale to extend this examination to clinical samples. Flett et al. (1994) 
found that SOP and SPP had significant positive correlations with the cognitive 
worry dimension of state anxiety as measured by the Endler Multidimensional 
Anxiety Scales (Endler et al., 1991). When each gender was examined separately, 
significant correlations between SPP and cognitive worry remained in females and 
males; however, the correlation between SOP and cognitive worry was only present 
in females. This provides support for SPP being related to cognitive worry. It also 
suggests that gender moderates the relationship between SOP and cognitive worry. 
Therefore, gender should be accounted for in future studies investigating the 
relationship between perfectionism dimensions and worry (Flett et al., 1994).  
Buhr and Dugas (2006) examined the associations between SOP, SPP and 
pathological worry as measured by the Penn State Worry Questionnaire (PSWQ; 
Meyer et al., 1990). SOP and SPP were each significantly associated with PSWQ 
scores after controlling for gender. SOP remained a significant positive predictor of 
PSWQ scores after controlling for demographics and intolerance of uncertainty, 
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whereas SPP did not. This is an important finding as it demonstrates that SOP 
explains additional variance in pathological worry to that accounted for by 
intolerance of uncertainty, which is one of the constructs in Dugas et al.’s (1998) 
model of GAD. It highlights that SOP is not always an adaptive form of 
perfectionism as has been previously contended (Stoeber & Otto, 2006). This finding 
is also important given that SOP is the dimension of Hewitt and Flett’s (1991a) 
multidimensional perfectionism scale that best reflects Shafran et al.’s (2002) 
concept of clinical perfectionism. The findings of SPP no longer significantly 
predicting PSWQ after accounting for demographics and intolerance of uncertainty 
suggest that intolerance of uncertainty may at least partly explain the relationship 
between SPP and PSWQ (Buhr & Dugas, 2006). Future studies need to examine the 
role of intolerance of uncertainty in the relationship between SPP and pathological 
worry.  
Frost et al.’s (1990) dimensions of perfectionism have also been related to 
measures of worry in student samples (Kawamura et al., 2001; Santanello & 
Gardner, 2007; Stoeber & Joormann, 2001). These studies are commendable because 
they investigated whether dimensions of perfectionism have relationships with worry 
after controlling for depression and certain types of anxiety. This is important given 
that perfectionism has exhibited associations with the symptoms of depression and 
various anxiety disorders in student and clinical samples (Egan et al., 2011).  
Kawamura et al. (2001) investigated the associations between maladaptive 
evaluative concerns (MEC = Concern over Mistakes + Doubts about Actions + 
Parental Criticism + Parental Expectations), Personal Standards (PS) and three 
anxiety factors. These anxiety factors had been factor analysed from seven specific 
anxiety measures and consisted of obsessive-compulsive disorder symptoms, post-
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traumatic stress disorder symptoms and a combined construct of social anxiety, trait 
anxiety and worry. By Kawamura et al. (2001) exploring the relationships between 
MEC, PS and each of these anxiety factors, these researchers could ascertain whether 
MEC and PS were related to particular anxiety symptom types, rather than to the 
characteristics that occur in all types of anxiety.  MEC had significant positive 
correlations with each anxiety factor; however, MEC only significantly predicted 
social anxiety/trait anxiety/worry after controlling for depression. PS was only 
associated with post-traumatic stress disorder symptoms and this became non-
significant after controlling for depression. Kawamura et al. (2001) commented that 
these results supported MEC having a relationship with social anxiety/trait 
anxiety/worry, which cannot be explained by the relationship between perfectionism 
and depression (Enns et al., 2001; Kawamura et al., 2001).  
A limitation of Kawamura et al.’s (2001) findings is that perfectionism was 
measured by the composite construct MEC. This makes it difficult to determine the 
specific perfectionism dimensions that have a relationship with this worry construct. 
Furthermore, pathological worry was included in a construct with social and trait 
anxiety, so it is possible that the finding emerged due to the associations that 
perfectionism has with trait anxiety (Hewitt & Flett, 1991a) and social anxiety (Frost 
et al., 1990) in student samples.  
Studies by Stoeber and Joormann (2001) and Santanello and Gardner (2007) 
partially overcame the limitations of Kawamura et al.’s (2001) study by separating 
MEC into two composite subscales: CM + DA and PE + PC. These researchers then 
examined the relationships between CM + DA, PE + PC, PS and pathological worry 
as measured by the PSWQ after controlling for anxiety and depression (Santanello & 
Gardner, 2007; Stoeber & Joormann, 2001). Stoeber and Joormann (2001) found that 
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CM + DA had a significant relationship with PSWQ scores after accounting for 
depression and anxiety. PS was not significantly correlated with PSWQ scores. 
Santanello and Gardner (2007) similarly demonstrated that CM + DA was 
significantly related to PSWQ scores after accounting for depression, social anxiety 
and experiential avoidance. PS was not significantly associated with PSWQ scores. 
Thus, in these student samples CM + DA is the construct that has a relationship with 
pathological worry independent from depression and certain forms of anxiety. 
Nevertheless, as the combined construct of CM + DA was used in these studies, it is 
still not known whether it is CM, DA or both constructs that are associated with 
pathological worry after accounting for depression and anxiety. There needs to be a 
study that examines the utility of each separate construct in predicting pathological 
worry after anxiety and depression are controlled. Moreover, despite previous 
findings of gender moderating the relationship between perfectionism dimensions 
and pathological worry (Flett et al., 1994), gender was not controlled in this study, 
thus future studies need to control for this. Finally, due to the use of student samples, 
it is not known whether these findings generalise to clinical samples of individuals 
with GAD. 
 Another variable of interest that has not been directly examined in regard to 
pathological worry is clinical perfectionism as measured by the Clinical 
Perfectionism Questionnaire (CPQ; Fairburn et al., 2003b). As discussed, links have 
been theorised between clinical perfectionism, worry, anxiety and stress (Shafran et 
al., 2002; Shafran et al., 2010); however, there is limited research examining the 
associations between CPQ scores and these symptoms. Chang and Sanna (2012) 
examined the utility of CPQ in predicting anxiety and stress in a student sample. 
Anxiety was measured using the Beck Anxiety Inventory (Beck et al., 1988) and 
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stress was measured by the Perceived Stress Scale (Cohen et al., 1983). CPQ scores 
were a significant positive predictor of anxiety and stress after accounting for 
negative affect. While Chang and Sanna’s (2012) findings have highlighted the 
associations between CPQ scores, anxiety and stress in a sample of students, these 
findings cannot be generalised to clinical populations. Furthermore, studies have not 
examined the relationship between CPQ scores and pathological worry in non-
clinical or clinical samples. It would be of interest to examine whether a relationship 
exists between these constructs in a clinical sample after accounting for gender, 
anxiety and depression, as this would enable findings to be generalised to clinical 
populations. Evidence to support the CPQ being associated with pathological worry 
would also provide support for the validity of the CPQ as a measure of clinical 
perfectionism (Fairburn et al., 2003b). 
In sum, three arguments have been presented for why perfectionism may be 
associated with pathological worry in individuals with GAD. First, perfectionism 
dimensions have been found to be associated with the symptoms of multiple 
disorders in clinical samples (Egan et al., 2011), therefore it is reasonable to examine 
whether perfectionism dimensions are also related to the symptoms of GAD. Second, 
theoretical links between perfectionism and worry have been proposed by 
researchers (Flett, Madorsky, et al., 2002; Norman et al., 1998; Pratt et al., 1997; 
Shafran et al., 2002; Shafran et al., 2010). Third, studies using student samples have 
found dimensions of perfectionism to be associated with pathological worry and in 
many of these studies these associations have remained after controlling for gender, 
anxiety and/or depression (Buhr & Dugas, 2006; Flett et al., 1994; Kawamura et al., 
2001; Santanello & Gardner, 2007; Stoeber & Joormann, 2001).  
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Given that pathological worry is a defining feature of GAD (DSM-5, APA, 
2013) it would also be relevant to examine whether dimensions of perfectionism can 
predict a principal diagnosis of GAD from a clinical sample with a range of 
diagnoses. Research investigating the role of other constructs (e.g., intolerance of 
uncertainty) in pathological worry and GAD has examined whether such constructs 
can differentiate between individuals with and without GAD (Cartwright-Hatton & 
Wells, 1997; Dugas et al., 1998; LaDouceur et al., 1998). Moreover, studies have 
also examined whether perfectionism dimensions can predict whether individuals 
have other disorders, including obsessive-compulsive disorder, social phobia and 
panic disorder with or without agoraphobia (Antony, Purdon, et al., 1998). To date 
however, research has not investigated whether perfectionism dimensions can predict 
a principal diagnosis of GAD in a clinical sample with a range of diagnoses. It would 
be of interest to examine whether this relationship emerged after controlling for 
gender and depression, given that gender has moderated the association between 
perfectionism dimensions and pathological worry (Flett et al., 1994) and 
perfectionism dimensions have shown relationships with depression (Egan et al., 
2011). It would be illogical to control for anxiety in this examination given that 
anxiety symptoms are part of the diagnostic criteria for GAD (DSM-5, APA, 2013). 
2.3. Rationale, Significance, Aims and Hypotheses of the Current Study 
The current study has two aims. The first aim is to explore the associations 
between perfectionism dimensions and pathological worry in adults with elevated 
perfectionism and GAD who presented for perfectionism treatment. This is the first 
study to examine these associations in a clinical sample. Evidence of significant 
relationships between perfectionism dimensions and pathological worry will provide 
a rationale for Study II of this thesis and future studies to investigate whether 
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perfectionism interventions can reduce the symptoms of GAD along with the 
symptoms of other disorders. 
 To overcome the limitation of previous studies using composite constructs of 
perfectionism (Kawamura et al., 2001; Santanello & Gardner, 2007; Stoeber & 
Joormann, 2001), this study examines the associations between single dimensions of 
perfectionism and pathological worry. Additionally, the relationship between a 
measure of clinical perfectionism and pathological worry is investigated, which has 
not before been examined. Importantly, this study will investigate whether 
perfectionism dimensions are related to pathological worry after controlling for 
gender, anxiety and depression, providing that these variables are first found to have 
significant zero-order correlations with pathological worry in this sample.  
The theories and research discussed inform the current hypotheses. 
Hypothesis 1 is stated below and predicts associations between CM, PS, DA and 
pathological worry after controlling for gender, anxiety and depression. The 
prediction about CM is based on the theoretical links between concern over mistakes 
and pathological worry (Flett, Madorsky, et al., 2002), as well as findings of 
CM+DA being associated with pathological worry in non-clinical samples 
(Kawamura et al., 2001; Santanello & Gardner, 2007; Stoeber & Joormann, 2001), 
and CM being related to anxiety symptoms in clinical samples (Egan et al., 2011). 
The prediction about PS is based on the theoretical links between personal standards 
and pathological worry (Flett, Madorsky, et al., 2002; Pratt et al., 1997). Although 
PS was not associated with pathological worry in non-clinical samples (Kawamura et 
al., 2001; Santanello & Gardner, 2007; Stoeber & Joormann, 2001), two studies have 
found PS to be associated with anxiety symptoms in clinical samples with other 
anxiety disorders (Iketani et al., 2002a; 2002b). The prediction about DA is based on 
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CM+DA predicting pathological worry in non-clinical samples (Kawamura et al., 
2001; Santanello & Gardner, 2007; Stoeber & Joormann, 2001) and DA being 
associated with anxiety symptoms in clinical samples (Egan et al., 2011). 
 
H1. After controlling for gender, anxiety, and depression, CM, PS and DA will each 
predict a significant proportion of unique variance in pathological worry (PSWQ). 
 
Hypothesis 2 is based on the theoretical links between clinical perfectionism and 
worry, anxiety and stress (Shafran et al., 2002; Shafran et al., 2010), as well as the 
findings of CPQ scores significantly predicting anxiety and stress in a non-clinical 
sample (Chang & Sanna, 2012). 
 
H2. After controlling for gender, anxiety and depression, CPQ scores will predict a 
significant proportion of unique variance in pathological worry (PSWQ).   
 
The second aim of this study is to investigate whether perfectionism 
dimensions significantly predict a principal diagnosis of GAD in a larger clinical 
sample with elevated perfectionism and a range of diagnoses who presented for 
perfectionism treatment. This is the first study to examine the utility of perfectionism 
in predicting a principal diagnosis of GAD. Importantly, this study will examine the 
predictive utility of perfectionism in this disorder after controlling for gender and 
depression, providing that these variables first demonstrate significant zero-order 
correlations with a principal diagnosis of GAD. As previously discussed, anxiety 
will not be controlled even it is shown to have a significant zero-order correlation 
with a principal diagnosis of GAD. Hypothesis 3 is based on pathological worry 
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being a defining feature of GAD (DSM-5, APA, 2013) and the reasoning that the 
perfectionism dimensions hypothesised to be associated with pathological worry 
(CM, PS, DA and CPQ scores) would also be significant predictors of a principal 
diagnosis of GAD.  
 
H3. After controlling for gender and depression, CM, PS, DA and CPQ scores will 
each predict a significant proportion of unique variance in the probability of having a 
principal diagnosis of GAD. 
2.4. Method 
2.4.1. Participants 
The first aim of this study was investigated with 36 adults (81% female, 19% 
male) who had elevated perfectionism and a DSM-IV-TR (APA, 2000) diagnosis of 
GAD. The mean age of participants was 30.86 years (SD = 11.30). These 36 
participants were a subset of a larger sample (N = 42) of adults with elevated 
perfectionism and a range of psychological disorders who were at baseline 
assessment for participation in a group CBT for clinical perfectionism treatment trial. 
This treatment trial is described in Study II. Participants had self-referred to this trial 
in response to letters and advertising fliers circulated to general practitioners, 
psychiatrists, psychologists, universities and workplaces across the Perth 
metropolitan area. Participants who had met the inclusion criteria of the trial were 
invited for a baseline assessment. As a result of one of the inclusion criteria of the 
trial, all participants had elevated perfectionism as defined by receiving a score of 
higher than 24.7 on the CM subscale (Frost et al., 1990). Elevated CM was used as 
the inclusion criterion rather than elevated CPQ score because to date limited studies 
have used the CPQ (Steele et al., 2013). CM has been frequently used in the 
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literature and has clinical relevance due to its associations with the symptoms of 
numerous disorders (Egan et al., 2011). The cut-off score of 24.7 was determined by 
averaging the mean CM scores from six studies that had explored perfectionism in 
anxiety disorder samples as cited in Egan et al.’s (2011) review. Eighty-three per 
cent of adults in this sample had a principal diagnosis of GAD as they had rated their 
worries and anxiety as being the most distressing of their reported symptoms. 
Seventeen per cent had GAD as their second or third diagnosis as they had rated the 
symptoms of at least one other disorder as currently causing them greater distress 
than their worry and anxiety. The average number of psychological disorders per 
person was 2.36 (SD =1.10). 
 The second aim of this study was investigated with the entire sample of 42 
adults (81% female, 19% male) who had elevated perfectionism and a range of 
psychological disorders and were at baseline assessment for participation in the 
clinical perfectionism treatment trial described above. All participants had elevated 
perfectionism defined by a score of higher than 24.7 on the CM subscale (Egan et al., 
2011; Frost et al., 1990). The mean age of this sample was 31.47 years (SD = 11.01).  
Ninety per cent of the sample had at least one psychological disorder based on DSM-
IV-TR criteria (APA, 2000). These disorders were GAD, social phobia, panic 
disorder, panic disorder with agoraphobia, obsessive-compulsive disorder, major 
depressive disorder, bipolar II disorder, bulimia nervosa, eating disorder not-
otherwise specified and alcohol dependence. Seventy-one per cent of the sample had 
a principal diagnosis of GAD. Ten per cent of adults did not have a current 
psychological disorder based on DSM-IV-TR criteria (APA, 2000); however, these 
adults each had depression in partial or full remission. The average number of 
disorders per person was 2.071 (SD = 1.26).  
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All participants gave written informed consent to take part in perfectionism 
treatment research. This research, from which the data for this study was derived, 
was approved by the Curtin University Human Research Ethics Committee and 
complied with the Helsinki Declaration (World Medical Association, 2008). 
2.4.2. Measures 
Concern over Mistakes, Personal Standards and Doubts about Actions 
subscales (Frost et al., 1990). The CM, PS and DA subscales from Frost et al.’s 
(1990) multidimensional perfectionism scale were used.  For each subscale, items 
are rated on 5-point Likert scales ranging from strongly disagree to strongly agree 
and responses for that subscale are summed to produce the total subscale score. 
Higher scores on the CM, PS and DA subscales denote greater concern over 
mistakes, personal standards and doubts about actions respectively. Each of these 
subscales has been found to have high internal consistency (CM= .88; PS = .83; DA 
= .77; Frost et al., 1990), as well as high validity (Antony, Purdon, et al., 1998; 
Bardone-Cone, 2007; Egan et al., 2011). For the current sample of 36 participants, 
Cronbach’s alpha was .91(CM), .82 (PS) and .73 (DA); for the sample of 42 
participants, it was .90 (CM), .81 (PS) and .72 (DA). 
Clinical Perfectionism Questionnaire (CPQ; Fairburn et al., 2003b). The 
CPQ contains 12 items that examine one’s degree of clinical perfectionism 
throughout the past month. Items are rated on 4-point Likert scales with response 
options ranging from not at all to all of the time. Items 2 and 8 are reverse coded and 
all items are summed to produce the CPQ score. Higher CPQ scores signify higher 
clinical perfectionism. Since this measure examines clinical perfectionism during the 
past month it is sensitive to clinical change (Riley et al., 2007). It has high test-retest 
reliability, internal consistency and validity in clinical and non-clinical samples 
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(Chang & Sanna, 2012; Egan, Shafran, et al., 2014; Steele, O’Shea, et al., 2011; 
Steele et al., 2013; Stoeber & Damian, in press).  In the current study, Cronbach’s 
alpha was .74 for the sample of 36 participants and .77 for the sample of 42 
participants. 
Mini International Neuropsychiatric Interview, Version 5.0 (MINI; 
Sheehan et al., 1998).  The MINI is a structured interview used to diagnose 
psychological disorders based on the criteria of the DSM-IV-TR (APA, 2000). When 
data was being collected for this research, the DSM-5 (APA, 2013) had not yet been 
released. The MINI has high levels of test-retest reliability, internal consistency and 
validity (Sheehan et al., 1997). For this study, the MINI was utilised to examine 
whether participants met the diagnostic criteria for GAD. These structured 
interviews were all conducted by the primary researcher (Handley), who at the time 
was blind to the scores each participant had received on the self-report measures. 
The primary researcher has a Master of Clinical Psychology degree and has had four 
years of experience administering the MINI. Given that there was only one 
interviewer, it was not possible to calculate the inter-rater reliability of the MINI in 
this study; however, the primary researcher discussed participants’ diagnoses in 
supervision with an experienced clinical psychologist (Egan) who confirmed the 
accuracy of these diagnoses.  
Penn State Worry Questionnaire (PSWQ; Meyer et al., 1990). The 16-
item PSWQ examines the uncontrollability, excessiveness and generality of clinical 
worry. Statements are rated on 5-point Likert scales. Items 1, 3, 8, 10 and 11 are 
reverse coded and then scores on all items are summed. Higher PSWQ scores signify 
high levels of clinical worry. The PSWQ has been found to have high test-retest 
reliability, internal consistency (Meyer et al., 1990) and discriminant validity 
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(Brown, Antony, & Barlow, 1992; Meyer et al., 1990). Consistent with the PSWQ 
being a measure of pathological worry, measures of other constructs theorised to be 
involved in pathological worry (e.g., meta-worry) have been found to significantly 
predict PSWQ scores (Wells & Carter, 1999). In the current study, Cronbach’s alpha 
was .88 for the sample of 36 participants and .91 for the sample of 42 participants. 
Beck Depression Inventory-II (BDI-II; Beck et al., 1996).  The BDI-II 
contains 21 items that measure the symptoms of depression. For each item, 
participants select one statement from a group of statements that describe how they 
have felt in regard to a depressive symptom over the past two weeks. The scores of 
these statements are summed and higher scores signify more severe depressive 
symptoms. The BDI-II has high internal consistency in outpatient (.92) and college 
(.93) samples. This measure has also been found to have high test-retest reliability 
and validity (Beck et al., 1996; Buckley, Parker, & Heggie, 2001). The BDI-II is 
deemed to be the gold standard measure of depression and has higher internal 
consistency than other measures of depression, such as the depression subscale of the 
Depression, Anxiety and Stress-21 Scale (Beck et al., 1996; Lovibond & Lovibond, 
1995). In the current study, Cronbach’s alpha was .92 for both the sample of 36 
participants and the sample of 42 participants. 
Depression, Anxiety and Stress Scale-21 (DASS-21; Lovibond, & 
Lovibond, 1995). The anxiety subscale of the DASS-21 was utilised in this study. 
This subscale contains seven items that examine the level of anxiety symptoms 
experienced throughout the past week. Items are rated on 4-point Likert scales 
ranging from did not apply to me at all to applied to me very much or most of the 
time. Item scores are summed and higher scores denote more severe anxiety 
symptoms. This subscale has been found to have high internal consistency and 
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moderately high concurrent validity (Antony, Bieling, Cox, Enns, & Swinson, 1998). 
In the current study, Cronbach’s alpha was .86 for the sample of 36 participants and 
.85 for the sample of 42 participants. 
2.4.3. Statistical Methods 
To explore the first aim, zero-order correlations were first computed between 
pathological worry and the perfectionism dimensions, gender, anxiety and 
depression.  At least two significant correlations were required to warrant a linear 
regression analysis (hierarchical or simultaneous). The pattern of significant zero-
order correlations (described in the results section) indicated that hierarchical linear 
regression analyses should be conducted (Tabachnick & Fidell, 2007).  The first 
regression analysis examined whether Frost et al.'s (1990) perfectionism dimensions 
significantly predicted pathological worry on the PSWQ after controlling for gender, 
anxiety and depression. The second regression analysis examined whether clinical 
perfectionism as assessed by the CPQ (Fairburn et al., 2003b) was a significant 
predictor of pathological worry on the PSWQ after controlling for gender, anxiety 
and depression. The utility of CPQ scores in predicting PSWQ was examined in a 
separate regression analysis as the CPQ is a more recent measure and the association 
between clinical perfectionism and PSWQ had not previously been explored in non-
clinical or clinical samples.  
To explore the second aim, zero-order correlations were calculated between 
the probability of having a principal diagnosis of GAD and the perfectionism 
dimensions, pathological worry, gender, anxiety and depression. At least two 
significant correlations were required to warrant a binary logistic regression analysis 
(hierarchical or simultaneous). The zero-order correlations (described in the results 
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section) yielded only one significant correlation, which made the binary logistic 
regression analysis redundant (Tabachnick & Fidell, 2007).  
The Pearson correlation between the binary variables (gender and GAD) and 
each of the other variables is best known as the point-biserial correlation 
(Tabachnick & Fidell, 2007). Based on the present sample sizes, the point-biserial 
and Pearson correlations would have to be moderate to large, which is equivalent to 
a ρ of approximately .4, to have an 80% likelihood of reaching statistical 
significance at an alpha-level of .05 (GPower Version 3.1; Faul, Erdfelder, Lang, & 
Buchner, 2007). The most complex linear regression model contained five 
predictors.  Based on the present sample sizes, the relationships between each of the 
five predictors and the dependent variable would also have to be moderate to large, 
which is equivalent to an sr
2
 of around .16, to have an 80% likelihood of reaching 
statistical significance at an alpha-level of .05 (GPower Version 3.1; Faul et al., 
2007).  
2.5. Results 
2.5.1. Assumption testing 
Hierarchical linear regression analysis has three assumptions: linearity, 
normality and homoscedasticity of the residuals (Tabachnick & Fidell, 2007). For 
each regression analysis, scatterplots of the standardised studentised residuals against 
the standardised predicted values were examined to test whether these assumptions 
had been violated. For each scatterplot, the points appeared to be randomly 
distributed around the central horizontal axis; no systematic patterns were evident. 
This suggested that the assumptions of linearity, normality and homoscedasticity 
were met (Tabachnick & Fidell, 2007). Examination of the range of Cook’s values 
for each scatterplot indicated that no value exceeded 1, which suggested that no 
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participant’s data had a disproportionate impact on the regression parameters. The 
tolerance values for each predictor in each regression model were adequately high to 
suggest that predictors were not multicollinear (Tabachnick & Fidell, 2007). 
2.5.2. The Associations between Perfectionism and Pathological Worry 
In regard to the first aim of the study, Table 1 displays the means, standard 
deviations and zero-order correlations for gender, the perfectionism dimensions, 
pathological worry, anxiety and depression. CM, PS and CPQ scores each displayed 
significant moderate relationships with PSWQ scores. DA did not have a significant 
correlation with PSWQ scores. As gender, anxiety and depression were each found 
to be significantly correlated with PSWQ scores, these variables were controlled by 
entering them as covariates in the following hierarchical linear regression models.  
When conducting the first hierarchical linear regression model, gender, CM 
and PS were entered on Step 1, and DASS-anxiety and BDI-II were entered on Step 
2. Gender was entered from the outset of the analysis as it was important to see 
whether CM and PS were related to pathological worry after controlling for this 
variable. DASS-anxiety and BDI-II were entered at Step 2 of the model rather than 
at Step 1 so one could first examine whether any relationships between the 
perfectionism dimensions and pathological worry emerged after controlling for 
gender, and could then determine whether these relationships remained after 
controlling for anxiety and depression. As BDI-II scores were available for 34 
participants, this analysis was performed on a sample of 34 participants. Table 2 
displays the results of the first hierarchical linear regression analysis. 
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Table 1 
Means (Standard Deviations) and Zero-order Correlations among Gender, 
Perfectionism, Pathological Worry, Anxiety and Depression in Participants with 
Generalised Anxiety Disorder (n= 36) 
Measure Mean 
(SD) 
Gender CM PS DA CPQ PSWQ DASS
- Anx 
BDI-
II 
a
 
Gender 
 
- - .30 .12 .00 -.01 .39* .21 .07 
CM 33.19  
(6.47) 
 - .32 .44** .52** .68** .58** .49** 
PS 28.61  
(4.46) 
  - .51** .58** .49** .35* .38* 
DA 15.86  
(2.85) 
   - .60** .30 .57** .43* 
CPQ 32.19  
(8.54) 
    - .49** .60** .56** 
PSWQ 67.28  
(8.54) 
     - .41* .35* 
DASS-
Anx 
12.83 
(10.65) 
      - .73** 
BDI-II
 a
 19.44 
(11.51) 
       - 
Note. CM = Concern over Mistakes subscale of the Frost Multidimensional Perfectionism Scale 
(FMPS); PS = Personal Standards subscale of the FMPS; DA = Doubts about Actions subscale of the 
FMPS; CPQ = Clinical Perfectionism Questionnaire; PSWQ = Penn State Worry Questionnaire; 
DASS-Anx = Anxiety subscale of the Depression, Anxiety and Stress Scale-21; BDI-II = Beck 
Depression Inventory-II.  
a 
Descriptive statistics and correlations for the BDI-II were calculated for 34 participants. 
*p < .05 **p < .01 
131 
 
Table 2 
Hierarchical Linear Regression Analysis Predicting Pathological Worry from 
Perfectionism in Individuals with Generalised Anxiety Disorder (n=34)  
Predictors  Adjusted R
2
 ▲ R2 B 95% CI Beta sr2 
Step 1                                                                                                              
    Gender 
    CM        
    PS 
Step 2    
   Gender 
   CM 
   PS 
   DASS-Anx 
   BDI-II 
.58**
 
 
 
.56** 
 
 
 
.02 
 4.77 
 0.66 
 0.54 
 
 5.07 
 0.74 
 0.57 
-0.13 
 0.03 
 -0.15, 9.70 
0.34, 0.98 
0.09, 0.98 
 
-0.08, 10.22 
 0.36,   1.12 
 0.09,   1.04 
-0.42,   0.16 
-0.23,   0.29 
 0.24 
 0.53 
 0.29 
 
 0.25 
 0.59 
 0.31 
-0.17 
 0.05 
 
.05 
.23*** 
.08* 
 
.05 
.21*** 
.08* 
.01 
.00 
Note. ▲ R2 = Change in R2; B = unstandardised regression coefficient; Beta = standardised regression 
coefficient; sr
2
 = part-correlation squared; CM = Concern over Mistakes subscale of the FMPS; PS = 
Personal Standards subscale of the FMPS; DA = Doubts about Actions subscale of the FMPS; PSWQ 
= Penn State Worry Questionnaire; BDI-II = Beck Depression Inventory-II; DASS-Anx = Anxiety 
subscale of the Depression, Anxiety and Stress Scale-21.  
* p < .05  ** p < .01 *** p < .001 
 
As seen in Table 2, at Step 1 of the analysis, gender accounted for a non-
significant 5 per cent of the variance in pathological worry (sr
2
 x 100 = 5, p = .057). 
CM uniquely accounted for a significant 23 per cent of the variance in pathological 
worry (sr
2
 x 100 = 23, p < .001), with higher scores on CM significantly predicting 
higher scores on pathological worry. PS uniquely accounted for a significant 8 per 
cent of the variance in pathological worry (sr
2
 x 100 = 8, p = .019), with higher 
scores on PS significantly predicting higher scores on pathological worry. The sr
2 
values of CM and PS suggested that CM was a stronger predictor of pathological 
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worry than PS.  When DASS-anxiety and BDI-II were entered at Step 2, CM 
uniquely explained a significant 21 per cent of the variance in pathological worry 
(sr
2
 x 100 = 21, p < .001), and PS uniquely explained a significant 8 per cent of the 
variance in pathological worry (sr
2
 x 100 = 8, p = .021). Higher scores on CM and 
PS each significantly predicted higher pathological worry scores. The sr
2
 values 
suggested that CM was a stronger predictor of pathological worry than PS. 
When conducting the second hierarchical linear regression analysis, gender 
and CPQ scores were entered at Step 1, and DASS-anxiety and BDI-II were entered 
at Step 2. As BDI-II scores were only available for 34 participants, the hierarchical 
linear regression analysis was performed on a sample of 34 participants. Table 3 
displays the results of the second hierarchical linear regression analysis.  
Table 3 
Hierarchical Linear Regression Analysis Predicting Pathological Worry from 
Clinical Perfectionism Questionnaire scores in Individuals with GAD (n=34) 
Predictors  Adjusted R
2
 ▲ R2 B 95% CI Βeta sr2 
Step 1 
    Gender 
    CPQ                                                                                                 
Step 2       
   Gender 
   CPQ 
   DASS-Anx                
   BDI-II                     
.35*** 
 
.32** 
 
 
.03 
 
 9.00 
0.68
 
 9.29 
 0.63 
-0.08 
 0.13 
 
 3.24, 14.76 
0.23, 1.14
  
 3.05, 15.54 
 0.03,   1.23 
-0.45,   0.28 
-0.19,   0.44 
 
 0.45 
 0.43 
 
 0.46 
 0.40 
-0.11 
 0.18 
 
.20** 
.18** 
 
.19** 
  .09* 
  .00 
  .01 
Note. GAD = Generalised Anxiety Disorder ▲ R2 = Change in R2; CI = confidence interval; B = 
unstandardised regression coefficient; Beta = standardised regression coefficient; sr
2
 = part-
correlation squared; CPQ = Clinical Perfectionism Questionnaire; PSWQ = Penn State Worry 
Questionnaire; DASS-Anx = Anxiety subscale of the Depression, Anxiety and Stress Scale-21; BDI-
II = Beck Depression Inventory-II. * p < .05. ** p < .01 *** p < .001 
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As seen in Table 3, at Step 1, gender accounted for a significant 20 per cent 
of the variance in pathological worry scores (sr
2
 x 100 = 20, p = .003) with the 
positive direction of the regression coefficient indicating that females received 
higher pathological worry scores than males. CPQ scores accounted for a significant 
18 per cent of the variance in pathological worry (sr
2
 x 100 = 18, p = .005) where 
higher CPQ scores significantly predicted higher pathological worry scores. When 
DASS-anxiety and BDI-II were entered at Step 2, CPQ scores explained a significant 
9 per cent of the variance in pathological worry scores (sr
2
 x 100 = 9, p = .041). 
Higher CPQ scores significantly predicted higher pathological worry scores. 
2.5.3. The Associations between Perfectionism and a Principal Diagnosis of 
GAD 
In relation to the second aim of this study, Table 4 displays the means and 
standard deviations of the perfectionism dimensions, pathological worry, anxiety and 
depression. These descriptive statistics were calculated for the sub-sample of 
participants with a principal diagnosis of GAD (N = 30), as well as for the entire 
sample (N =42). Table 5 displays the zero-order correlations among gender, the 
perfectionism dimensions, pathological worry, anxiety, depression and a principal 
diagnosis of GAD. There was a significant moderate correlation between DA and a 
principal diagnosis of GAD. CM, PS and CPQ scores were not significantly 
correlated with a principal diagnosis of GAD. While anxiety was significantly 
correlated with a principal diagnosis of GAD, it was not necessary to control for this 
variable as previously discussed. As gender and depression did not exhibit 
significant correlations with a principal diagnosis of GAD, a binary logistic 
regression model was redundant.  
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Table 4 
Means and (Standard Deviations) for Perfectionism, Pathological Worry, Anxiety 
and Depression in the Sample with a Principal Diagnosis of GAD and the Full 
Sample. 
 CM PS DA CPQ PSWQ DASS-Anx BDI-II
a
  
Principal 
GAD  
sample 
(n=30) 
33.47 
(6.07) 
29.07 
(4.23) 
16.43 
(2.56) 
32.23 
(5.35) 
67.50 
(8.57) 
 14.20 
(11.10) 
 20.29 
(12.04)  
Full 
sample 
(n=42)
 
 
33.07 
(6.06) 
28.40 
(4.23) 
15.62 
(2.83) 
31.57 
(5.62) 
65.95 
(9.72) 
 12.00 
(10.17) 
 18.89 
(11.13) 
Note. CM = Concern over Mistakes subscale of the Frost Multidimensional Perfectionism Scale 
(FMPS); PS = Personal Standards subscale of the FMPS; DA = Doubts about Actions subscale of the 
FMPS; CPQ = Clinical Perfectionism Questionnaire; PSWQ = Penn State Worry Questionnaire; 
DASS-Anx = Anxiety subscale of the Depression, Anxiety and Stress Scale-21; BDI-II = Beck 
Depression Inventory-II.  
a
 Descriptive statistics for the BDI-II were calculated for 28 participants in the principal GAD sample 
and 38 participants in the full sample.  
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Table 5 
Zero-order Correlations between Gender, Perfectionism, Pathological Worry, 
Anxiety, Depression and a Principal Diagnosis of GAD in the Full Sample (n = 42) 
 Gender CM PS DA CPQ PSWQ DASS-
anx 
BDI-
II
a
 
Principal 
GAD  
Gender - .27 .13 -.00 .01 .34* .21 .05 .10 
CM  - .31* .42** .48** .54** .58** .49** .10 
PS   - .45** .55** .43** .34* .35* .25 
DA    - .60** .42** .58** .46** .46** 
CPQ     - .54** .61** .55** .19 
PSWQ      - .41** .37* .26 
DASS-
anx 
      - .74** 
 
.35* 
 
BDI-II        - .21 
Principal 
GAD  
        - 
Note. CM = Concern over Mistakes subscale of the Frost Multidimensional Perfectionism Scale 
(FMPS); PS = Personal Standards subscale of the FMPS; DA = Doubts about Actions subscale of the 
FMPS; CPQ = Clinical Perfectionism Questionnaire; PSWQ = Penn State Worry Questionnaire; 
DASS-anx = Anxiety subscale of the Depression, Anxiety and Stress Scale-21; BDI-II = Beck 
Depression Inventory-II. 
a
 Correlations for the BDI-II were calculated for 38 participants. 
*   p < .05  ** p < .01  
 
2.6. Discussion 
The first aim of this study was to examine the relationships between 
perfectionism dimensions and pathological worry in adults with elevated 
perfectionism and GAD who presented for perfectionism treatment. Dimensions of 
perfectionism as measured by CM, PS and CPQ scores each significantly predicted 
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pathological worry and remained significant after accounting for gender, anxiety and 
depression. These findings uniquely contribute to the literature, as previous research 
has not examined the associations between perfectionism dimensions and 
pathological worry in individuals with GAD after controlling for gender, anxiety and 
depression.  
The finding of CM being significantly related to pathological worry after 
accounting for anxiety and depression supports theoretical links between concern 
over mistakes and worry (Flett, Madorsky, et al., 2002). It also concurs with the 
findings of previous studies utilising student samples (Kawamura et al., 2001; 
Santanello & Gardner, 2007; Stoeber & Joormann, 2001). The current finding 
provides evidence that the relationship between CM and pathological worry in 
individuals with GAD is important of its own accord and not an artefact of the 
relationships CM has with anxiety and depression (Antony, Purdon, et al., 1998; 
Enns et al., 2001; Kawamura et al., 2001). Importantly, the current finding 
generalises to clinical populations of individuals with elevated perfectionism and 
GAD.  
Furthermore, this is the first study to find that PS has a significant 
relationship with pathological worry in a clinical sample. This finding provides 
empirical support for the theorised links between elevated personal standards and 
pathological worry (Flett, Madorsky, et al., 2002; Pratt et al., 1997). As this finding 
emerged in a clinical sample but not in student samples, this may reflect PS being 
differentially associated with pathological worry in non-clinical and clinical samples 
(Kawamura et al., 2001; Santanello & Gardner, 2007; Stoeber & Joormann, 2001).  
The current finding is also noteworthy as it is only the third finding of PS being 
significantly related to anxiety symptoms in a clinical sample. While Iketani et al. 
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(2002a; 2002b) found that PS was related to panic disorder with agoraphobia 
symptoms, most studies have reported that PS was not significantly related to 
anxiety symptoms (Egan et al., 2011).  
The current finding of PS being significantly related to pathological worry in 
individuals with GAD indicates that PS is not a purely positive construct as has been 
put forward by Stoeber and Otto (2006). Stoeber and Otto (2006) argued that 
particularly when maladaptive components of perfectionism were controlled (CM, 
DA, PE, PC, SPP), the positive achievement striving dimension of perfectionism 
(PS, O, SOP) is a positive construct associated with positive characteristics. 
However, in the current study, CM was statistically controlled by being entered as a 
predictor in the hierarchical linear regression analysis, but the significant relationship 
between PS and pathological worry still emerged. This significant association also 
remained after controlling for gender, depression and anxiety. This suggested that a 
unique relationship between PS and pathological worry was present that cannot be 
attributed to the relationship reported between positive achievement striving and 
depression (Hewitt & Flett, 1993). The current findings add to those of Iketani et al. 
(2002a; 2002b) in demonstrating that PS has a significant relationship with certain 
anxiety symptoms in clinical samples. Together with studies showing PS to be 
consistently associated with eating disorder symptoms (Bardone-Cone et al., 2007; 
Bardone-Cone et al., 2008), as well as studies showing that positive achievement 
striving components such as SOP are associated with depression (Hewitt & Flett, 
1993; Norman et al., 1998), this adds support for positive achievement striving 
perfectionism being maladaptive in some circumstances (Egan et al., 2012). 
The significant association between CPQ scores and pathological worry 
further contributes to the literature as it demonstrates for the first time that clinical 
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perfectionism is significantly associated with pathological worry in a clinical sample. 
This relationship remained after controlling for gender, anxiety and depression, 
which supports the relationship between clinical perfectionism and pathological 
worry being important of its own accord. This finding is consistent with the 
theoretical links between clinical perfectionism and adverse consequences such as 
worry, anxiety and stress (Shafran et al. 2002; Shafran et al., 2010) and provides 
support for the validity of the CPQ as a measure of clinical perfectionism (Fairburn 
et al., 2003b). This finding also extends those of Chang and Sanna (2012) by 
highlighting that clinical perfectionism is not just significantly related to anxiety and 
stress, but also has a unique relationship with pathological worry and that this 
relationship is present in a clinical sample with GAD.   
Collectively, the findings of perfectionism as measured by CM, PS and CPQ 
scores significantly predicting pathological worry after controlling for gender, 
anxiety and depression add to the growing body of research supporting perfectionism 
being a process which occurs across psychological disorders (Egan et al., 2011). 
These findings provide a rationale for Study II of this thesis and future studies to 
investigate whether perfectionism treatments can decrease GAD symptoms in 
addition to the symptoms of other psychological disorders. The current findings also 
provide justification for future studies to investigate whether adding a treatment 
module targeting perfectionist standards and concern over mistakes can improve the 
efficacy of psychological treatments based on current models of GAD (Dugas et al., 
1998; Wells, 1995; 1999).  
In the current study, a significant correlation between DA and pathological 
worry did not emerge. This differs from previous studies that found this relationship 
in student samples (Kawamura et al., 2001; Santanello & Gardner, 2007; Stoeber & 
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Joormann, 2001). There are many reasons why these non-significant findings may 
have occurred. First, the previous studies examining the relationships between Frost 
et al.’s (1990) perfectionism dimensions and pathological worry only explored the 
associations between composite constructs of perfectionism (i.e., MEC, CM+DA) 
and pathological worry (Kawamura et al., 2001; Santanello & Gardner, 2007; 
Stoeber & Joormann, 2001). It is therefore possible that the significant association 
between the composite construct of perfectionism and pathological worry reported in 
student samples is an artefact of the significant association between CM and 
pathological worry (Kawamura et al., 2001; Santanello & Gardner, 2007; Stoeber & 
Joormann, 2001). If this is the case, this would be congruent with the current 
findings of CM being a significant predictor of pathological worry. A second 
possibility is that due to all adults in this sample having elevated perfectionism, the 
data may have been affected by restriction of range on the study variables, which 
may have weakened the associations between the predictors and the dependent 
variable (Tabachnick & Fidell, 2007). A third possibility is that due to the sample 
size, a Type II error may have occurred where the study had insufficient power to 
detect a relationship between DA and pathological worry in this sample, even if one 
is present in the population. The non-significant zero-order correlation then resulted 
in DA being excluded from the first hierarchical linear regression model. A Type II 
error is quite likely given that the zero-order correlation between DA and 
pathological worry had a significance value of p = .07 (Tabachnick & Fidell, 2007). 
Future studies need to examine the relationships between these perfectionism 
dimensions and pathological worry in a larger sample of individuals with GAD and 
include participants with a wider range of perfectionism scores to overcome the 
limitations of the current study. 
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The second aim of this study was to examine whether perfectionism 
dimensions significantly predicted a principal diagnosis of GAD in a clinical sample 
of adults with elevated perfectionism and a range of diagnoses who presented for 
perfectionism treatment. The findings revealed that DA was a significant positive 
predictor of a principal diagnosis of GAD. Interestingly, CM, PS and CPQ scores 
were not significant predictors of a principal diagnosis of GAD.  The significant 
predictive utility of DA is consistent with this perfectionism dimension being an 
important construct in GAD, which again supports perfectionism being a 
transdiagnostic process (Egan et al., 2011). As DA has been found to be a significant 
construct in obsessive-compulsive disorder and social phobia (Antony, Purdon, et 
al., 1998; Rheaume et al., 1995), the current finding of DA being a significant 
positive predictor of a principal diagnosis of GAD may indicate a cognitive process 
that is shared across these disorders. Nevertheless, the specific function of DA in a 
principal diagnosis of GAD requires clarification in future research as it is unusual 
that DA did not significantly predict pathological worry, yet it was a significant 
predictor of a principal diagnosis of GAD. These findings can be reconciled by again 
proposing that the non-significant correlation between DA and pathological worry 
arose due to a Type II error (Tabachnick & Fidell, 2007); however, future research is 
needed to clarify this.  
It is also unusual that CM, PS and CPQ scores were not significantly related 
to a principal diagnosis of GAD given that each of these dimensions of perfectionism 
significantly predicted pathological worry. One possibility for the non-significant 
zero-order correlations between these perfectionism dimensions and pathological 
worry is a restriction of range on the study variables. Additionally, as 71 per cent of 
the adults in this sample met the criteria for a principal diagnosis of GAD, the 
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sample may not have been sufficiently diverse for these variables to arise as 
significant predictors (Tabachnick & Fidell, 2007). Future investigation is required 
using samples that have greater diversity. 
Some additional limitations of this study require discussion. First, as all 
participants had elevated perfectionism, findings of CM, PS and CPQ scores being 
significant predictors of pathological worry can only be generalised to adults with 
elevated perfectionism and GAD; whereas the finding of DA being a significant 
predictor of a principal diagnosis of GAD can only be generalised to adults with 
elevated perfectionism. Additionally, this study did not incorporate a non-clinical 
control group, which prevented the perfectionism levels of individuals with GAD 
from being compared to those of non-clinical controls. Future research needs to 
include a sample with GAD and a sample of non-clinical controls. Furthermore, 
while this study controlled for gender, anxiety and depression, it did not control for 
other constructs associated with pathological worry and GAD, such as intolerance of 
uncertainty and meta-beliefs about worry (Dugas et al., 1997; Dugas et al., 1998; 
LaDouceur et al., 1998; LaDouceur, 2000; Wells, 1995; 1999; Wells & Carter, 
1999). Future studies in clinical samples need to explore whether perfectionism 
dimensions account for additional variance in GAD symptomatology to that 
accounted for by these established constructs (Dugas et al., 1998; Wells, 1995; 
1999). Finally, the cross-sectional design of this study prevents inferences about the 
directions of effect. Future research needs to utilise prospective designs to examine 
whether dimensions of perfectionism temporally precede pathological worry and 
GAD. 
Nonetheless, the current study has still provided a significant contribution to 
the literature by demonstrating that significant relationships exist between CM, PS, 
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CPQ scores and pathological worry in individuals with elevated perfectionism and 
GAD. Additionally, this study has revealed that DA can significantly predict a 
principal diagnosis of GAD in a clinical sample with elevated perfectionism and a 
range of diagnoses. These findings support perfectionism being a transdiagnostic 
process and provide a rationale for Study II of this thesis and other studies to 
investigate whether perfectionism interventions can reduce the symptoms of GAD in 
addition to the symptoms of other psychological disorders (Bieling, Summerfeldt, et 
al., 2004; Egan et al., 2011).  
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CHAPTER 3 
 STUDY II 
Examining the Efficacy of Group Cognitive Behavioural Therapy 
for Clinical Perfectionism 
3.1. Overview of Study II 
A promising implication of perfectionism being a transdiagnostic process is 
that interventions that target perfectionism may ameliorate the symptoms of multiple 
psychological disorders (Egan et al., 2011). To date, few randomised controlled trials 
(RCTs) have explored the efficacy of cognitive behaviour therapy (CBT) for 
perfectionism and each of these RCTS examined CBT for perfectionism 
administered in an individual format (e.g., Pleva & Wade, 2006; Riley et al., 2007; 
Steele & Wade, 2008). Only one of these RCTs used CBT strategies based on 
Shafran et al.’s (2002) model of clinical perfectionism (Riley et al., 2007). As yet, no 
RCT has evaluated the efficacy of CBT for clinical perfectionism delivered in a 
group format (group CBT-CP). This is important to investigate as group treatments 
offer greater time efficiency and cost savings (APS, 2013; Himle et al., 2003), as 
well as the potential for therapeutic advantages compared to individual treatments 
(Bieling et al., 2006; Yalom, 1995; Yalom & Leszcz, 2005). In Study II of this 
thesis, an RCT is conducted to examine the efficacy of group CBT-CP in a clinical 
sample. In addition to examining the effect of this treatment on perfectionism and 
psychopathology, the impact of group CBT-CP on quality of life is explored as 
previous perfectionism trials have not included a quality of life outcome measure 
(Riley et al., 2007; Steele & Wade, 2008).  
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3.2. Cognitive Behavioural Therapy for Perfectionism in Non-Clinical Samples 
There is a substantially smaller body of research on CBT for perfectionism 
compared to CBT for specific disorders (Egan et al., 2012) and the limitations of 
these studies prevent the generalisation of findings. Four RCTs have examined CBT 
for perfectionism in non-clinical samples (Arpin-Cribbie et al., 2008; Arpin-Cribbie 
et al., 2012; Pleva & Wade, 2006; Radhu et al., 2012). These studies utilised a 
variety of CBT protocols for perfectionism; however, none of these protocols were 
based on Shafran et al.’s (2002) model of clinical perfectionism. Arpin-Cribbie et al. 
(2008) explored the efficacy of an online intervention for perfectionism in a sample 
of 83 students with elevated Perfectionism Cognition Inventory (PCI) scores. This 
intervention consisted of stress management techniques as well as CBT strategies for 
perfectionism that focussed on altering perfectionist beliefs and the impact of these 
beliefs on mood (Arpin-Cribbie et al., 2008). The online intervention produced 
significantly greater reductions in Socially-Prescribed Perfectionism (SPP) and 
depression compared to a pure stress management condition and a control condition. 
Arpin-Cribbie et al. (2012) conducted a second RCT to examine this online 
treatment in 77 students with elevated PCI scores. This intervention led to 
significantly greater reductions in Concern over Mistakes (CM), Self-Oriented 
Perfectionism (SOP), SPP and PCI scores compared to a pure stress management 
condition and a control condition; as well as significantly greater reductions in 
anxiety and depression compared to a control condition.   
Radhu et al. (2012) compared a web-based CBT intervention for 
perfectionism to a waitlist control condition in a sample of 24 students with elevated 
PCI scores. This intervention focused on altering the beliefs associated with 
perfectionism and the influence of these beliefs on mood (Radhu et al., 2012). The 
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web-based intervention resulted in significantly greater reductions in automatic 
thoughts and anxiety sensitivity relative to a waitlist control condition. These studies 
in student samples have demonstrated that web-based CBT interventions have 
produced reductions in dimensions of perfectionism and psychopathology; however, 
due to the use of non-clinical samples, findings cannot be generalised to clinical 
populations (Arpin-Cribbie et al., 2008; Arpin-Cribbie et al., 2012; Radhu et al., 
2012).  
In Pleva and Wade’s (2006) RCT, guided self-help CBT for perfectionism 
was compared to pure self-help CBT for perfectionism in a non-clinical sample of 49 
adults. While both interventions were based on Antony and Swinson’s (1998) CBT 
self-help book; participants in the guided self-help condition received minimal 
therapist guidance, whereas those in the pure self-help condition only followed 
written guidelines. Guided self-help CBT for perfectionism produced significantly 
greater improvements in obsessive-compulsive symptoms relative to pure self-help 
CBT for perfectionism. Post-treatment decreases in CM and depression were evident 
in both conditions and the guided self-help condition also displayed post-treatment 
reductions in PS and DA. Decreases in perfectionism were maintained at 3-month 
follow-up. While this study provided support for self-help versions of CBT for 
perfectionism, the non-clinical sample prevents generalisation of findings to clinical 
populations.  
3.3. Cognitive Behavioural Therapy for Perfectionism in Clinical Samples 
Two studies used multiple baseline single case series designs to examine the 
effectiveness of CBT for clinical perfectionism (CBT-CP) in clinical samples (Egan 
& Hine, 2008; Glover et al. 2007). This CBT-CP was derived from Shafran et al.’s 
(2002) model of clinical perfectionism. Glover et al. (2007) examined a sample of 
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nine adults with elevated Clinical Perfectionism Questionnaire (CPQ) scores, as well 
as depression or an anxiety disorder. Following CBT-CP there were statistically and 
clinically significant changes in SOP, CPQ scores and Dysfunctional Attitude Scale-
Self Criticism (DAS-SC) scores. There were also clinically significant reductions in 
depression. Egan and Hine (2008) examined a sample of four adults who had 
elevated total perfectionism scores on the Frost Multidimensional Perfectionism 
Scale (FMPS), as well as depression or an anxiety disorder. After CBT-CP, there 
were clinically significant reductions in total FMPS scores and CM. While these 
studies have produced preliminary evidence for the effectiveness of CBT-CP in 
clinical samples, in both studies sample sizes were small and there were no control 
groups (Egan & Hine, 2008; Glover et al., 2007). This reduces the extent to which 
these findings can be attributed to CBT-CP. 
Two RCTs have examined individual CBT for perfectionism in clinical 
samples (Riley et al., 2007; Steele & Wade, 2008). Steele and Wade (2008) 
investigated the efficacy of guided self-help CBT for perfectionism (Antony & 
Swinson, 1998) in comparison to CBT for bulimia nervosa (Cooper, 1993, as cited in 
Steele & Wade, 2008) and a condition containing dismantled mindfulness 
components (Segal et al., 2002) in 48 women with eating disorders.  Significant 
reductions in CM, PS, depression and eating disorder symptoms as well as 
significant improvements in self-esteem were reported by participants in all 
conditions. Guided self-help CBT for perfectionism tended to produce greater effect 
sizes for the non-targeted symptoms of depression and anxiety compared to the other 
conditions. These trends have clinical relevance as they are in accord with 
perfectionism having a transdiagnostic role (Egan et al., 2011). Post-treatment gains 
in all outcomes except PS were maintained at 6-month follow-up. This study is to be 
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commended for its use of a clinical sample; however, a limitation is the absence of a 
pure control condition.  
Riley et al. (2007) examined the efficacy of CBT for clinical perfectionism 
(CBT-CP) in a sample of 20 adults deemed to have clinical perfectionism based on a 
semi-structured interview. Seventy per cent of these participants had diagnoses of an 
anxiety disorder or depression. The treatment protocol was derived from Shafran et 
al.’s (2002) model of clinical perfectionism. CBT-CP resulted in significantly greater 
decreases in CPQ scores compared to a waitlist control condition. Significant 
changes in measures of multidimensional perfectionism did not occur. Post-
intervention scores on the CPQ, the Clinical Perfectionism Examination (CPE), total 
FMPS, SOP, as well as depression and anxiety were significantly lower than 
baseline scores and were still lower than baseline scores at 4-month follow-up. 
Clinically significant decreases in scores on the CPE were reported by 75 per cent of 
adults and the number of depression and anxiety disorder diagnoses had halved 
following the intervention. While this treatment utilised a waitlist control condition, 
the sample size was small and only 70 per cent of the sample had clinical diagnoses. 
3.4. Group Cognitive Behavioural Therapy for Perfectionism 
As CBT targeting perfectionism may concurrently reduce the symptoms of 
multiple disorders (Bieling et al., 2004; Egan et al., 2011), this treatment may offer  
greater time efficiency for the psychologist and client, as well as decreased cost for 
the client compared to the sequential administration of disorder-specific treatments 
(Craske, 2012; Egan et al., 2012). If this transdiagnostic intervention is delivered in a 
group format instead of an individual format, this could lead to further time 
efficiency for the psychologist and added cost savings for the client (APS, 2013; 
Himle et al., 2003). A group CBT format may also offer therapeutic advantages 
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compared to an individual CBT format due to several mechanisms of change 
proposed to occur in the context of a group (Bieling et al., 2006; Yalom, 1995; 
Yalom & Leszcz, 2005). As discussed in the literature review, these mechanisms of 
change are inclusion, optimism, group learning, shifting self-focus, correction of 
maladaptive relational patterns, group cohesiveness and the processing of emotions 
in a group setting (Bieling et al., 2006; Yalom, 1995; Yalom & Leszcz, 2005).  
Despite these potential benefits of group CBT for perfectionism, very few 
studies have examined group delivery of this treatment. Moreover, the only studies 
in the area have all utilised designs with lower internal validity than an RCT, which 
prevents findings from being confidently attributed to the intervention (Egan & 
Stout, 2007; Kutlesa & Arthur, 2008; Steele et al., 2013). Kutlesa and Arthur (2008) 
conducted a quasi-experimental study examining group CBT for perfectionism in 90 
students. The 8-week CBT course included techniques by Beck (1993) as well as 
interpersonal process techniques by Yalom (1995). As this treatment was not based 
on Shafran et al.’s (2002) model, it was not group CBT for clinical perfectionism. 
Participants in the group CBT for perfectionism condition reported significantly 
greater reductions in SOP, Other-Oriented Perfectionism (OOP), anxiety and 
depression relative to those in a psychology class and a career-planning condition. 
However, this study has limitations such as self-selection to conditions, significant 
differences between conditions in baseline variables and the absence of a follow-up 
assessment, which reduce internal validity. It also used a student sample, which 
prevents generalisation to clinical populations (Kutlesa & Arthur, 2008). 
Two preliminary studies have examined group CBT-CP in clinical samples 
(Egan & Stout, 2007; Steele et al., 2013). The treatment protocols for both of these 
studies were based on the maintenance model of clinical perfectionism (Shafran et 
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al., 2002). Steele et al.’s (2013) group CBT-CP also targeted performance-related 
behaviours based on Shafran et al.’s (2010) updated model of clinical perfectionism. 
Each study produced promising findings; however, did not include separate control 
conditions. Egan and Stout’s (2007) case series methodology study was conducted 
with three individuals who had elevated total FMPS, PS and CM as well as 
depression or an anxiety disorder. Trends of decreases in total FMPS, CM, PS, 
anxiety and depression were observed, with one of the three adults exhibiting 
clinically significant declines in depression. Steele et al. (2013) conducted a case 
series design with 21 adults who had elevated CM scores as well as an anxiety 
disorder or current or past depression. Psycho-education about perfectionism did not 
lead to statistically significant changes; however, following group CBT-CP, 
participants reported statistically significant decreases in CPQ scores, PS, CM, DAS-
SC scores, anxiety, stress and depression. Post-treatment changes were maintained at 
3-month follow-up, with clinically significant change in CPQ scores reported by 32 
per cent of participants. These studies are to be commended for utilising clinical 
samples; however, a limitation is the absence of a separate control condition, which 
means that findings could have occurred due to confounds such as the passage of 
time (Egan & Stout, 2007; Steele et al., 2013). To overcome these limitations, there 
needs to be an RCT examining the efficacy of group CBT-CP in a clinical sample. 
This would enable findings to be more confidently attributed to group CBT-CP; 
however, to date this RCT has not been conducted. 
3.5. Exploring the Effect of Group CBT-CP on Quality of Life 
Studies have indicated that individuals with psychological disorders have a 
lower quality of life than those without psychological disorders (Mond et al., 2005; 
Rapaport et al., 2005). Moreover, having co-morbid psychological disorders has also 
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been found to be related to a lower quality of life than the presence of one or no 
psychological disorder (Pirkola et al., 2009). As interventions targeting 
perfectionism have been proposed to decrease the symptoms of multiple 
psychological disorders (Egan et al., 2011), such interventions may also increase 
quality of life.  To date, no perfectionism treatment trial has incorporated a quality of 
life outcome measure, therefore it is not known whether CBT for perfectionism can 
improve quality of life. 
3.6. Rationale, Aims and Significance of the Current Study 
Group CBT-CP has the potential to concurrently reduce the symptoms of 
multiple disorders (Egan et al., 2011) in a manner that provides increased time 
efficiency for psychologists, reduced costs for clients (APS, 2013; Craske, 2012; 
Egan et al., 2012; Himle et al., 2003) and the potential for additional therapeutic 
benefits (Bieling et al., 2006; Yalom, 1995; Yalom & Leszcz, 2005); however, as 
yet, no RCT has examined group CBT-CP in a clinical sample. The primary aim of 
this study is to conduct an RCT that compares group CBT-CP to a waitlist control 
condition in a clinical sample. This can provide information about whether group 
CBT-CP works, in regard to producing improvements in perfectionism and related 
psychopathology (Chambless & Hollon, 1998; Egan et al., 2011); or whether the 
treatment at least does no harm compared to not receiving any treatment (Lilienfeld, 
2007). The efficacy of an intervention is established once two independent studies 
find the intervention to provide greater benefit than no treatment (Chambless & 
Hollon, 1998). If group CBT-CP is found to produce significant changes, this would 
be the first study to contribute toward establishing the efficacy of group CBT-CP 
(Chambless & Hollon, 1998). Furthermore, to date, published perfectionism 
treatment trials have not incorporated a quality of life outcome measure (e.g., Pleva 
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& Wade, 2006; Riley et al., 2007; Steele & Wade, 2008). Therefore, a secondary aim 
of this study is to explore whether group CBT-CP significantly increases quality of 
life. This adds to the literature by indicating whether group CBT-CP can improve 
overall wellbeing in addition to reducing psychological symptoms.  
3.7. Hypotheses 
A number of hypotheses about the effects of group CBT-CP were generated. 
Hypothesis 1 is based on group CBT-CP targeting the maintaining factors of clinical 
perfectionism (Shafran et al., 2002; Shafran et al., 2010), as well as previous findings 
of group CBT-CP producing reductions in CPQ scores and other perfectionism 
dimensions such as PS, CM and DAS-SC scores (e.g., Steele et al., 2013). 
 
H1. There will be significant Group x Time interactions such that participants 
receiving group CBT-CP will show significantly greater therapeutic changes in all 
perfectionism outcomes (CPQ, CM, PS, DA, DAS-SC, distress, interference) 
between pre-test and post-test than participants in the waitlist control group.  
 
Hypothesis 2 is based on findings of perfectionism being associated with depression, 
eating disorders and anxiety disorders (Egan et al., 2011). The findings of Study I of 
this thesis also informed this hypothesis by demonstrating that significant 
associations occurred between CM, PS, CPQ scores, DA and GAD symptomatology. 
Hypothesis 2 is also consistent with Shafran et al.’s (2002) proposition that CBT-CP 
assists participants to become less reliant on judging their self-worth primarily on 
achievement, which should produce increases in self-esteem.  
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H2.  There will be significant Group x Time interactions such that participants 
receiving group CBT-CP will show significantly greater decreases in measures of 
psychopathology (depression, eating disorder and anxiety symptoms) and 
significantly greater increases in self-esteem between the pre-test and the post-test 
than participants in the waitlist control group.  
 
Hypothesis 3 is based on findings of psychological disorders being associated with a 
lower quality of life (Mond et al., 2005; Pirkola et al., 2009; Rapaport et al., 2005), 
and findings of CBT-CP being associated with reductions in psychological 
symptoms (Riley et al., 2007; Steele et al., 2013). 
 
H3. There will be a significant Group x Time interaction such that participants 
receiving group CBT-CP will show significantly greater increases in quality of life 
between the pre-test and the post-test than participants in the waitlist control group. 
 
In regard to Hypothesis 4, it is logical to predict that when the waitlist control group 
receives group CBT-CP, they will demonstrate comparable changes to those shown 
by the intervention group. 
 
H4. Once the waitlist control group receives group CBT-CP, they will demonstrate 
significant reductions in measures of perfectionism and psychopathology and 
significant increases in self-esteem and quality of life between their pre- and post-
test, which will be comparable to the pre-post changes demonstrated by the treatment 
group.  
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Hypothesis 5 is based on findings showing that treatment gains from interventions 
targeting perfectionism are maintained at follow-up (Pleva & Wade, 2006; Riley et 
al., 2007; Steele & Wade, 2008; Steele et al., 2013).  
 
H5. For the entire sample, post-intervention changes in measures of perfectionism, 
psychopathology, self-esteem and quality of life will be maintained at 3-month and 
6-month follow-ups. 
 
Hypotheses 6-9 make predictions about reliable and clinically significant  
change. It is anticipated that the changes specified in Hypotheses 1 – 4 would not 
only happen at a group level but also at an individual level (Chambless & Hollon, 
1998; Jacobson & Truax, 1991). Hypotheses 6 - 9 are based on group CBT-CP 
targeting the maintaining factors of clinical perfectionism (Shafran et al., 2002; 
Shafran et al., 2010) and the literature of perfectionism being a transdiagnostic 
process (Egan et al., 2011). These hypotheses are also informed by propositions of 
CBT-CP assisting participants to make their self-esteem less reliant on achievement, 
which should translate into increases in self-esteem (Shafran et al., 2002). Moreover, 
Hypotheses 6- 9 are based on findings of CBT-CP resulting in clinically significant 
change in CPQ scores (Glover et al., 2007; Riley et al., 2007; Steele et al., 2013) and 
CM (Egan & Hine, 2008); as well as CBT-CP leading to recovery from 
psychological disorders (Riley et al., 2007).   
 
H6. A significantly higher proportion of individuals in the group CBT-CP condition 
will demonstrate pre-post reliable change in measures of perfectionism, 
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psychopathology (depressive, anxiety and eating disorder symptoms), self-esteem 
and quality of life compared to those in the waitlist control condition.  
 
H7. A significantly higher proportion of individuals in the group CBT-CP condition 
will experience pre-post clinically significant change in clinical perfectionism (CPQ 
scores) and Concern over Mistakes (CM) relative to those in the waitlist control 
condition.  
 
H8. A significantly higher proportion of individuals in the group CBT-CP condition 
will demonstrate pre-post recovery from their psychological disorder(s) (i.e., will no 
longer meet their pre-treatment diagnosis at post-treatment) relative to those in the 
waitlist control condition.  
 
H9. Once the waitlist control group receives group CBT-CP, the proportions of 
individuals showing reliable change, clinically significant change and recovery from 
psychological disorders will be comparable to that of the treatment group.  
 
3.8. Method 
3.8.1. Participants  
3.8.1.1. Power analysis and sample size. The primary hypotheses 
(Hypotheses 1 to 3) predict Group x Time interactions. In Riley et al.’s (2007) RCT 
the Group x Time interaction for CPQ scores was ‘large’ (Cohen’s d = 1.36; Cohen, 
1988). G*Power (Version 3.1; Faul et al., 2007) was utilised to provide an estimate 
of the number of participants needed for an 80% chance of detecting a ‘moderate to 
large’ interaction (i.e., f = .29) between group (treatment, control) and time (pre-test, 
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post-test) at an alpha-level of .05. G*Power generated an estimate of 26 participants 
(13 participants per group). As the Group x Time interaction was the effect requiring 
the greatest number of participants in the analyses, 26 participants was therefore 
deemed to be adequate to detect the effects predicted in the other hypotheses, 
providing that these effects were also ‘moderate to large’ (Faul et al., 2007). 
 These sample estimates could be affected by participant attrition (Holden et 
al., 2008). Fortunately, the Generalised Linear Mixed Model (GLMM; the statistical 
procedure utilised to test the current hypotheses) is less sensitive to participant 
attrition than standard statistical procedures used to analyse behavioural change, 
such as repeated measures ANOVA (Holden et al., 2008). This is because GLMM is 
not dependent on participants providing data at each assessment period (Holden et 
al., 2008). Rather, the GLMM maximum likelihood procedure is a full information 
estimation procedure, which utilises all of the data available at each assessment 
period. Use of this procedure decreases sampling bias and the need for missing data 
to be replaced (Holden et al., 2008). 
GLMM can utilise the data that is available at each assessment period 
primarily because time (pre, post) is interpreted as a Level 1 variable, which is 
nested within participant at Level 2 (Holden et al., 2008). Although GLMM can 
compensate for participant attrition, the primary researcher deemed it sensible to 
recruit an additional 14 participants (N = 40, 20 per group) to ensure that the GLMM 
analysis had adequate power to capture ‘moderate’ Group x Time interactions 
(Holden et al., 2008). 
3.8.1.2. Recruitment. Participants self-referred in response to letters and 
advertising fliers circulated to general practitioners, psychiatrists, psychologists, 
universities and workplaces across the metropolitan area of Perth, Australia. The 
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covering letter and advertisement flyer are displayed in Appendices A and B 
respectively. Participants were required to be over 18 years of age and needed to 
have elevated perfectionism as determined by a score larger than 24.7 on the CM 
subscale of the FMPS (Frost et al., 1990). Even though this study trialled group CBT 
for clinical perfectionism, to date limited studies have used the CPQ (Fairburn et al., 
2003b). Consequently, the inclusion criterion for this trial was based on elevated CM 
as it has been frequently reported in the perfectionism literature and has clinical 
relevance due to its associations with multiple psychological disorders (Egan et al., 
2011). Elevated CM was also used as an inclusion criterion in Steele et al.’s (2013) 
study of group CBT-CP. As there are currently no norms for measures of 
perfectionism, the cut-off score of 24.7 was determined by averaging the mean CM 
scores from six studies that examined perfectionism in anxiety disorder samples, 
which are referred to in Egan et al.’s (2011) review.  Another inclusion criterion for 
this study was that participants needed to be willing to refrain from external 
psychotherapy between baseline and 6-month follow-up. Furthermore, participants 
taking anti-depressant medication were required to be on a stable dose of this 
medication for one month before the study and throughout the trial. The latter two 
criteria were employed to ensure that any treatment effects exhibited after group 
CBT-CP could be attributed to the intervention, rather than to the effects of external 
psychotherapy or medication.  
Participants were excluded from this study if they met the criteria for 
moderate or high suicidality, self-harm, psychosis, substance abuse, substance 
dependence, anorexia nervosa or a body mass index lower than 17.5, as assessed by 
the Mini International Neuropsychiatric Interview (MINI; Sheehan et al., 1998). 
Excluded participants were referred to suitable treatment services. 
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3.8.2. Design and Procedure 
The design of this research is an RCT where one active treatment (group 
CBT-CP) is compared to a waitlist control condition. The design of this RCT is 
displayed in Figure 3 and is written in accordance with CONSORT guidelines 
(Moher et al., 2010). As Figure 3 also includes information about the flow of 
participants through the study, this figure is presented in the participant flow section 
of this chapter on page 180. Individuals who expressed interest in this study were 
sent an information sheet, consent forms and the CM subscale of the FMPS (Frost et 
al., 1990).  The information sheet and consent forms are displayed in Appendices C, 
D and E respectively. Participants who met the inclusion criterion of elevated CM 
and consented to participate in the research were telephoned by the primary 
researcher (Handley) to further evaluate their eligibility.  Individuals who did not 
meet the elevated CM inclusion criterion were recommended external treatment 
services. The telephone screen involved administering the Mini International 
Neuropsychiatric Interview-Screen (Sheehan & LeCrubier, 2006) and assessing 
whether participants met the remaining inclusion criteria for the research. Individuals 
meeting the exclusion criteria were referred to appropriate treatment services.  
Participants who were eligible for the research attended a 1.5 hour baseline 
assessment with the primary researcher where they completed a questionnaire 
package, were asked five questions about their perfectionism (Steele et al., 2013) and 
were administered the MINI (Sheehan et al., 1998). The five perfectionism questions 
are listed in Appendix F. Eligible participants were then randomised to the group 
CBT-CP or waitlist control condition. Randomisation was accomplished using 
randomised number lists created by Saghei’s (2004) Random Allocation Software 
Version 1.0. The number and size of groups were entered to ensure equivalent group 
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sizes (Steele & Wade, 2008). Twenty-one participants were randomised to the group 
CBT-CP condition and 21 were randomised to the waitlist condition. 
Participants in the group CBT-CP condition (n = 21) received eight sessions 
of group CBT-CP over eight weeks. This was delivered by running two therapy 
groups; one group had 10 members and one group had 11 members. Participants in 
the waitlist condition (n = 21) received no psychological treatment for eight weeks. 
Participants from the group CBT-CP condition had their post-treatment assessment, 
whereas participants from the waitlist condition had their post-waitlist assessment. 
These assessments were conducted by the primary researcher and involved 
participants completing a questionnaire package and being administered the MINI 
(Sheehan et al., 1998). This was the key point at which group CBT-CP was 
compared to the waitlist control condition because after this point there was no 
longer a bona-fide control condition against which intervention effects could be 
assessed (Tabachnick & Fidell, 2007). Since the primary researcher conducted all 
assessments and ran all therapy groups, it was not possible for the assessor to be 
blind to participants’ condition when conducting the post-waitlist and post-treatment 
assessments. 
 After the waitlist control participants had completed their post-waitlist 
assessment, they received the eight sessions of group CBT-CP over eight weeks. 
This treatment was delivered by running two therapy groups; one group had 10 
members and one group had 11 members. This was followed by a post-treatment 
assessment (this treated group henceforth referred to as the ‘treated control group’). 
Participants from the initial treatment group and the treated control group attended 
follow-up assessments 3-months and 6-months after their post-treatment 
assessments. These follow-up assessments were conducted by the primary researcher 
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and involved participants completing the questionnaire package and being 
administered the MINI (Sheehan et al., 1998). This RCT was conducted and written 
in accordance with CONSORT guidelines (Moher et al., 2010). Ethics approval was 
received from the Curtin University Human Research Ethics Committee (Approval 
Number: HR75/2011) and this study was registered as a clinical trial with the 
Australian and New Zealand Clinical Trials Registry (2007). 
3.8.2.1. Treatment 
The group CBT-CP treatment comprised of eight 2-hour sessions of group 
therapy administered by two co-facilitators over an eight week period. Treatment 
sessions were held at the Curtin University Psychology and Speech Clinic. The 
CBT-CP material was derived from Shafran et al.’s (2010) book ‘Overcoming 
perfectionism: a self-help guide using cognitive behavioural techniques’, which was 
adapted for delivery in a group setting. The same CBT protocol was previously 
employed in a pilot trial of group CBT-CP utilising a different sample (Steele et al., 
2013). This treatment protocol was derived from the maintenance model of clinical 
perfectionism (Shafran et al., 2002; Shafran et al., 2010) 
The objectives of the first session were to introduce participants to the group, 
provide participants with psycho-education about clinical perfectionism, socialise 
participants to the maintenance model of clinical perfectionism (Shafran et al., 2010) 
and explore motivation to change. The psycho-education component consisted of 
discussing the features of clinical perfectionism, how it differs from healthy striving, 
the range of difficulties co-occurring with perfectionism and the potential causes of 
perfectionism (Shafran et al., 2010). The maintenance model of clinical 
perfectionism was explained and participants were given an opportunity to complete 
their individual maintenance model using a case study example for guidance 
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(Shafran et al., 2010). Motivation to change perfectionism was explored through a 
group discussion about the advantages and disadvantages of perfectionism as well as 
the advantages and disadvantages of changing perfectionism (Shafran et al., 2010). 
The objectives of the second session were to assist participants to identify their areas 
of perfectionism, introduce participants to self-monitoring of their perfectionist 
thoughts and behaviours, discuss common behaviours related to perfectionism and 
examine the accuracy of various perfectionist beliefs (e.g., the harder an individual 
works, the better they will do) (Shafran et al., 2010).  
Sessions 3 to 8 introduced participants to cognitive-behavioural strategies 
that targeted the maintaining factors of clinical perfectionism outlined in Shafran et 
al.’s (2010) model. Session 3 introduced participants to behavioural surveys and 
behavioural experiments and demonstrated how these strategies can be used to 
challenge the perfectionist beliefs that underpin inflexible standards and perfectionist 
behaviours (Shafran et al., 2010). Session 4 discussed the maintaining roles of 
dichotomous thinking and rigid rule setting in clinical perfectionism and provided 
strategies such as looking at performance on a continuum, as well as behavioural 
experiments to assist in replacing rules with guidelines (Shafran et al., 2010). 
Session 5 provided an explanation of the common cognitive biases that maintain 
clinical perfectionism, such as negative filter and discounting the positive. 
Participants were then taught cognitive-behavioural strategies to challenge these 
biases. Such strategies included broadening attention and completing diaries to 
highlight the positive components of one’s performance. Participants were socialised 
to thought diaries as a strategy to challenge unhelpful cognitions and construct 
rational cognitions (Shafran et al., 2010). 
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The primary objective of Session 6 was to discuss the maintaining role of 
procrastination in clinical perfectionism and introduce participants to strategies to 
reduce procrastination. These strategies included thought diaries, behavioural 
experiments, coping statements, imagery restructuring, dividing tasks into chunks, 
realising that action precedes motivation and problem-solving. Secondary objectives 
were to provide participants with strategies for time management and to highlight the 
importance of pleasant event scheduling (Shafran et al., 2010). Session 7 focussed on 
the detrimental impact of self-criticism and its maintaining role in clinical 
perfectionism. Strategies were then provided to reduce self-criticism and increase 
self-compassion. These strategies included the use of thought diaries to identify self-
criticism, applying friendship values to oneself to increase self-compassion, as well 
as the use of compassionate voice index cards and the acceptance technique to 
reduce self-criticism (Shafran et al., 2010). Session 8 focused on the detrimental 
effect of self-esteem being overly reliant on achievement and presented participants 
with strategies to develop additional means from which to derive their self-esteem. 
Such strategies included setting flexible and realistic goals, making goals in new 
areas of life and completing diaries that focus attention on achievement. An 
additional objective of this session was to discuss strategies to maintain treatment 
gains such as re-visiting the readings and helpful exercises, as well as discussing set-
back management and relapse prevention (Shafran et al., 2010). 
3.8.2.2. Therapists 
Three psychologists administered the group CBT-CP in this research. The 
first psychologist was the primary researcher (Handley) who has a Master of Clinical 
Psychology degree and delivered the group CBT-CP in Steele et al.’s (2013) 
previous trial. This psychologist conducted four therapy groups. The remaining two 
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psychologists were female post-graduate students in the Master of Clinical 
Psychology program. These post-graduate students each co-facilitated two therapy 
groups with the primary researcher. Prior to delivering the group CBT-CP, the post-
graduate students received a package of training material to read and underwent a 2-
hour training session with one of the authors of the treatment protocol (Egan). The 
training material contained Shafran et al.’s (2010) book, as well as readings about 
perfectionism as a transdiagnostic process (Egan et al., 2011), cognitive-behavioural 
therapy (Rees, 2010), therapeutic factors in group psychotherapy (Yalom & Leszcz, 
2005) and conceptualising and constructing behavioural experiments (Bennett-Levy 
et al., 2004; Rouf, Fennell, Westbrook, Cooper, & Bennett-Levy, 2004). The 2-hour 
training session included discussion of the definition and maintenance cycle of 
clinical perfectionism (Shafran et al., 2002; Shafran et al., 2010), an overview of the 
eight group CBT-CP sessions, as well as discussion about specific issues related to 
running group CBT-CP, such as the influence of clients’ cultural backgrounds on 
how their clinical perfectionism may present. The co-facilitators were each given a 
DVD to watch, which included two of the co-authors of the CBT-CP treatment 
(Egan and Shafran) role playing the main therapy techniques embodied in the CBT-
CP treatment (Shafran et al., 2010). 
Prior to delivering each group CBT-CP session, the primary researcher 
provided each co-facilitator with a script that detailed the session components the co-
facilitator was to deliver. This ensured that all aspects of the session were covered 
and also meant that the co-facilitators were covering the same content across CBT-
CP groups. All psychologists received weekly supervision by a clinical psychologist 
who was a co-author of the treatment protocol (Egan) to further ascertain that the 
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group CBT-CP protocol was correctly delivered and to trouble-shoot any difficulties 
that emerged with clients. 
3.8.2.2. Treatment Adherence and Session Quality  
Five randomly selected video-tapes of the group therapy sessions from this 
study were rated by two clinical psychologists who were external to this research. 
Each of these clinical psychologists has over a decade of clinical experience. As 
established measures assessing adherence to group CBT-CP were not available in the 
literature, the primary researcher (Handley) constructed a session checklist that 
consisted of the key objectives of each group CBT-CP session. A similar approach 
of checklist construction was employed in an RCT of group and individual CBT for 
obsessive-compulsive disorder (Anderson & Rees, 2007). In the current study, prior 
to adherence being rated, the checklist was examined by the co-author of the CBT-
CP treatment manual (Egan) to ensure it had a high degree of content validity. 
Adherence to each objective in a session was rated on a 7-point Likert scale that 
ranged from (1) not at all covered to (7) completely covered. This session checklist 
is included in Appendix G. Once the external clinical psychologists had rated the 
checklist, the inter-rater reliability of this measure was calculated and found to be 
strong (r = .89). In the current study, mean adherence to treatment protocol across 
sessions was rated as 6.71/7 (SD = 0.977).  
Session quality was rated using nine items that assessed therapist behaviours 
(e.g., warmth, empathy) from the Collaborative Study Psychotherapy Rating Scale-6 
(CSPRS-6; Evans, Piasecki, Kriss, & Hollon, 1984). These items formed the factor 
subscale ‘collaborative structure’ and were previously found to have adequate inter-
rater reliabilities (.72, .82; Startup & Shapiro, 1993). The external clinical 
psychologists rated the session quality of five video-taped therapy sessions. In the 
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current study, the mean scores for therapist behaviours were: supportive 
encouragement = 6.6/7 (SD = 0.52); warmth: 6.1/7 (SD = 0.87); rapport: 5.5/7 (SD = 
1.08); empathy: 5.8/7 (SD = 0.92); formality: 5.8/7 (SD = .63); conveyance of 
expertise: 5.6/7 (SD = 0.97); collaboration: 4.7/7 (SD = 1.83); relating improvement 
to cognitive change: 5.5/7 (SD = 1.43); and encouragement of independence: 5.4/7 
(SD = 1.07).  
3.8.3. Measures  
Mini-Screen (Sheehan & Lecrubier, 2006). This screening measure 
contains 21 questions that assess whether participants meet the first one or two key 
symptoms of a psychological disorder according to the DSM-IV-TR (APA, 2000). 
Participants respond ‘yes’ or ‘no’ to each question. This measure was utilised in the 
telephone screen to provide initial information about participants’ psychological 
difficulties. 
Clinical Perfectionism Questionnaire (CPQ; Fairburn et al., 2003b). The 
Clinical Perfectionism Questionnaire contains 12 items that examine one’s degree of 
clinical perfectionism throughout the past month. This measure was described in 
detail in Study I.  
Concern over Mistakes, Personal Standards and Doubts about Actions 
subscales (Frost et al., 1990). The Concern over Mistakes, Personal Standards and 
Doubts about Actions subscales of the Frost Multidimensional Perfectionism Scale 
(Frost et al., 1990) were described in detail in Study I. As in Steele et al.’s (2013) 
study, these multidimensional perfectionism measures were included in the current 
study to better enable findings to be compared to previous perfectionism treatment 
trials (e.g., Riley et al., 2007; Steele & Wade, 2008; Steele et al., 2013). 
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Dysfunctional Attitudes Scale-Self Criticism (DAS-SC; Imber et al., 
1990; Weissman & Beck, 1978). This perfectionism subscale was developed from 
Imber et al.’s (1990) factor analysis of Weissman and Beck’s (1978) Dysfunctional 
Attitudes Scale. It contains 15 items that examine the perception individuals have of 
themselves and others when their standards are not reached. Individuals rate their 
agreement with each statement on 7-point Likert scales that range from totally 
disagree to totally agree. Item responses are summed to produce a total score, with 
higher scores on this subscale reflecting greater perfectionism (Imber et al., 1990; 
Weissman & Beck, 1978). The DAS-SC has demonstrated high internal consistency 
in a clinical sample (Cronbach’s alpha = .94; Steele et al., 2013), as well as high 
levels of stability over 18-months (Blatt et al., 1995). The DAS-SC has been found 
to provide an accurate measure of the maladaptive self-critical components of 
perfectionism (Dunkley et al., 2004) and has demonstrated incremental predictive 
validity (Dunkley et al., 2006; 2009). In the current study, DAS-SC had a 
Cronbach’s alpha of .93.  
Distress and Interference Scales (Brown, DiNardo, & Barlow, 1994). 
Two 1-item scales were adapted from the Anxiety Disorders Interview Schedule-
Adult version (Brown et al., 1994). The first scale assesses the degree of distress 
associated with perfectionism. Individuals responded on a 9-point Likert scale 
ranging from no distress at all to very severe distress. The second scale assesses the 
degree of interference associated with perfectionism. Individuals responded on a 9-
point Likert scale ranging from no interference at all to very severe interference. 
Higher scores on the distress and interference scales reflect greater distress and 
interference associated with perfectionism respectively. As each scale contained only 
1 item, their internal consistencies could not be calculated. 
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Depression, Anxiety and Stress Scale-21 (DASS-21; Lovibond & 
Lovibond, 1995). This 21-item scale measures symptoms of depression, anxiety and 
stress experienced throughout the previous week. Participants rate the degree to 
which they have experienced symptoms on 4-point Likert scales that range from did 
not apply to me at all to applied to me very much or most of the time. Items are 
summed to form three subscale scores: depression (Items 3, 5, 10, 13, 16, 17 and 21), 
anxiety (Items 2, 4, 7, 9, 15, 19 and 20), and stress (Items 1, 6, 8, 11, 12, 14 and 18). 
Higher scores reflect more severe symptoms. These subscales have been found to 
have high internal consistencies in a clinical sample (Cronbach’s alpha = .94 for 
depression, .87 for anxiety, and .91 for stress; Antony, Bieling, et al., 1998). The 
concurrent validity of this measure is also moderately high (Antony, Purdon, et al., 
1998). In the present study, Cronbach’s alpha was .86 for each of the three subscales.   
 Eating Disorders Examination Questionnaire (EDE-Q; Fairburn & 
Beglin, 1994). This 36-item questionnaire measures concerns regarding weight, 
shape and eating, as well as engagement in disordered eating behaviours during the 
past month. Participants answer items on 7-point Likert scales or by indicating 
whether they have partaken in certain eating behaviours. Items are summed to form 
four subscale scores: restraint, weight concern, eating concern and shape concern, as 
well as a total score. Higher scores reflect greater eating pathology. The EDE-Q has 
demonstrated high levels of internal consistency in non-clinical (Cronbach alphas = 
.73 – .93; Mond, Hay, Rogers, Owen, & Beaumont, 2004b) and clinical samples 
(Cronbach alphas = .70 - .90; Peterson et al., 2007). It has been found to have good 
concurrent and criterion validity (Mond, Hay, Rogers, Owen, & Beaumont, 2004a). 
In the present study, Cronbach alphas were .84 (restraint), .85 (weight concern), .86 
(eating concern), .91 (shape concern) and .96 (EDE-Q total).  
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Penn State Worry Questionnaire (PSWQ; Meyer et al., 1990). The Penn 
State Worry Questionnaire consists of 16 items which examine the uncontrollability, 
excessiveness and generality of clinical worry. This measure was described in detail 
in Study I. 
 Beck Depression Inventory-II (Beck et al., 1996).The Beck Depression 
Inventory-II contains 21 items that measure the symptoms of depression. This 
measure was described in detail in Study I. 
Fear of Negative Evaluation Scale-Brief Version (FNE-B; Collins, 
Westra, Dozois, & Stewart, 2005). This measure is adapted from the scales of 
Watson and Friend (1969) and Leary (1983) and provides an assessment of social-
evaluative anxiety. Participants rate the degree to which items are characteristic of 
them on 5-point Likert scales that range from not at all characteristic of me to 
extremely characteristic of me. Higher scores on this measure reflect greater social-
evaluative anxiety (Collins et al., 2005). Collins et al. (2005) found this subscale to 
have excellent internal consistency (Cronbach’s alpha = .97), test re-test reliability (r 
= .94), discriminant validity and convergent validity in a clinical sample. In the 
current study, Cronbach’s alpha was .90. 
Obsessive Compulsive Inventory-Revised (OCI-R; Foa et al., 2002). The 
OCI-R examines the distress experienced from obsessive-compulsive behaviours 
throughout the last month. For each item, participants rate their degree of distress on 
5-point Likert scales ranging from not at all to extremely. The items from this 
measure form six subscale scores: checking (Items 2, 8 and 14), obsessing (Items 6, 
12 and 18), ordering (Items 3, 9 and 15), washing (Items 5, 11 and 17), neutralising 
(Items 4, 10 and 16) and hoarding (Items 1, 7 and 13), as well as a total OCI-R score. 
This measure has high internal consistency in a clinical sample (Cronbach’s alpha = 
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.81 for the total score, ranging between .86 to .90 for the subscales; Foa et al., 2002). 
The OCI-R has high levels of test-retest reliability, as well as high discriminant and 
convergent validity (Foa et al., 2002; Huppert et al., 2007; Hodgson & Rachman, 
1987). In the current study, Cronbach alphas were .87 (checking), .62 (obsessing), 
.94 (ordering), .85 (washing), .83 (neutralising), .82 (hoarding) and .91 (total score). 
Anxiety Sensitivity Index Version 3 (ASI-3; Taylor et al. 2007). The ASI-
3 is an adaptation of the scales from Reiss, Peterson, Gursky, and McNally (1986) 
and Taylor and Cox (1998). It measures fear of the physical sensations induced by 
anxiety. Participants rate the extent to which they agree with items on 5-point Likert 
scales ranging from Very Little to Very Much. The items form three subscales: 
physical concerns (Items 3, 4, 5, 8, 12 and 15); cognitive concerns (Items 2, 5, 10, 
14, 16 and 18) and social concerns (Items 1, 6, 9, 11, 13 and 17). The sum of all 18 
items forms the ASI-3-total score. The ASI-3 subscales have been found to have 
high internal consistencies across non-clinical and clinical samples, with Cronbach 
alphas ranging between .79 and .86 for physical concerns, between .79 and .91 for 
cognitive concerns, and between .73 and .86 for social concerns. This measure has 
also shown high levels of convergent, criterion, discriminant and factorial validity 
(Taylor et al., 2007). In the current study, Cronbach alphas were .70 (physical 
concerns), .91 (cognitive concerns), .75 (social concerns) and .88 (total score). 
Mini International Neuropsychiatric Interview, Version 5.0; (MINI; 
Sheehan et al., 1998). The MINI was described in Study I. In Study I the MINI was 
utilised to determine whether participants received a diagnosis of Generalised 
Anxiety Disorder. In the current study, specific modules of the MINI (suicidality, 
substance dependence, anorexia nervosa and psychosis) were administered over the 
telephone to screen participants for the exclusion criteria. All modules of the MINI 
169 
 
were then administered at each assessment point to determine whether participants 
had diagnoses of any psychological disorders. 
Rosenberg Self-Esteem Scale (RSES; Rosenberg, 1965). This 10-item 
questionnaire provides a measure of global self-esteem. Participants rate their 
agreement with each item on 4-point Likert scales ranging from strongly agree to 
strongly disagree. Items that are positively worded require reverse coding. The 
scores from all items are summed and larger scores reflect higher global self-esteem. 
This measure has demonstrated high internal consistency in a clinical sample 
(Cronbach’s alpha = .89; Steele & Wade, 2008), as well as high test-retest reliability 
and construct validity in non-clinical samples (Fleming & Courtney, 1984; Gray-
Little, Williams, & Hankins, 1997). In the current study, Cronbach’s alpha was .88. 
Quality of Life, Enjoyment and Satisfaction Questionnaire-18 (Q-LES-
Q-18; Ritsner et al., 2005). This 18-item measure is adapted from Endicott et al.’s 
(1993) 93-item scale and examines levels of enjoyment and satisfaction during the 
past week. Participants rate items on 5-point Likert scales ranging from not at 
all/never to frequently/all the time. Items form five subscales: subjective feelings 
(Items 5, 6, 7, 8 and 9), physical health (Items 1, 2, 3 and 4), leisure time activity 
(Items 10, 11 and 12), social relationships (Items 13, 14, 15, 16 and 17) and 
medication satisfaction (Item 18). A total quality of life score is calculated by 
dividing the sum of all items by the number of items. For participants on medication, 
this equates to the sum of 18 items divided by 18; for participants not on medication 
this equates to the sum of the first 17 items divided by 17.  Ritsner et al. (2005) 
found this measure to have high test re-test reliability and internal consistency 
(Cronbach’s alphas between .74 and .97), as well as high construct and concurrent 
validity across clinical samples. In the current study, Cronbach’s alpha was .91. 
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Client adherence to treatment. Adherence to treatment was assessed by 
recording the number of group sessions attended by each participant and by 
administering a weekly measure of reading and homework compliance. Reading and 
homework compliance were assessed with items adapted from Thiels, Schmidt, 
Troop, Treasure, and Garth (2001) and Troop et al. (1996). This measure was 
utilised in the pilot trial of group CBT-CP and found to have moderate internal 
consistency (Steele et al., 2013). In the current study, it had a Cronbach’s alpha of 
.73. 
Adherence to restrictions of medication change and external treatment. 
A 10-item measure adapted from Steele et al. (2013) assessed whether participants 
had abstained from changing anti-depressant medication and receiving external 
psychotherapy throughout the treatment trial. This measure was given to participants 
at their post-waitlist/post-treatment assessments and at each follow-up. This measure 
is displayed in Appendix H. 
 Revision of treatment components over the follow-up period. A 6-item 
measure adapted from Steele and Wade (2008) and Steele et al. (2013) was given to 
participants at each follow-up and assessed whether participants had reviewed the 
readings, worksheets and homework exercises over the follow-up period. 
Participants were also asked whether they had practiced the CBT-CP strategies over 
the follow-up period and to list the strategies they had found to be the most useful. 
This measure is displayed in Appendix I. 
3.8.4. Statistical Methods 
To analyse the changes in the psychometric outcomes (H1-H5), a multi-level 
mixed effects linear regression model was used (Bryk & Raudenbush, 1987; Dimitrov 
& Rumrill, 2003; Holden et al., 2008). There were two categorical random effects 
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(participant, therapy group), one categorical fixed effect (group: treatment versus 
control), and one ordinal fixed effect (time: pre- test, post-test, 3-month follow-up, 6-
month follow-up) (Bryk & Raudenbush, 1987; Dimitrov & Rumrill, 2003; Holden et 
al., 2008). This linear regression model was tested via SPSS’s Generalised Linear 
Mixed Models (GLMM: SPSS, Version 22). To test the associations between the 
fixed effects and the psychometric outcomes, GLMM makes the assumption of a 
normal probability distribution for the psychometric outcomes and connects them to 
the fixed effects using an identity function. If any outcomes were not normally 
distributed, robust statistics were used to compute the parameter estimates of the 
covariance matrix. To analyse changes in the binary outcomes (H6 –H9), Fisher’s 
Exact 1-sided tests were used (Bryk & Raudenbush, 1987; Dimitrov & Rumrill, 
2003; Holden et al., 2008). 
3.8.4.1. Assumption testing. For repeated measures design, the traditional 
ANOVA model makes assumptions of homogeneity of variance, normality and 
sphericity (Tabachnick & Fidell, 2007). The GLMM ‘robust statistics’ specifier 
accounts for violations of homogeneity of variance and normality (Holden et al., 
2008). Therefore, in the present study, variables that were skewed and variables 
which had unequal variances across the two groups were analysed using robust 
statistics (Holden et al., 2008). Violations of sphericity are applicable for data that is 
collected across more than two waves (Tabachnick & Fidell, 2007). GLMM 
accounts for violations of sphericity by altering the covariance matrix from 
compound symmetry (the default) to autoregressive (Holden et al., 2008). Although 
GLMM accounts for unequally spaced points of data collection and unequal group 
sizes (Holden et al., 2008), the current study ensured that data collection points were 
equally spaced and that group sizes at baseline were equal.  
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 For repeated measures design, the traditional ANOVA model also makes the 
assumption of independence of observations (Tabachnick & Fidell, 2007). This 
assumption was likely to be violated in the present study given that CBT-CP was 
delivered in a group format (Kenny, Manetti, Pierro, Livi, & Kashy, 2002). Intra-
group dependencies that emerge from the clustering of outcome scores within the 
four therapy groups can only happen after participants have had the group treatment. 
As each GLMM analysis contained at least one group of participants who had 
received the group treatment, intra-group dependencies could have possibly 
compromised all of the GLMM analyses (Kenny et al., 2002; Killip, Mahfoud, & 
Pearce, 2004; Rabe-Hesketh & Skrondal, 2005). To ascertain the degree of the 
problem, the intra-class correlation (ICC) was calculated for every outcome variable 
across the treatment group and the treated control group immediately after their 
group treatment. The ICCs provided an approximation of the amount of intra-group 
dependency in the data and were calculated with SPSS’s Linear Mixed Models 
procedure (Kenny et al., 2002; Killip et al., 2004; Rabe-Hesketh & Skrondal, 2005). 
Table 6 reports the direction, magnitude and significance of the ICCs for each 
outcome variable. 
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Table 6. 
Direction, Magnitude and Significance of the Intra-Class Correlation Coefficients 
for each Outcome Measure  
Outcome Direction of ICC Magnitude of ICC
 a
 Significance of ICC 
CM 
PS 
DA 
CPQ 
DAS-SC 
Distress 
Interference 
DASS-dep 
DASS-anx 
DASS-stress 
EDEQ-sc 
EDEQ-wc 
EDEQ-ec 
EDEQ-res 
EDEQ-total 
BDI-II 
PSWQ 
FNE-B 
ASI-3 
OCI-R 
RSES 
Q-LES-Q 
Positive 
Negative 
Positive 
Negative 
Positive 
Negative 
Negative 
Negative 
Negative 
Negative 
Negative 
Negative 
Negative 
Negative 
Negative 
Negative 
Negative 
Negative 
Negative 
Negative 
Positive 
Negative 
.002 
- 
.184 
- 
.072 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
.051 
- 
.987 
- 
.417 
- 
.623 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
.697 
- 
Note. ICC = Intra-class correlation; CM = Concern over Mistakes subscale of the FMPS; PS=Personal 
Standards subscale of the FMPS; DA = Doubts about Actions subscale of the FMPS; CPQ = Clinical 
Perfectionism Questionnaire; DAS-SC = Dysfunctional Attitudes Scale-Self-Criticism; Distress = 
Distress of perfectionism; Interference = Interference from perfectionism; DASS-dep = Depression 
subscale of Depression, Anxiety and Stress Scale-21 (DASS-21); DASS-anx = Anxiety subscale of 
DASS-21; DASS-stress = Stress subscale of DASS-21; EDEQ-sc = Shape Concerns subscale of the 
EDEQ; EDEQ-wc = Weight Concerns subscale of the EDEQ; EDEQ-EC = Eating Concern subscale 
of the EDEQ; EDEQ-res = Restraint subscale of the EDEQ; EDEQ-total = EDEQ total score; BDI-II 
= Beck Depression Inventory-II; PSWQ = Penn State Worry Questionnaire; FNE-B= Brief Fear of 
Negative Evaluation Scale; ASI-3 = Anxiety Sensitivity Index-3; OCI-R = Obsessive-Compulsive 
Inventory-Revised; RSES= Rosenberg Self-Esteem Scale; Q-LES-Q-18 = Quality of Life Enjoyment 
and Satisfaction Questionnaire-18. 
a
 SPSS’s Linear Mixed Models procedure is unable to converge on 
a solution when ICCs are negative (Tabachnick & Fidell, 2007) 
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The intra-class correlation coefficients for CM, DA, DAS-SC and RSES 
scores were positive. This suggested that scores on these variables were more similar 
for individuals attending the same therapy group as compared to individuals 
participating in different therapy groups. Positive intra-class correlation coefficients 
are expected following group treatment given the interaction of participants within a 
particular therapy group (Kenny et al., 2002; Killip et al., 2004). The intra-class 
correlation coefficients for the remaining outcomes were negative. This denoted a 
rare form of intragroup dependency where scores on the variables were less similar  
for individuals attending the same therapy group as compared to individuals 
participating in different therapy groups (Kenny et al., 2002). 
Kenny et al. (2002) argued that intragroup dependencies can lead to inflations 
in the Type I or Type II error rate. Murray and Hannan (1990) stated that one should 
be concerned if positive intra-class correlation coefficients have values greater than 
.02 regardless of their statistical significance. Kenny, Kashy, and Bolger (1998) 
argued that because intra-class correlations can distort p-values even when they are 
not statistically significant, the best strategy when analysing data from groups that 
contain four or more participants is to make the assumption that intragroup 
dependency does exist in the data without the need to consider its significance. 
Consequently, in the present GLMM analyses, both positive and negative intra-
group dependencies were controlled by specifying the multilevel nature of the data 
(participant nested within therapy group) in the GLMM syntax (Holden et al., 2008).  
3.8.4.2. Statistically significant change. The first GLMMs to be tested 
investigated whether there was a significant Group x Time interaction between the 
pre-test and the post-test for each outcome variable. The GLMMs comprised two 
nominal random effects (participant and therapy group), one categorical fixed effect 
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(group: treatment versus waitlist control), one ordinal fixed effect (time: pre-test 
versus post-test), and one fixed interaction term (Group x Time). By specifying a 
GLMM in which participants were nested within therapy groups, intra-group 
dependencies were able to be controlled (Bryk & Raudenbush, 1987; Dimitrov & 
Rumrill, 2003; Holden et al., 2008; Kenny et al., 2002; Killip et al., 2004).  
A separate GLMM analysis was run for each outcome measure to maximise 
the likelihood of convergence (Holden et al., 2008). As analysing each outcome 
independently of other outcomes inflates the family-wise error rate, the per-test alpha 
had to be corrected so that the inflation was controlled. In the current study, the 
alpha correction was applied within groups of conceptually related outcomes so that 
statistical power was conserved (Tabachnick & Fidell, 2007). The perfectionism 
category contained seven outcome measures (.05/7, α =.007), the eating disorder 
category consisted of five outcome measures (.05/5, α =.010), and the depression 
category contained two outcome measures (.05/2, α =.025). The remaining 
categories (general anxiety, stress, social anxiety, pathological worry, anxiety 
sensitivity, obsessive-compulsive symptoms, self-esteem and quality of life), each 
consisted of one outcome measure, therefore the standard alpha level was applied to 
the outcome measure in each of these categories (.05/1, α =.05). 
Effect sizes for the GLMM analyses were estimated by partial eta-squared 
(partial η2). An effect size of .01 is considered to be ‘small’, .06 ‘moderate’ and .15 
‘large’ (Richardson, 2011). For each outcome that yielded a significant Group x 
Time interaction, the nature of this interaction was explored by conducting pre-post 
least significant difference (LSD) comparisons within each of the two groups 
(Keppel & Wickens, 2004). Effect sizes for the LSD comparisons were estimated 
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with Cohen’s d. An effect size of 0.2 signifies a ‘small’ effect, 0.5 a ‘moderate’ 
effect and ‘0.8’ a large effect (Cohen, 1988). 
 To examine whether individuals originally from the waitlist control 
condition showed changes on the outcome variables comparable to the treatment 
group after they received group CBT-CP, a GLMM analysis was conducted where 
the group fixed effect contrasted the treatment and treated control groups, and the 
time fixed effect had four levels: pre-treatment, post-treatment, 3-month follow-up 
and 6-month follow-up. If the Group x Time interaction effects for the outcome 
variables were small and non-significant this would suggest comparable trends 
across time for the treatment and the treated control groups (Bryk & Raudenbush, 
1987; Dimitrov & Rumrill, 2003; Holden et al., 2008).  
To examine whether post-treatment gains were maintained at the 3-month 
and 6-month follow-ups, a GLMM that included a single fixed effect, time (pre-
treatment, post-treatment, 3-month  follow-up, 6-month follow-up) was tested (Bryk 
& Raudenbush, 1987; Dimitrov & Rumrill, 2003; Holden et al., 2008). For outcome 
variables where there was a significant main effect of time, post-hoc LSD contrasts 
were conducted between pre-treatment and post-treatment, pre-treatment and 3-
month follow-up, and pre-treatment and 6-month follow-up (Keppel & Wickens, 
2004). If each of these post-hoc analyses were significant for a particular outcome 
variable, this would suggest that the post-treatment gains had been maintained at the 
3-month and 6-month follow-ups (Keppel & Wickens, 2004). 
3.8.4.3. Reliable and clinically significant change. For outcome variables 
that demonstrated a significant Group x Time interaction between pre- and post-
treatment, reliable and clinically significant change analysis was conducted 
(Jacobson & Truax, 1991). Reliable change analysis determines whether the change 
177 
 
in an outcome variable is reflective of a genuine behavioural change, rather than the 
variation of an unreliable measurement tool (Jacobson & Truax, 1991). Reliable 
change indices (RCIs) were calculated for each person on each outcome measure. 
The formula for the RCI is (Xpretest – Xposttest)/ √2 (SE)
2
, where Xpretest  is the 
individual’s pre-test score on the outcome, Xposttest is the individual’s post-test score 
on the outcome and SE is the standard error of measurement. SE is calculated as 
S1√(1 – rel), where S1  is estimated by the outcome measure’s variability at pre-
intervention (T1) and rel is the reliability of the outcome measure. An RCI equal to 
or greater than an absolute value of 1.96 on a particular outcome indicates a reliable 
change on that outcome (Jacobson & Truax, 1991). Fisher’s 1-sided tests were used 
to investigate whether the treatment group had a significantly greater proportion of 
participants experiencing reliable change on an outcome relative to the waitlist 
control group. Fisher’s 1-sided tests were also used to compare the treatment group 
to the treated control group in regard to the proportion of participants experiencing 
reliable change on an outcome. After the entire sample had received group CBT-CP, 
the total proportion of individuals experiencing reliable change on the outcome 
measures at post-treatment and 6-month follow-up were calculated. 
Clinically significant change analysis determines whether an individual has 
made a significant shift away from the dysfunctional population in the direction of 
the functional population. To examine whether clinically significant change in 
perfectionism occurred, a cut-off point for clinical significance was first calculated 
(Jacobson & Truax, 1991). Jacobson and Truax (1991) proposed that this clinical 
cut-off point can be defined in three different ways; however, only the first of these 
definitions can be used in the absence of population norms. As there are no 
established dysfunctional or functional population norms for the perfectionism 
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outcome variables, the first definition was utilised. According to this definition, the 
cut-off point for clinical significance is the score that is two standard deviations 
away from the mean of the dysfunctional population (Jacobson & Truax, 1991). 
Consistent with Riley et al.’s (2007) approach of calculating the clinical significance 
of CBT-CP, the standard deviation and mean used in this definition were derived 
from the pre-treatment scores of the current sample. As clinically significant change 
in CPQ and CM were calculated, the pre-treatment CPQ and CM scores of the 
current sample were used to calculate the respective clinical cut-offs for these 
measures. Providing that an individual first experienced reliable change on CPQ (or 
CM) between pre- and post-treatment, if their post-treatment CPQ (or CM) score 
crossed the corresponding clinical cut-off in the functional direction, the individual 
has experienced clinically significant change (Jacobson & Truax, 1991).  
Hageman and Arrindell (1999) specified categories for clients based on 
whether they experienced reliable and/or clinically significant change. If an 
individual has experienced reliable change and their post-treatment score has 
exceeded the clinical cut-off in the functional direction, the client is deemed to be 
“recovered” (Hageman & Arrindell, 1999, p. 1170). If a client has experienced 
reliable change and has not crossed this cut-off point, they have not experienced 
clinically significant change but instead are deemed to be “improved but not 
recovered” (Hageman & Arrindell, 1999, p. 1170). If a client has not experienced 
reliable change, they are deemed to be “unchanged” (Hageman & Arrindell, 1999, p. 
1170). If a client has experienced reliable change in the direction that suggests a 
genuine worsening, they are deemed to be “deteriorated” (Hageman & Arrindell, 
1999, p. 1170). Fisher’s 1-sided tests were utilised to examine whether the 
intervention group had a significantly greater proportion of recovered individuals 
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relative to the waitlist control group. After the entire sample had received group 
CBT-CP, the total number of individuals deemed recovered, improved, unchanged 
and deteriorated in perfectionism (CPQ and CM) between pre-treatment and post-
treatment and pre-treatment and 6-month follow-up were calculated. 
To examine whether clients demonstrated clinically significant change in 
their psychological disorders between pre-treatment and post-treatment, recovery 
from disorders was examined for each participant (Tabachnick & Fidell, 2007). A 
participant recovered from a psychological disorder if they had a DSM-IV-TR (APA, 
2000) diagnosis of the disorder at pre-treatment and did not have that diagnosis at 
post-treatment. They were not recovered if they had a diagnosis of the disorder at 
pre-treatment and at post-treatment (Tabachnick & Fidell, 2007). Fisher’s 1-sided 
tests were utilised to determine whether a significantly larger proportion of 
participants from the group CBT-CP condition demonstrated pre-post recovery from 
a psychological disorder compared to the waitlist control condition (Tabachnick & 
Fidell, 2007). Once all participants had received group CBT-CP, the total number of 
participants demonstrating recovery between pre-treatment and post-treatment and 
between pre-treatment and 6-month follow-up were calculated for each 
psychological disorder. 
3.9. Results 
3.9.1. Participant flow 
During the recruitment phase of this study, 155 individuals expressed 
interest. Five participants (3%) were excluded immediately (2 did not return 
telephone call and 3 were younger than 18 years). The screening questionnaire was 
sent to 150 individuals of which 83 (55%) were excluded. Seven of these 83 
individuals (8%) did not meet the criteria for inclusion (4 had CM scores below 24.7, 
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1 had psychosis, 1 was not fluent in English and 1 was inappropriate for a group due 
to being very critical of others). Seventy-six of the 83 individuals declined (33 
unable to make session time/too busy, 23 did not return measure, 7 wanted to have 
external psychotherapy, 6 declined without providing a reason, 5 did not think they 
were appropriate for the treatment and 1 was changing medication). 
The remaining 67 individuals were offered a telephone screening 
appointment. One of these individuals could not be contacted. Sixty-six telephone 
interviews were conducted, which resulted in 23 individuals being excluded (12 were 
of moderate to high suicide risk and/or were engaging in self-harm, 2 wanted to have 
external psychotherapy, 2 had a body mass index ≤ 17.5 and disordered eating, 1 had 
a mood disorder with psychotic features and 6 dropped out prior to assessment). 
Baseline assessments were conducted with 43 individuals. One individual withdrew 
to continue external psychotherapy. Forty-two eligible participants were randomised 
to the intervention and control conditions. Figure 3 displays the CONSORT diagram 
describing the flow of eligible participants through the study (Moher et al., 2010). 
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Figure 3. CONSORT diagram of RCT showing the flow of eligible participants 
through the study (Moher et al., 2010). 
Waitlist (n=21) 
 21 completed waitlist. 
Randomisation (n=42) 
Group CBT-CP (n=21) 
 At least 1 treatment session (n=20) 
 1 withdrew due to work 
Baseline assessment (n = 43) 
Post-waitlist assessment (n=21) 
 Completed (n=20), not completed 
(n=1) 
Post-group assessment (n=20) 
 Completed (n=19); not completed 
(n=1) 
Group CBT-CP  
 At least 1 treatment session (n=17)  
 3 withdrew (1 = work, 1 = anxiety 
about group, 1 = no reason) 
6-month follow-up assessment 
 Completed(n=19), not completed(n= 1) 
 
3-month follow-up assessment 
 Completed(n=19), not completed (n=1) 
6-month follow-up assessment 
 Completed (n= 15), not completed(n= 2) 
 
3-month follow-up assessment 
 Completed (n=17), not completed (n=0) 
 
Post-group assessment  
 Completed(n=17), not completed (n=0) 
 
 
 Withdrew after baseline assessment 
(n=1) 
Assessed for eligibility (n=155) 
 Excluded (n=5)  
 
Sent screening questionnaire (n=150) 
 
Excluded (n=83) 
 Did not meet inclusion criteria (n=7)  
 Declined (n=76)  
Excluded (n=24) 
 Drop-out before phone interview (n=1) 
 Not appropriate (n=17) 
 Drop-out prior to assessment (n=6) 
 
Phone interview (n=67) 
 
Analysed (n=21) 
 
Analysed (n=21) 
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3.9.2. Sample Characteristics 
Table 7 displays the baseline demographic and clinical characteristics for 
participants in the intervention and control conditions. Fisher’s exact tests (2-sided) 
indicated that participants in these conditions did not significantly differ in terms of 
gender, race, first language, occupation, or anti-depressant medication status. There 
were no significant differences between conditions in the number of individuals with 
a current psychological disorder or in the number of individuals with depression in 
remission. Independent samples t-tests indicated that participants in the intervention 
and control conditions did not differ significantly in age or in their number of 
psychological disorders.  
Table 8 displays the mean baseline scores on the outcome measures for 
participants in the intervention and control conditions. Independent samples t-tests 
revealed that participants in these conditions did not significantly differ on any 
outcome variable. Table 9 displays the principal and secondary diagnoses of 
participants in the intervention and control conditions. Fisher’s exact tests (2-sided) 
indicated that there were no significant differences in the total number of participants 
in each condition who had major depressive disorder (p = 1.00), bipolar I or II 
disorder (p = 1.00), obsessive-compulsive disorder (p = 1.00), social phobia (p = 
.719), panic disorder (p = .488), eating disorder not otherwise specified (p = 1.00), 
bulimia nervosa (p =.488), or alcohol dependence (p =1.00). There was however, a 
significantly greater number of individuals with generalised anxiety disorder in the 
intervention condition compared to the control condition (p = .021); but this was 
likely to work against the hypotheses.  
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Table 7.  
Baseline Demographic Characteristics (n, %) for Participants in the Intervention and Control Conditions. 
 Intervention (n = 21) Control (n = 21) Fisher’s exact test (2-sided) Entire sample (n = 42) 
Age (years) (std error) 28.86 (1.80)  33.00 (2.68) t(40) = -1.28, p = .208 a 30.93 (1.63) 
Gender (female) 17 (81%) 17 (81%)  p = 1.00 34 (81%) 
Race 19 Caucasian (90%) 
2 Asian (10%) 
0 African (0%) 
17 Caucasian (81%) 
3 Asian (14%) 
1 African (5%) 
 p = .663 
 p = 1.00 
 p = 1.00 
36 (86%) 
5 (12%) 
1 (2%) 
English first language  17 (81%) 19 (90%)  p = .663 36 (86%) 
Occupation  11 students (52%)  
10 employed (48%) 
11 students (52%),  
10 employed (48%) 
 p = 1.00 
 p = 1.00 
22 students (52%) 
20 employed (48%) 
Medication (yes)  8 (38%)  6 (29%)  p = .744 14 (33%) 
Psychological disorder  21 with disorder (100%) 17 with disorder 
(81%) 
 p = .107 
 
38 with disorder (90%)
b
 
Depression in 
remission (yes) 
10 (48%) 11 (52%)  p = 1.00 
 
21 (50%) 
Number of disorders 
(mean, std error) 
2.096 (0.23) 1.95 (1.47) t(40) = 3.64, p = .718 a 2.02 (1.26) 
Note. 
a
   t-tests rather than fisher’s exact-sided tests were used to test for group differences in scale outcome variables. 
             
 
b
 The 4 participants who did not have a current diagnosis all had depression in remission. *p < .05 
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Table 8.  
Means and (Standard Errors) of Baseline Outcome Variables for the Intervention 
Condition, Control Condition and Entire Sample. 
Measure Intervention 
 (n = 21) 
Control  
(n = 21) 
t(df)                 p Entire sample  
(n = 42) 
CM 33.14 (1.32) 33.14 (1.35) t(40) = 0.00,   p =1.000 33.14 (0.93) 
PS 28.86 (1.04) 28.57 (0.78) t(40) = 0.22,   p = .827 28.71 (0.64) 
DA 15.61 (0.64) 15.66 (0.61) t(40) =-0.05,   p = .957 15.64 (0.44) 
CPQ 32.10 (1.17) 31.24 (1.26) t(40) = 0.50,   p = .620 31.67 (0.85) 
DAS-SC 68.43 (2.74) 71.29 (4.05) t(40) =-0.59,   p = .562 69.86 (2.42) 
Distress  6.62  (0.36)   6.10 (0.41) t(40) = 0.95,   p = .346   6.36 (0.27) 
Interference  6.90  (0.35)   6.19 (0.43) t(40) = 1.28,   p = .208   6.55 (0.28) 
EDEQ-sc   2.20 (0.30)   2.70 (0.39) t(40) =-1.01,   p = .321    2.45 (0.25) 
EDEQ-wc   2.02 (0.36)   2.62 (0.40) t(40) =-1.12,   p = .271   2.32 (0.27) 
EDEQ-ec   0.94 (0.26)   1.19 (0.33) t(40) =-0.59,   p = .559   1.07 (0.21) 
EDEQ-res   1.08 (0.31)   0.94 (0.26) t(40) =-1.74,   p = .090   1.50 (0.25) 
EDEQ-total   1.56 (0.27)   2.11 (0.34) t(40) =-1.24,   p = .222   1.83 (0.22) 
BDI-II 17.45 (2.61) 18.59 (2.67) t(36) =-0.18,   p = .856 18.39 (1.84) 
DASS-dep 15.43 (2.31) 13.52 (2.02) t(40) =  0.62,  p = .539 14.48 (1.52) 
DASS-anx 12.10 (2.38) 11.62 (2.16) t(40) =  0.15,  p = .883 11.86 (1.59) 
DASS-stress 23.33 (1.70) 24.10 (2.26) t(40) = -0.27,  p = .789 23.71 (1.40) 
FNE-Ba 49.93 (2.22) 50.79 (1.99) t(26) = -0.29,  p = .776 50.36 (1.47) 
ASI-3 b  25.62 (3.15) 27.33 (3.95) t(26) = -0.33,  p = .742 26.54 (2.53) 
OCI-R c  24.60 (4.61) 24.24 (4.45) t(21) =  0.06,  p  = .955   24.39 (3.14) 
PSWQ 65.10 (1.65) 66.90 (2.51) t(40) = -0.60,  p = .551 66.00 (1.49) 
RSES 25.05 (0.75) 25.81(1.30) t(40) =  -0.51, p = .614 25.43 (0.74) 
185 
 
Q-LES-Q 3.20 (0.16) 3.36 (0.17) t(40) = -0.60, p = .555   3.28 (0.11) 
Note. CM = Concern over Mistakes subscale of the Frost Multidimensional Perfectionism Scale 
(FMPS); PS = Personal Standards subscale of the FMPS; DA = Doubts about Actions subscale of the 
FMPS; CPQ = Clinical Perfectionism Questionnaire; DAS-SC = Dysfunctional Attitudes Scale-Self-
Criticism; Distress = Distress of perfectionism; Interference = Interference from perfectionism; 
EDEQ-sc = Shape Concerns subscale of the Eating Disorder Examination Questionnaire (EDEQ); 
EDEQ-wc = Weight Concerns subscale of the EDEQ; EDEQ-EC = Eating Concern subscale of the 
EDEQ; EDEQ-res = Restraint subscale of the EDEQ; EDEQ-total= EDEQ total score; BDI-II = Beck 
Depression Inventory-II; DASS-dep = Depression subscale of the Depression, Anxiety and Stress 
Scale-21 (DASS-21); DASS-anx = Anxiety subscale of the DASS-21; DASS-stress = Stress subscale 
of the DASS-21; FNE-B = Brief Fear of Negative Evaluation Scale;  ASI-3 = Anxiety Sensitivity 
Index-3; OCI-R = Obsessive-Compulsive Inventory-Revised; PSWQ = Penn State Worry 
Questionnaire; RSES= Rosenberg Self-Esteem Scale; Q-LES-Q-18 = Quality of Life Enjoyment and 
Satisfaction Questionnaire-18.  
a 
FNE-B =   intervention condition n = 14; control condition n = 14; total n = 28  
b
 ASI-3  =   intervention condition n = 13; control condition n = 15; total n = 28  
c
 OCI-R =   intervention condition n = 10; control condition n = 13; total n = 23 
* p < .05.  ** p < .01. *** p < .001. 
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Table 9. 
Baseline Psychological Disorders of Participants Randomised to the Intervention and Control Conditions. 
 Intervention Condition (n = 21) Control Condition (n = 21) 
Psychological disorder Principal 
diagnosis 
Secondary  
diagnosis 
Total Principal 
diagnosis 
Secondary 
diagnosis 
Total 
Major Depressive Disorder   1    (5%) 6 (29%)  7   (33%)  3 (14%) 5 (24%) 8 (38%) 
Bipolar I or II Disorder  0    (0%) 1   (5%)  1     (5%)  0   (0%) 0   (0%) 0   (0%) 
Generalised Anxiety Disorder  19   (90%) 2  (10%) 21 (100%)
a
 11 (52%) 4  (19%) 15 (72%)
 b
 
Obsessive Compulsive Disorder  0    (0%) 4  (19%)  4   (19%)  0   (0%) 3  (14%) 3  (14%) 
Social Phobia  0    (0%) 4  (19%)   4   (19%)  0   (0%) 6  (29%) 6  (29%) 
Panic Disorder with/without 
Agoraphobia 
 0    (0%) 2  (10%)   2   (10%)  0   (0%) 0    (0%) 0    (0%) 
Bulimia Nervosa  0    (0%) 0    (0%)   0     (0%)  1   (5%) 1     (5%) 2  (10%) 
EDNOS  1    (5%) 4   (19%)   5   (24%)  2  (10%) 2   (10%) 4  (19%) 
Alcohol Dependence    0     (0%) 0    (0%)   0     (0%)  0   (0%)          1     (5%)    1    (5%) 
Note. Change in subscript denotes a significant difference between groups. 
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3.9.3. Compliance with Treatment 
3.9.3.1. Attrition. Five participants withdrew prior to receiving the active 
intervention (intervention condition: n = 1; control condition: n = 4). An additional 
three participants withdrew between post-treatment and 6-month follow-up 
(intervention condition: n = 1; treated control condition: n = 2). Thus, eight out of 42 
participants (19.04%) did not complete the treatment trial.  
3.9.3.2. Session attendance. The treatment and treated control groups did not 
differ significantly in the number of group therapy sessions attended (intervention 
condition: M = 5.85, SD = 1.93; treated control condition: M = 5.39, SD = 2.30;  
p = .51). 
3.9.3.3. Reading and homework compliance. On average, the treatment 
group read 49.14% (SD = 28.80) of the readings each week, whereas the treated 
control group read 66.27% (SD = 21.61) of the readings each week. The difference 
between these percentages was not statistically significant (t [35] = 2.02, p = .052). 
The entire sample read an average of 57.01% (SD = 26.84) of the readings each 
week. In regard to homework compliance, on average, the treatment group 
completed 40.51 % (SD = 24.13) of the homework exercises each week, whereas the 
treated control group completed 39.43 % (SD = 19.83) of the homework exercises 
each week. The difference between these two percentages was not statistically 
significant (t [35] = 0.15, p = .884). The entire sample completed an average of 
40.01% (SD = 21.96) of the homework exercises each week.  
3.9.4. The Effects of Group CBT-CP on Dimensions of Perfectionism 
As displayed in Table 10, there were significant Group x Time interaction 
effects for all measures of perfectionism (CPQ, CM, PS, DA, DAS-SC, distress and 
interference) at the Bonferroni-adjusted alpha level of .007. Partial eta-squared 
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values indicated that the size of the interaction effects for CM, DAS-SC, distress and 
interference were large, whereas the size of the interaction effects for CPQ scores, 
PS and DA were moderate. Post-hoc LSD contrasts indicated that the group 
receiving group CBT-CP displayed significant pre-post decreases in all measures of 
perfectionism. Cohen’s d values indicated that the size of all pre-post decreases were 
large except the decrease in PS, which was moderate. The waitlist control group did 
not display significant pre-post changes on any measure of perfectionism. 
3.9.5. The Effect of Group CBT-CP on Depression, Eating Disorder Symptoms, 
Anxiety Symptoms and Self-Esteem 
There was a large significant Group x Time interaction for the BDI-II at a 
Bonferroni-adjusted alpha level of .025. At a Bonferroni-adjusted alpha level of .010 
there were large significant Group x Time interactions for eating pathology as 
assessed EDEQ-shape concerns and EDEQ-weight concerns. There was also a 
moderate significant Group x Time interaction for eating pathology as measured by 
EDEQ-total. At a standard alpha level of .05, there were moderate significant Group 
x Time interactions for social anxiety (FNE-B) and anxiety sensitivity (ASI-3); and a 
large significant Group x Time interaction for self-esteem (RSES). The Group x 
Time interactions for the other psychopathology variables were not significant at the 
Bonferroni-adjusted alpha levels.  
Post-hoc LSD contrasts indicated that the group receiving group CBT-CP 
exhibited moderate significant pre-post decreases in BDI-II and small significant 
pre-post decreases in total eating disorder pathology, shape concerns and weight 
concerns. This group also exhibited a large significant pre-post decrease in social 
anxiety, a small significant pre-post decrease in anxiety sensitivity and a large 
significant pre-post increase in self-esteem. The waitlist control group exhibited a 
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small significant pre-post decrease in BDI-II and small significant pre-post increases 
in shape concerns and weight concerns. The waitlist control group did not exhibit 
significant pre-post changes in total eating disorder pathology, social anxiety, 
anxiety sensitivity or self-esteem.  
3.9.6. The Effect of Group CBT-CP on Quality of Life 
At a standard alpha level of .05, there was a moderate significant Group x 
Time interaction for quality of life. Post-hoc LSD contrasts indicated that the 
treatment group reported a small significant pre-post increase in quality of life. The 
waitlist control group did not report a significant pre-post change in quality of life.  
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Table 10.  
Adjusted Means and (Standard Errors) of Outcome Variables at Baseline and Post-treatment/Post-waitlist for the Intervention and Control 
Conditions. 
Measure Group 
 Effect 
Time  
Effect 
Group*Time 
Effect 
  Partial       
    eta
2
 
Intervention Condition Control Condition 
     Baseline 
 
M (SE) 
Post-
treatment 
M (SE) 
Cohen’s 
d 
 Baseline 
M (SE) 
Post-
waitlist 
M (SE) 
Cohen’s 
d 
CM F(1,77) = 5.04 
p = .028* 
 
F(1,77) = 16.42 
p < .001*** 
F(1,77) = 19.03  
p < .001*** 
0.20 33.14
 a
 
(1.36)
 
 
25.66
 b
 
 (1.40) 
1.23 33.14
 a
 
 (1.36)
 
 
33.42
a
      
(1.38)
 
 
0.04 
PS F(1,77) = 0.90 
p = .347 
 
F(1,77) = 13.49 
p < .001*** 
F(1,77) = 10.04  
p = .002** 
0.12 28.86
 a
 
 (0.95)
 
 
25.64
 b 
 (0.97)
 
? 
0.69 28.57
 a 
 (0.95)
 
 
28.34
 a 
(0.96)
 
 
0.06 
DA F(1,77) = 2.80 
p = .098 
 
F(1,77) =  5.54 
p = .021* 
F(1,77)  =  8.42  
p = .005** 
0.10 15.62
 a
 
 (0.61)
 
 
13.38
 b
 
 (0.64)
 
 
0.81 15.67
 a
 
 (0.61)
 
 
15.90
 a
 
(0.62)
 
 
0.08 
CPQ F(1,77) = 0.81 
p = .372 
 
F(1,77) = 28.83 
p < .001*** 
F(1,77)  =  9.33  
p = .003** 
0.11 32.10
 a
 
 (1.16)
 
 
26.04
 b
 
 (1.19)
 
 
1.20 31.24
 a
 
 (1.16)
 
 
29.57 
a
 
(1.17)
 
 
0.31 
DAS-SC F(1,77) = 6.10 
p = .016 
 
F(1,77) = 22.73 
p < .001*** 
F(1,77) = 18.40  
p < .001*** 
0.19 68.43
 a
 
 (3.55)
 
 
50.18
 b
 
 (3.65)
 
 
1.48 71.29
 a
 
 (3.55)
 
 
70.32
 a
 
(3.60)
 
 
0.05 
Distress F(1,77) = 1.03 
p = .314 
 
F(1,77) =   8.78 
p = .004** 
F(1,77) = 23.89  
p < .001*** 
0.24   6.62
 a
 
 (0.37)
 
 
   4.98
 b
 
  (0.38)
 
 
0.95   6.10
 a
 
 (0.37)
 
 
  6.50
a    
 (0.38)
 
 
0.24 
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Int F(1,77) =  0.59 
p = .445 
 
F(1,77) = 30.19 
p < .001*** 
F(1,77) = 30.31  
p < .001*** 
0.28   6.91
 a
 
 (0.40)
 
 
 4.65
 b
 
(0.41)
 
 
1.27   6.19
 a
 
  (0.40)
 
 
  6.19
 a
 
 (0.41)
 
 
0.00 
EDEQ-
SC 
F(1,77) = 36.69 
p < .001*** 
 
F(1,77) =   0.56 
p = .458 
F(1,77) = 31.59  
p < .001*** 
0.29   2.20 
a
 
 (0.12)
 
 
 1.73 
b 
(0.15)
 
 
0.35   2.70 
a
 
 (0.00)
 
 
 3.06
 b
 
(0.14)
 
 
0.19 
EDEQ-
WC 
F(1,77) =  7.98 
p = .006** 
 
F(1,77) = 12.26 
p = .001** 
F(1,77) = 45.47  
p < .001*** 
0.37   2.02 
a
 
 (0.10) 
 1.61 
b
 
(0.04) 
0.29   2.62
 a
 
 (0.27) 
 2.75 
b
 
(0.32) 
0.07 
EDEQ-
EC 
F(1,77) =  1.59 
p = .211 
 
F(1,77) =   0.45 
p = .506 
F(1,77) =   0.74 
p = .392 
0.01   0.94 
a
 
 (0.19) 
 0.81
a
 
(0.09) 
0.12   1.19
 a
 
 (0.14) 
  1.21 
a
 
 (0.29) 
0.01 
EDEQ-
res 
F(1,77) =  8.75 
p = .004** 
 
F(1,77) =   6.67 
p = .012* 
F(1,77) =   2.18  
p = .143 
0.03   1.08 
a
 
 (0.14) 
 0.76 
b
 
(0.02) 
0.26   1.92
 a
 
  (0.26) 
  1.83
 a
 
 (0.37) 
0.05 
EDEQ-
total 
F(1,77) =  9.38 
p = .003** 
 
F(1,77) =   3.42 
p = .068 
F(1,77) = 11.66  
p = .001** 
0.13   1.56
 a
 
  (0.14)
 
 
 1.23 
b
 
 (0.08)
 
 
0.30   2.11 
a
 
 (0.17)
 
 
  2.21 
a
 
 (0.28)
 
 
0.06 
BDI-II F(1,73) =  5.73 
p = .019* 
 
F(1,73) =157.48 
p < .001*** 
F(1,73) = 38.00  
p < .001*** 
0.34  17.45
 a
 
  (1.14)
 
 
10.40 
b
 
 (0.82)
 
 
0.74 18.59 
a
 
 (1.40)
 
 
16.19 
b
 
 (0.72)
 
 
0.22 
DASS-
dep 
F(1,77) =  0.10  
p = .753 
 
F(1,77)  =   8.91   
p = .004** 
F(1,77) =   1.04  
p = .310 
0.01  15.43
 a
 
  (1.64) 
  9.98
 b
 
 (0.09) 
0.61 13.52
 a
 
 (2.51) 
10.85
 a
 
 (0.41) 
0.30 
DASS-
anxiety 
F(1,77) =  0.30 
p = .585 
 
F(1,77) = 12.58 
p=.001** 
F(1,77) =  1.94  
p =.168 
0.03  12.10
 a
 
  (1.01)
 
 
  7.33 
b
 
 (1.51)
 
 
0.56 11.62 
a
 
 (1.90)
 
 
  9.54
 a
 
 (0.03)
 
 
0.25 
DASS-
stress 
F(1,77) =  1.66 
p = .202 
F(1,77) = 13.42 
p < .001*** 
F(1,77) =  2.74 
 p = .102 
0.03  23.33
 a
 
  (1.98) 
15.67 
b
 
 (2.06) 
0.95 24.10 
a
 
 (1.98)
 
 
21.20
 b
 
 (2.02)
 
 
0.29 
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FNEB F(1,52) = 0.90  
p = .347 
 
F(1,52) = 17.13  
p < .001*** 
F(1,52) =   7.12  
p = .010* 
.12  50.41
 a
 
  (4.04) 
40.18
 b
 
 (4.03) 
1.38 51.65 
a
 
 (4.07) 
49.44 
a
 
 (4.07) 
0.25 
ASI-3 F(1,53) = 0.00 
p = .992 
 
F(1,53) = 14.35 
p < .001*** 
F(1,53) =   5.03 
p =.029* 
.09 27.49
 a
 
  (4.72) 
22.37
 b
 
 (5.75)
 
 
0.43 25.64
 a
    
 (1.78) 
24.32
 a
 
 (0.42) 
0.09 
OCI-R F(1,45) = 1.25 
p = .270 
 
F(1,45) = 42.39 
p < .001*** 
F(1,45) =   1.28 
p =.264 
.03   22.84
a
    
  (0.78) 
16.86 
b
 
 (1.65) 
0.50 23.48
 a
 
 (1.26) 
19.27
b
   
 (0.04) 
0.30 
PSWQ F(1,77) = 2.63 
p = .109 
 
F(1,77) = 16.36 
p < .001*** 
F(1,77) =   2.35  
p = .129 
.03  65.10
 a
 
  (2.69) 
59.95 
b
 
 (1.24) 
0.57 66.91
 a
 
  (0.88) 
64.59
 b
 
 (0.25) 
0.21 
RSES F(1,77) = 3.10 
p = .082 
 
F(1,77) = 12.32 
p = .001** 
F(1,77) = 13.46 
p < .001*** 
.15  25.05 
a
 
  (0.44) 
28.44 
b
 
 (0.36) 
1.03 25.81 
a
 
 (0.80) 
25.73 
a
 
 (0.30) 
0.01 
QLESQ F(1,77) = 0.03 
p = .868 
 
F(1,77) =  1.19 
p = .279 
F(1,77) =   5.70  
p = .019* 
.07    3.20 
a
 
  (0.16)
 
 
  3.48
 b
 
 (0.16)
 
 
0.43   3.36
 a
 
 (0.16) 
  3.25 
a
 
 (0.16) 
0.13 
Note. Change in subscript denotes a significant change between baseline and post-treatment/post-waitlist. Partial η2 = partial eta squared; CM = Concern over Mistakes  
subscale of the Frost Multidimensional Perfectionism Scale (FMPS); PS = Personal Standards subscale of the FMPS; DA = Doubts about Actions subscale of the FMPS;  
CPQ = Clinical Perfectionism Questionnaire; DAS-SC = Dysfunctional Attitudes Scale-Self-Criticism; Distress = Rating of Distress of perfectionism; Interference: Rating of  
interference from perfectionism; EDEQ-sc = Shape Concerns subscale of the Eating Disorder Examination Questionnaire (EDEQ); EDEQ-wc = Weight Concerns subscale of  
the EDEQ; EDEQ-EC = Eating Concern subscale of the EDEQ; EDEQ-res = Restraint subscale of the EDEQ; EDEQ-total = EDEQ total score; BDI-II = Beck Depression  
Inventory-II; DASS-dep = Depression subscale of the Depression, Anxiety and Stress Scale-21 (DASS-21); DASS-anx = Anxiety subscale of the DASS-21; DASS-stress  
= Stress subscale of the DASS-21; FNE-B= Brief Fear of Negative Evaluation Scale; ASI-3 = Anxiety Sensitivity Index-3; OCI-R = Obsessive-Compulsive Inventory- 
Revised; PSWQ = Penn State Worry Questionnaire; RSES= Rosenberg Self-Esteem Scale; Q-LES-Q-18 = Quality of Life Enjoyment and Satisfaction Questionnaire-18.  
* p < .05.  ** p < .01. *** p < .001. 
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3.9.7. Comparison of the Treatment and Treated Control Groups 
After the waitlist control group received group CBT-CP their pattern of change 
was compared to that of the treatment group. As reported in Table 11, comparisons 
between the treated control group and treatment group across the four assessments (pre-
treatment, post-treatment, 3-month follow-up and 6-month follow-up) revealed a non-
significant Group x Time interaction for each outcome measure. This suggested that the 
treated control group and treatment group showed comparable time-related changes on 
all outcomes, which was consistent with the groups demonstrating comparable 
responses to the group CBT-CP treatment.  
3.9.8. Maintenance of Changes at 3-Month and 6-Month Follow-ups 
As the treated control and treatment groups demonstrated a comparable pattern 
of change over time on all outcomes, the sample was analysed as a whole to increase 
statistical power (Tabachnick & Fidell, 2007). As seen in Table 11, there were 
significant main effects of time across the four assessments (pre-treatment, post-
treatment, 3-month follow-up and 6-month follow-up) for all perfectionism outcomes, 
depression (BDI-II), total eating disorder pathology, shape concerns, weight concerns, 
social anxiety, anxiety sensitivity, self-esteem and quality of life. As seen in Table 12, 
post-hoc LSD contrasts indicated significant pre-post decreases for all perfectionism 
outcomes, depression (BDI-II), total eating disorder pathology, shape concerns, weight 
concerns, social anxiety and anxiety sensitivity; as well as significant pre-post increases 
for self-esteem and quality of life.  Post-hoc LSD contrasts also indicated that the 
changes in each outcome variable remained significant between pre-treatment and 3-
month follow-up, as well as between pre-treatment and 6-month follow-up. This was 
consistent with all changes being maintained at 3-month and 6-month follow-ups. 
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Table 11. 
Table of Effects and Adjusted Means (Standard Errors) for the Entire Sample at Pre-treatment, Post-treatment, 3-month Follow-up and 6-month 
Follow-up. 
Measure Group effect Time effect Group x Time 
effect 
Partial 
Eta
2
  
Pre-tx Post-tx 3-month 
follow-up 
6-month 
follow-up 
CM F(1,139) = 0.07 
p = .798 
 
F(3,139) = 25.27 
p < .001*** 
F(3,139) = 0.27 
p = .844 
.01 33.51  
(1.23) 
26.42      
(1.27) 
26.47  
(1.27) 
25.54  
(1.29) 
PS F(1,139) = 0.02 
p = .901 
 
F(3,139) = 14.22 
p < .001*** 
F(3,139) = 0.33 
p = .807 
.01 28.70 
(0.71) 
25.71    
(0.74) 
25.51 
(0.70) 
25.67  
(0.75) 
DA F(1,139) = 0.04 
p = .835 
 
F(3,139) = 17.80 
p < .001*** 
F(3,139) = 0.68 
p = .566 
.01 15.82  
(0.51) 
13.75  
(0.53) 
12.90
 
  
(0.54) 
12.57  
(0.55) 
CPQ F(1,139) = 1.19 
p = .278 
 
F(3,139) = 20.52 
p < .001*** 
F(3,139) = 0.95 
p = .420 
.02 30.82  
(0.85) 
25.97 
(0.89) 
24.98 
(0.89) 
24.93  
(0.91) 
DAS-SC F(1,139) = 0.14 
p = .713 
 
F(3,139) = 32.75 
p < .001*** 
F(3,139) = 0.79 
p = .500 
.02 70.11  
(2.77) 
53.28   
(2.85) 
53.28 
(2.85) 
51.72  
(2.89) 
Dis F(1,139) = 0.84 
p = .362 
 
F(3,139) = 32.55 
p < .001*** 
F(3,139) = 1.22 
p = .304 
.03   6.56  
 (0.25) 
  4.98  
 (0.27) 
  4.17 
 (0.27) 
  4.37  
 (0.27) 
Int F(1,139) = 0.67 
p = .413 
 
F(3,139) = 31.48 
p < .001*** 
F(3,139) = 2.47 
p = .064 
.05   6.55 
 (0.28) 
  4.91  
 (0.30) 
  3.78
 
 
 (0.30) 
  4.13  
  (0.31) 
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BDI-II F(1,136) = 0.30 
p = .583 
F(3,136) = 14.51 
p < .001*** 
F(3,136) = 2.38 
p =.072 
.05 16.81  
(1.70) 
10.46   
(1.59) 
  8.32  
 (1.29) 
 8.73 
(1.40) 
         
EDEQ-sc F(1,139) = 2.22 
p = .138 
F(3,139) =  7.59 
p < .001*** 
F(3,139) = 0.44 
p = .726 
.01   2.68  
(0.27) 
  2.15  
 (0.27) 
  1.87  
 (0.26) 
 1.83  
(0.24) 
 
EDEQ-
wc 
F(1,139) = 2.00 
p = .159 
F(3,139) =  6.75 
p < .001*** 
F(1,139) = 2.08 
p = .105 
.04   2.44
 
 
 (0.27) 
  2.02
 
 
 (0.25) 
  1.73
 
  
 (0.27) 
 1.66   
(0.24) 
 
EDEQ-
total 
F(1,139) = 2.37 
p = .126 
F(3,139) =  8.12 
p < .001*** 
F(3,139) = 1.27 
p = .288 
.03   1.93  
 (0.22) 
  1.57  
 (0.22) 
  1.31  
 (0.21) 
 1.18  
(0.16) 
 
FNE-B F(1,93)  =  0.00 
p = .988 
F(3,93)  = 11.17 
p < .001*** 
F(3, 93)  = 0.67 
p = .571 
.02 49.41  
(2.55) 
41.82 
(2.60) 
40.75 
 (2.62) 
41.08 
(2.62) 
 
ASI-3 F (1,97) =  0.92 
p = .340 
 
F (3,97) =   9.43 
p < .001*** 
F(3,97)  = 0.72 
p = .540 
.02 24.90
 
 
(2.39) 
17.91
 
 
(2.12) 
16.55
 
 
 (1.61) 
15.20
 
 
(1.68) 
RSES F(1,139) = 0.00 
p = .986 
F(3,139) = 20.57 
p < .001*** 
F(3,139) = 2.53 
p =.060 
.05 25.42
 
 
(0.61) 
27.48
 
  
(0.62) 
28.82
 
  
 (0.69) 
29.44 
(0.78) 
 
QLES-Q F(1,139) = 0.33 
p = .569 
F(3,139) = 12.25 
p < .001*** 
F(3,139) = 0.21 
p =.890 
.00   3.23  
 (0.13) 
  3.53  
 (0.13) 
  3.73  
 (0.13) 
  3.70  
 (0.14) 
Note. Change in subscript for a variable denotes that a significant change occurred. Pre-tx = pre-treatment; Post-tx = post-treatment; CM = Concern over Mistakes subscale  
of the Frost Multidimensional Perfectionism Scale (FMPS); PS = Personal Standards subscale of the FMPS; DA = Doubts about Actions subscale of the FMPS; CPQ =  
Clinical Perfectionism Questionnaire; DAS-SC = Dysfunctional Attitudes Scale-Self-Criticism; Distress = Rating of Distress caused by perfectionism; Interference = Rating  
of interference caused by perfectionism; BDI-II = Beck Depression Inventory-II; EDEQ-sc = Shape Concerns subscale of the Eating Disorder Examination Questionnaire  
(EDEQ);  EDEQ-wc = Weight Concerns subscale of the EDEQ; EDEQ-total = EDEQ total score; FNE-B= Brief Fear of Negative  Evaluation Scale; ASI-3 = Anxiety  
Sensitivity Index-3; RSES= Rosenberg Self-esteem Scale; Q-LES-Q-18 = Quality of Life Enjoyment and Satisfaction Questionnaire-18.  
* p < .05  ** p < .01 *** p < .001 
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Table 12. 
Significance of Change and Effect Sizes between Pre-treatment and Post-treatment, Pre-treatment and 3-month Follow-up, and Pre-treatment 
and 6-month Follow-up for the Entire Sample. 
Measure Pre- to post-treatment 
change 
Cohen’s 
d 
Pre-treatment to 3-month 
follow-up 
Cohen’s 
d 
Pre-treatment to 
 6-month follow-up 
Cohen’s d 
CM t(139) = 6.78, p < .001***  1.13 t(139) =-6.73, p < .001*** 1.08 t(139) = 7.45, p < .001*** 1.13 
PS t(139) = 5.17, p < .001***  0.66 t(139) = 5.51, p < .001*** 0.67 t(139) = 5.11, p < .001*** 0.66 
DA t(139) = 4.43, p < .001***  0.76 t(139) = 5.98, p < .001*** 0.97 t(139) = 6.51, p < .001*** 1.10 
CPQ t(139) = 5.53, p < .001***  0.99 t(139) = 6.65, p < .001*** 1.07 t(139) = 6.56, p < .001*** 1.02 
DAS-SC t(139) = 7.81, p < .001***  1.07 t(139) = 7.81, p < .001*** 1.02 t(139) = 8.34, p < .001*** 1.07 
Distress t(139) = 5.88, p < .001***  0.98 t(139) = 8.89, p < .001*** 1.55 t(139) = 7.97, p < .001*** 1.32 
Interference t(139) = 5.28, p < .001***  0.89 t(139) = 8.90, p < .001*** 1.56 t(139) = 7.63, p < .001*** 1.31 
EDEQ-sc t(139) = 3.28, p = .001**  0.30 t(139) = 4.19, p < .001*** 0.48 t(139) = 4.53, p < .001*** 0.54 
EDEQ-wc t(139) = 2.63, p= .010** 0.25 t(139) = 4.31, p < .001*** 0.40 t(139) = 4.00, p < .001*** 0.47 
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BDI-II t(136) = 3.70,p < .001*** 0.63 t(136) = 5.93, p < .001*** 0.88 t(136) = 5.80,  p< .001*** 0.85 
EDEQ-total t(139) = 2.81, p = .006** 0.25 t(139) = 3.86, p < .001*** 0.44 t(139)  = 4.93,  p< .001*** 0.62 
FNE-B t( 93)  = 4.36, p < .001*** 0.84 t( 93)  = 4.89, p < .001*** 0.83 t (93)   = 4.70  p< .001*** 0.94 
ASI-3 t(97)  =  3.89, p < .001*** 0.55 t( 97)  = 4.16, p < .001*** 0.72 t (97)   = 5.23, p< .001*** 0.82 
RSES t(139) =-3.38, p = .001** 0.52 t(139) =-6.88, p< .001*** 0.82 t(139)  =-6.86, p< .001*** 0.92 
Q-LES-Q t(139) =-3.17, p = .002** 0.40 t(139) =-5.43, p <.001*** 0.68 t(139)  =  4.96,p< .001*** 0.58 
Note. CM = Concern over Mistakes subscale of the Frost Multidimensional Perfectionism Scale (FMPS); PS = Personal Standards subscale of the FMPS; DA = Doubts about  
Actions subscale of the FMPS; CPQ = Clinical Perfectionism Questionnaire; DAS-SC = Dysfunctional Attitudes Scale-Self-Criticism; Distress = Distress of perfectionism;  
Interference = Interference from perfectionism; BDI-II = Beck Depression Inventory-II; EDEQ-sc = Shape Concerns subscale of the Eating Disorder Examination   
Questionnaire (EDEQ); EDEQ-wc: Weight Concerns subscale of the EDEQ; EDEQ-total= EDEQ total score; FNE-B= Brief Fear of Negative Evaluation Scale; ASI-3 =  
Anxiety Sensitivity Index-3; RSES = Rosenberg Self-esteem Scale; Q-LES-Q-18 = Quality of Life Enjoyment and Satisfaction Questionnaire-18.  
* p < .05  ** p < .01 *** p < .001 
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3.9.9. Reliable Change 
Table 13 displays the number and percentage of individuals from the 
intervention condition and the waitlist control condition (prior to the waitlist control 
participants receiving group CBT-CP) who experienced reliable change on the outcome 
variables. This table also displays the number and percentage of individuals from the 
treated control group who experienced reliable change on the outcome variables. 
Fisher’s exact 1-sided tests indicated that a significantly greater proportion of 
participants in the group CBT-CP condition demonstrated reliable change in dimensions 
of perfectionism (CM, DA, DAS-SC), shape concerns (EDEQ-sc), self-esteem (RSES) 
and quality of life (Q-LES-Q) compared to the waitlist control condition. Fisher’s exact 
1-sided tests indicated that once those from the waitlist control group received group 
CBT-CP, there were no longer significant differences between conditions in the 
proportion of participants exhibiting reliable change on these outcomes. Thus, 
individuals from the treated control group made comparable gains to individuals from 
the treatment group on these outcomes. The last four columns in Table 13 display the 
number and percentage of participants from the entire sample who experienced reliable 
change on the outcome measures immediately after receiving group CBT-CP and at 6-
month follow-up. 
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Table 13. 
Number (%) of Participants in the Intervention and Control Conditions Experiencing Reliable Change at Post-treatment/Post-Waitlist,  the 
Number (%) of Participants in the Treated Control Condition Experiencing Reliable Change After Treatment, and the Number (%) of 
Participants from the Entire Sample  Experiencing Reliable Change After Treatment. 
Measure Treatment 
(n = 19) 
Control 
(n = 20) 
Fisher’s   
exact test  
(1-sided) 
Treated Control 
(n = 17) 
Fisher’s   
exact test  
(1-sided) 
Entire sample after 
group CBT-CP 
(n=36) 
Entire sample at 6-
month follow-up 
(n=34) 
 ↓ n, % ↑ n, % ↓n, % ↑ n, % ↓n, % ↑ n, %  ↓n, %      ↑ n, % ↓n, % ↑ n, % 
CM 12 (63%)
a
 0 (0%) 1   (5%) 1   (5%) p < .001***   9 (53%) 0  (0%) p = .736 21 (58%) 0 (0%) 18 (53%)   0 (0%) 
PS   7 (37%) 0 (0%) 3 (15%) 0   (0%) p = .116   7 (41%) 1  (6%) p = 1.00 14 (39%) 1 (3%) 11 (32%)   1 (3%) 
DA   6 (32%) 0 (0%) 1   (5%) 3 (15%) p = .044*   6 (35%) 1  (6%) p = 1.00 12 (33%) 1 (3%) 15 (44%)   0 (0%) 
CPQ   7 (37%) 0 (0%) 3 (15%) 0   (0%) p = .155   4 (24%) 1  (6%) p =.481 11 (31%) 1 (3%) 10 (29%)   0 (0%) 
DAS-SC 12 (63%) 0 (0%) 2 (10%) 1   (5%) p = .001** 11 (65%) 1  (6%) p = 1.00 23 (64%) 1 (3%) 19 (56%)   0 (0%) 
BDI-II
 b
   6 (35%) 1 (6%) 3 (17%) 2 (11%) p = .192  5 (29%) 1  (6%) p = 1.00 11 (31%) 2 (6%) 14 (44%)   0 (0%) 
EDEQsc   4 (21%) 1 (5%) 0   (0%) 1   (5%) p = .047*  3 (18%) 0  (0%) p = 1.00   7 (19%) 1 (3%)   7 (21%)   0 (0%) 
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EDEQwc   3 (16%) 0 (0%) 0   (0%) 0   (0%) p = .106  1   (6%) 0  (0%) p = .345   4 (11%) 0 (0%)   6 (18%)   0 (0%) 
EDEQtot   5 (26%) 2 (11%) 1   (5%) 0   (0%) p = .080   4 (24%) 0   (0%) p = .577   9 (25%) 2 (6%) 13 (38%)   0 (0%) 
FNE-B
 b 
   9 (69%) 0   (0%) 5 (38%) 3 (23%) p = .119   4 (36%) 0   (0%) p = .115 13 (36%) 0 (0%) 16 (70%)   2 (9%) 
ASI-3
 b 
   2 (17%) 0   (0%) 3 (20%) 2 (13%) p = .612   3 (23%) 0   (0%) p = .541   5 (14%) 0 (0%)  7  (29%)   0 (0%) 
QLESQ
c
    1   (5%) 5 (26%) 2 (10%) 0   (0%) p = .020*   2 (12%) 4 (24%) p = 1.00   3 ( 8%) 9(25%)  1   (3%) 15 (44% 
RSES
c
   1   (5%) 8 (42%) 1   (5%) 0   (0%) p = .001**   1   (6%) 2 (12%) p = .065   2 ( 6%) 10(28%)  0   (0%) 14(41%) 
Note.  ↓ n %: the number and percentage of participants experiencing a reliable decrease on an outcome variable; ↑ n, %: the number and percentage of participants 
experiencing a reliable increase on an outcome variable;  CM = Concern over Mistakes subscale of the Frost Multidimensional Perfectionism Scale (FMPS); PS = Personal 
Standards subscale of the FMPS; DA = Doubts about Actions subscale of the FMPS; CPQ = Clinical Perfectionism Questionnaire; DAS-SC = Dysfunctional Attitudes Scale- 
Self-Criticism; BDI-II = Beck Depression Inventory-II; EDEQ-sc = Shape Concerns subscale of the Eating Disorder Examination Questionnaire (EDEQ); EDEQ-wc: Weight 
Concerns subscale of the EDEQ; EDEQ-total = EDEQ total score; FNE-B= Brief Fear of Negative Evaluation Scale; ASI-3 = Anxiety Sensitivity Index-3; Q-LES-Q-18 = 
Quality of Life Enjoyment and Satisfaction Questionnaire-18; RSES: Rosenberg Self-esteem Scale.  
a Percentages are rounded.  
b BDI-II: n = 17 in treatment condition, n = 18 in control condition; n = 17 in treated control condition; n = 34 total who received treatment; n = 32 at 6-month follow-up  
   FNE-B: n = 13 in treatment condition, n =13 in control condition; n = 11 in treated control condition; n = 24 total who received treatment; n = 23 at 6-month follow-up 
   ASI-3:  n = 12 in treatment condition, n = 15 in control condition; n = 13 in treated control condition; n = 25 total who received treatment; n = 24 at 6-month follow-up 
c An increase in score suggests an improvement. 
* p < .05.  ** p < .01. *** p < .001 
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3.9.10. Clinically Significant Change in Perfectionism 
Table 14 displays the number and percentage of individuals from the 
intervention and waitlist control condition classified as recovered, improved, 
unchanged and deteriorated based on their change in CM and CPQ scores between 
baseline and post-treatment/post-waitlist (Hageman & Arrindell, 1999). In regard to 
CM, Fisher’s exact 1-sided tests indicated that a significantly greater proportion of 
participants from the group CBT-CP condition were deemed recovered compared to 
the waitlist control condition.  A significantly greater proportion of participants from 
the waitlist control condition were deemed unchanged compared to the group CBT-
CP condition. Fisher’s exact 1-sided tests revealed that once the waitlist control 
group received group CBT-CP, the conditions no longer significantly differed in the 
proportion of participants deemed recovered or unchanged on the CM outcome 
variable. Therefore, the treated control group made similar clinically significant 
improvements in CM to the treatment group following group CBT-CP.  
In regard to CPQ scores, Fisher’s exact 1-sided tests indicated that there were 
no significant differences between the group CBT-CP condition and waitlist control 
condition in the proportion of individuals deemed recovered, improved, unchanged 
or deteriorated. Once the waitlist control group received the group CBT-CP, there 
were still no significant differences between the treated control group and treatment 
group in the proportion of individuals classified as recovered, improved, unchanged 
or deteriorated on the CPQ outcome variable. 
Once the entire sample had received group CBT-CP, the total percentages of 
participants deemed to be recovered, improved, unchanged and deteriorated based on 
their CM and CPQ scores at post-treatment and 6-month follow-up were calculated 
(Hageman & Arrindell, 1999). These percentages are displayed in Table 15. 
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Table 14. 
Number (%) of Participants in the Intervention and Control Conditions Deemed 
Recovered, Improved, Unchanged and Deteriorated at Post-treatment/Post-waitlist 
and the Number (%) of Participants in the Treated Control Condition Deemed 
Recovered, Improved, Unchanged and Deteriorated at Their Post-treatment. 
Measure Intervention 
(n=19) 
Control 
(n = 20) 
Fisher’s 
exact test 
(1-sided) 
Treated 
Control 
(n = 17) 
Fisher’s exact 
test (1-sided) 
CM      
Recovered   6 (32%) 
  6 (32%) 
  7 (37%) 
  0  (0%) 
  0  (0%) 
  1  (5%) 
18 (90%) 
  1  (5%) 
p = .008** 2 (12%) 
7 (41%) 
8 (47%) 
0  (0%) 
p = .153 
Improved p = .039* p = .401 
No change p = .001** p = .389 
Deteriorated
 
  p = .513 p = 1.00 
CPQ      
Recovered   0   (0%)   0  (0%) p = 1.00   2 (12%) p = .216 
Improved   7 (37%)   3(15%) p = .116   2 (12%) p = .087 
No change 12 (63%) 17(85%) p = .116 12 (71%) p = 1.00 
Deteriorated   0   (0%)   0  (0%) p = 1.00   1   (6%) p = .513 
 
Note. CM = Concern over Mistakes subscale of the Frost Multidimensional Perfectionism Scale  
(FMPS); CPQ = Clinical Perfectionism Questionnaire. 
 
 * p < .05.  ** p < .01. *** p < .001 
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Table 15.  
Number (%) of Participants from the Entire Sample Deemed Recovered, Improved, 
Unchanged and Deteriorated between Pre-treatment and Post-treatment and 
between Pre-treatment and 6-month Follow-up. 
 Pre-post 
treatment  
CM (n = 36) 
Pre-treatment to  
6-month follow-up   
CM (n = 34) 
Pre-post 
treatment  
CPQ (n=36) 
Pre-treatment to  
6-month follow-up  
CPQ (n = 34) 
Recovered   8 (22%) 
13 (36%) 
15 (42%) 
  0  (0%) 
  9 (26%) 
  9 (26%) 
16 (47%) 
  0   (0%) 
  2   (6%)   5 (15%) 
Improved   9 (25%)   5 (15%) 
No change 24 (67%) 24 (71%) 
Deteriorated   1   (3%)   0   (0%) 
 
Note. CM = Concern over Mistakes subscale of the Frost Multidimensional Perfectionism Scale (FMPS); 
CPQ = Clinical Perfectionism Questionnaire. 
 
3.9.11. Clinically Significant Change in Psychological Disorders 
 
Fisher’s exact 1-sided tests indicated that a significantly higher proportion of 
participants in the group CBT-CP condition demonstrated pre-post recovery from 
depression compared to the waitlist control condition (p =.035). Significant 
differences did not emerge between the proportions of participants in the 
intervention and waitlist control condition who recovered from an eating disorder  
(p = .083), obsessive-compulsive disorder (p = .371) social phobia (p = .262) or 
generalised anxiety disorder (p = .171).  Fisher’s 1-sided tests could not be 
conducted to assess for group differences in recovery from panic disorder with or 
without agoraphobia as the waitlist control condition did not contain any participants 
who had a baseline diagnosis of panic disorder with or without agoraphobia. 
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Once participants from the waitlist control condition received group CBT-
CP, there were no longer significant differences between the treatment and treated 
control conditions in the proportions of participants who recovered from depression. 
Thus, the treated control group made comparable recovery from depression 
following group CBT-CP. Table 16 displays the total number and percentage of 
individuals with a psychological disorder at pre-treatment who recovered from their 
disorder immediately after group CBT-CP and at 6-month follow-up. Over 80 per 
cent of the individuals with a pre-treatment diagnosis of depression or obsessive-
compulsive disorder no longer met these diagnoses at post-treatment. Two thirds of 
the individuals with panic disorder with or without agoraphobia at pre-treatment no 
longer met this diagnosis at post-treatment. One third to one half of the individuals 
who had an eating disorder, social phobia or generalised anxiety disorder at pre-
treatment no longer had these diagnoses at post-treatment. At 6-month follow-up, 
over 80 per cent of the individuals with a pre-treatment diagnosis of depression, an 
eating disorder, obsessive-compulsive disorder, generalised anxiety disorder or panic 
disorder with or without agoraphobia no longer met these diagnoses. Two thirds of 
the individuals with social phobia at pre-treatment no longer had this diagnosis at 6-
month follow-up.  
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Table 16. 
Number (%) of Participants with a Disorder at Pre-treatment who Recovered from 
the Disorder at Post-treatment and at 6-month Follow-up 
Disorder n with the 
disorder at pre-
treatment  
(n, %) who 
recovered from the 
disorder at post-
treatment 
(n, %) who 
recovered from 
the disorder at 6-
month follow-up 
Depression 13 12 (92%) 11 (87%) 
Eating Disorder 10   4 (40%)   8 (80%) 
Obsessive-Compulsive 
Disorder 
  6   5 (83%)   5 (83%) 
Social Phobia   6   3 (50%)   4 (67%) 
Generalised Anxiety 
Disorder 
30 10 (33%) 24 (80%)  
Panic Disorder   3   2 (67%)   3 (100%) 
 
3.10. Discussion 
The primary aim of this study was to conduct an RCT to investigate the 
efficacy of group CBT-CP in a clinical sample. As previous RCTs have not 
examined group delivery of this intervention in a clinical sample (e.g., Riley et al., 
2007), this study uniquely contributes to the literature. A secondary aim was to 
examine whether group CBT-CP significantly increases quality of life. Previous 
perfectionism treatment trials have not included a quality of life outcome measure 
(Pleva & Wade, 2006; Riley et al., 2007; Steele & Wade, 2008). Therefore, this 
study provides unique information about whether group CBT-CP has a 
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multidimensional impact of reducing perfectionism and psychopathology, as well as 
improving quality of life.  
3.10.1. The Effect of Group CBT-CP on Dimensions of Perfectionism 
Based on group CBT-CP targeting the maintaining factors of clinical 
perfectionism (Shafran et al., 2002; Shafran et al., 2010), as well as previous 
research demonstrating that CBT-CP reduces CPQ scores and other dimensions of 
perfectionism (Riley et al., 2007; Steele et al., 2013), it was anticipated that 
participants randomised to receive group CBT-CP would display significantly 
greater reductions in all measured dimensions of perfectionism relative to 
participants in the waitlist control condition. It was also anticipated that once the 
waitlist control condition received group CBT-CP they would display comparable 
reductions in these perfectionism dimensions, and that for the entire sample these 
reductions would be maintained at 3-month and 6-month follow-ups. The current 
findings supported all hypotheses. Group CBT-CP produced reductions of moderate 
to large effect size in perfectionism as measured by CPQ, PS, CM, DA, DAS-SC, as 
well as in the distress and interference associated with perfectionism. The waitlist 
control condition made comparable gains once they received the treatment. Post-
treatment decreases in all perfectionism dimensions were maintained at 3-month and 
6-month follow-ups. These findings support group CBT-CP producing lasting 
decreases in clinical perfectionism and related dimensions of perfectionism. 
The finding of group CBT-CP producing significantly greater changes in 
CPQ scores than a waitlist control group is in line with the findings from Riley et 
al.’s (2007) RCT of individual CBT-CP. The current finding adds to the validity of 
maintenance models of clinical perfectionism (Shafran et al., 2002; Shafran et al., 
2010) by accenting that CBT targeting these maintaining factors actually leads to 
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significant reductions in clinical perfectionism. Additionally, this is the first RCT to 
demonstrate that CBT-CP produces significantly greater decreases in PS, CM, DA 
and DAS-SC scores in addition to CPQ scores than a separate waitlist control group.  
Previous RCTs have not reported significant interaction effects for perfectionism as 
assessed by the multidimensional scales and these trials did not measure DAS-SC 
(Pleva & Wade, 2008; Riley et al., 2007; Steele & Wade, 2008). As the interaction 
effects for the multidimensional perfectionism measures arose in a trial of group 
CBT-CP but not in previous trials of individual CBT-CP, it would be beneficial for 
future studies to examine whether group CBT-CP has greater efficacy than 
individual CBT-CP. This could be investigated by conducting an RCT that compares 
group CBT-CP and individual CBT-CP to a waitlist control condition. If group CBT-
CP is found to have greater efficacy than individual CBT-CP, future studies could 
examine the particular aspects of group therapy that contribute to its greater efficacy. 
For example, specific therapeutic factors proposed to occur in group but not 
individual CBT could be examined (e.g., clients experiencing inclusion, the effect of 
clients learning from other group members) to determine if these factors can 
significantly predict treatment outcome (Bieling et al., 2006; Yalom, 1995; Yalom & 
Leszcz, 2005). 
Moreover, this is the first RCT to demonstrate that CBT-CP produces 
significantly greater decreases in the interference and distress associated with 
perfectionism than a waitlist control condition. Previous RCTs have not assessed the 
impact of this intervention on these outcomes (Pleva & Wade, 2007; Riley et al., 
2007; Steele & Wade, 2008). Steele et al.’s (2013) case design study reported 
reductions in interference and distress following group CBT-CP; however, due to the 
absence of a separate control condition, Steele et al.’s (2013) findings cannot be 
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confidently attributed to group CBT-CP. The higher internal validity of the current 
RCT means that one can state with greater confidence that group CBT-CP has 
produced the current findings.  
3.10.2. The Effect of Group CBT-CP on Psychopathology and Self-Esteem 
Based on the literature of perfectionism occurring across depressive, anxiety 
and eating disorders (Egan et al., 2011) as well as the findings of Study I of this 
thesis, it was anticipated that participants receiving group CBT-CP would experience 
significantly greater reductions in a range of psychopathology symptoms relative to 
those in the waitlist control condition. Furthermore, as Shafran et al. (2002) argued 
that CBT-CP assists individuals to expand the domains upon which they base their 
self-esteem, it was anticipated that this treatment would increase self-esteem. It was 
expected that the waitlist control participants would make comparable changes in 
these outcomes after receiving group CBT-CP and that the entire sample would 
maintain these gains at the follow-ups. Consistent with predictions, participants 
receiving group CBT-CP exhibited significantly greater decreases in depression 
(BDI-II), eating disorder symptoms, social anxiety and anxiety sensitivity, as well as 
significantly greater increases in self-esteem relative to those in the waitlist control 
condition. Comparable changes on these outcomes were made after the waitlist 
control participants received group CBT-CP. For the whole sample, decreases in 
these psychological symptoms and increases in self-esteem were maintained at the 3-
month and 6-month follow-ups. Collectively, these findings provide support for 
Egan et al.’s (2011) argument of perfectionism being a transdiagnostic process by 
demonstrating that CBT targeting clinical perfectionism produces significant lasting 
effects on multiple forms of psychopathology.  
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The findings of group CBT-CP leading to decreases in depression as 
measured by the BDI-II are consistent with Riley et al.’s (2007) findings and the 
body of literature supporting the role of perfectionism dimensions in depression 
(e.g., Enns & Cox, 1999; Wheeler et al., 2011). Even so, it is intriguing why 
significant interaction effects for depression as measured by DASS-depression did 
not emerge. Such a discrepancy in findings may have arisen from differences in 
clinical sensitivity between the BDI-II and DASS-depression, which needs to be 
explored in future studies. The finding of group CBT-CP leading to reductions in 
anxiety sensitivity is in accord with Radhu et al.’s (2012) findings in a student 
sample; however, the current use of a clinical sample now enables this finding to be 
generalised to clinical populations. The current finding is also consistent with 
previous research showing perfectionism to be associated with anxiety sensitivity in 
a clinical sample (Cox et al., 2001). 
This RCT is the first to demonstrate that group CBT-CP significantly 
decreases eating disorder symptoms, social anxiety, as well as increases self-esteem. 
The significant effects of this treatment on eating disorder symptoms concurs with 
the literature highlighting the role of perfectionism dimensions in eating disorder 
pathology (e.g., Bardone-Cone et al., 2007); however, such findings differ from 
those of Steele and Wade (2008) who found that guided self-help CBT for 
perfectionism produced comparable effects on eating disorder symptoms to that of 
other treatments in the trial. This is another rationale for future studies to compare 
the efficacy of group CBT-CP to individual CBT-CP. Another reason for the 
discrepancy in findings may have been because the current study utilised a waitlist 
control condition, whereas Steele and Wade’s (2008) placebo condition of 
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dismantled mindfulness (Segal et al., 2002) was argued to have therapeutic 
components.   
The significant effect of group CBT-CP on social anxiety is unique as 
previous RCTs of perfectionism treatments have not included measures of this 
construct (Pleva & Wade, 2006; Riley et al., 2007; Steele & Wade, 2008). The 
current findings are in accordance with previous studies highlighting the role of 
perfectionism dimensions in social anxiety (Juster et al., 1996; Lundh & Ost, 2001; 
Saboonchi et al., 1999). The significant effects of group CBT-CP on self-esteem 
have not been reported, as in Steele and Wade’s (2008) study such effects did not 
emerge. This may have been due to the current study implementing a group 
intervention or utilising a waitlist control. The current findings of significant 
increases in self-esteem support the validity of the model of clinical perfectionism 
(Shafran et al., 2002; Shafran et al., 2010) and are consistent with the proposition 
that CBT-CP assists individuals to realise that their self-worth is not dependent on 
achievement, which translates into increases in self-esteem (Shafran et al., 2002). 
Although there were trends of group CBT-CP producing greater decreases in 
DASS-anxiety and DASS-stress than a waitlist control condition, the interaction 
effects for these outcomes were not significant. The non-significant findings for 
DASS-anxiety are in line with those of previous RCTs (Pleva & Wade, 2006; Steele 
& Wade, 2008). While Steele et al. (2013) found that participants receiving group 
CBT-CP demonstrated significant pre-post reductions in DASS-anxiety and DASS-
stress, the absence of a separate control group in this study meant that these effects 
may have occurred due to confounds such as the passage of time. The absence of 
significant interaction effects for DASS-anxiety and DASS-stress in the current 
study are unusual given the significant interaction effects demonstrated for social 
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anxiety and anxiety sensitivity.  It is possible that group CBT-CP may result in 
smaller effects for the type of anxiety captured by the DASS-anxiety scale as 
compared to social anxiety and anxiety sensitivity and that the current RCT and 
earlier RCTs (e.g., Pleva & Wade, 2006; Steele & Wade, 2008) did not have 
sufficient power to capture these effects. Another possibility is that DASS-anxiety is 
not as clinically sensitive as the FNE-B and ASI-3 (Tabachnick & Fidell, 2007). 
Future studies utilising larger samples and additional measures of anxiety are 
required to determine the effect of group CBT-CP on different aspects of anxiety. 
Nevertheless, the current findings do suggest that CBT-CP does significantly 
decrease social anxiety and anxiety sensitivity.  
 In this study, group CBT-CP tended to produce greater reductions in 
pathological worry than a waitlist control condition; however, the interaction effect 
for pathological worry was not significant. This is intriguing given that Study I of 
this thesis reported significant relationships between CM, PS, CPQ and pathological 
worry in a clinical sample. It is likely that Type II errors occurred in the current 
study. The impact of group CBT-CP on pathological worry may be smaller than the 
impact of group CBT-CP on social anxiety and anxiety sensitivity, which may have 
meant that the current sample size of 42 was not sufficient to capture this effect 
(Tabachnick & Fidell, 2007). While an alternative explanation may be that group 
CBT-CP is not a sufficient treatment for generalised anxiety disorder symptoms, this 
explanation does not fit with the current findings of recovery from a generalised 
anxiety disorder (GAD) diagnosis. Specifically, one third of the individuals with 
GAD at pre-treatment no longer met a GAD diagnosis at post-treatment, and 80 per 
cent of individuals with GAD at pre-treatment no longer met this diagnosis at 6-
month follow-up. This provides indirect evidence for reductions in GAD 
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symptomatology following group CBT-CP. Future studies utilising larger samples 
are required to clarify these findings. 
Furthermore, in this study, no significant interaction effect for obsessive-
compulsive symptoms was found. This is again puzzling given that previous studies 
have found significant relationships between CM, DA and obsessive-compulsive 
symptoms in clinical samples (Antony, Purdon, et al., 1998). The current non-
significant finding also differs from Pleva and Wade’s (2006) findings of guided 
self-help CBT for perfectionism producing greater decreases in obsessive-
compulsive symptoms than pure self-help CBT for perfectionism. Nevertheless, the 
current non-significant finding may have occurred due to composition of the current 
sample. There were small numbers of individuals with OCD in the intervention  
(n = 4) and control (n = 3) groups compared to individuals with disorders such as 
depression. This likely meant that baseline OCI-R scores were not high to begin with 
potentially creating a floor effect (Rosnow & Rosenthal, 2002). Alternatively, the 
non-significant finding may also be because group CBT-CP did not include specific 
exposure and response prevention components, which have been repeatedly shown 
to reduce OCD symptoms (Kobak, Greist, Jefferson, Katzelnick, & Henk, 1998). 
However, this latter explanation does not fit with the current findings of recovery 
from an OCD diagnosis where 83 per cent of individuals with OCD at pre-treatment 
no longer had an OCD diagnosis at post-treatment and at 6-month follow-up.  Future 
studies utilising larger samples are needed to clarify these findings.  
3.10.3. The Effect of Group CBT-CP on Quality of Life 
Based on arguments of perfectionism treatments potentially decreasing 
numerous psychological disorders (Bieling, Summerfeldt, et al., 2004; Egan et al., 
2011), and findings of psychological disorders being associated with a lower quality 
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of life (Mond et al., 2004b; Pirkola et al., 2009; Rapaport et al., 2005), it was 
anticipated that participants receiving group CBT-CP would demonstrate 
significantly greater increases in quality of life scores at post-treatment compared to 
participants in the waitlist control group. It was also expected that the waitlist control 
participants would make comparable changes in quality of life scores after receiving 
group CBT-CP and that for the entire sample this increase in quality of life would be 
maintained at the 3-month and 6-month follow-ups. Results supported all 
hypotheses. This is the first RCT to report that CBT-CP produces significant 
increases in quality of life that last for at least six months. Previous RCTs of 
perfectionism treatments have not examined the impact of this treatment on quality 
of life (Pleva & Wade, 2006; Riley et al., 2007; Steele & Wade, 2008).  These 
findings uniquely contribute to the literature as they demonstrate that CBT-CP not 
only reduces perfectionism and psychological symptoms, but also enhances life 
enjoyment and satisfaction (Rapaport et al., 2005). 
3.10.4. Reliable and Clinically Significant Change 
It was anticipated that changes in perfectionism, psychopathology, self-
esteem and quality of life would not only happen at a group level but also at an 
individual level (Jacobson & Truax, 1991; Hageman & Arrindell, 1999). Consistent 
with predictions, a significantly greater proportion of individuals in the group CBT-
CP condition exhibited reliable change in CM, DA, DAS-SC, shape concerns, self-
esteem and quality of life than the waitlist control condition. These findings 
highlight that genuine changes in perfectionism, shape concerns, self-esteem and 
quality of life are produced following group CBT-CP (Jacobson & Truax, 1991). In 
comparison to Pleva and Wade’s (2006) findings, it appears that a greater proportion 
of participants exhibited reliable change in CM and DA, and a comparable 
214 
 
proportion of participants exhibited reliable change in PS after group CBT-CP 
compared to guided and pure self-help CBT; however, statistical analyses comparing 
the proportions of reliable change in the current study and in Pleva and Wade’s 
(2006) study would be needed to test this. Previous RCTs of perfectionism 
treatments have not examined whether treatment and control conditions differ in the 
proportion of individuals experiencing reliable change in DAS-SC, shape concerns, 
self-esteem or quality of life, thus the current findings contribute to the literature.  
Interestingly, there were no significant differences in the proportions of 
participants experiencing reliable change in CPQ scores, depression, social anxiety 
or anxiety sensitivity in the group CBT-CP compared to the waitlist control 
condition. The absence of a significant finding for CPQ scores was particularly 
intriguing given that the intervention targets clinical perfectionism (Shafran et al., 
2002; Shafran et al., 2010). However, these non-significant findings do not 
necessarily mean that group CBT-CP does not produce meaningful individual 
change in these outcome variables. Rather, this finding may have arisen because the 
current calculations of reliable change required the pre-intervention standard 
deviations of the outcome measures, which were large due to the use of a sample size 
of n = 42. This meant that the reliable change indices were very conservative 
(Jacobson & Truax, 1991; Tabachnick & Fidell, 2007). Future studies should 
investigate whether a significantly greater proportion of participants in a group CBT-
CP condition demonstrate reliable change relative to a control condition utilising 
larger samples or population norms. Under these circumstances, the standard 
deviation would be more accurate and thus the criteria for reliable change would be 
more realistic (Jacobson & Truax, 1991; Tabachnick & Fidell, 2007). 
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The hypothesis regarding clinically significant change in CM and CPQ was 
partially supported. Consistent with predictions, it was found that a significantly 
greater proportion of individuals in the group CBT-CP condition exhibited clinically 
significant change in perfectionism (CM) relative to the waitlist control condition. 
Once participants from the waitlist control condition received group CBT-CP, they 
demonstrated a comparable level of clinically significant change in CM to that of the 
intervention group. These findings alone suggest that group CBT-CP has assisted 
participants to shift away from a dysfunctional population defined by the presence of 
CM, which supports the efficacy of group CBT-CP (Hageman & Arrindell, 1999; 
Jacobson & Truax, 1991).  
However, inconsistent with predictions, there were no significant differences 
in the proportions of individuals experiencing clinically significant change in CPQ 
scores in the group CBT-CP condition compared to the waitlist control condition. 
Furthermore, once the entire sample had received group CBT-CP, the total 
proportions of participants who experienced clinically significant change in CM and 
CPQ scores were quite low. Clinically significant change in CM was exhibited by 22 
per cent of participants at post-treatment and 26 per cent of participants at 6-month 
follow-up. Clinically significant change in CPQ scores was exhibited by 6 per cent 
of participants at post-treatment and 15 per cent at 6-month follow-up.  
Nonetheless, it is likely that the current findings of relatively small 
proportions of participants exhibiting clinically significant change in CM and CPQ 
scores are artefacts of the very conservative cut-offs for clinical significance 
(Jacobson & Truax, 1991). Specifically, the absence of population norms for 
perfectionism meant that the cut-off utilised was two standard deviations below the 
mean of the dysfunctional population, which Jacobson and Truax (1991) 
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acknowledged can be conservative. Furthermore, in accordance with previous 
literature (Riley et al., 2007), the pre-treatment means and standard deviations of the 
current sample were utilised. Standard deviations derived from samples are typically 
larger than those derived from populations (Tabachnick & Fidell, 2007). 
Consequently, very conservative cut-offs for clinical significance were employed, 
which likely resulted in a lower number of participants being deemed clinically 
significantly changed. While significant group differences in the proportions of 
individuals experiencing clinically significant change in CM still emerged, the 
conservative cut-offs may explain the non-significant group differences in the 
proportions of individuals experiencing clinically significant change in CPQ scores. 
It also may explain the relatively small proportions of individuals from the entire 
sample who experienced clinically significant change in CM and CPQ scores 
(Jacobson & Truax, 1991). 
Previous perfectionism treatment trials in clinical samples have not 
calculated clinically significant change on the multidimensional perfectionism 
measures (Riley et al., 2007; Steele & Wade, 2008). Steele et al.’s (2013) case 
design study found higher percentages of clinically significant change in CPQ scores 
(21 per cent at post-treatment and 32 per cent at 3-month follow-up) than in the 
current study; however, this may have arisen due to differences in the standard 
deviations across samples creating different cut-off points for clinical significance 
across studies (Jacobson & Truax, 1991). Riley et al. (2007) calculated clinical 
significance in terms of change in scores on the CPE and found that 75 per cent of 
participants experienced clinically significant change. While this percentage is 
higher than the percentages reported in the current study, the clinically significant 
change documented in Riley et al.’s (2007) study was in a different measure that 
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only has moderate convergent validity (r = .57) with the CPQ (Riley et al., 2007). 
Furthermore, Riley et al.’s (2007) sample had a higher mean CPQ score at baseline 
than the current study and likely differed in its standard deviation, thus caution is 
needed in comparing findings. Future studies need to calculate clinical significance 
once population norms for perfectionism have been established (Jacobson & Truax, 
1991).  
The hypothesis regarding recovery from psychological disorders was 
partially supported. A significantly greater proportion of participants in the group 
CBT-CP condition demonstrated recovery from depression at post-treatment 
compared to the waitlist control condition. Once those from the waitlist group 
received group CBT-CP, they made a comparable level of recovery from depression 
to that exhibited by the treatment group. These findings suggest that group CBT-CP 
results in individuals no longer meeting a diagnosis of depression, even though the 
intervention did not directly focus on the symptoms of depression. This is a novel 
finding as there is limited research highlighting this effect. Pleva and Wade (2006) 
and Steele and Wade (2008) did not examine change in diagnoses in their RCTs. 
While Riley et al. (2007) found that individuals had a decreased number of diagnoses 
following individual CBT-CP, they did not specify whether it was a reduction in 
participants’ anxiety disorder or depression diagnoses.  
While a greater number of individuals from the group CBT-CP condition 
tended to recover from their eating disorders and anxiety disorders compared to the 
waitlist control condition, these differences were not significant. Nevertheless, these 
findings do not necessarily mean that group CBT-CP does not lead to a recovery 
from these disorders. Rather, these findings may be an artefact of the small numbers 
of participants with certain diagnoses in each condition as well as the DSM-IV-TR 
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(APA, 2000) criteria for disorder diagnosis. The number of participants with 
diagnoses of obsessive-compulsive disorder, social phobia and an eating disorder in 
each condition were lower than the number of participants with depression per 
condition, thus there may not have been sufficient power for these effects to be 
detected.  The non-significant differences in the proportions of individuals 
recovering from eating disorders and generalised anxiety disorder between 
conditions may also be due to the DSM-IV-TR (APA, 2000) diagnostic criteria for 
these disorders. A diagnosis of an eating disorder is based on the presence of 
symptoms over the most recent three months, whereas a diagnosis of generalised 
anxiety disorder is based on the presence of symptoms over the past six months. 
Thus, it was difficult for clients to no longer meet these latter two diagnoses over an 
eight week period even if they had benefitted from group CBT-CP (DSM-IV-TR; 
APA, 2000). As the design of the study was such that participants originally in the 
waitlist control condition then received group CBT-CP, one was not able to see if 
significant differences emerged between the intervention and control condition over 
longer periods of time.  
Even so, there is indirect evidence to support participants no longer meeting 
depressive, anxiety and eating disorder diagnoses following participating in group 
CBT-CP. For the entire sample, high percentages of individuals with pre-treatment 
diagnoses of depression, social phobia, obsessive-compulsive disorder and panic 
disorder with or without agoraphobia no longer met their diagnoses at post-
treatment. While post-treatment recovery from eating disorders and generalised 
anxiety disorder were lower than the other disorders, this was likely due to the DSM-
IV-TR (APA, 2000) criteria for these disorders as discussed above. The percentages 
of recovery from all psychological disorders were high six months after receiving 
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group CBT-CP. Overall, these findings are consistent with group CBT-CP being 
associated with recovery from psychological disorders and concur with the literature 
of perfectionism being a transdiagnostic process (Egan et al., 2011). Nonetheless, 
due to the waitlist control participants receiving the group CBT-CP after eight 
weeks, one cannot discount that these latter findings emerged due to the passage of 
time (Tabachnick & Fidell, 2007). Future studies need to incorporate a design where 
participants in the waitlist condition remain on the waitlist for a slightly longer 
duration to see if significant group differences in recovery occur. 
3.10.5. Strengths of this Study 
There are a number of strengths of this study. An RCT design was utilised 
and the sample size was sufficient to detect moderate to large treatment effects. 
Furthermore, all measures had high internal consistency and validity. Together, these 
features ensured that the study had high internal validity (Chambless & Hollon, 
1998; Faul et al., 2007). Additionally, all psychologists were trained in administering 
the CBT-CP treatment protocol (Shafran et al., 2010) and closely adhered to this 
protocol when administering the treatment. GLMM was utilised for analyses of 
statistically significant change, which presents numerous advantages over traditional 
statistical techniques (Holden et al., 1998). In addition to statistically significant 
change, reliable and clinically significant change were calculated, which is important 
when evaluating the efficacy of an intervention (Chambless & Hollon, 1998; 
Jacobson & Truax, 1991; Hageman & Arrindell, 1999).  
3.10.6. Limitations of this Study 
The limitations of this study require discussion. It was important for ethical 
reasons to have a design where participants who had been in the waitlist control 
condition received group CBT-CP after eight weeks. This meant that the active 
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intervention condition could only be directly compared to the waitlist control 
condition at post-treatment, which limited assessment of whether the group CBT-CP 
condition still significantly differed from the waitlist control condition at 6-month 
follow-up.  
Additionally, the current design compared an active intervention (group 
CBT-CP) to a waitlist control condition but did not have an active treatment 
comparison condition.  Researchers have argued that this design provides 
information about whether the treatment works (Chambless & Hollon, 1998), or at 
least does no harm compared to if participants received no treatment at all 
(Lilienfeld, 2007). Nonetheless, one still cannot discount that the effects of group 
CBT-CP emerged from participants’ expectations of change or the impact of 
receiving attention from the therapist (Chambless & Hollon, 1998). Future studies 
need to conduct RCTs that compare group CBT-CP to another active treatment 
condition and a waitlist control condition. If group CBT-CP demonstrates superiority 
to another active treatment condition and a waitlist control condition, it would be 
classed as efficacious and specific (Chambless & Hollon, 1998). If this other active 
treatment condition was a disorder-specific treatment, this would provide 
preliminary evidence to support group CBT-CP being utilised as a first line 
treatment for individuals presenting with that disorder (Egan et al., 2012). 
Other limitations require discussion. As the primary researcher (Handley) 
conducted all assessments and therapy groups, it was not possible for the primary 
researcher to be blind to participants’ randomisation condition when conducting the 
post-treatment, post-waitlist and follow-up assessments. This may have introduced 
bias into the data (Tabachnick & Fidell, 2007). Moreover, having the primary 
researcher conduct the post-treatment assessments may have increased the likelihood 
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of participants who had just received the active intervention responding in such a 
way as to please their therapist. This is likely in this sample given clinical reports of 
individuals with perfectionism aiming to be a perfect client in a therapy context (e.g., 
Hirsch & Hayward, 1998). Future studies need to utilise assessors who are blind to 
participants’ randomisation condition.  
While the current sample included individuals who had diverse psychological 
disorders, the majority of individuals presented with a principal diagnosis of GAD, 
with smaller numbers of participants with diagnoses of obsessive-compulsive 
disorder, social phobia and panic disorder with or without agoraphobia. Future 
research needs to utilise samples with a greater diversity of psychological disorders 
to better enable findings to be generalised to these populations. Finally, the absence 
of population norms for perfectionism variables meant that very conservative clinical 
cut-offs were utilised. Future studies need to calculate population norms for 
perfectionism variables and then calculate the cut-offs for clinical significance on the 
basis of these norms (Jacobson & Truax, 1991). 
3.10.7. Conclusions 
Taking into account all of the findings of this RCT, group CBT-CP has been 
shown to significantly decrease multiple dimensions of perfectionism, numerous 
psychological symptoms, as well as increase self-esteem and quality of life, with 
treatment gains lasting for at least six months. There was support for reliable change 
in CM, DA, DAS-SC, eating disorder symptoms, self-esteem and quality of life, as 
well as some clinically significant change in CM and recovery from psychological 
disorders. This is the first study to contribute toward establishing the efficacy of 
group CBT-CP (Chambless & Hollon, 1998). The findings of this study have 
significant clinical implications.  Given the high prevalence of diagnostic co-
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morbidity in community samples (Kessler, Chiu, et al., 2005), if psychologists can 
administer this transdiagnostic treatment instead of consecutively treating a client’s 
psychological disorders, this could result in substantial time savings for the 
psychologist and the client, as well as decreased cost for the client (Craske, 2012; 
Egan et al., 2012). Furthermore, administering this treatment in a group format could 
bestow additional time and cost savings (APS, 2013; Himle et al., 2003), as well as 
potential therapeutic benefits relative to individual administration of this treatment 
(Bieling et al., 2006; Yalom, 1995; Yalom & Leszcz, 2005). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
223 
 
CHAPTER 4 
 General Discussion 
4.1. Overview 
This thesis presented two linked studies that aimed to increase the knowledge 
of perfectionism and how it can be treated. This chapter provides a summary of the 
major findings of each study, how these findings uniquely contribute to the literature 
and the implications of these findings. The strengths and limitations of this research 
are discussed. Directions for future research are outlined prior to the conclusion. 
4.2. Major Findings, Unique Contributions and Implications 
4.2.1. Major findings of Study I. The first aim of Study I was to investigate 
the relationships between perfectionism dimensions and pathological worry in 
individuals with elevated perfectionism and generalised anxiety disorder (GAD) who 
presented for perfectionism treatment. The second aim was to investigate whether 
perfectionism dimensions can significantly predict a principal diagnosis of GAD in a 
larger clinical sample with elevated perfectionism and a range of diagnoses who 
presented for perfectionism treatment. This study was an important precursor to 
Study II as it provided a rationale for Study II to examine whether group CBT for 
clinical perfectionism (group CBT-CP) can reduce the symptoms of GAD in addition 
to the symptoms of other psychological disorders (Egan et al., 2011).  
In regard to the first aim, Concern over Mistakes (CM), Personal Standards 
(PS) and Clinical Perfectionism Questionnaire (CPQ) scores each significantly 
predicted pathological worry and remained significant after accounting for gender, 
anxiety and depression. This indicated that the relationships between these 
perfectionism dimensions and pathological worry in this clinical sample are not due 
to the associations that perfectionism dimensions have with anxiety and depression 
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(Egan et al., 2011). The significant relationship between CM and pathological worry 
was in accord with the research findings utilising non-clinical samples (Kawamura et 
al., 2001; Santanello & Gardner, 2007; Stoeber & Joormann, 2001). The significant 
association between PS and pathological worry differed from the findings of non-
clinical samples (Kawamura et al., 2001; Santanello & Gardner, 2007; Stoeber & 
Joormann, 2001); however, was congruent with research that found PS to be related 
to anxiety symptoms in other clinical samples (Iketani et al., 2002a; 2002b). The 
current finding suggested that PS is not a purely positive construct as posited by 
Stoeber and Otto (2006). Together, the findings of PS and CM being significantly 
associated with pathological worry provided empirical support for the theorised links 
between elevated personal standards, concern over mistakes and worry (Flett, 
Madorsky, et al., 2002; Pratt et al., 1997).  
The significant association between CPQ scores and pathological worry 
extended Chang and Sanna’s (2012) findings by highlighting that clinical 
perfectionism has relationships with pathological worry in addition to the 
relationships it has with anxiety and stress. The current finding demonstrated that 
this relationship exists in a clinical sample of individuals with elevated perfectionism 
and GAD. The relationship between CPQ scores and pathological worry also 
provided empirical support for the theorised links between clinical perfectionism and 
adverse consequences such as worry (Shafran et al., 2002; Shafran et al., 2010).  
The finding of Doubts about Actions (DA) not having a significant 
relationship with pathological worry did not concur with previous research in non-
clinical samples (Kawamura et al., 2001; Santanello & Gardner, 2007; Stoeber & 
Joormann, 2001). This non-significant finding may have occurred due to DA being 
measured as an independent construct rather than as a composite construct of 
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CM+DA as in previous research (Kawamura et al., 2001; Santanello & Gardner, 
2007; Stoeber & Joormann, 2001). Alternatively, due to the sample size, as well as 
all participants having elevated perfectionism, there may have been a restriction of 
range of the outcome variables or a Type II error (Tabachnick & Fidell, 2007). 
In regard to the second aim, DA significantly predicted a principal diagnosis 
of GAD, which supported its influence in this disorder. This finding was consistent 
with previous research showing DA to have predictive utility in other disorders such 
as obsessive-compulsive disorder and social phobia (Antony, Purdon, et al., 1998). 
Nevertheless, it was intriguing that DA did not significantly predict pathological 
worry, yet it significantly predicted a principal diagnosis of GAD. It was also 
unusual that CM, PS and CPQ scores significantly predicted pathological worry but 
not a principal diagnosis of GAD; however, the sample size and the reduced 
diversity arising from the high percentage of individuals with a principal diagnosis 
of GAD may have prevented these relationships from emerging in this sample 
(Tabachnick & Fidell, 2007). 
4.2.2. Unique contributions of Study I to the literature. The findings of 
Study I provide multiple unique contributions to the literature. This is the first study 
to demonstrate in a clinical sample that significant relationships exist between CM, 
CPQ scores and pathological worry. Previous studies had not examined these 
relationships in a clinical sample (Kawamura et al., 2001; Santanello & Gardner, 
2007; Stoeber & Joormann, 2001). This study is also the first to find a significant 
relationship between PS and pathological worry across clinical and non-clinical 
samples, as the non-clinical studies did not find this relationship (Kawamura et al., 
2001; Santanello & Gardner, 2007; Stoeber & Joormann, 2001) and it has not 
previously been measured in clinical samples. This is only the third study to 
226 
 
demonstrate in a clinical sample that PS is significantly associated with anxiety 
symptoms. A final unique contribution of this study is the finding of DA 
significantly predicting a principal diagnosis of GAD in a clinical sample with a 
range of diagnoses. Previous studies have not investigated whether perfectionism 
dimensions can predict a diagnosis of this disorder (Antony, Purdon, et al., 1998). 
These unique findings have implications for the conceptualisation of perfectionism, 
as well as the conceptualisation, assessment and treatment of GAD. 
4.2.3. Implications of Study I. The findings of CM being related to 
pathological worry and DA being associated with a principal diagnosis of GAD add 
weight to the notion of maladaptive evaluative concerns (CM, DA, PE, PC, SPP) 
being associated with psychopathology (Egan et al., 2011). Notably however, the 
finding of PS being associated with pathological worry suggests that positive 
achievement striving (PS, O, SOP) is not a purely positive construct as put forward 
by Stoeber and Otto (2006). This discovery contributes to the growing body of 
research supporting dimensions of positive achievement striving being associated 
with psychopathology (Bardone-Cone et al., 2007; Bardone-Cone et al., 2008; Cox 
et al., 2001; Flett & Hewitt, 2006; Hewitt & Flett, 1993; Iketani et al., 2002a, 
2002b). The current finding also provides a rationale for future studies to examine 
the circumstances under which positive achievement striving is adaptive and 
maladaptive (Egan et al., 2012). The discovery of CPQ scores being associated with 
pathological worry supports the validity of Shafran et al.’s (2002) clinical 
perfectionism definition by providing support for theorised associations between 
clinical perfectionism and negative outcomes such as worry. This finding also 
supports the validity of the Clinical Perfectionism Questionnaire (Fairburn et al., 
2003b) in a sample with elevated perfectionism and GAD. 
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By highlighting that CM, PS, DA and CPQ scores are associated with GAD 
symptomatology, these findings add weight to the argument of perfectionism being a 
transdiagnostic process (Egan et al., 2011). Additionally, these findings highlight the 
need to include questions about perfectionism in the initial assessment session for 
clients presenting with GAD, with a view to including perfectionism in a client’s 
formulation if it is maintaining his/her GAD symptoms (Egan et al., 2011; Egan et 
al., 2012). Importantly for this thesis, these findings provided a rationale for Study II 
and future studies to investigate whether perfectionism interventions can reduce the 
symptoms of GAD in addition to the symptoms of other psychological disorders 
(Bieling, Summerfeldt, et al., 2004; Egan et al., 2011).  
The findings of Study I also provide impetus for future research to 
investigate whether CM, PS, DA and CPQ scores are uniquely associated with the 
symptoms of GAD after accounting for the constructs from established models of 
GAD (Dugas et al., 1998; Wells, 1995, 1999). If the findings from cross-sectional 
studies support the unique predictive utility of these perfectionism dimensions, 
prospective studies could investigate whether CM, PS, DA and CPQ scores are 
uniquely associated with the onset and maintenance of GAD symptoms (Dugas et 
al., 1998; Wells, 1995, 1999). If support is obtained for CM, PS, DA and CPQ scores 
prospectively predicting the onset and maintenance of GAD symptoms after 
accounting for the constructs in established models of GAD (Dugas et al., 1998; 
Wells, 1995, 1999), there would be sufficient rationale to update existing theoretical 
models of GAD to recognise the role of perfectionism (Dugas et al., 1998, Wells, 
1995, 1999).  
If existing theoretical models of GAD (Dugas et al., 1998; Wells, 1995, 
1999) are updated, a similar model expansion to that of Fairburn et al.’s (2003) 
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transdiagnostic model of eating disorders could occur, where perfectionism is 
classed as an additional maintaining factor that may interact with the other 
maintenance factors of GAD (Dugas et al., 1998; Wells, 1995, 1999). This model 
expansion is consistent with Shafran et al.’s (2002) proposition of clinical 
perfectionism interacting with the primary maintenance factors of a disorder to 
maintain the disorder and negatively affect treatment. In regard to Dugas et al.’s 
(1998) model, elevated perfectionism could possibly interact with intolerance of 
uncertainty to more frequently trigger the worry cycle (Buhr & Dugas, 2006; Dugas 
et al., 1998). Alternatively, elevated perfectionism could potentially interact with 
positive beliefs about worry to increase the tendency to engage in and persist with 
the worry process (Dugas et al., 1998; Pratt et al., 1997). In regard to Wells’ (1995, 
1999) meta-cognitive model, elevated perfectionism could possibly interact with 
positive meta-beliefs about the need to engage in Type 1 worry to cope, which may 
trigger the worry process. If an individual experiences negative consequences 
associated with worry (e.g., experiencing worries as more intrusive), this may 
interact with their elevated perfectionism to more strongly activate and reinforce 
negative meta-beliefs about worry, leading to the occurrence of Type 2 worry 
(Wells, 1995, 1999). Based on this updated model, future studies could examine 
whether the efficacy of current psychological interventions for GAD (Dugas et al., 
1998; Wells, 1995, 1999) could be increased through the addition of a treatment 
module targeting elevated perfectionism. 
4.2.4. Major findings of Study II.  The primary aim of Study II was to 
conduct an RCT to investigate the efficacy of group CBT-CP in a clinical sample. A 
secondary aim was to investigate whether group CBT-CP significantly increases 
quality of life. Participants receiving group CBT-CP exhibited significantly greater 
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pre-post reductions in all dimensions of perfectionism (CPQ, PS, CM, DA, 
Dysfunctional Attitude Scale-Self-Criticism scores), as well as in the distress and 
interference associated with perfectionism relative to participants from the waitlist 
control condition. Once participants from the waitlist control condition received 
group CBT-CP they made comparable gains to the treatment condition. For the 
entire sample, post-treatment reductions in all perfectionism measures were 
maintained at 3-month and 6-month follow-ups. The significant effect of group 
CBT-CP on CPQ scores was consistent with Riley et al.’s (2007) findings. It 
supported the validity of maintenance models of clinical perfectionism (Shafran et 
al., 2002; Shafran et al., 2010) and the validity of the CPQ as a measure of clinical 
perfectionism (Fairburn et al., 2003b). The significant effect of group CBT-CP on 
CM, PS and DA differed from the findings of RCTs of individual perfectionism 
treatments (Pleva & Wade, 2008; Riley et al., 2007; Steele & Wade, 2008), which 
provided a rationale for future research to examine whether group CBT-CP is more 
efficacious than individual CBT-CP. The significant effect of group CBT-CP on 
DAS-SC scores as well as the distress and interference associated with perfectionism 
were consistent with the findings from Steele et al.’s (2013) case series design; 
however, as the current study used an RCT design, the current findings can be better 
attributed to group CBT-CP.  
Participants receiving group CBT-CP displayed significantly greater pre-post 
decreases in depression (BDI-II), eating disorder symptoms, social anxiety and 
anxiety sensitivity, as well as significantly greater pre-post increases in self-esteem 
compared to those from the waitlist control condition.  Once the waitlist control 
participants received group CBT-CP they made comparable changes on these 
variables to the treatment condition. For the entire sample, post-treatment gains were 
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maintained at 3-month and 6-month follow-ups. Together, these findings offered 
support for perfectionism being a transdiagnostic process (Egan et al., 2011).  
The significant effects of group CBT-CP on depression (BDI-II), anxiety 
sensitivity and social anxiety were in line with the literature reporting relationships 
between perfectionism dimensions and these symptoms (e.g., Cox et al., 2001; Enns 
& Cox, 1999; Juster et al., 1996; Lundh & Ost, 2001; Wheeler et al., 2011). The 
findings for BDI-II and anxiety sensitivity were consistent with the treatment 
findings of Riley et al. (2007) and Radhu et al. (2012) respectively; whereas the 
finding for social anxiety provides a unique contribution to the literature. The 
significant effect of group CBT-CP on eating disorder symptoms was congruent with 
the literature supporting the associations between perfectionism dimensions and 
eating disorder pathology (Bardone-Cone et al., 2007). The significant effect of 
group CBT-CP on self-esteem supported the validity of the maintenance model of 
clinical perfectionism (Shafran et al., 2002; Shafran et al., 2010) and was in line with 
the proposition of CBT-CP increasing self-esteem through helping individuals to 
realise that their self-esteem is not singularly dependent on achievement (Shafran et 
al., 2002; Shafran et al., 2010). Nevertheless, the current findings for eating disorder 
pathology and self-esteem differed from those of Steele and Wade (2008), which 
was argued to provide impetus for future research to examine the efficacy of group 
CBT-CP compared to individual CBT for perfectionism.  
Group CBT-CP tended to produce greater decreases in pathological worry, 
obsessive-compulsive symptoms, DASS-anxiety and DASS-stress than the waitlist 
control condition; however, these effects were not significant. The non-significant 
finding for pathological worry was inconsistent with the findings reported in Study I 
of this thesis; however, likely arose due to a Type II error (Tabachnick & Fidell, 
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2007). The non-significant finding for obsessive-compulsive symptoms differed 
from previous findings of perfectionism dimensions being related to obsessive-
compulsive symptoms (Antony, Purdon, et al., 1998), and differed from the findings 
of Pleva and Wade’s (2006) treatment trial; however may have been due the small 
numbers of individuals with baseline OCD diagnoses creating a floor effect (Rosnow 
& Rosenthal, 2002). The non-significant finding for DASS-anxiety was consistent 
with previous RCTs (Pleva & Wade, 2006; Steele & Wade, 2008); however, the 
non-significant findings for DASS-anxiety and DASS-stress differed from Steele et 
al.’s (2013) case series design findings. The current non-significant findings were 
intriguing given the significant effect of group CBT-CP on social anxiety and 
anxiety sensitivity. It was argued that group CBT-CP may have had a smaller 
treatment effect for the type of anxiety measured by DASS-anxiety compared to 
social anxiety and anxiety sensitivity, and that there was inadequate power for this 
effect to be detected. Another possibility put forward was that DASS-anxiety may be 
less clinically sensitive than measures of social anxiety and anxiety sensitivity 
(Tabachnick & Fidell, 2007). 
The second aim was to investigate whether group CBT-CP significantly 
increases quality of life. Participants receiving the intervention demonstrated 
significantly greater pre-post increases in quality of life compared to those in the 
waitlist control condition. Once the waitlist control participants received group CBT-
CP they made comparable gains and the entire sample maintained their post-
treatment gains at 3-month and 6-month follow-ups. This is a new finding and has 
implications for the multidimensional effect of group CBT-CP. 
In regard to reliable change, a significantly greater proportion of individuals 
from the group CBT-CP condition exhibited pre-post reliable change in CM, DA, 
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DAS-SC scores, eating disorder symptoms, self-esteem and quality of life relative to 
the waitlist control condition. These differences between conditions became non-
significant once participants from the waitlist control condition received group CBT-
CP.  These findings supported group CBT-CP producing meaningful changes in 
these outcomes at an individual level in addition to a group level (Jacobson & Truax, 
1991). Interestingly, there were no significant differences between the treatment 
condition and the waitlist control condition in the proportions of individuals 
experiencing reliable change in CPQ scores, depression (BDI-II), social anxiety and 
anxiety sensitivity; however, this may have been due to the conservative cut-offs for 
reliable change used in this study (Jacobson & Truax, 1991). 
In relation to clinically significant change, a significantly greater proportion 
of individuals from the group CBT-CP condition experienced pre-post clinically 
significant change in CM compared to the waitlist control condition. This difference 
became non-significant after the waitlist control participants received group CBT-
CP. These findings supported the efficacy of group CBT-CP (Chambless & Hollon, 
1998; Jacobson & Truax, 1991). However, there were no significant differences 
between the treatment and waitlist control condition in the proportions of individuals 
experiencing pre-post clinically significant change in CPQ scores. This was unusual 
given that the intervention targeted clinical perfectionism (Shafran et al., 2002; 
Shafran et al., 2010). After the entire sample had received group CBT-CP, clinically 
significant change in CM was exhibited by 22 per cent of individuals at post-
treatment and 26 per cent at 6-month follow-up; whereas clinically significant 
change in CPQ scores was exhibited by 6 per cent of individuals at post-treatment 
and 15 per cent at 6-month follow-up. The non-significant differences between 
conditions in the proportions of participants experiencing clinically significant 
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change in CPQ scores, and the low total percentages of clinically significant change 
occurring in CM and CPQ scores were argued to be due to the very conservative cut-
offs for clinical significance used in this study (Jacobson & Truax, 1991; Riley et al., 
2007).  
  A significantly greater proportion of participants from the group CBT-CP 
condition experienced recovery from depression compared to the waitlist control 
condition. This difference became non-significant once the waitlist control 
participants received group CBT-CP. This finding suggested that group CBT-CP 
results in individuals no longer meeting a diagnosis of depression. There were no 
significant differences between conditions in the proportions of individuals who 
recovered from the other psychological disorders; however, this may have been a by-
product of the small number of participants with certain diagnoses per condition and 
the timeframes of the criteria for particular diagnoses (DSM-IV-TR, APA, 2000). 
For the total sample, the percentages of individuals who recovered from depression, 
an eating disorder, obsessive-compulsive disorder, social phobia, GAD and panic 
disorder with or without agoraphobia were high at 6-month follow-up. This provided 
indirect support for group CBT-CP being associated with recovery from 
psychological disorders six months after treatment. 
4.2.5. Unique contributions of Study II to the literature. This study 
provides many unique contributions to the literature. It is the first RCT to investigate 
the efficacy of group CBT-CP in a clinical sample. As this study has higher internal 
validity than previous studies examining group CBT-CP (Egan & Stout, 2007; Steele 
et al., 2013), the current findings can be better attributed to this intervention. This is 
the first RCT to show that CBT targeting perfectionism produces significantly 
greater decreases in CM, PS, DA, DAS-SC scores, as well as the distress and 
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interference associated with perfectionism relative to a waitlist control condition. 
Previous RCTs did not find significant interaction effects for the measures of 
multidimensional perfectionism and did not measure DAS-SC or the distress or 
interference associated with perfectionism (Pleva & Wade, 2006; Riley et al., 2007; 
Steele & Wade, 2008). This study is the first to demonstrate that group CBT-CP 
leads to significantly greater decreases in eating disorder pathology and social 
anxiety as well as significantly greater increases in self-esteem compared to a control 
condition. A previous perfectionism treatment trial found that CBT for perfectionism 
exhibited comparable effects on eating disorder pathology and self-esteem to other 
conditions in the trial (Steele & Wade, 2008) and previous trials in this area have not 
included a measure of social anxiety (Pleva & Wade, 2006; Riley et al., 2007; Steele 
& Wade, 2008). Additionally, this is the first perfectionism treatment trial to find 
that CBT-CP significantly increases quality of life. Other perfectionism treatment 
trials have not incorporated a quality of life outcome measure (Pleva & Wade, 2006; 
Riley et al., 2007; Steele & Wade, 2008).  
The reliable and clinically significant change findings also uniquely 
contribute to the literature. This study is the first to show that CBT-CP produces 
significantly greater reliable change in DAS-SC scores, eating disorder symptoms, 
self-esteem and quality of life than a waitlist control condition. Previous RCTs of 
perfectionism treatments have not examined reliable change in these measures (Pleva 
& Wade, 2006; Riley et al., 2007; Steele & Wade, 2008). This is the first study to 
find that group CBT-CP produces significantly greater clinically significant change 
in CM and recovery from depression than a waitlist control condition. Group 
differences in clinically significant change in CM and recovery from psychological 
disorders have not previously been examined. Finally, this study is the first to report 
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high percentages of recovery from multiple psychological disorders six months after 
receiving group CBT-CP.  These unique findings have implications for the validity 
of the maintenance model of clinical perfectionism (Shafran et al., 2002; Shafran et 
al., 2010) and the establishment of group CBT-CP as a possibly efficacious 
treatment (Chambless & Hollon, 1998). These findings also contribute toward the 
evidence base for CBT-CP as a transdiagnostic treatment (Egan et al., 2011; Egan et 
al., 2012).  
4.2.6. Implications of Study II. The findings from Study II provide evidence 
that CBT-CP delivered in a group format works in that it is able to produce 
reductions in multiple measures of perfectionism and psychopathology, and produce 
increases in self-esteem and quality of life (Chambless & Hollon, 1998). 
Importantly, it provides evidence that group CBT-CP does no harm compared to if 
participants received no treatment at all (Lilienfeld, 2007). The current findings 
provide support for the validity of Shafran et al.’s (2002) conceptualisation of 
clinical perfectionism and the maintenance model of clinical perfectionism (Shafran 
et al., 2002; Shafran et al., 2010) by highlighting that CBT targeting the maintaining 
factors of clinical perfectionism yields significant changes in perfectionism, 
psychopathology and self-esteem. Such evidence further informs the debate 
regarding how to best conceptualise perfectionism (Hewitt et al., 2003; Shafran et 
al., 2002; Shafran et al., 2003). 
The current findings also contribute toward establishing the efficacy of group 
CBT-CP (Chambless & Hollon, 1998). It is important to note that one cannot yet 
conclude from these findings that group CBT-CP is an efficacious intervention, as 
this is only the first of two studies required to establish efficacy. An additional RCT 
conducted by independent researchers producing non-contradictory results is needed 
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to establish the efficacy of this intervention. The current findings provide a rationale 
for this second RCT to be conducted (Chambless & Hollon, 1998). 
Regardless, the impact of the current findings cannot be dismissed. The 
current findings still result in group CBT-CP being labelled a possibly efficacious 
treatment (Chambless & Hollon, 1998). These findings also provide evidence that 
group CBT-CP has a multidimensional impact of decreasing perfectionism and 
psychopathology, as well as enhancing self-esteem and quality of life. Based on the 
World Health Organisation’s (1948, p. 100) definition of health as “a state of 
complete physical, mental and social well-being and not merely the absence of 
disease”, this intervention significantly increases individuals’ overall health. 
Psychologists are therefore presented with an alternative format for delivering CBT-
CP that offers greater time efficiency for psychologists and substantial cost savings 
for clients relative to individually administered CBT-CP (APS, 2013; Himle et al., 
2003). In a society where there are long waitlists for psychological services at 
Government organisations and Government rebates only provided for 10 psychology 
sessions per year, it is valuable for psychologists to have another method of 
delivering CBT-CP (APS, 2013; Egan et al., 2012; Himle et al., 2013). Group 
delivery of this intervention may also enable clients to receive additional therapeutic 
benefits relative to individual administration of this treatment (Bieling et al., 2006; 
Yalom, 1995; Yalom & Leszcz, 2005). Therefore, these findings have given 
psychologists a beneficial alternative format of delivering CBT-CP. 
On a broader scale, the current findings add to the evidence base of CBT for 
perfectionism being an efficacious transdiagnostic treatment (Pleva & Wade, 2006; 
Riley et al., 2007; Steele & Wade, 2008). By increasing this evidence-base, 
psychologists are given an increasingly credible transdiagnostic alternative to 
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disorder-specific treatment protocols (Egan et al., 2012). Given the high co-
morbidity of psychological disorders (Kessler, Berglund, et al., 2005; Kessler, Chiu, 
et al., 2005), the administration of this transdiagnostic treatment rather than the 
sequential administration of disorder-specific treatment protocols may create 
additional time-efficiency for the psychologist and client, and may produce cost-
savings for the client (Craske, 2012; Egan et al., 2012).  
Nonetheless, Egan et al. (2012) have advised that psychologists need to 
carefully consider their decision to administer this transdiagnostic treatment instead 
of a disorder-specific treatment protocol. This is because there is still a greater 
evidence base for disorder-specific treatments compared to transdiagnostic 
treatments. Egan et al. (2012) have put forward guidelines specifying when CBT 
targeting perfectionism should be implemented. If elevated perfectionism is the 
primary problem with which a client presents, and the client’s formulation indicates 
that elevated perfectionism is the primary factor maintaining other psychological 
symptoms, CBT-CP can be administered (Egan et al., 2012; Shafran et al., 2002; 
Shafran et al., 2010). If the primary presenting problem is an eating disorder, anxiety 
disorder or depression, where elevated perfectionism is a maintaining factor but 
other disorder-specific factors have a more important maintenance role, the 
psychologist should first administer the evidence-based treatment for that specific 
disorder. If a client’s perfectionism impedes their progress with this disorder-specific 
treatment, the psychologist should switch to delivering CBT-CP until the client’s 
perfectionism symptoms have ameliorated. If symptoms of the psychological 
disorder are still present, the psychologist should recommence the disorder-specific 
treatment (Egan et al., 2012; Shafran et al., 2002). Egan et al. (2012) posited that due 
to the imbalance of evidence for transdiagnostic treatments versus disorder-specific 
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treatments, it is currently difficult to advise which treatment to administer when a 
client presents with multiple disorders. These researchers recommended that for a 
client with co-morbidities, the psychologist needs to be guided by their formulation 
of which disorder-specific and transdiagnostic factors maintain the client’s disorders.  
Egan et al.’s (2012) guidelines are sensible based on the current state of the 
empirical evidence for transdiagnostic versus disorder-specific treatments. 
Nonetheless, the findings of this RCT highlight the importance of continued research 
investigating the efficacy of CBT-CP to contribute to the evidence-base for this 
transdiagnostic treatment. Importantly, RCTs examining the efficacy of CBT-CP 
compared to disorder-specific treatments and control conditions are needed (Egan et 
al., 2012). There is also a need for studies to examine the effectiveness of CBT-CP 
(Chambless & Hollon, 1998). Such research may lead to future revisions of Egan et 
al.’s (2012) guidelines, where it is recommended that CBT-CP be the first treatment 
option for clients presenting with an eating disorder, anxiety disorder or depression, 
or multiple disorders that are maintained by perfectionism. 
4.3. Strengths and Limitations of the Current Research  
4.3.1. Strengths and limitations of Study I. There are many strengths of 
Study I. The measures utilised to assess the constructs in this study have all shown 
high internal consistency and validity in previous studies (Antony, Bieling, et al., 
1998; Antony, Purdon, et al., 1998; Beck et al., 1996; Chambless & Hollon, 1998; 
Egan, Shafran, et al., 2014; Frost et al., 1990; Meyer et al., 1990) and demonstrated 
high internal consistencies in the current study. Diagnoses of GAD were assigned by 
administering a reliable and valid structured interview (MINI; Sheehan et al., 1998) 
that is based on the standardised criteria of the DSM-IV-TR (APA, 2000). The 
interviewer had had four years of experience administering this measure and baseline 
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diagnoses were assigned while the interviewer was blind to participants’ scores on 
the self-report measures. Accuracy of GAD diagnoses was confirmed through 
supervision with an experienced clinical psychologist (Egan). The use of these 
reliable and valid self-report measures and structured interviews reduces the error 
variance in the data (Tabachnick & Fidell, 2007). 
 There are also strengths in the result analyses. Prior to analyses, data was 
screened to ensure that statistical assumptions had not been violated to further ensure 
result accuracy (Holden et al., 2008). When zero-order correlations indicated that 
gender, depression and anxiety were related to pathological worry, these variables 
were controlled in the hierarchical regression analyses. This ensured that the 
relationships between perfectionism dimensions and pathological worry were 
independent of the associations perfectionism has with anxiety and depression (Egan 
et al., 2011). Collectively, the strengths of this study increase the accuracy of the 
current findings.  
The limitations of this study require discussion. The size of the sample, as 
well as all participants having elevated perfectionism may have prevented significant 
relationships between variables from emerging in this sample (Tabachnick & Fidell, 
2007). Additionally, this study did not include a non-clinical control group so one 
could not examine whether individuals with GAD have significantly higher CM, PS, 
DA and CPQ scores compared to non-clinical controls. Moreover, 71 per cent of the 
entire sample had a principal diagnosis of GAD. The latter two limitations further 
reduced the diversity of the sample, which may have also prevented significant 
relationships from arising (Tabachnick & Fidell, 2007). Future studies examining the 
relationship between perfectionism and GAD symptomatology should include larger 
samples with a range of perfectionism levels. These studies should incorporate non-
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clinical control groups as well as clinical groups with a greater diversity of 
diagnoses.  
Another limitation is that this study did not examine whether CM, PS, DA 
and CPQ had unique predictive utility above other constructs included in models of 
GAD, such as intolerance of uncertainty and meta-beliefs about worry (Dugas et al., 
1998; Wells, 1995, 1999; Wells & Carter, 1999). Future studies should account for 
these constructs to examine whether CM, PS, DA and CPQ still explain unique 
variance in GAD symptoms in a clinical sample. A final limitation is that this study 
had a cross-sectional design. Consequently, the only inferences that can be made are 
that CM, PS and CPQ scores are associated with pathological worry and that DA is 
associated with a principal diagnosis of GAD. It cannot be inferred that these 
perfectionism dimensions cause the symptoms of GAD. Future studies need to utilise 
prospective designs to examine whether CM, PS, DA and CPQ precede the onset of 
GAD symptoms.  
4.3.2. Strengths and limitations of Study II. There are multiple strengths of 
Study II. These strengths arise from the primary researcher having closely adhered to 
Chambless and Hollon’s (1998) guidelines for conducting an efficacy trial. In regard 
to the design of this study, an RCT design was utilised.  An a priori power analysis 
was conducted to determine the minimum number of participants required for this 
study to have sufficient power to detect moderate to large treatment effects. A 
sample size that exceeded this minimum number was recruited. Thus, the study was 
adequately powered to detect moderate to large treatment effects (Faul et al., 2007; 
Holden et al., 2008). The use of an RCT design with an adequate sample size 
increases confidence that any intervention effects can be attributed to group CBT-CP 
(Chambless & Hollon, 1998).  
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Additionally, participants randomised to the group CBT-CP and waitlist 
control conditions did not significantly differ on any baseline demographic or 
outcome variables except for a diagnosis of GAD. This prevents the intervention 
effects from being attributed to baseline differences between conditions. Participants 
were required to abstain from changing their medication and/or seeking external 
psychological treatment between baseline and 6-month follow-up and compliance 
with this requirement was measured throughout the study. This means that 
intervention effects cannot be attributed to the effects of medication or external 
treatment. Collectively, the design features of this study ensure that any intervention 
effects can be credited to group CBT-CP (Chambless & Hollon, 1998; Tabachnick & 
Fidell, 2007). An additional strength of this design is that it is able to demonstrate 
that group CBT-CP does no harm compared to if participants received no treatment 
at all (Lilienfeld, 2007). A final strength of the design is that a 6-month follow-up 
was included, which provided important information about whether post-treatment 
changes are maintained over a 6-month period (Chambless & Hollon, 1998).  
There are also strengths in the treatment administered. The treatment was 
derived from Shafran et al.’s (2010) published book, which enables the treatment to 
be replicated by others (Chambless & Hollon, 1998). The primary researcher had had 
experience delivering this treatment in a previous trial (Steele et al., 2013) and the 
two co-facilitators received substantial training prior to implementing the therapy. 
The primary researcher and co-facilitators received weekly supervision while 
implementing the therapy. Two clinical psychologists external to the research rated 
therapist adherence and competence and high ratings were obtained on both 
constructs (Chambless & Hollon, 1998). 
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There are strengths in the measurement of constructs. All self-report 
measures had shown high reliability and validity in previous studies (Antony, 
Bieling, et al., 1998; Antony, Purdon, et al., 1998; Beck et al., 1996; Chambless & 
Hollon, 1998; Egan et al., 2011; Foa et al., 2002; Meyer et al., 1990; Peterson et al., 
2007; Riley et al., 2007; Ritsner et al., 2005; Steele & Wade, 2008). These measures 
also demonstrated high internal consistencies in the current study.  To supplement 
the self-report measures, participants were administered a reliable, valid structured 
interview (Chambless & Hollon, 1998; Sheehan et al., 1998). The interviewer had 
had experience administering this measure and in assigning diagnoses. Accuracy of 
diagnoses was confirmed through supervision with an experienced clinical 
psychologist (Egan) (Chambless & Hollon, 1998). These procedures are 
commendable as they minimise error in the data (Tabachnick & Fidell, 2007). 
Furthermore, as recommended by Chambless and Hollon (1998), this research not 
only examined the impact of an intervention on psychopathology, but also included a 
measure of quality of life (Ritsner et al., 2005).  
There are strengths in the analysis utilised. GLMM was utilised to analyse 
the data, which has multiple advantages relative to traditional statistical techniques 
(Bryk & Raudenbush, 1987; Dimitrov & Rumrill, 2003; Holden et al., 2008). The use 
of this statistical technique reduces error in the data, therefore increasing the 
accuracy of the findings (Holden et al., 2008). As this was a trial of a group 
treatment, intra-group dependencies were statistically controlled, which minimises 
error in the data (Kenny et al., 2002; Killip et al., 2004; Rabe-Hesketh & Skrondal, 
2005). Analyses of statistically significant change were supplemented by 
calculations of reliable and clinically significant change. This ascertained whether 
changes also transpired at the level of the individual, which is vital when assessing 
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the efficacy of an intervention (Chambless & Hollon, 1998; Hageman & Arrindell, 
1999; Jacobson & Truax, 1991). 
There are also limitations of this study. Once participants from the waitlist 
control condition had their post-waitlist assessment, they received group CBT-CP. 
While this is important for ethical reasons, it meant that the direct comparison 
between the active intervention condition and the waitlist control condition could 
only occur for eight weeks. While the findings indicated that the entire sample 
maintained their post-treatment gains at 6-month follow-up, one could not compare 
whether the group CBT-CP condition significantly differed from the waitlist control 
condition at 6-month follow-up.  
Furthermore, in this study an active treatment (group CBT-CP) was 
compared to a waitlist control condition but there was no active treatment 
comparison condition. While the data from this study provides information about 
whether group CBT-CP works (Chambless & Hollon, 1998), one cannot exclude the 
possibility that treatment effects emerged from various non-specific therapy factors 
such as therapist attention (Chambless & Hollon, 1998). Consequently, the current 
findings contribute toward establishing the efficacy of group CBT-CP, but do not 
enable inferences about the specificity of group CBT-CP. Future RCTs should 
compare group CBT-CP to another active treatment condition and a waitlist control 
condition to contribute toward establishing the efficacy and specificity of group 
CBT-CP (Chambless & Hollon, 1998). 
There are also limitations in regard to the composition and size of the sample. 
The sample size was sufficient to detect moderate to large treatment effects; 
however, the study may have been underpowered to detect smaller interaction effects 
(Faul et al., 2007; Tabachnick & Fidell, 2007). Future studies should utilise larger 
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samples to examine whether significant interaction effects emerge for variables such 
as DASS-anxiety, DASS-stress and pathological worry. Furthermore, the sample 
contained small numbers of participants with a baseline diagnosis of obsessive-
compulsive disorder. This likely meant that baseline levels of obsessive-compulsive 
symptoms were low, which may have created a floor effect, potentially accounting 
for the non-significant finding for obsessive-compulsive symptoms (Rosnow & 
Rosenthal, 2002). Additionally, the sample contained small numbers of participants 
with baseline diagnoses of social phobia and panic disorder with or without 
agoraphobia. The small numbers of individuals with social phobia may have 
prevented significant differences between conditions in the proportions of 
individuals recovering from social phobia. The small numbers of individuals with 
panic disorder with or without agoraphobia prevented any differences between 
conditions in recovery from this disorder from being examined. Future studies 
should include samples where there are a greater number of individuals with these 
diagnoses.  
There are also limitations in the assessment process. The majority of the 
measures utilised in this study were self-report measures. Additionally, the primary 
researcher delivered the therapy and conducted all assessments so was not blind to 
participants’ condition when conducting the post-treatment, post-waitlist and follow-
up assessments. These factors may have biased the data (Tabachnick & Fidell, 
2007). The latter limitation may have also increased the likelihood of participants 
from the group CBT-CP condition exaggerating their treatment gains to please the 
therapist. Future studies should utilise a greater amount of interviewer-administered 
assessments and have an interviewer blind to participants’ condition to conduct the 
assessments (Tabachnick & Fidell, 2007).  
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The final limitation is the absence of established population norms for the 
perfectionism variables, which resulted in the use of very conservative cut-offs for 
the clinically significant change calculations (Jacobson & Truax, 1991; Riley et al., 
2007). This likely accounted for the non-significant group differences in the 
proportions of individuals exhibiting clinically significant change in CPQ scores. It 
also likely accounted for the low total proportions of individuals who experienced 
clinically significant change in CM and CPQ scores after the treatment and at 6-
month follow-up. Future studies need to calculate population norms for the 
perfectionism variables and then calculate the cut-offs for clinically significant 
change on the basis of these norms. This would produce more accurate estimates of 
clinically significant change (Jacobson & Truax, 1991). 
4.4. Future Research Directions  
4.4.1. Future research directions in relation to Study I. As discussed, 
additional studies with clinical samples are needed to further explore the 
relationships between perfectionism dimensions and GAD symptomatology. There is 
a need to examine whether perfectionism dimensions are elevated in individuals with 
GAD relative to individuals with other anxiety disorders and non-clinical controls. 
This has been examined for nearly every other depressive, eating and anxiety 
disorder (Antony, Purdon, et al., 1998; Bardone-Cone et al., 2007; Wheeler et al., 
2011), but small sample sizes in past research have prevented this from being 
examined in individuals with GAD (Wheeler et al., 2011).  There is also a need for 
cross-sectional and prospective studies to explore the utility of perfectionism 
dimensions in predicting GAD symptoms after controlling for other constructs 
posited to maintain GAD (Dugas et al., 1998; Wells, 1995, 1999), as this may lead to 
revisions of theoretical models of GAD (Dugas et al., 1998; Wells, 1995, 1999). 
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Future studies could also examine whether perfectionism is a significant predictor of 
poorer treatment outcome in current treatments for GAD (Dugas et al., 1998; Wells, 
1995, 1999) to provide further information about whether perfectionism maintains 
this disorder.  
As discussed, it would be beneficial for future studies to investigate whether 
the efficacy of psychological treatments based on current models of GAD (Dugas et 
al., 1997; Wells & Carter, 1999) can be increased by the addition of a treatment 
module targeting perfectionism. There is also a need for additional research to 
investigate whether CBT-CP can reduce pathological worry and other GAD 
symptoms. While Study II of this thesis reported trends of group CBT-CP reducing 
pathological worry to a greater extent than a waitlist control condition, this was not 
significant, which was likely due to a Type II error (Tabachnick & Fidell, 2007). 
Nevertheless, this study did report that one third of the individuals with GAD at pre-
treatment no longer met a GAD diagnosis at post-treatment, and 80 per cent of 
individuals with GAD at pre-treatment no longer met this diagnosis at 6-month 
follow-up, which provided indirect evidence of reductions in GAD symptoms 
following group CBT-CP.  Future studies should explore the impact of CBT-CP on 
GAD symptoms utilising a larger clinical sample than that used in Study II. 
4.4.2. Future research directions in relation to Study II. The findings of 
Study II generate numerous areas for future research. As discussed, it is crucial for 
researchers to replicate the current study as the production of consistent findings 
would enable group CBT-CP to be deemed efficacious (Chambless & Hollon, 1998). 
There is also a need for studies to investigate the efficacy of group CBT-CP relative 
to conditions where non-specific processes are controlled. If group CBT-CP 
demonstrated superiority to these conditions, it would be labelled efficacious and 
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specific (Chambless & Hollon 1998). A variety of studies could be conducted to 
examine the efficacy and specificity of group CBT-CP. Researchers could conduct a 
series of RCTs where group CBT-CP is compared to individual CBT-CP, online 
CBT-CP and guided self-help CBT-CP, each of which would include a waitlist 
control condition. Such findings would also enable researchers to ascertain the most 
efficacious format of delivery of CBT-CP (Chambless & Hollon, 1998).  
Another method of examining the efficacy and specificity of group CBT-CP 
is for researchers to conduct RCTs that compare group CBT-CP to group CBT for 
specific disorders and a waitlist control condition (Chambless & Hollon, 1998). 
Researchers could also compare individual CBT-CP to individual CBT for specific 
disorders and a waitlist control condition. Evidence in support of the efficacy and 
specificity of CBT-CP relative to other CBT treatments would contribute to the 
evidence base for this transdiagnostic treatment. This could further inform treatment 
recommendations for clients who present with psychological disorders that are being 
maintained by perfectionism (Chambless & Hollon, 1998; Egan et al., 2012).  
Future RCTs could also compare CBT-CP with other transdiagnostic 
treatment protocols and a waitlist control condition. The comparison transdiagnostic 
treatment protocols may include the unified transdiagnostic intervention for 
emotional disorders (Bossieau et al., 2010; Ellard et al., 2010; Wilamowska et al., 
2010) or Enhanced Cognitive Behaviour Therapy (Fairburn et al., 2003a). Such 
studies could again vary the format of delivery of these interventions by comparing 
group CBT-CP to group delivery of the comparison transdiagnostic treatment; or 
individual CBT-CP to individual delivery of the comparison transdiagnostic 
treatment. The findings of these studies could inform treatment approaches for 
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clients presenting with co-morbid disorders that are being maintained by these 
transdiagnostic processes (Egan et al., 2012). 
The value of an intervention also needs to be demonstrated through 
effectiveness studies, which examine whether an intervention is beneficial in actual 
clinical practice (Chambless & Hollon, 1998; Lambert & Ogles, 2004). Lambert and 
Ogles (2004, p. 160) have argued that “the ability of researchers and evaluators to 
demonstrate that laboratory treatments also work in the real world will eventually 
lead to a better understanding of the effects of therapy as it is typically offered”. 
Chambless and Hollon (1998) propose that there are five factors to consider when 
assessing the clinical utility of an intervention: generalisability across populations, 
generalisability across therapists and settings, patient acceptance and compliance, 
ease of dissemination and cost-effectiveness. A consideration of each of these factors 
leads to the generation of additional research opportunities. 
Generalisability across populations refers to the degree to which evidence of 
treatment efficacy applies to the type of client that actually presents in clinical 
practice (Chambless & Hollon, 1998; Lambert & Ogles, 2004).  While the clients in 
the current study were homogenous in their elevated perfectionism, the majority of 
the clients in this sample had co-morbid psychological disorders. This suggests that 
the current findings could generalise to clients presenting with elevated 
perfectionism and co-morbid psychological disorders in clinical practice. Even so, 
participants in this study were screened for exclusion criteria such as self-harm, 
moderate or high suicidality and anorexia nervosa, thus there is a question of 
whether the current findings would generalise to the full range of clients presenting 
in routine clinical practice (Chambless & Hollon, 1998; Lambert & Ogles, 2004). 
Consequently, there is a need for studies to examine the effectiveness of group CBT-
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CP in samples of individuals who are engaging in self-harm, samples of individuals 
with moderate suicidality and samples of individuals with anorexia nervosa. There 
are rationales for such studies to be conducted given that the literature has reported 
significant relationships between perfectionism dimensions and self-harm, suicidality 
and anorexia nervosa (Bardone-Cone et al., 2007; Chambless & Hollon, 1998; 
Hewitt et al., 1996; Hewitt, Norton, et al., 1998; O’Connor et al., 2010).   
Generalisability across therapists and settings refers to whether the findings 
from RCTs can be generalised to regular clinical settings where therapists may have 
lower levels of training and supervision in the treatment and potentially greater 
flexibility to adapt the treatment to suit client needs compared to the therapists in 
RCTs (Chambless & Hollon, 1998; Kendall, Holmbeck, & Verduin, 2004). In the 
current study, the treatment was administered by therapists who received reading 
material, a face to face training session and weekly supervision. Previous RCTs of 
individual CBT-CP were similarly conducted under conditions of high therapist 
training and weekly supervision (Pleva & Wade, 2006; Riley et al., 2007; Steele & 
Wade, 2008). It is important for future research to investigate whether comparable 
outcomes occur if CBT-CP is administered by psychologists with a lower amount of 
face to face training and supervision in the treatment (Chambless & Hollon, 1998). 
For example, instead of face to face training and supervision, psychologists may be 
given Egan, Shafran, Wade, and Antony’s (in press) book ‘Cognitive behavioural 
treatment of perfectionism’ to provide instruction in applying the CBT-CP strategies.  
If comparable outcomes emerge, this would support the generalisation of treatment 
findings to a context where therapists have a lower level of training and supervision 
(Chambless & Hollon, 1998).   
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The idea that research and clinical settings differ in the flexibility of 
treatment administration is based on the notion that adherence to treatment manuals 
in research settings automatically restricts flexibility; however, there is mixed 
support for the veracity of this notion (Chambless & Hollon, 1998; Kendall et al., 
2004). In fact, Kendall et al. (2004, p.25) asserted that “contemporary treatment 
manuals allow the therapist to attend to each client’s specific needs, concerns and co-
morbid conditions without deviating from the manual”. Indeed, the current protocol 
involved presenting clients with the formulation of clinical perfectionism and CBT-
CP strategies and then assisting clients to individualise the formulation and strategies 
(Shafran et al., 2002; Shafran et al., 2010). Furthermore, this transdiagnostic 
treatment protocol was designed to be suitable for many of the client’s co-morbid 
disorders (Egan et al., 2011; Shafran et al., 2002; Shafran et al., 2010). 
Consequently, it is likely that this transdiagnostic treatment protocol would be 
delivered in a similar manner across research and clinical settings; therefore, it is 
likely that comparable findings would emerge in clinical settings.  Nonetheless, 
future studies could investigate whether comparable treatment outcomes emerge 
under a condition where therapists rigorously adhere to the group CBT-CP treatment 
protocol versus a condition where psychologists can deviate from the protocol to suit 
the needs of a client (Chambless & Hollon, 1998; Kendall et al., 2004). If 
comparable outcomes emerge, this would support the generalisation of the current 
findings to a context where greater flexibility in protocol administration may occur 
(Chambless & Hollon, 1998; Kendall et al., 2004). 
Patient acceptance and compliance relates to how acceptable the intervention 
is to the client as well as the probability of the client complying with the intervention 
(Chambless & Hollon, 1998). The current study found that 80.95 per cent of 
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participants completed the trial up to 6-month follow-up. Participants attended 70.25 
per cent of the sessions and on average read 57.01 per cent of the weekly readings 
and completed 40.01 per cent of the weekly homework exercises. This provides 
some evidence of patient acceptance and compliance with group CBT-CP; however, 
future studies could further quantify the acceptability of this treatment through the 
use of a rating scale of acceptability. Qualitative studies could also explore the 
reasons for the acceptability of group CBT-CP.  Future studies should continue to 
measure acceptance and compliance through assessing treatment completion, session 
attendance as well as reading and homework compliance. This would enable 
comparisons to occur between the acceptance and compliance demonstrated in group 
CBT-CP relative to other treatments such as individual CBT-CP and disorder-
specific treatments (Chambless & Hollon, 1998).  
Ease of dissemination refers to the ease with which a treatment can be 
circulated to the broader community of psychologists (Chambless & Hollon, 1998). 
Chambless and Hollon (1998) argued that interventions that are simple and able to 
be learnt easily have a greater likelihood of being disseminated relative to treatments 
of greater complexity. Egan et al. (2012) argued that due to transdiagnostic 
treatments implementing one set of treatment strategies to treat the symptoms of 
multiple disorders, they have greater simplicity, are easier to learn and therefore have 
a greater ease of dissemination compared to implementing multiple disorder-specific 
protocols. Nonetheless, an avenue for future research may be to further increase the 
ease of dissemination by considering whether additional simplifications to the group 
CBT-CP protocol can occur (Chambless & Hollon, 1998). Future studies could 
investigate the efficacy of the current group CBT-CP treatment relative to a group 
CBT-CP intervention that contains a smaller number of treatment components 
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(Shafran et al., 2010). If comparable outcomes emerge, this may assist with greater 
dissemination of this intervention into the community of psychologists (Chambless 
& Hollon, 1998).  
Cost-effectiveness refers to the economic viability of administering the 
intervention in the short-term and long-term (Chambless & Hollon, 1998). As 
discussed in previous chapters, group CBT-CP may lead to reduced therapy costs for 
clients in the short-term relative to individual CBT-CP and disorder-specific 
treatments (APS, 2013; Craske, 2012; Egan et al., 2012; Himle et al., 2003). 
Nonetheless, Chambless and Hollon (1998) have advised that because various 
psychological treatments differ in the longevity of their effects, this may lead to 
differential access of mental health services over the long-term, which may create 
differences in the long-term costs of treatments. While the current findings suggest 
that group CBT-CP produces gains that are maintained up until at least six months, 
there is a need for future studies to examine whether group CBT-CP presents greater 
long-term cost savings to clients relative to individual CBT-CP and disorder-specific 
treatments (Chambless & Hollon, 1998; Egan et al., 2012; LeCrubier, 2001).  
4.5. Conclusions 
The overall aim of this research was to increase the knowledge of 
perfectionism and how it can be treated. Two principal discoveries emerged from 
this research. The first discovery was that dimensions of perfectionism are associated 
with GAD symptomatology in a clinical sample. These relationships had not 
previously been found in a clinical sample. The findings add weight to maladaptive 
evaluative concerns perfectionism and positive achievement striving perfectionism 
being associated with psychopathology (Bardone-Cone et al., 2007; Bardone-Cone et 
al., 2008; Cox et al., 2001; Egan et al., 2011; Flett & Hewitt, 2006; Hewitt & Flett, 
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1993; Iketani et al., 2002a, 2002b) and support the validity of Shafran et al.’s (2002) 
conceptualisation of clinical perfectionism. The findings provide a rationale for 
research to investigate whether these dimensions of perfectionism demonstrate 
unique predictive utility in GAD symptoms after accounting for established 
constructs in this disorder (Dugas et al., 1998; Wells, 1995, 1999), which may lead 
to the modification of current models of GAD (Dugas et al., 1998; Wells, 1995, 
1999). The findings highlight the need to include questions about perfectionism 
when assessing clients with GAD. Most importantly for this thesis, these findings 
provided a rationale for Study II and future studies to investigate whether 
interventions focusing on perfectionism can decrease GAD symptoms in addition to 
the symptoms of other disorders (Egan et al., 2011). 
The second discovery of this research was that group CBT-CP is an 
intervention that works, in that it produces improvements at a group level and an 
individual level in perfectionism, a variety of psychopathology, self-esteem and 
quality of life (Chambless & Hollon, 1998; Jacobson & Truax, 1991). This was the 
first RCT to evaluate group CBT-CP in a clinical sample, as well as the first RCT of 
a perfectionism treatment to investigate the impact of this treatment on quality of 
life. The current findings support the validity of Shafran et al.’s (2002) definition of 
clinical perfectionism, as well as the maintenance model of clinical perfectionism 
(Shafran et al., 2002; Shafran et al., 2010). Additionally, the findings contribute 
toward establishing the efficacy of group CBT-CP (Chambless & Hollon, 1998) and 
highlight the multidimensional effect of this treatment in reducing symptoms and 
improving quality of life. Psychologists are therefore presented with an alternative 
format of administering CBT-CP that can increase time efficiency for the 
psychologist, decrease costs for the client (APS, 2013; Himle et al., 2003) and 
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potentially provide additional therapeutic benefits compared to individual treatment 
(Bieling et al., 2006; Yalom, 1995; Yalom & Leszcz, 2005). Broadly, the findings 
contribute to the evidence base for CBT for perfectionism as a transdiagnostic 
treatment and provide psychologists with an increasingly credible alternative to that 
of disorder-specific protocols for treating clients with perfectionism and related 
psychopathology (Egan et al., 2011; Egan et al., 2012). 
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APPENDIX A:  
COVER LETTER SENT TO COLLEAGUES 
 
 
 
 
Dear Colleague, 
   
Curtin University Psychology Clinic is conducting a group cognitive behavioural 
therapy (CBT) program for individuals with clinical perfectionism. CBT for clinical 
perfectionism can effectively decrease clinical perfectionism, anxiety, depression 
and eating concerns. The group program will run for two hours per week over eight 
weeks. It is based on the book ‘Overcoming Perfectionism’, by Professor Roz 
Shafran (University of Reading, UK), Dr. Sarah Egan (Curtin University, WA), and 
Professor Tracey Wade (Flinders University, SA).   
 
You are invited to refer patients who have clinical perfectionism to these groups. 
This includes patients who: 
 
 Set excessively high standards even when it results in negative outcomes 
such as tiredness, anxiety, depression, and eating concerns  
 Are very self-critical of their accomplishments  
 Base their self-esteem on whether they think they have met their standards 
 
We are running these groups to examine if group CBT is more effective in 
decreasing clinical perfectionism and psychological symptoms than being in an eight 
week waitlist control condition. Participants initially allocated to the waitlist control 
condition will receive group CBT for clinical perfectionism after the eight week 
waiting period. 
 
We look forward to receiving your referrals. These referrals can be made by 
telephoning the Curtin Psychology Clinic on (08) 9266 3436 or by emailing 
alicia.handley@postgrad.curtin.edu.au   
 
We would also appreciate you placing the enclosed advertisement in your waiting 
room. 
 
Thank you, 
 
 
Yours Sincerely, 
 
 
Alicia Handley    Associate Professor Clare Rees   Dr. Sarah Egan 
PhD Student     Clinical Psychologist         Clinical Psychologist 
Curtin University    Curtin University          Curtin University 
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APPENDIX B:  
                                                         FLYER          
Is what you do never good enough? 
 
Do you set excessively high standards and constantly try to reach 
these standards even if it leads to negative effects like tiredness, 
anxiety, depression and eating concerns?  
 
Do you constantly criticise yourself?  Do you feel worthless if you 
think you haven’t reached your standards? 
 
If you answered yes to these questions, you may be suffering from 
clinical perfectionism. 
 
We will shortly be running an 8-week group treatment for clinical 
perfectionism at the Curtin University Psychology and Speech Clinic. 
This treatment will show you how to use Cognitive Behavioural 
Therapy (CBT) strategies to address the unhelpful aspects of your 
perfectionism. There will be 8 x two-hour group sessions that focus on: 
 Understanding perfectionism and looking at the costs and benefits 
of change 
 Examining common beliefs about perfectionism 
 Trying out different behaviours 
 Identifying and challenging unhelpful thinking styles 
 Reducing procrastination and increasing time management 
 Reducing self-criticism and increasing self-worth 
We will be examining whether this group treatment is effective in 
reducing unhelpful perfectionism and related symptoms such as 
anxiety, depression and eating concerns.  
 
If you are interested in participating and would like more information 
please email Alicia Handley at alicia.handley@postgrad.curtin.edu.au 
or telephone Alicia at the Curtin University Psychology and Speech 
Clinic on (08) 9266 3436. There is no charge for you.  
 
This study has been approved by the Curtin University Human Research Ethics Committee 
(Approval Number HR75/2011). 
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APPENDIX C: 
 PARTICIPANT INFORMATION SHEET 
 
Information sheet  
Group cognitive behavioural therapy for clinical perfectionism 
 
Please keep this information sheet 
 
My name is Alicia Handley, and I am a PhD student at Curtin University. For my 
research, I am investigating the effectiveness of a group psychological treatment for 
clinical perfectionism. Studies have found that high levels of perfectionism can result 
in people experiencing symptoms of anxiety, depression and eating disorders. 
Treating perfectionism may help to decrease these symptoms. 
 
PURPOSE OF THIS RESEARCH 
The purpose of this research is to investigate if group treatment for clinical 
perfectionism is more effective in dealing with unhelpful perfectionism and other 
psychological symptoms than being on a waitlist.  If you wish to participate in this 
research you will be assigned to either a) receive the treatment for clinical 
perfectionism straight away, or b) wait for eight weeks and then receive the 
treatment. The treatment will involve coming to a 2-hour group session, once a week 
for 8 weeks. The sessions will be held at the Curtin University Psychology and 
Speech Clinic. 
 
YOUR PARTICIPATION IS VOLUNTARY 
Participation in this research is voluntary. If you do not wish to participate, you do 
not have to. If you choose to participate and then change your mind, you can 
withdraw from the research at any time without any negative consequences. If you 
withdraw, you can continue to have treatment at the Curtin University Psychology 
and Speech Clinic or you can be referred to another place for treatment. 
 
WHAT THE RESEARCH INVOLVES 
1)    If you would like to participate, please read and sign the consent forms and 
complete the attached questionnaire, and then send them back to the Curtin 
University Psychology and Speech Clinic in the envelope provided. 
 
2)   I will then telephone you. During this telephone call, I will ask you some 
questions to see if you are suitable to receive the perfectionism treatment. At this 
stage, you may be encouraged to seek a different treatment that will better meet 
your needs. I will give you the numbers of these other places. If you are suitable 
for the perfectionism treatment, I will invite you to have an interview with me at 
the Curtin University Psychology and Speech Clinic. 
 
3)   In the interview, you will fill in some questionnaires and then you will be asked 
some questions about your perfectionism and any other symptoms you may have.  
 
4)  After the interview, I will allocate you to either receive the perfectionism 
treatment straight away or wait eight weeks and then receive the treatment. The 
perfectionism treatment will involve coming to a 2-hour group session once a 
week for 8 weeks. The group will contain 9 other people with similar concerns to 
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you. In these sessions, myself and another psychologist will help you to work 
through a self-help book on clinical perfectionism.  
 
5)  After the group treatment has finished you will be invited to have another 
interview with me. At this interview you will fill in some questionnaires and then 
will be asked about your perfectionism and any other symptoms you have. You 
will be invited to have another one of these interviews three months after 
treatment, and then six months after treatment. 
 
 
OTHER THINGS TO KNOW ABOUT THIS RESEARCH 
Potential benefits of this research: Previous studies have found that treating 
clinical perfectionism can decrease unhelpful perfectionism, as well as anxiety, 
depression and eating concerns. Even so, this does not guarantee that you will 
benefit from this treatment. 
 
Potential risks of this research: It is possible that during the interview or group 
sessions, a question or discussion may lead you to feel slight discomfort or 
embarrassment. However, you are able to withdraw at any time from the study. In 
addition, you can always discuss any concerns with me on 9266 3436, my supervisor 
Dr. Sarah Egan on 9266 2367 or my other supervisor Associate Professor Clare Rees 
on 9266 3442. You will be given numbers of additional treatment places if needed.   
 
Medications: If you are currently taking anti-depressants, you will need to be stable 
on your medication for one month before taking part in this study. I also ask that you 
agree not to stop your current medication or change the type or dose of your 
medication until after your final interview six months after the group treatment.   
 
Other Psychological Treatments I ask that you do not have other forms of 
psychological treatment (e.g., go to sessions with another psychologist) from the 
time of your first interview for this study, until the final interview six months after 
the group treatment. If during this time, you feel distressed and feel that it is 
important for you to receive treatment straight away, you will be able to have six 
extra psychology sessions with a clinical psychologist trainee at the Curtin 
University Psychology and Speech Clinic. The clinical psychologist trainee 
delivering these six extra sessions will not be involved in the research project. 
Alternatively if you wish to have other psychological treatment, you are able to 
withdraw from the study. In this case you can still receive the perfectionism 
treatment or I can refer you for treatment elsewhere. 
 
Confidentiality: All information collected will remain confidential to those outside 
the study. The information will be stored for five years in a locked cupboard at the 
Curtin University Psychology and Speech Clinic. The data from each person will be 
given a three digit code before it is entered into the computer. If the study is 
published, you will not be identified. To ensure that myself and the other 
psychologist running the group are providing high quality treatment, all psychology 
sessions will be recorded on DVD, and small parts of these sessions will be viewed 
only by me, the other psychologist running the group, Dr. Sarah Egan, Associate 
Professor Clare Rees and Dr. Fiona Michel. These DVDs will be stored for 5 years 
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in a locked cupboard in the Curtin University Psychology and Speech Clinic and 
then will be destroyed. 
  
Further information: Please keep this information sheet. If you have any questions 
or would like more information, you can contact me at the Curtin University 
Psychology and Speech Clinic on (08) 9266 3436, or via email at 
alicia.handley@postgrad.curtin.edu.au Alternatively, you can contact my supervisor 
Associate Professor Clare Rees on (08) 9266 3442 or via email at 
c.rees@curtin.edu.au or my other supervisor Dr. Sarah Egan on (08) 9266 2367 or 
via email at s.egan@curtin.edu.au  
 
This study has been approved by the Curtin University Human Research Ethics 
Committee (Approval Number HR75/2011). The Committee is comprised of 
members of the public, academics, lawyers, doctors and pastoral carers. Its main 
role is to protect participants. If needed, verification of approval can be obtained 
either by writing to the Curtin University Human Research Ethics Committee, c/- 
Office of Research and Development, Curtin University, GPO Box U1987, Perth, 
6845, or by telephoning 9266 2784, or by emailing hrec@curtin.edu.au. 
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                              APPENDIX D:  
                 PARTICIPANT CONSENT FORM 
                                                      Consent form 
               Please return this page to the therapist 
 
I ____________________________________, 
 
have read the information sheet and voluntarily consent to participate in this 
research. 
 
 I understand that the purpose of this research is to trial a perfectionism treatment 
and that there is a chance I may not benefit from this treatment. 
 
 I understand that I will be randomly allocated to either receive the perfectionism 
treatment straight away or wait eight weeks and then receive the perfectionism 
treatment. 
 
 If I am currently on anti-depressants, I agree that I have been on a stable dose of 
this medication for the past month. I also agree that I will not stop my current anti-
depressants or change the type or dose of my anti-depressants from the time of my 
first interview with Alicia until my interview six months after the group treatment. 
 
 I agree that I will not have other forms of psychological treatment from the time of 
my first interview with Alicia until the final interview six months after the group 
treatment. I understand that during this time, if I am distressed and feel that it is 
important to receive treatment straight away, I will be able to have six extra 
psychology sessions with a clinical psychologist trainee at the Curtin University 
Psychology and Speech Clinic. The clinical psychologist trainee delivering these six 
extra sessions will not be involved in the research project. I also understand that if I 
want to have other psychological treatment during the study, I can withdraw from the 
study. 
 
 I understand that my personal information will remain confidential from people 
outside of the study.  I understand that it will be stored for 5 years in a locked 
cupboard in the Curtin University Psychology and Speech Clinic. I realise that if the 
research is published, I will not be identified. 
 
 I understand that each psychology session will be recorded on DVD and that these 
DVDs will be stored for five years in a locked cupboard in the Curtin University 
Psychology and Speech Clinic. 
 
 I understand that my participation in this research is voluntary, and that I can 
withdraw from this study at any time without negative consequences. I understand 
that if I withdraw from this study I can still receive treatment at the Curtin University 
Psychology and Speech Clinic, or I can be referred to another place for treatment. 
 
SIGNED_____________________________________ 
NAME  _____________________________________DATE  __________________ 
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                              APPENDIX E:  
PARTICIPANT VIDEO CONSENT FORM 
Curtin University of Technology 
School of Psychology 
Adult Psychology Clinic 
 
 
 
 
 
INFORMATION FOR THE CLIENT: 
 
1. All video tape recordings of any consultation are part of your confidential  
psychological record and as such are securely stored. 
 
2. Sessions are recorded for the purpose of supervising our clinic staff  
undertaking post-graduate training in clinical psychology.  
 
3. Supervision may be both on an individual basis or involve a group of  
trainees who may also view the tape. 
 
4. All staff are bound by the professional code of ethics 
 
5.   The video tape allows the consultant to gain feedback about their approach  
with the view to ensuring that the service you receive is of high standard 
 
       6.  The video recording is erased once the supervision process has been 
completed. The tape is  not intended as a permanent record. 
 
 
CLIENT CONSENT TO VIDEO TAPE CONSULTATIONS: 
 
I have read and understand the above information. 
I hereby consent to have video recordings made of my consultations, on the above 
conditions. 
 
________________________ 
Client name (in block letters) 
 
________________________________________ ______________ 
Client signature Date 
 
________________________________________ ______________ 
Clinical Psychology Trainee’s Signature                    Date 
 
 
 
 
 
 
VIDEO CONSENT FORM 
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APPENDIX F: 
 
PERFECTIONISM QUESTIONS ASKED IN ASSESSMENTS 
 
 
1) How does your perfectionism affect your day-to-day life?  
 
2) What are the types of situations in which it is really important for you to reach  
     your standards?  
 
3) What are the consequences if you feel you don’t reach your standards?  
 
4) Does it affect the way that you feel about yourself?  
 
5) Can you please give me a recent example in detail about a time where you set  
     standards for yourself, didn’t meet them and how you responded to this? 
     
    Adapted from Steele et al. (2013) 
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APPENDIX G: 
SESSION CHECKLIST TO ASSESS THERAPIST ADHERENCE TO 
SHAFRAN, EGAN, AND WADE’S (2010) TREATMENT PROTOCOL 
 
THERAPIST ADHERENCE ITEMS: SESSION 1 
 
Session 1: Understanding perfectionism, the first steps and the costs of changing 
 
Aims: 
 To welcome participants to the group and provide an overview of the 
program. 
 To provide psycho-education on perfectionism, the problems that co-occur 
with perfectionism, the causes of perfectionism and how it is maintained. 
 For participants to construct a diagram of what maintains their perfectionism 
 To explore the pros and cons of changing perfectionism. 
 
Session objectives Did 
not 
cover 
Partly 
covered 
 Completely     
       covered 
Welcome to the group 
 Therapists to welcome participants to 
group, go through housekeeping (toilets, 
session time and duration, maximum 
number of sessions missed). Therapists to 
engage group members in an ice-breaker 
activity. 
 
   
 
1       2       3       4       5       6       7 
Overview of the group program 
 Therapist to provide an overview of the 
group program (where treatment material is 
derived from, structure of group sessions, 
and participant contribution). Therapists to 
work with participants to develop group 
rules. 
 
    
 
 1       2       3       4       5       6       7 
Psycho-education about what perfectionism 
is 
 Therapist to define perfectionism by 
referring to three main features (setting 
demanding standards and self-criticism, 
striving even when there are negative 
consequences, self-worth being overly 
reliant on meeting standards in specific 
areas). 
 
     
 
 1       2       3       4       5       6       7 
Psycho-education about the problems that 
co-occur with perfectionism 
 Therapist to provide psycho-education 
about the problems that co-occur with 
    
 
 1       2       3       4       5       6       7 
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perfectionism. This includes the problems 
perfectionism causes in its own right, as 
well as anxiety disorders (social phobia, 
obsessive-compulsive disorder), obsessive-
compulsive personality disorder, 
depression and eating disorders. 
 
Psycho-education about the causes of 
perfectionism 
 Therapist to provide information about the 
causes of perfectionism and to highlight 
that successful treatment for perfectionism 
does not focus on the causes of 
perfectionism but focuses on what 
maintains it.  
 
    
 
1       2       3       4       5       6       7 
Psycho-education about the maintenance of 
perfectionism 
 Therapist to provide information about the 
maintenance cycle of perfectionism with 
reference to the following factors: self-
esteem, high standards and rigid rules, 
cognitive biases, performance-related 
behaviour, high likelihood of perceived 
failure and self-criticism, avoidance of 
meeting standards, temporarily attaining 
standards and discounting success. 
 
    
 
1       2       3       4       5       6       7 
Diagram about the maintenance of 
perfectionism  
 Therapist to read out the example of ‘John’ 
and participants to look at John’s diagram 
of perfectionism. Therapist to highlight that 
the goal of perfectionism treatment is not to 
eliminate striving for standards, but to 
reduce self-esteem being overly reliant on 
achievement and striving and to decrease 
self-criticism. Therapist to give an example 
of two musicians. 
 
     
 
1       2       3       4       5       6       7 
 Participants to start filling in their own 
diagram of how their perfectionism is 
maintained. 
    
1       2       3       4       5       6       7 
Pros and cons of changing perfectionism 
 Therapist to normalise feelings of 
uncertainty about changing perfectionism. 
Therapist to collaboratively explore with 
participants the pros and cons of changing 
perfectionism and not changing 
perfectionism. 
    
 
1       2       3       4       5       6       7 
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Assign homework 
 Therapist to assign homework, highlighting 
that there is no right or wrong way to do 
homework. 
 
    
1       2       3       4       5       6       7 
COMMENTS: 
 
 
 
 
 
 
 
Signature of rater:________________________________________           
 
Date:______________ 
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THERAPIST ADHERENCE ITEMS: SESSION 2 
 
Session 2:  Identifying problem areas and psycho-education 
 
Aims: 
 To identify problem areas of perfectionism 
 To introduce self-monitoring of perfectionism 
 To discuss common behaviours associated with perfectionism 
 To provide information about what is fact and what is fiction in regard to 
perfectionism. 
 
Session objectives 
 
 
Did 
not 
cover 
Partly 
covered 
 Completely     
       covered 
Homework review 
 Therapist to check in with clients about their 
homework. 
 
     
1       2       3       4       5       6       7 
 Identifying areas in life where perfectionism is 
a problem 
 Therapist to read out Box 7.1.1 Example areas 
of perfectionism and typical thoughts and 
behaviours. 
 
    
1       2       3       4       5       6       7 
 Participants to complete Worksheet 7.1.1 
Which areas of perfectionism apply to me?  
 
    
1       2       3       4       5       6       7 
 Self-monitoring of perfectionism 
 Therapist to introduce self-monitoring with a 
focus on why it is important to self-monitor 
perfectionism, tips for self-monitoring and 
overcoming obstacles to self-monitoring. 
 
    
 
1       2       3       4       5       6       7 
 Common behaviours related to perfectionism  
 Therapist to define and discuss behaviours 
commonly related to perfectionism 
(avoidance, procrastination, performance 
checking, and other counter-productive 
behaviours) and provide examples of these 
behaviours. 
 
    
 
1       2       3       4       5       6       7 
 Participants to be introduced to Worksheet 
7.1.3 Monitoring Record of Perfectionism 
Thoughts, Emotions and Behaviours. 
 
    
1       2       3       4       5       6       7 
 Provide information about fact versus fiction 
regarding perfectionism 
 Therapist to introduce fact versus fiction, 
emphasising the importance of discovering 
    
 
1       2       3       4       5       6       7 
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how much of one’s beliefs are fact and how 
much are fiction in regard to perfectionism. 
Therapist to read out ‘Bernie’ example. 
 
 Therapist to discuss the belief ‘the harder you 
work the better you will do’, including 
discussing the factors affecting achievement, 
and the U-shaped relationship between 
stress/arousal and performance (Yerkes-
Dodson Law, 1908). Therapist to read out 
‘Soo-Lee’ example. 
 
    
 
1       2       3       4       5       6       7 
 Therapist to briefly discuss nine statements to 
differentiate fact from fiction in regard to 
perfectionism. 
 
    
1       2       3       4       5       6       7 
 Assign homework 
 Therapist to assign homework. 
 
    
1       2       3       4       5       6       7 
COMMENTS: 
 
 
 
 
 
 
 
Signature of rater:________________________________________           
 
Date:______________ 
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THERAPIST ADHERENCE ITEMS: SESSION 3 
 
Session 3:  Behavioural surveys and behavioural experiments 
 
Aim 
 To provide awareness into the use of behavioural strategies for challenging 
perfectionism 
 
Session objectives 
 
 
Did 
not 
cover 
Partly 
covered 
Completely     
      covered 
Homework review 
 Therapist to check in with clients about their 
homework  
 
    
1       2       3       4       5       6       7 
Behavioural strategies for challenging 
perfectionism 
 Therapist to provide rationale for conducting 
surveys for perfectionism and define surveys 
for perfectionism. Therapist to read out 
example of ‘Hannah’  
 
     
 
1       2       3       4       5       6       7 
 Therapist to discuss overcoming obstacles to 
conducting a survey (i.e., social isolation and 
finding it hard to construct the survey). 
Therapist to emphasise that surveys for 
perfectionism usually entail asking how 
frequently one engages in a behaviour or the 
time spent on a task. Therapist to read out Box 
7.3.1 Examples of Survey Questions. 
 
     
 
1       2       3       4       5       6       7 
 Therapist to read out Box 7.3.2 What beliefs 
can be tested by surveys, whom to ask and 
what to ask them, to provide examples of the 
types of beliefs that can be tested and how to 
test them. 
 
     
 
1       2       3       4       5       6       7 
 Participants to look at Worksheet 7.1.1 Which 
areas of perfectionism apply to me? from 
previous week that focused on thoughts for a 
perfectionism area and derive survey 
questions to test these thoughts. 
 
     
1       2       3       4       5       6       7 
 Therapist to discuss how to interpret survey 
responses, with an emphasis on three 
outcomes: survey responses being a reality 
check, assisting to identify all or nothing 
thinking and providing a basis for behavioural 
experiments. 
     
 
1       2       3       4       5       6       7 
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 Therapist to introduce behavioural 
experiments, emphasising that the goal of a 
behavioural experiment is to test one’s belief 
about a specific action or behaviour. Therapist 
to provide examples of behavioural 
experiments. Therapist to describe the 
behavioural experiment ‘Jeff’ conducted. 
 
     
 
1       2       3       4       5       6       7 
 Therapist to briefly discuss how behavioural 
experiments can have different forms and then 
take participants through a completed example 
of a behavioural experiment in Box 7.4.1 An 
example of a behavioural experiment. 
 
     
 
1       2       3       4       5       6       7 
 Participants asked to devise their own 
behavioural experiment by working through 
the steps in Worksheet 7.4.1 Behavioural 
Experiment 
 
     
1       2       3       4       5       6       7 
Assign homework 
 Therapist to assign homework. 
 
    
1       2       3       4       5       6       7 
COMMENTS: 
 
 
 
 
 
 
 
 
Signature of rater:________________________________________           
 
Date:______________ 
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THERAPIST ADHERENCE ITEMS: SESSION 4 
 
Session 4:  From all or nothing thinking to flexibility and freedom 
 
Aim:  
 To investigate all or nothing thinking 
 
Session objectives 
 
Did 
not 
cover 
Partly 
covered 
Completely     
      covered 
Homework review 
 Therapist to check in with clients about their 
homework  
 
    
1       2       3       4       5       6       7 
Investigating all or nothing thinking 
 Therapist to introduce participants to ‘all or 
nothing thinking’ by defining it and describing 
how it maintains perfectionism.  Therapist to 
read out examples of all or nothing thinking 
from Box 7.5.1  
 
     
 
1       2       3       4       5       6       7 
 Therapist to read out Box 7.5.3 which details 
the behavioural experiment conducted by 
‘Tony’ to challenge his all or nothing thinking. 
 
     
1       2       3       4       5       6       7 
 Participants asked to fill in Worksheet 7.5.1 
Testing all or nothing beliefs with a 
behavioural experiment. 
 
     
1       2       3       4       5       6       7 
 Therapist to introduce participants to the 
continuum approach. This involves defining 
this approach and referring to the example of 
‘Ifioma’ to explain how to use the four-step 
procedure to challenge all or nothing thinking 
about work and eating.  
 
     
 
1       2       3       4       5       6       7 
 Participants asked to fill in Worksheet 7.5.2 
Testing all or nothing thinking with continuums 
 
     
1       2       3       4       5       6       7 
 Therapist to introduce participants to the idea of 
replacing rules with guidelines. This involves 
discussing how rigid rule setting is problematic, 
giving an example of a rule and a guideline, and 
asking participants to make their own list of 
rules for living. 
 
     
 
1       2       3       4       5       6       7 
 Therapist to discuss behavioural experiments 
aimed at doing things less than perfectly, with 
reference to ‘Maggie’ in Box 7.5.6. Therapist to 
     
 
1       2       3       4       5       6       7 
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discuss behavioural experiments aimed at 
reducing the amount of time spent on a task, 
with reference to ‘Suzie’ in Box 7.5.7 
 
 Therapist to discuss the idea of accepting less 
than perfect performance, with a description of 
‘Chloe’. 
 
     
1       2       3       4       5       6       7 
Assign homework 
 Therapist to assign homework. 
 
     
1       2       3       4       5       6       7 
COMMENTS: 
 
 
 
 
 
 
 
 
Signature of rater:________________________________________           
 
Date:______________ 
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THERAPIST ADHERENCE ITEMS: SESSION 5 
 
Session 5:  Learning to notice the positive and changing thinking styles 
 
Aim  
 To challenge the cognitive distortions that commonly occur in perfectionism 
 
Session objectives 
 
Did 
not 
cover 
Partly 
covered 
Completely     
      covered 
Homework review 
 Therapist to check in with clients about their 
homework  
 
     
1       2       3       4       5       6       7 
Focussing on the negative aspects of performance 
 Therapist to introduce the cognitive distortion 
‘noticing the negative aspects of performance’, 
by describing it and discussing ‘Aimee’. 
 
    
 
1       2       3       4       5       6       7 
 Therapist to read out Box 7.6.1 Examples of 
‘noticing the negative’ in different areas of 
perfectionism. 
 
    
1       2       3       4       5       6       7 
 Therapist to read through Box 7.6.2: Aimee’s 
worksheet: noticing the negative and broadening 
attention. Participants asked to fill in Worksheet 
7.6.1 Noticing the negative and broadening 
aspects of attention. Therapist to highlight the 
importance of participants broadening attention 
at the time they notice negative thoughts. 
 
    
 
1       2       3       4       5       6       7 
Discounting the positive 
 Therapist to describe the cognitive distortion 
‘discounting the positive’. Therapist to introduce 
participants to the strategy of completing a diary 
in which they record positive aspects of 
performance and the absence of negative aspects 
of performance, which participants will complete 
for homework. 
 
     
 
1       2       3       4       5       6       7 
 Therapist to discuss the impact of thoughts on 
feelings and behaviour. Therapist to discuss three 
other cognitive distortions associated with 
perfectionism: double-standards, over-
generalising and should statements.  
 
     
 
1       2       3       4       5       6       7 
 Therapist to briefly describe six other cognitive 
distortions: catastrophising, emotional reasoning, 
labelling, personalisation, mind-reading and 
     
1       2       3       4       5       6       7 
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predictive thinking. 
 
 Therapist to define ‘cognitive restructuring’ and 
define ‘thoughts’ and ‘feelings’. Therapist to 
briefly describe thought diaries as a technique to 
challenge unhelpful thoughts and construct 
rational thoughts. Therapist to go through Boxes 
7.7.3 and 7.7.4, which describe the five steps of a 
thought diary and detail how ‘Aimee’ completed 
a thought diary.  
 
     
 
1       2       3       4       5       6       7 
 Therapist and group members to assist a 
volunteer from the group to challenge his/her 
thoughts on the whiteboard  using the five steps 
of the thought diary. Therapist to highlight how 
completing a thought diary can be hard at first 
but becomes easier with practice. 
 
     
 
1       2       3       4       5       6       7 
 Assign homework 
 Therapist to assign homework. 
 
     
1       2       3       4       5       6       7 
COMMENTS: 
 
 
 
 
 
 
 
 
 
 
 
Signature of rater:________________________________________           
 
Date:______________ 
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THERAPIST ADHERENCE ITEMS: SESSION 6 
 
Session 6:  Procrastination, problem-solving, time management, pleasant events 
and putting it all together 
Aims: 
 To highlight the relationship between procrastination and perfectionism and 
provide strategies to reduce procrastination.  
 To develop problem solving strategies 
 To develop time management strategies 
 To explore the importance of pleasant events. 
 
Session objectives 
 
Did 
not 
cover 
Partly 
covered 
Completely     
      covered 
Homework review 
 Therapist to check in with clients about their 
homework  
 
     
1       2       3       4       5       6       7 
Procrastination  
 Therapist to define procrastination and ask 
participants to complete Worksheet 7.8.1 In 
which areas of my life do I procrastinate in?  
 
     
 
1       2       3       4       5       6       7 
 Therapist to read through Box 7.8.1 Rob’s self-
monitoring of procrastination to explain how to 
self-monitor procrastination. 
 
     
1       2       3       4       5       6       7 
 Therapist to discuss the maintenance cycle of 
procrastination and perfectionism with reference 
to how procrastination enhances one’s belief in 
perfectionist predictions and how procrastination 
maintains self-evaluation being excessively 
reliant on achievement. Therapist to briefly 
introduce the idea of considering the costs and 
benefits of procrastination, with an example of 
procrastination and its impact on anxiety. 
 
     
 
1       2       3       4       5       6       7 
Strategies to reduce procrastination 
 Therapist to discuss thought diaries and 
behavioural experiments as strategies for 
procrastination. Therapist to read out Box 7.8.4 
Gemma’s thought diary to challenge 
procrastination. Therapist and group members to 
help a volunteer from the group use the thought 
diary steps to challenge thoughts on the 
whiteboard. Therapist to read out Box 7.8.3 
Gemma’s behavioural experiment to overcome 
procrastination. Therapist and group members to 
help the volunteer devise a behavioural 
    
 
 
 
1       2       3       4       5       6       7 
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experiment to reduce procrastination. 
 
 Therapist to discuss coping statements and 
flashcards, the ‘just do it’ approach and the 
strategy of changing one’s image of coping. 
 
     
1       2       3       4       5       6       7 
Additional strategies for procrastination and 
problem-solving. 
 Therapist to discuss dividing tasks into a series of 
manageable chunks, the strategy of ‘action 
comes before motivation’ and using a problem-
solving approach to reduce procrastination. 
Therapist to read out Box 7.8.8 Problem-solving: 
the example of Aimee to explain the six steps of 
the problem-solving approach. 
 
     
1       2       3       4       5       6       7 
Time management strategies 
 Therapist to discuss time management schedules 
with reference to ‘Aimee’. Participants asked to 
construct a time-management schedule using 
Worksheet 7.8.11 Time management schedule. 
 
     
 
1       2       3       4       5       6       7 
Pleasant event scheduling 
 Therapist to discuss pleasant event scheduling. 
Participants to look at Worksheet 7.8.12 List of 
pleasant events and activities and asked to 
schedule in one pleasant activity to complete this 
week. Therapist to briefly discuss how all of the 
strategies covered in the perfectionism sessions 
can be employed to better determine one’s 
reality. 
 
     
 
 
1       2       3       4       5       6       7 
Assign homework 
 Therapist to assign homework. 
 
     
1       2       3       4       5       6       7 
COMMENTS: 
 
 
 
 
 
 
 
Signature of rater:________________________________________           
 
Date:______________ 
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THERAPIST ADHERENCE ITEMS: SESSION 7 
 
Session 7:  Self-criticism and compassion 
Aim: 
 To provide strategies to reduce self-criticism and increase self-compassion. 
 
Session objectives 
 
Did 
not 
cover 
Partly 
covered 
Completely 
covered    
      covered 
 Homework review 
 Therapist to check in with clients about their 
homework  
 
 
1       2       3       4       5       6       7 
Self-criticism and strategies to reduce it 
 Therapist to define self-criticism and state why it 
can be destructive. Participants asked to read Box 
8.1 Am I self-critical? Therapist to provide a 
brief explanation as to the potential reasons why 
individuals are self-critical. 
 
 
 
1       2       3       4       5       6       7 
 Therapist to read out Box 8.2 Which coach would 
you choose? Therapist to discuss the negative 
effects of self-criticism and question participants 
as to which coach they would prefer. Therapist to 
highlight that the goal is not to eliminate self-
criticism but to reduce self-criticism and increase 
self-compassion. 
 
 
 
1       2       3       4       5       6       7 
 Therapist to introduce participants to the first of 
three steps to reduce self-criticism: ‘Identifying 
the critical voice’. Therapist to explain 
Worksheet 8.1 Diary to help identify the self-
critical thoughts and refer to example ‘Gemma’. 
Participants to start Worksheet 8.1 and finish the 
rest for homework. 
 
 
 
1       2       3       4       5       6       7 
 Therapist to introduce the second step for 
reducing self-criticism: ‘Identifying the 
compassionate voice’. Participants to look at 
Worksheet 8.2 What values are important to you 
in your friendships? and encouraged to 
brainstorm more factors. Therapist to ask 
participants whether they apply any of the above 
values to themselves. Participants to complete 
Worksheet 8.3 What values do you apply to 
yourself? 
 
 
 
1       2       3       4       5       6       7 
 Therapist to explain Worksheet 8.4 Diary to help 
identify the compassionate thoughts. Participants 
asked to start Worksheet 8.4. 
 
1       2       3       4       5       6       7 
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 Therapist to introduce the third step for reducing 
self-criticism: ‘How to react to the critical voice 
when it starts speaking’. Therapist to discuss the 
first of two strategies for reacting to the critical 
voice: writing compassionate voice responses on 
index cards. Participants to look at examples of 
compassionate voice responses on page 233. 
 
 
 
1       2       3       4       5       6       7 
 Therapist to discuss the second of two strategies 
for reacting to the critical voice: the acceptance 
technique. 
 
 
1       2       3       4       5       6       7 
 Therapist to highlight that at some points in life 
the self-critical voice may become louder at 
times and briefly discuss how to handle this. 
 
 
1       2       3       4       5       6       7 
Assign homework 
 Therapist to assign homework. 
 
 
1       2       3       4       5       6       7 
COMMENTS: 
 
 
 
 
 
Signature of rater:________________________________________           
 
Date:______________ 
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THERAPIST ADHERENCE ITEMS: SESSION 8 
 
Session 8:  Self-evaluation and freedom 
 
Aims: 
 To weaken the link between participants’ self-evaluation and their achievements, 
and assist in developing new ways to evaluate themselves. 
 To assist participants in planning ahead, including setting goals, developing 
action plans and developing strategies to manage setbacks. 
 
Session objectives 
 
Did 
not 
cover 
Partly 
covered 
Completely     
      covered 
 Homework review 
 Therapist to check in with clients about their 
homework  
 
 
1       2       3       4       5       6       7 
Weakening the link between self-evaluation and 
achievement 
 Therapist to discuss how in clinical 
perfectionism, self-worth is excessively reliant 
on meeting standards in specific areas. Therapist 
to discuss the multiple disadvantages of this 
with tips on how to weaken this link. 
 
 
 
 
1       2       3       4       5       6       7 
 Therapist to introduce participants to the idea of 
hot spots for self-evaluation, which are life areas 
that make one feel very good/very bad when 
they are going well/poorly. Therapist to refer 
participants to Box 9.1 Stephen’s diary to help 
identify the areas of life he uses to evaluate 
himself. Therapist to highlight that Stephen has 
discounted certain areas of his life and only two 
areas greatly influence his self-evaluation. 
 
 
 
 
1       2       3       4       5       6       7 
 Therapist to explain Worksheet 9.1 Diary to 
help identify the areas of your life that you 
currently use to evaluate yourself. Participants 
to complete worksheet with one or two 
examples and devise an if-then statement 
relating achievement in specific areas to self-
evaluation. 
 
 
 
1       2       3       4       5       6       7 
Developing new ways of self-evaluation 
(independent from achievement), including goal 
setting. 
 Therapist to encourage participants to reflect on 
times in their life congruent with the perspective 
‘even when I don’t achieve the standards I set 
 
 
 
 
1       2       3       4       5       6       7 
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myself, it doesn’t make me any less worthwhile 
as a person’ and consider what makes them 
worthwhile apart from meeting their standards. 
Therapist to discuss the setting of flexible and 
realistic goals using ‘Stephen’ as an example. 
 
 Participants to look at Worksheet 9.3 Expanding 
my self-evaluation across different life areas and 
asked to select four life areas different to those 
previously selected at the start of the course. 
Participants to start making short-term goals in 
two of these new areas using Worksheet 9.4 
Goals to work on for the next six months that 
will expand the areas of my life that contribute 
to my self-worth.  
 
 
 
1       2       3       4       5       6       7 
 Therapist to encourage participants to retrain 
their attention to focus on what they have 
achieved using the daily log of achievements. 
Therapists to refer to Box 9.3 Stephen’s daily 
log of achievements as an example. 
 
 
 
1       2       3       4       5       6       7 
Developing an action plan 
 Therapist to highlight that the amount of change 
experienced differs with different people and 
emphasise that small changes are important. 
Participants encouraged to see treatment as part 
of an ongoing process. Participants encouraged 
to re-visit the book and exercises in their own 
time and write short summaries of helpful 
strategies. Therapist to emphasise the 
importance of having realistic and 
compassionate expectations. 
 
 
 
 
 
1       2       3       4       5       6       7 
Dealing with setbacks/relapse prevention 
 Therapist to discuss how to deal with potential 
set-backs so as to prevent relapses. 
 
 
1       2       3       4       5       6       7 
Assign homework 
 Therapist to assign homework for participants to 
do in their own time. 
 
 
1       2       3       4       5       6       7 
COMMENTS: 
 
 
 
Signature of rater:________________________________________           
 
Date:______________ 
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APPENDIX H: 
MEASURE ASSESSING ADHERENCE TO RESTRICTIONS OF 
MEDICATION CHANGE AND EXTERNAL PSYCHOTHERAPY 
 
Are you currently receiving any form of treatment for your perfectionism? (apart from 
participating in this group treatment for clinical perfectionism) 
 Yes 
 No 
IF YES, what type of treatment are you receiving (e.g., psychological intervention, medication, other)? 
 For how long have you been receiving this treatment? 
_______________________________________________________________________________________
_____________________________________________________________________________________ 
Has there been another time over the past 8 weeks where you have received any form 
of treatment for your perfectionism? (apart from participating in this group treatment 
for clinical perfectionism) 
 
 Yes 
 No 
IF YES, what type of treatment did you receive (e.g., psychological intervention, medication, other)?  
For how long did you receive this treatment? 
_______________________________________________________________________________________
_____________________________________________________________________________________       
                                                                  
Are you currently receiving any form of treatment for your anxiety/depression/eating 
concerns or other concerns? (apart from participating in this group treatment for 
clinical perfectionism) 
 Yes 
 No 
 Yes 
 No 
IF YES, what type of treatment did you receive (e.g., psychological intervention, medication, other)?  
For how long did you receive this treatment? 
________________________________________________________________________________________
___________________________________________________________________________________                                                                                
Has there been another time over the past 8 weeks where you have received any form 
of treatment for your anxiety/depression/eating concerns or other concerns? (apart 
from participating in this group treatment for clinical perfectionism) 
 Yes 
 No  
 
IF YES, what type of treatment did you receive (e.g., psychological intervention, medication, other)? 
For how long did you receive this treatment? 
________________________________________________________________________________________
___________________________________________________________________________________                                                                                
Is there anything else that you think is important for me to know? 
 
 Yes 
 No  
IF YES please record below: 
________________________________________________________________________________________
______________________________________________________________________________________ 
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APPENDIX I: 
MEASURE ASSESSING REVISION OF TREATMENT OVER 
FOLLOW-UP PERIODS 
 
IF YES what sections were read? How much time was spent reading them? 
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________
___________________________________________________________________ 
 
IF YES, what worksheets were reviewed? How much time was spent reviewing 
them? What exercises were practiced? How much time was spent practicing them? 
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________ 
 
IF YES, please list the strategies that you have used: 
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________ 
IF YES, which strategies did you find the most useful during the past 3 months? 
Please order these strategies below, with 1 = most useful strategy, 2 = second most 
useful strategy etc. 
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________ 
 
Over the past 3 months, have you read any sections of the readings? 
 
 Yes 
 
 No 
Over the past 3 months, have you reviewed any of the worksheets or 
practiced any of the exercises? 
 
 Yes 
 
 No 
Over the past 3 months, have you used any of the strategies that you 
learnt in the perfectionism group? 
 
 Yes 
 
 No 
